{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1182.399","meta":{"versionId":"12","lastUpdated":"2020-06-23T01:00:22.000-04:00"},"text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \u003ch2\u003eElective Procedure\u003c/h2\u003e\n      \u003cp\u003eThis value set includes codes from the following code systems:\u003c/p\u003e\n      \u003cul\u003e\n        \u003cli\u003eInclude these codes as defined in \n          \u003ccode\u003ehttp://www.nlm.nih.gov/research/umls/hcpcs\u003c/code\u003e\n          \u003ctable class\u003d\"none\"\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e\n                \u003cb\u003eCode\u003c/b\u003e\n              \u003c/td\u003e\n              \u003ctd\u003e\n                \u003cb\u003eDisplay\u003c/b\u003e\n              \u003c/td\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0001M\u003c/td\u003e\n              \u003ctd\u003eInfectious disease, hcv, six biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0001U\u003c/td\u003e\n              \u003ctd\u003eRed blood cell typing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0002M\u003c/td\u003e\n              \u003ctd\u003eLiver disease, ten biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, haptoglobin, ast, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and alcoholic steatohepatitis (ash)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0003M\u003c/td\u003e\n              \u003ctd\u003eLiver disease, ten biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, haptoglobin, ast, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and nonalcoholic steatohepatitis (nash)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0003U\u003c/td\u003e\n              \u003ctd\u003eMeasurement of proteins associated with ovarian cancer in serum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0004M\u003c/td\u003e\n              \u003ctd\u003eScoliosis, dna analysis of 53 single nucleotide polymorphisms (snps), using saliva, prognostic algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0004U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with antibiotic resistance in bacterial culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0005U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with prostate cancer in urine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0006M\u003c/td\u003e\n              \u003ctd\u003eOncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0007M\u003c/td\u003e\n              \u003ctd\u003eOncology (gastrointestinal neuroendocrine tumors), real-time pcr expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0008M\u003c/td\u003e\n              \u003ctd\u003eOncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0008U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting Helicobacter pylori genes associated with antibiotic resistance in tissue sample\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0009M\u003c/td\u003e\n              \u003ctd\u003eFetal aneuploidy (trisomy 21, and 18) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0009U\u003c/td\u003e\n              \u003ctd\u003eGene analysis of breast tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0010M\u003c/td\u003e\n              \u003ctd\u003eOncology (high-grade prostate cancer), biochemical assay of four proteins (total psa, free psa, intact psa and human kallidrein 2 (hk2)) plus patient age, digital rectal examination status, and no history of positive prostate biopsy, utilizing plasma, prognostic algorithm reported as a probability score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0010U\u003c/td\u003e\n              \u003ctd\u003eTyping of bacterial strain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0011M\u003c/td\u003e\n              \u003ctd\u003eOncology, prostate cancer, mrna expression assay of 12 genes (10 content and 2 housekeeping), rt-pcr test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0012M\u003c/td\u003e\n              \u003ctd\u003eOncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0012U\u003c/td\u003e\n              \u003ctd\u003eGene analysis for germline disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0013M\u003c/td\u003e\n              \u003ctd\u003eOncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0013U\u003c/td\u003e\n              \u003ctd\u003eGene analysis of solid organ tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0014U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0015U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with drug metabolism in blood or cheek swab\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0016U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0017U\u003c/td\u003e\n              \u003ctd\u003eTest for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0018U\u003c/td\u003e\n              \u003ctd\u003eMicroRNA gene analysis of thyroid nodule tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0019U\u003c/td\u003e\n              \u003ctd\u003eRNA gene analysis of tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0021U\u003c/td\u003e\n              \u003ctd\u003eDetection of 8 autoantibodies in prostate tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0022U\u003c/td\u003e\n              \u003ctd\u003eDNA and RNA gene analysis for non-small cell lung cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0023U\u003c/td\u003e\n              \u003ctd\u003eDNA gene analysis for acute myelogenous leukemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0026U\u003c/td\u003e\n              \u003ctd\u003eDNA and microRNA gene analysis of thyroid nodule tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0027U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Janus kinase 2) of targeted sequence exons 12-15\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0028U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) for copy number variants and common variants with follow-up targeted sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0029U\u003c/td\u003e\n              \u003ctd\u003eGene analysis of targeted sequences for adverse drug reactions and drug response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0030U\u003c/td\u003e\n              \u003ctd\u003eGene analysis of targeted sequences for warfarin drug response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0031U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450 family 1, subfamily A, member 2) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0032U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (catechol-O-methyltransferase) for c.472G\u0026gt;A (rs4680) variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0033U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (5-hydroxytryptamine receptor 2A) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0034U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (thiopurine S-methyltransferase) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0035U\u003c/td\u003e\n              \u003ctd\u003eTesting for presence of prion protein in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0036U\u003c/td\u003e\n              \u003ctd\u003eExome gene analysis for somatic mutation in tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0037U\u003c/td\u003e\n              \u003ctd\u003eDNA gene analysis of 324 genes in solid organ tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0040U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (t(9;22)) for translocation analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0041U\u003c/td\u003e\n              \u003ctd\u003eIgM antibody detection test for Borrelia burgdorferi\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0042U\u003c/td\u003e\n              \u003ctd\u003eIgG antibody detection test for Borrelia burgdorferi\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0043U\u003c/td\u003e\n              \u003ctd\u003eIgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0044U\u003c/td\u003e\n              \u003ctd\u003eIgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0045U\u003c/td\u003e\n              \u003ctd\u003emRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0046U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fms-related tyrosine kinase 3) for internal tandem duplication variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0047U\u003c/td\u003e\n              \u003ctd\u003emRNA gene analysis of 17 genes in prostate tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0048U\u003c/td\u003e\n              \u003ctd\u003eDNA gene analysis of 468 genes in solid organ tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0049U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (nucleophosmin)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0050U\u003c/td\u003e\n              \u003ctd\u003eDNA gene analysis of targeted sequences in 194 genes for acute myelogenous leukemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0053U\u003c/td\u003e\n              \u003ctd\u003eFISH analysis of 4 genes in prostate needle biopsy specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0054T\u003c/td\u003e\n              \u003ctd\u003eComputer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0055T\u003c/td\u003e\n              \u003ctd\u003eMusculoskeletal surgical navigational orthopedic operation using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0055U\u003c/td\u003e\n              \u003ctd\u003eDNA gene analysis of 96 target sequences in plasma for heart transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0056U\u003c/td\u003e\n              \u003ctd\u003eWhole genome sequencing in blood or bone marrow for acute myelogenous leukemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0057U\u003c/td\u003e\n              \u003ctd\u003emRNA gene analysis of 51 genes in solid organ tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0060U\u003c/td\u003e\n              \u003ctd\u003eGene analysis for identical twins in maternal blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0062U\u003c/td\u003e\n              \u003ctd\u003eIgG and IgM analysis of 80 biomarkers of systemic lupus erythematosus in serum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0063U\u003c/td\u003e\n              \u003ctd\u003eTesting for amines associated with autism spectrum disorder in plasma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0067U\u003c/td\u003e\n              \u003ctd\u003eProtein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0068U\u003c/td\u003e\n              \u003ctd\u003eDetection of Candida species by amplified probe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0069U\u003c/td\u003e\n              \u003ctd\u003emRNA expression profiling of miR-31-3 in colon tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0070U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) for common and select rare variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0071U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0072U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D7 hybrid gene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0073T\u003c/td\u003e\n              \u003ctd\u003eCompensator-based beam modulation radiation treatment delivery per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0073U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D6 hybrid gene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0074U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for non-duplicated gene when duplication/multiplication is trans\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0075U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 5 gene duplication/multiplication\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0076U\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 3 gene duplication/multiplication\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0078U\u003c/td\u003e\n              \u003ctd\u003eGene analysis of 16 genes to evaluate risk of opioid-use disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0079U\u003c/td\u003e\n              \u003ctd\u003eDNA analysis of urine and cheek swabs for specimen identity verification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0080U\u003c/td\u003e\n              \u003ctd\u003eAnalysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130 in plasma, with clinical risk factors, to evaluate probability of lung cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0081U\u003c/td\u003e\n              \u003ctd\u003eOncology (uveal melanoma), mrna, gene-expression profiling by real-time rt-pcr of 15 genes (12 content and 3 housekeeping genes), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0083U\u003c/td\u003e\n              \u003ctd\u003eEvaluation of response to chemotherapy drugs using motility contrast tomography of fresh or frozen tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0092T\u003c/td\u003e\n              \u003ctd\u003eInsertion of upper spine artificial disc with decompression of nerve roots\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0123T\u003c/td\u003e\n              \u003ctd\u003eSurgical creation of drainage tract to relieve increased eye pressure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0178T\u003c/td\u003e\n              \u003ctd\u003eElectrocardiogram (ECG) 64 leads or greater with graphic presentation, analysis interpretation, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0179T\u003c/td\u003e\n              \u003ctd\u003eTracing of electrocardiogram (ECG) 64 leads or greater with graphic presentation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0180T\u003c/td\u003e\n              \u003ctd\u003eInterpretation and report of electrocardiogram (ECG) 64 leads or greater with graphic presentation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0182T\u003c/td\u003e\n              \u003ctd\u003eHigh dose rate electronic brachytherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0188T\u003c/td\u003e\n              \u003ctd\u003eRemote real-time interactive video-conferenced critical care, 30-74 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0189T\u003c/td\u003e\n              \u003ctd\u003eRemote real-time interactive video-conferenced critical care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0191T\u003c/td\u003e\n              \u003ctd\u003eInternal insertion of eye fluid drainage device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0197T\u003c/td\u003e\n              \u003ctd\u003eLocalization and tracking of target or patient motion during radiation therapy delivery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0206T\u003c/td\u003e\n              \u003ctd\u003eRemote analysis of ECG-derived data with computer assessment and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0223T\u003c/td\u003e\n              \u003ctd\u003eAcoustic ECG analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0224T\u003c/td\u003e\n              \u003ctd\u003eAcoustic multiple interval ECG analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0226T\u003c/td\u003e\n              \u003ctd\u003eDiagnostic anal examination using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0227T\u003c/td\u003e\n              \u003ctd\u003eExamination and biopsy of anus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0253T\u003c/td\u003e\n              \u003ctd\u003eInsertion of eye fluid drainage device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0286T\u003c/td\u003e\n              \u003ctd\u003eNear-infrared spectroscopy studies of wounds of legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0287T\u003c/td\u003e\n              \u003ctd\u003eNear-infrared guidance to assess patency of potential vascular access sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0289T\u003c/td\u003e\n              \u003ctd\u003eCorneal incisions in the donor cornea created using a laser in preparation for penetrating or lamellar keratoplasty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0290T\u003c/td\u003e\n              \u003ctd\u003eCorneal incisions in the recipient cornea created using a laser in preparation for penetrating or lamellar keratoplasty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0293T\u003c/td\u003e\n              \u003ctd\u003eInsertion of left upper heart monitor with communication module and pressure sensor, with radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0294T\u003c/td\u003e\n              \u003ctd\u003eInsertion of left upper heart monitor and pacing defibrillator pulse generator, with radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0295T\u003c/td\u003e\n              \u003ctd\u003eExternal EKG recording for more than 48 hours up to 21 days with analysis, report, review and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0296T\u003c/td\u003e\n              \u003ctd\u003eExternal EKG recording for more than 48 hours up to 21 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0297T\u003c/td\u003e\n              \u003ctd\u003eAnalysis and report of external EKG recording for more than 48 hours up to 21 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0301T\u003c/td\u003e\n              \u003ctd\u003eDestruction or reduction of malignant breast tumor with externally applied microwave therapy, including placement of catheter and monitoring probe under ultrasound heat guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0308T\u003c/td\u003e\n              \u003ctd\u003eInsertion of prosthetic telescope in eye for the treatment of central vision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0312T\u003c/td\u003e\n              \u003ctd\u003eImplantation of neurostimulator electrodes and pulse generator for vagus nerve blocking therapy for obesity using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0313T\u003c/td\u003e\n              \u003ctd\u003eRevision or replacement of neurostimulator electrodes for vagus nerve blocking therapy for obesity using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0314T\u003c/td\u003e\n              \u003ctd\u003eRemoval of neurostimulator electrodes and pulse generator for vagus nerve blocking therapy for obesity using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0315T\u003c/td\u003e\n              \u003ctd\u003eRemoval of pulse generator for vagus nerve blocking therapy for treatment of obesity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0316T\u003c/td\u003e\n              \u003ctd\u003eReplacement of pulse generator for vagus nerve blocking therapy for treatment of obesity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0319T\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of electrode and defibrillator generator implantable beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0320T\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrode beneath the skin for defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0321T\u003c/td\u003e\n              \u003ctd\u003eInsertion of defibrillator generator implantable beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0322T\u003c/td\u003e\n              \u003ctd\u003eRemoval of defibrillator device accessed beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0323T\u003c/td\u003e\n              \u003ctd\u003eReplacement of defibrillator device accessed beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0324T\u003c/td\u003e\n              \u003ctd\u003eRemoval of electrode of defibrillator device accessed beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0331T\u003c/td\u003e\n              \u003ctd\u003eImaging of heart muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0332T\u003c/td\u003e\n              \u003ctd\u003eImaging of heart muscle with SPECT\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0347T\u003c/td\u003e\n              \u003ctd\u003eInsertion of devices in bone for visualization and measurement using radiostereometric analysis (RSA)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0348T\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine with radiostereometric analysis (RSA)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0349T\u003c/td\u003e\n              \u003ctd\u003eX-ray of arms with radiostereometric analysis (RSA)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0358T\u003c/td\u003e\n              \u003ctd\u003eWhole body composition tissue and fluid measurements with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0359T\u003c/td\u003e\n              \u003ctd\u003eBehavior identification assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0360T\u003c/td\u003e\n              \u003ctd\u003eObservational behavioral follow-up assessment first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0361T\u003c/td\u003e\n              \u003ctd\u003eObservational behavioral follow-up assessment additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0362T\u003c/td\u003e\n              \u003ctd\u003eBehavior identification supporting assessment for patient exhibiting destructive behavior, each 15 minutes of technicians\u0027 face-to-face time\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0363T\u003c/td\u003e\n              \u003ctd\u003eExposure behavioral follow-up assessment each additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0364T\u003c/td\u003e\n              \u003ctd\u003eBehavior treatment by protocol administered by technician first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0365T\u003c/td\u003e\n              \u003ctd\u003eBehavior treatment by protocol administered by technician each additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0366T\u003c/td\u003e\n              \u003ctd\u003eGroup behavior treatment by protocol administered by technician first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0367T\u003c/td\u003e\n              \u003ctd\u003eGroup behavior treatment by protocol administered by technician each additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0368T\u003c/td\u003e\n              \u003ctd\u003eBehavior treatment with protocol modification administered by physician or other qualified health care professional first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0369T\u003c/td\u003e\n              \u003ctd\u003eBehavior treatment with protocol modification administered by physician or other qualified health care professional each additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0370T\u003c/td\u003e\n              \u003ctd\u003eFamily behavior treatment guidance administered by physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0371T\u003c/td\u003e\n              \u003ctd\u003eMultiple-family group behavior treatment guidance administered by physician or other qualified health care professional\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0372T\u003c/td\u003e\n              \u003ctd\u003eBehavior treatment social skills group administered by physician or other qualified health care professional\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0373T\u003c/td\u003e\n              \u003ctd\u003eAdaptive behavior treatment with protocol modification for patient exhibiting destructive behavior, each 15 minutes of technicians\u0027 face-to-face time\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0375T\u003c/td\u003e\n              \u003ctd\u003eInsertion of artificial upper spine discs anterior approach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0387T\u003c/td\u003e\n              \u003ctd\u003eTranscatheter insertion or replacement of permanent leadless pacemaker, ventricular\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0388T\u003c/td\u003e\n              \u003ctd\u003eTranscatheter removal of permanent leadless pacemaker, ventricular\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0389T\u003c/td\u003e\n              \u003ctd\u003eProgramming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report, leadless pacemaker system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0390T\u003c/td\u003e\n              \u003ctd\u003ePeri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure or test with analysis, review and report, leadless pacemaker system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0394T\u003c/td\u003e\n              \u003ctd\u003eHigh dose rate electronic brachytherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0395T\u003c/td\u003e\n              \u003ctd\u003eHigh dose rate electronic brachytherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0396T\u003c/td\u003e\n              \u003ctd\u003eIntra-operative use of kinetic balance sensor for joint implant stability during knee replacement surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0408T\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of pulse generator and electrodes of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0409T\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of pulse generator of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0410T\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of electrodes in upper chamber of heart for heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0411T\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of electrodes in lower chamber of heart for heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0412T\u003c/td\u003e\n              \u003ctd\u003eRemoval of pulse generator for heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0413T\u003c/td\u003e\n              \u003ctd\u003eRemoval of electrode for heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0414T\u003c/td\u003e\n              \u003ctd\u003eReplacement of pulse generator of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0415T\u003c/td\u003e\n              \u003ctd\u003eRepositioning of electrode of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0417T\u003c/td\u003e\n              \u003ctd\u003eProgramming evaluation of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0418T\u003c/td\u003e\n              \u003ctd\u003eInterrogation evaluation of heart contractility modulator system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0422T\u003c/td\u003e\n              \u003ctd\u003eTactile imaging of one or both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0438T\u003c/td\u003e\n              \u003ctd\u003eInjection of biodegradable material adjacent to prostate, accessed by perineal region using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0449T\u003c/td\u003e\n              \u003ctd\u003eInsertion of aqueous fluid drainage device into eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0450T\u003c/td\u003e\n              \u003ctd\u003eInsertion of aqueous fluid drainage device into eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0479T\u003c/td\u003e\n              \u003ctd\u003eLaser destruction of scar tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0480T\u003c/td\u003e\n              \u003ctd\u003eLaser destruction of scar tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0482T\u003c/td\u003e\n              \u003ctd\u003eMeasurement of blood flow in heart muscle at rest and under stress\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0494T\u003c/td\u003e\n              \u003ctd\u003ePreparation and storage of donor lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0495T\u003c/td\u003e\n              \u003ctd\u003eInitiation and monitoring of circulation in donor lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0497T\u003c/td\u003e\n              \u003ctd\u003eConnection of external patient-activated EKG event recorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0498T\u003c/td\u003e\n              \u003ctd\u003eReview and interpretation of external patient-activated EKG event recordings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0500T\u003c/td\u003e\n              \u003ctd\u003eInfectious agent detection by nucleic acid (DNA or RNA); human papillomavirus (HPV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0515T\u003c/td\u003e\n              \u003ctd\u003eInsertion of complete wireless heart stimulator system for pacing of lower left chamber of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0516T\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrode of wireless heart stimulator system for pacing of lower left chamber of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0517T\u003c/td\u003e\n              \u003ctd\u003eInsertion of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0518T\u003c/td\u003e\n              \u003ctd\u003eRemoval of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0519T\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0521T\u003c/td\u003e\n              \u003ctd\u003eEvaluation of parameters of wireless heart stimulator system for pacing of lower left chamber of heart including connection, recording, disconnection, and analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0522T\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of wireless heart stimulator system for pacing of lower left chamber of heart with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0528T\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of monitoring system for deficient blood flow in heart muscle with analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e0529T\u003c/td\u003e\n              \u003ctd\u003eEvaluation of parameters of monitoring system for deficient blood flow in heart muscle with analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e10160\u003c/td\u003e\n              \u003ctd\u003eAspiration of abscess, blood accumulation, blister, or cyst\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11055\u003c/td\u003e\n              \u003ctd\u003eRemoval of single thickened skin growth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11056\u003c/td\u003e\n              \u003ctd\u003eRemoval of 2 to 4 thickened skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11057\u003c/td\u003e\n              \u003ctd\u003eRemoval of more than 4 thickened skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11200\u003c/td\u003e\n              \u003ctd\u003eRemoval of up to and including 15 skin tags\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11201\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin tags\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11300\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11301\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11302\u003c/td\u003e\n              \u003ctd\u003eShaving of 1.1 to 2.0 centimeters skin growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11303\u003c/td\u003e\n              \u003ctd\u003eShaving of over 2.0 centimeters skin growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11305\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.5 centimeters or less skin growth of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11306\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.6 centimeters to 1.0 centimeters skin growth of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11307\u003c/td\u003e\n              \u003ctd\u003eShaving of 1.1 to 2.0 centimeters skin growth of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11308\u003c/td\u003e\n              \u003ctd\u003eShaving of over 2.0 centimeters skin growth of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11310\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11311\u003c/td\u003e\n              \u003ctd\u003eShaving of 0.6 centimeters to 1.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11312\u003c/td\u003e\n              \u003ctd\u003eShaving of 1.1 to 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11313\u003c/td\u003e\n              \u003ctd\u003eShaving of over 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11400\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.5 centimeters or less) of the trunk, arms or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11401\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11402\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11403\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11404\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (3.1 to 4.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11406\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (4.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11420\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.5 centimeters or less) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11421\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.6 to 1.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11422\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11423\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (2.1 to 3.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11424\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (3.1 to 4.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11426\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (over 4.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11440\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.5 centimeters or less) of the face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11441\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11442\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11443\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth (2.1 to 3.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11444\u003c/td\u003e\n              \u003ctd\u003eRemoval (3.1 to 4.0 centimeters) growth of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11446\u003c/td\u003e\n              \u003ctd\u003eRemoval (over 4.0 centimeters) growth of the face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11450\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of underarms for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11451\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of underarms for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11462\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of groin for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11463\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of groin for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11470\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of anus or navel for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11471\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin and tissue beneath the skin of anus or navel for excessive sweating\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11600\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.5 centimeters or less) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11601\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11602\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11603\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11604\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (3.1 to 4 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11606\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11620\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.5 centimeters or less) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11621\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.6 to 1.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11622\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11623\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (2.1 to 3.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11624\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (3.1 to 4 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11626\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (over 4.0 centimeters) of the scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11640\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.5 centimeters or less) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11641\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11642\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11643\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (2.1 to 3.0 centimeters) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11644\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (3.1 to 4.0 centimeters) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e11646\u003c/td\u003e\n              \u003ctd\u003eRemoval of malignant growth (over 4.0 centimeters) of the face, ears, eyelids, nose, or lips\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15931\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore of sacrum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15934\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at sacrum with skin graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15936\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at sacrum in preparation of muscle flap or skin graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15940\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at lower pelvic bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15944\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore with skin graft at lower pelvic bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15950\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at hip bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15952\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at hip bone with skin graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15956\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore at hip bone in preparation of muscle flap or skin graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e15999\u003c/td\u003e\n              \u003ctd\u003eRemoval of pressure sore\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17000\u003c/td\u003e\n              \u003ctd\u003eDestruction of skin growth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17003\u003c/td\u003e\n              \u003ctd\u003eDestruction of 2-14 skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17004\u003c/td\u003e\n              \u003ctd\u003eDestruction of 15 or more skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17106\u003c/td\u003e\n              \u003ctd\u003eDestruction of skin growth (less than 10 sq centimeters)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17107\u003c/td\u003e\n              \u003ctd\u003eDestruction of skin growth (10.0 to 50.0 sq centimeters)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17108\u003c/td\u003e\n              \u003ctd\u003eDestruction of skin growth (over 50.0 sq centimeters)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17110\u003c/td\u003e\n              \u003ctd\u003eDestruction of up to 14 skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17111\u003c/td\u003e\n              \u003ctd\u003eDestruction of 15 or more skin growths\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17250\u003c/td\u003e\n              \u003ctd\u003eApplication of chemical agent to excessive wound tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17260\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.5 centimeters or less) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17261\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17262\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17263\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17264\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (3.1 to 4.0 centimeters) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17266\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (over 4.0 centimeters) of trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17270\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.5 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17271\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17272\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17273\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (2.1 to 3.0 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17274\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (3.1 to 4.0 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17276\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (over 4.0 centimeters) of scalp, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17280\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17281\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17282\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17283\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (2.1 to 3.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17284\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (3.1 to 4.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17286\u003c/td\u003e\n              \u003ctd\u003eDestruction of malignant growth (over 4.0 centimeters) of face, ears, eyelids, nose, lips, or mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17311\u003c/td\u003e\n              \u003ctd\u003eRemoval and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17312\u003c/td\u003e\n              \u003ctd\u003eRemoval and microscopic examination of growth of the head, neck, hands, feet, or genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17313\u003c/td\u003e\n              \u003ctd\u003eRemoval and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17314\u003c/td\u003e\n              \u003ctd\u003eRemoval and microscopic examination of growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17315\u003c/td\u003e\n              \u003ctd\u003eRemoval and microscopic examination of growth of the trunk, arms, or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17340\u003c/td\u003e\n              \u003ctd\u003eChemical treatment of acne\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17360\u003c/td\u003e\n              \u003ctd\u003eChemical treatment of acne\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e17380\u003c/td\u003e\n              \u003ctd\u003eHair removal by electrolysis, each 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19000\u003c/td\u003e\n              \u003ctd\u003eAspiration of breast cyst\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19001\u003c/td\u003e\n              \u003ctd\u003ePuncture aspiration of breast cyst\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19030\u003c/td\u003e\n              \u003ctd\u003eInjection for X-ray imaging of breast duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19120\u003c/td\u003e\n              \u003ctd\u003eRemoval of 1 or more breast growth, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19125\u003c/td\u003e\n              \u003ctd\u003eRemoval of breast growth, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19126\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth of chest wall and ribs, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19281\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with mammographic guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19282\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with mammographic guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19283\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with stereotactic guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19284\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with stereotactic guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19285\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with ultrasound guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19286\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with ultrasound guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19287\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with MRI guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19288\u003c/td\u003e\n              \u003ctd\u003ePlacement of breast localization devices accessed through the skin with MRI guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19294\u003c/td\u003e\n              \u003ctd\u003ePreparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19297\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter into breast for radiation therapy concurrent with partial breast removal using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19301\u003c/td\u003e\n              \u003ctd\u003ePartial removal of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e19302\u003c/td\u003e\n              \u003ctd\u003ePartial removal of breast and underarm lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21011\u003c/td\u003e\n              \u003ctd\u003eRemoval of (less than 2 centimeter) tissue growth beneath the skin of face and scalp\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21012\u003c/td\u003e\n              \u003ctd\u003eRemoval of (2 centimeters or greater) tissue growth beneath the skin of face and scalp\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21116\u003c/td\u003e\n              \u003ctd\u003eInjection for X-ray imaging of hinged joint of upper and lower jaw bones\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21240\u003c/td\u003e\n              \u003ctd\u003eRepair of hinged joint of upper and lower jaw bones\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21242\u003c/td\u003e\n              \u003ctd\u003eRepair of hinged joint of upper and lower jaw bones with donor graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21243\u003c/td\u003e\n              \u003ctd\u003eRepair of hinged joint of upper and lower jaw bones with prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21552\u003c/td\u003e\n              \u003ctd\u003eRemoval of (3 centimeters or greater) tissue growth beneath the skin of neck or front of chest\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21555\u003c/td\u003e\n              \u003ctd\u003eRemoval of (less than 3 centimeters) tissue growth beneath the skin of neck or front of chest\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e21931\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of back or flank\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e22902\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin in abdominal wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e22903\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin in abdominal wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23071\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of shoulder area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23075\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin of shoulder area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23350\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of shoulder joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23420\u003c/td\u003e\n              \u003ctd\u003eRepair of torn shoulder tendons\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23470\u003c/td\u003e\n              \u003ctd\u003eProsthetic repair of shoulder joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23472\u003c/td\u003e\n              \u003ctd\u003eProsthetic repair of shoulder joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23473\u003c/td\u003e\n              \u003ctd\u003eRevision of total shoulder repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e23474\u003c/td\u003e\n              \u003ctd\u003eRevision of total shoulder repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24071\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of upper arm or elbow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24075\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin of upper arm or elbow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24220\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of elbow joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24360\u003c/td\u003e\n              \u003ctd\u003eRepair of elbow joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24361\u003c/td\u003e\n              \u003ctd\u003eRepair of elbow joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24362\u003c/td\u003e\n              \u003ctd\u003eRepair of elbow joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24363\u003c/td\u003e\n              \u003ctd\u003eProsthetic repair of elbow joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24365\u003c/td\u003e\n              \u003ctd\u003eRepair of forearm bone at elbow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24366\u003c/td\u003e\n              \u003ctd\u003eRepair of forearm bone at elbow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24370\u003c/td\u003e\n              \u003ctd\u003eRevision of total elbow repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e24371\u003c/td\u003e\n              \u003ctd\u003eRevision of total elbow repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25071\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin at forearm and/or wrist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25075\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin at forearm and/or wrist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25246\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of wrist joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25332\u003c/td\u003e\n              \u003ctd\u003eRepair of wrist joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25441\u003c/td\u003e\n              \u003ctd\u003eRemoval of forearm bone at wrist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25442\u003c/td\u003e\n              \u003ctd\u003eRemoval of forearm bone at wrist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25443\u003c/td\u003e\n              \u003ctd\u003eRemoval of wrist bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25444\u003c/td\u003e\n              \u003ctd\u003eRemoval of wrist bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25445\u003c/td\u003e\n              \u003ctd\u003eRemoval of wrist bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25446\u003c/td\u003e\n              \u003ctd\u003eRemoval of forearm bone at wrist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25447\u003c/td\u003e\n              \u003ctd\u003eRemoval of bone joints between wrist and fingers\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e25449\u003c/td\u003e\n              \u003ctd\u003eRemoval and reinsertion of implant at wrist joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26111\u003c/td\u003e\n              \u003ctd\u003eRemoval (1.5 centimeters or greater) tissue beneath the skin growth of hand or finger\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26115\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 1.5 centimeters) tissue beneath the skin growth of hand or finger\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26530\u003c/td\u003e\n              \u003ctd\u003eRepair of joint of hand bone and finger\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26531\u003c/td\u003e\n              \u003ctd\u003eRepair of joint of hand bone and finger\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26535\u003c/td\u003e\n              \u003ctd\u003eRepair of finger joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e26536\u003c/td\u003e\n              \u003ctd\u003eRepair of finger joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27043\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of pelvis or hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27047\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth of pelvis or hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27093\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of hip joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27095\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for X-ray imaging of hip under anesthesia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27096\u003c/td\u003e\n              \u003ctd\u003eInjection procedure into sacroiliac joint for anesthetic or steroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27327\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin of thigh or knee\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27332\u003c/td\u003e\n              \u003ctd\u003eRemoval of knee cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27333\u003c/td\u003e\n              \u003ctd\u003eRemoval of knee cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27337\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of thigh or knee\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27347\u003c/td\u003e\n              \u003ctd\u003eRemoval of growth of knee cartilage or capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27369\u003c/td\u003e\n              \u003ctd\u003eInjection of contrast for imaging of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27370\u003c/td\u003e\n              \u003ctd\u003eInjection of contract for X-ray imaging of knee\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27403\u003c/td\u003e\n              \u003ctd\u003eIncision and repair of knee cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27405\u003c/td\u003e\n              \u003ctd\u003eRepair of torn collateral ligament and/or knee joint capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27407\u003c/td\u003e\n              \u003ctd\u003eRepair of torn cruciate ligament and/or knee joint capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27409\u003c/td\u003e\n              \u003ctd\u003eRepair of torn collateral and cruciate ligaments or knee joint capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27420\u003c/td\u003e\n              \u003ctd\u003eRepair of dislocating knee cap\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27422\u003c/td\u003e\n              \u003ctd\u003eRepair of dislocating knee cap\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27424\u003c/td\u003e\n              \u003ctd\u003eReconstruction of dislocating knee cap\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27427\u003c/td\u003e\n              \u003ctd\u003eReconstruction of knee joint ligaments\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27428\u003c/td\u003e\n              \u003ctd\u003eReconstruction of knee joint ligaments, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27429\u003c/td\u003e\n              \u003ctd\u003eReconstruction of knee joint ligaments, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27437\u003c/td\u003e\n              \u003ctd\u003eRepair of knee cap\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27438\u003c/td\u003e\n              \u003ctd\u003eRepair of knee cap with insertion of prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27440\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27441\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27442\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27443\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27445\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint with hinged prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27446\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27447\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27486\u003c/td\u003e\n              \u003ctd\u003eRevision of one component of total knee joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27487\u003c/td\u003e\n              \u003ctd\u003eRevision of lower thigh bone and both shin bone components of total knee joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27618\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 3 centimeters) tissue growth beneath the skin of leg or ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27632\u003c/td\u003e\n              \u003ctd\u003eRemoval (3 centimeters or greater) tissue growth beneath the skin of leg or ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27648\u003c/td\u003e\n              \u003ctd\u003eInjection for X-ray imaging of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27700\u003c/td\u003e\n              \u003ctd\u003eRepair of ankle joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27702\u003c/td\u003e\n              \u003ctd\u003eRepair of ankle joint with prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e27703\u003c/td\u003e\n              \u003ctd\u003eRepair of ankle joint with revision of prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28039\u003c/td\u003e\n              \u003ctd\u003eRemoval (1.5 centimeters or greater) tissue growth beneath the skin of foot or toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28043\u003c/td\u003e\n              \u003ctd\u003eRemoval (less than 1.5 centimeters) tissue growth beneath the skin of foot or toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28285\u003c/td\u003e\n              \u003ctd\u003eCorrection of toe joint deformity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28286\u003c/td\u003e\n              \u003ctd\u003eCorrection of fifth toe joint deformity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28289\u003c/td\u003e\n              \u003ctd\u003eCorrection of rigid deformity of first joint of big toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28290\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28291\u003c/td\u003e\n              \u003ctd\u003eCorrection of rigid deformity of first joint of big toe using implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28292\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28293\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28294\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28295\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28296\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28297\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28298\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28299\u003c/td\u003e\n              \u003ctd\u003eCorrection of bunion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28313\u003c/td\u003e\n              \u003ctd\u003eReconstruction of soft tissue angular deformity of toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28340\u003c/td\u003e\n              \u003ctd\u003eReconstruction of abnormal toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28341\u003c/td\u003e\n              \u003ctd\u003eReconstruction of abnormal toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28345\u003c/td\u003e\n              \u003ctd\u003eRemoval of congenital web space deformity of toes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28755\u003c/td\u003e\n              \u003ctd\u003eFusion of great toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e28760\u003c/td\u003e\n              \u003ctd\u003eFusion of great toe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29800\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of jaw joint using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29804\u003c/td\u003e\n              \u003ctd\u003eExamination of jaw joint using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29805\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of shoulder using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29819\u003c/td\u003e\n              \u003ctd\u003eRemoval of loose or foreign body of shoulder using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29826\u003c/td\u003e\n              \u003ctd\u003eShaving of shoulder bone using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29830\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of elbow joint using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29834\u003c/td\u003e\n              \u003ctd\u003eRemoval of loose or foreign body of elbow using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29840\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of the wrist using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29843\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of the wrist using an endoscope for infection, irrigation, and drainage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29860\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of hip using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29870\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of knee using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29871\u003c/td\u003e\n              \u003ctd\u003eIrrigation and drainage of knee joint for infection using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29880\u003c/td\u003e\n              \u003ctd\u003eRemoval of both knee cartilages using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29881\u003c/td\u003e\n              \u003ctd\u003eRemoval of one knee cartilage using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29882\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29883\u003c/td\u003e\n              \u003ctd\u003eRepair of knee joint using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29888\u003c/td\u003e\n              \u003ctd\u003eRepair of anterior cruciate ligament of knee with assistance of an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29889\u003c/td\u003e\n              \u003ctd\u003eRepair of posterior cruciate ligament of knee with assistance of an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29893\u003c/td\u003e\n              \u003ctd\u003eRepair of fibrous tissue of foot using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29900\u003c/td\u003e\n              \u003ctd\u003eBiopsy of lining of joint of finger using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e29999\u003c/td\u003e\n              \u003ctd\u003eJoint procedure using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30400\u003c/td\u003e\n              \u003ctd\u003eReshaping of tip of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30410\u003c/td\u003e\n              \u003ctd\u003eReshaping of bone, cartilage, or tip of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30420\u003c/td\u003e\n              \u003ctd\u003eReshaping of bony cartilage dividing nasal passages\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30430\u003c/td\u003e\n              \u003ctd\u003eRevision to reshape nose or tip of nose after previous repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30435\u003c/td\u003e\n              \u003ctd\u003eRevision to reshape nasal bones after previous repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30450\u003c/td\u003e\n              \u003ctd\u003eRevision to reshape nasal bones and tip of nose after previous repair\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30460\u003c/td\u003e\n              \u003ctd\u003eRepair of congenital nasal defect to lengthen tip of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30462\u003c/td\u003e\n              \u003ctd\u003eRepair of congenital nasal defect with lengthening of tip of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30465\u003c/td\u003e\n              \u003ctd\u003eWidening of nasal passage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30520\u003c/td\u003e\n              \u003ctd\u003eReshaping of nasal cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30540\u003c/td\u003e\n              \u003ctd\u003eReconstruction to create nasal passages\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30545\u003c/td\u003e\n              \u003ctd\u003eReconstruction to create nasal passages\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30620\u003c/td\u003e\n              \u003ctd\u003eRepair of mucous lining of nasal passage with graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e30630\u003c/td\u003e\n              \u003ctd\u003eRepair of openings in nasal cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31505\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of voice box using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31510\u003c/td\u003e\n              \u003ctd\u003eBiopsy of voice box using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31515\u003c/td\u003e\n              \u003ctd\u003eAspiration of voice box using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31520\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of voice box using an endoscope, newborn\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31525\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of voice box using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31526\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of voice box using an endoscope with operating microscope or telescope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31535\u003c/td\u003e\n              \u003ctd\u003eBiopsy of voice box using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31536\u003c/td\u003e\n              \u003ctd\u003eBiopsy of voice box using an endoscope with operating microscope or telescope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31575\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of voice box using flexible endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31576\u003c/td\u003e\n              \u003ctd\u003eBiopsy of voice box using a flexible endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31579\u003c/td\u003e\n              \u003ctd\u003eExamination to assess movement of vocal cord flaps using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31615\u003c/td\u003e\n              \u003ctd\u003eExamination of windpipe and lung airways through permanent skin opening to windpipe using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31622\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of lung airways using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31623\u003c/td\u003e\n              \u003ctd\u003eExamination of lung airways using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31624\u003c/td\u003e\n              \u003ctd\u003eIrrigation and suction of lung airways to obtain cells using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31625\u003c/td\u003e\n              \u003ctd\u003eBiopsy of lung airways using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31626\u003c/td\u003e\n              \u003ctd\u003eInsertion of radiation therapy markers into lung airways using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31627\u003c/td\u003e\n              \u003ctd\u003eComputer-assisted image-guided navigation of lung airways using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31628\u003c/td\u003e\n              \u003ctd\u003eBiopsy of one lobe of lung using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31629\u003c/td\u003e\n              \u003ctd\u003eNeedle biopsy of windpipe cartilage, airway, and/or lung using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31632\u003c/td\u003e\n              \u003ctd\u003eBiopsy of lung using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31633\u003c/td\u003e\n              \u003ctd\u003eNeedle biopsy of lung using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31652\u003c/td\u003e\n              \u003ctd\u003eExamination of lung airways using an endoscope with imaging guidance and ultrasound\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31653\u003c/td\u003e\n              \u003ctd\u003eExamination of lung airways using an endoscope with imaging guidance and ultrasound\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31717\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter into airway of lung for brush biopsy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e31830\u003c/td\u003e\n              \u003ctd\u003eRevision of permanent windpipe opening scar\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32851\u003c/td\u003e\n              \u003ctd\u003eTransplant of lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32852\u003c/td\u003e\n              \u003ctd\u003eTransplant of lung on heart-lung machine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32853\u003c/td\u003e\n              \u003ctd\u003eTransplant of both lungs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32854\u003c/td\u003e\n              \u003ctd\u003eTransplant of both lungs on heart-lung machine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32855\u003c/td\u003e\n              \u003ctd\u003ePreparation of one lung from a cadaver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e32856\u003c/td\u003e\n              \u003ctd\u003ePreparation of two cadaver lungs for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33202\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrodes to outer layer of heart, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33203\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrodes to outer layer of heart using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33206\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of permanent pacemaker and upper chamber electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33207\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of permanent pacemaker and lower chamber electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33208\u003c/td\u003e\n              \u003ctd\u003eInsertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33210\u003c/td\u003e\n              \u003ctd\u003ePlacement of temporary pacemaker leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33211\u003c/td\u003e\n              \u003ctd\u003ePlacement of temporary pacemaker leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33212\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacemaker pulse generator with existing single lead\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33213\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacemaker pulse generator with existing dual leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33214\u003c/td\u003e\n              \u003ctd\u003eConversion to two chamber pacemaker system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33215\u003c/td\u003e\n              \u003ctd\u003eRepositioning of implanted pacemaker or defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33216\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrode for permanent pacemaker or pacing defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33217\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrodes for permanent pacemaker or pacing defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33218\u003c/td\u003e\n              \u003ctd\u003eRepair of electrode for permanent pacemaker or defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33220\u003c/td\u003e\n              \u003ctd\u003eRepair of 2 electrodes for permanent pacemaker or defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33221\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacemaker pulse generator with existing multiple leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33222\u003c/td\u003e\n              \u003ctd\u003eRelocation of pacemaker generator skin pocket\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33223\u003c/td\u003e\n              \u003ctd\u003eRelocation of defibrillator device skin pocket\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33224\u003c/td\u003e\n              \u003ctd\u003eInsertion of left heart electrode with attachment to pacemaker or pacing defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33225\u003c/td\u003e\n              \u003ctd\u003eInsertion of left heart electrode for pacing defibrillator device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33226\u003c/td\u003e\n              \u003ctd\u003eRepositioning of implanted left heart electrode\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33227\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of single lead permanent pacemaker pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33228\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of dual lead permanent pacemaker pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33229\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of multiple lead permanent pacemaker pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33230\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacing defibrillator pulse generator with existing dual leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33231\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacing defibrillator pulse generator with existing multiple leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33233\u003c/td\u003e\n              \u003ctd\u003eRemoval of permanent pacemaker pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33234\u003c/td\u003e\n              \u003ctd\u003eRemoval of electrode from right heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33235\u003c/td\u003e\n              \u003ctd\u003eRemoval of electrodes from right heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33236\u003c/td\u003e\n              \u003ctd\u003eRemoval of permanent right heart electrodes and pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33237\u003c/td\u003e\n              \u003ctd\u003eRemoval of permanent right heart electrodes and pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33238\u003c/td\u003e\n              \u003ctd\u003eRemoval of permanent pacemaker venous electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33240\u003c/td\u003e\n              \u003ctd\u003eInsertion of pacing defibrillator pulse generator with existing single lead\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33241\u003c/td\u003e\n              \u003ctd\u003eRemoval of defibrillator pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33243\u003c/td\u003e\n              \u003ctd\u003eRemoval of defibrillator electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33244\u003c/td\u003e\n              \u003ctd\u003eRemoval of defibrillator electrodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33249\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of single or dual chamber pacing defibrillator leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33262\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of defibrillator pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33263\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of defibrillator pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33264\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of defibrillator pulse generator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33270\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of defibrillator with electrode\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33271\u003c/td\u003e\n              \u003ctd\u003eInsertion of defibrillator electrode\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33272\u003c/td\u003e\n              \u003ctd\u003eRemoval of defibrillator electrode\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33273\u003c/td\u003e\n              \u003ctd\u003eRepositioning of previously implanted defibrillator electrode\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33274\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of permanent leadless pacemaker into lower right chamber of heart via catheter using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33275\u003c/td\u003e\n              \u003ctd\u003eRemoval of permanent leadless pacemaker from lower right chamber of heart via catheter using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33930\u003c/td\u003e\n              \u003ctd\u003eHarvest of donor heart and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33933\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor heart and lung for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33935\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor heart and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33944\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor heart for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e33945\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e36598\u003c/td\u003e\n              \u003ctd\u003eContrast injections for X-ray imaging procedure to evaluate central venous access device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38200\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for X-ray imaging of the spleen and portal (liver) vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38205\u003c/td\u003e\n              \u003ctd\u003eCollection of donor stem cells for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38206\u003c/td\u003e\n              \u003ctd\u003eCollection of stem cells for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38207\u003c/td\u003e\n              \u003ctd\u003eFreezing, preservation, and storage of stem cells for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38208\u003c/td\u003e\n              \u003ctd\u003eThawing of previously frozen stem cells for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38209\u003c/td\u003e\n              \u003ctd\u003eThawing and washing of previously frozen stem cells for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38210\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with removal of T cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38211\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with removal of tumor cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38212\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with red blood cell removal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38213\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with removal of platelets\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38214\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with reduction of excessive opening blood fluid (plasma) volume\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38215\u003c/td\u003e\n              \u003ctd\u003ePreparation of stem cells for transplantation with cell concentration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38220\u003c/td\u003e\n              \u003ctd\u003eDiagnostic bone marrow aspiration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38221\u003c/td\u003e\n              \u003ctd\u003eBone marrow biopsy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38222\u003c/td\u003e\n              \u003ctd\u003eBone marrow biopsy and aspiration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38240\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor bone marrow or blood-derived stem cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38241\u003c/td\u003e\n              \u003ctd\u003eTransplantation of patient\u0027s bone marrow or blood-derived stem cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38242\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor stem cells from bone marrow or blood with infusion of donor white blood cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38243\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor bone marrow or blood-derived stem cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38790\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for X-ray imaging of the lymphatic system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e38792\u003c/td\u003e\n              \u003ctd\u003eInjection of radioactive dye for X-ray identification of lymph node\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e41019\u003c/td\u003e\n              \u003ctd\u003eInsertion of needles, catheters, or devices into head and/or neck for radiation delivery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42550\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray of salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42820\u003c/td\u003e\n              \u003ctd\u003eRemoval of tonsils and adenoid glands patient younger than age 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42821\u003c/td\u003e\n              \u003ctd\u003eRemoval of tonsils and adenoid glands patient age 12 or over\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42825\u003c/td\u003e\n              \u003ctd\u003eRemoval of tonsils patient younger than age 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42826\u003c/td\u003e\n              \u003ctd\u003eRemoval of tonsils patient age 12 or over\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42830\u003c/td\u003e\n              \u003ctd\u003eRemoval of adenoids patient younger than age 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42831\u003c/td\u003e\n              \u003ctd\u003eRemoval of adenoids patient age 12 or over\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42835\u003c/td\u003e\n              \u003ctd\u003eRemoval of adenoids patient younger than age 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42836\u003c/td\u003e\n              \u003ctd\u003eRemoval of adenoids patient age 12 or over\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42860\u003c/td\u003e\n              \u003ctd\u003eRemoval of remaining tonsil tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e42870\u003c/td\u003e\n              \u003ctd\u003eRemoval or destruction of growth of tongue lymph node\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43180\u003c/td\u003e\n              \u003ctd\u003eRemoval of esophagus tissue using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43191\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43192\u003c/td\u003e\n              \u003ctd\u003eInjections of substance in tissue lining of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43193\u003c/td\u003e\n              \u003ctd\u003eBiopsy of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43197\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43198\u003c/td\u003e\n              \u003ctd\u003eBiopsy of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43200\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43201\u003c/td\u003e\n              \u003ctd\u003eInjections into esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43202\u003c/td\u003e\n              \u003ctd\u003eBiopsy of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43204\u003c/td\u003e\n              \u003ctd\u003eInjection of dilated esophageal veins using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43205\u003c/td\u003e\n              \u003ctd\u003eTying of esophageal veins using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43206\u003c/td\u003e\n              \u003ctd\u003eMicroscopic examination of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43210\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of esophagus, stomach, and/or upper small bowel with repair of muscle at esophagus and stomach using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43211\u003c/td\u003e\n              \u003ctd\u003eRemoval of tissue lining of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43212\u003c/td\u003e\n              \u003ctd\u003ePlacement of stent on esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43217\u003c/td\u003e\n              \u003ctd\u003eRemoval of esophageal polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43229\u003c/td\u003e\n              \u003ctd\u003eDestruction of growths of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43231\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43232\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided fine needle aspiration or biopsy of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43235\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43236\u003c/td\u003e\n              \u003ctd\u003eInjections of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43237\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43238\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided needle aspiration or biopsies of esophagus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43239\u003c/td\u003e\n              \u003ctd\u003eBiopsy of the esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43240\u003c/td\u003e\n              \u003ctd\u003eDrainage of cyst of the esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43241\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter or tube in esophagus stomach and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43242\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43247\u003c/td\u003e\n              \u003ctd\u003eRemoval of foreign bodies of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43250\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43251\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43252\u003c/td\u003e\n              \u003ctd\u003eMicroscopic examination of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43253\u003c/td\u003e\n              \u003ctd\u003eInjection of diagnostic or therapeutic substances or markers in esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43254\u003c/td\u003e\n              \u003ctd\u003eRemoval of tissue lining of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43255\u003c/td\u003e\n              \u003ctd\u003eControl of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43257\u003c/td\u003e\n              \u003ctd\u003eHeat delivery to muscle at esophagus and/or stomach to treat gastric reflux using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43259\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of esophagus, stomach and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43266\u003c/td\u003e\n              \u003ctd\u003ePlacement of stent in esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43270\u003c/td\u003e\n              \u003ctd\u003eDestruction of growths on esophagus, stomach, and/or upper small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43644\u003c/td\u003e\n              \u003ctd\u003eBypass operation of stomach using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43645\u003c/td\u003e\n              \u003ctd\u003eBypass operation of stomach with reconstruction of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43770\u003c/td\u003e\n              \u003ctd\u003eInsertion of adjustable stomach reduction device using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43771\u003c/td\u003e\n              \u003ctd\u003eRevision of stomach reduction device using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43772\u003c/td\u003e\n              \u003ctd\u003eRemoval of stomach reduction device using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43773\u003c/td\u003e\n              \u003ctd\u003eReplacement of stomach reduction device using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43774\u003c/td\u003e\n              \u003ctd\u003eRemoval of stomach reduction device and port beneath the skin using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43775\u003c/td\u003e\n              \u003ctd\u003eStomach reduction procedure with partial removal of stomach using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43842\u003c/td\u003e\n              \u003ctd\u003eBanding of upper stomach to reduce size\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43843\u003c/td\u003e\n              \u003ctd\u003eReduction of size of upper stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43845\u003c/td\u003e\n              \u003ctd\u003ePartial removal of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43846\u003c/td\u003e\n              \u003ctd\u003ePartial removal of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43847\u003c/td\u003e\n              \u003ctd\u003ePartial removal of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43848\u003c/td\u003e\n              \u003ctd\u003eRevision of upper stomach bypass, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43886\u003c/td\u003e\n              \u003ctd\u003eRevision of skin level port of stomach banding device, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43887\u003c/td\u003e\n              \u003ctd\u003eRemoval of skin level port of stomach banding device, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e43888\u003c/td\u003e\n              \u003ctd\u003eRemoval and replacement of skin level port of stomach banding device, open procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44135\u003c/td\u003e\n              \u003ctd\u003eTransplantation of small bowel from cadaver donor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44136\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor small bowel\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44360\u003c/td\u003e\n              \u003ctd\u003eExamination of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44361\u003c/td\u003e\n              \u003ctd\u003eBiopsy of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44376\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44377\u003c/td\u003e\n              \u003ctd\u003eBiopsy of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44379\u003c/td\u003e\n              \u003ctd\u003eInsertion of small bowel stent using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44380\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of small bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44381\u003c/td\u003e\n              \u003ctd\u003eBalloon dilation of small bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44382\u003c/td\u003e\n              \u003ctd\u003eBiopsy of small bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44383\u003c/td\u003e\n              \u003ctd\u003eInsertion of small bowel stent using an endoscope which is inserted through abdominal opening into small bowel\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44384\u003c/td\u003e\n              \u003ctd\u003ePlacement of stent in small bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44385\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of defect in wall of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44386\u003c/td\u003e\n              \u003ctd\u003eBiopsy of small bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44388\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44389\u003c/td\u003e\n              \u003ctd\u003eBiopsies of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44391\u003c/td\u003e\n              \u003ctd\u003eControl of bleeding in large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44392\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44393\u003c/td\u003e\n              \u003ctd\u003eDestruction of large bowel polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44394\u003c/td\u003e\n              \u003ctd\u003eRemoval of large bowel polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44397\u003c/td\u003e\n              \u003ctd\u003eInsertion of large bowel stent using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44401\u003c/td\u003e\n              \u003ctd\u003eDestruction of large bowel growths using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44402\u003c/td\u003e\n              \u003ctd\u003eStent placement in large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44403\u003c/td\u003e\n              \u003ctd\u003eResection of large bowel tissue using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44404\u003c/td\u003e\n              \u003ctd\u003eInjections of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44405\u003c/td\u003e\n              \u003ctd\u003eBalloon dilation of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44406\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44407\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided fine needle aspiration/biopsies of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44408\u003c/td\u003e\n              \u003ctd\u003eDecompression of large bowel using an endoscope which is inserted through abdominal opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44715\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor small bowel for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44720\u003c/td\u003e\n              \u003ctd\u003eReconstruction of donor small bowel for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e44721\u003c/td\u003e\n              \u003ctd\u003eReconstruction of donor small bowel for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45100\u003c/td\u003e\n              \u003ctd\u003eBiopsy of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45300\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45303\u003c/td\u003e\n              \u003ctd\u003eDilation of rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45305\u003c/td\u003e\n              \u003ctd\u003eBiopsy of rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45308\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyp or growth of rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45309\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyp or growth of rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45315\u003c/td\u003e\n              \u003ctd\u003eRemoval of multiple polyps or growths in rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45317\u003c/td\u003e\n              \u003ctd\u003eControl of bleeding in rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45320\u003c/td\u003e\n              \u003ctd\u003eDestruction of polyps or growths of the rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45321\u003c/td\u003e\n              \u003ctd\u003eRelease of twisted bowel in rectum and large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45327\u003c/td\u003e\n              \u003ctd\u003eInsertion of rectal or large bowel stent using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45330\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45331\u003c/td\u003e\n              \u003ctd\u003eBiopsy of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45333\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45334\u003c/td\u003e\n              \u003ctd\u003eControl of bleeding in large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45335\u003c/td\u003e\n              \u003ctd\u003eInjections into large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45337\u003c/td\u003e\n              \u003ctd\u003eRelease of twisted large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45338\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45339\u003c/td\u003e\n              \u003ctd\u003eDestruction of polyps or growths of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45340\u003c/td\u003e\n              \u003ctd\u003eDilation of large bowel stricture using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45341\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45342\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided needle aspiration or biopsy of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45345\u003c/td\u003e\n              \u003ctd\u003eInsertion of stent in lower large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45346\u003c/td\u003e\n              \u003ctd\u003eDestruction of polyps or growths of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45347\u003c/td\u003e\n              \u003ctd\u003ePlacement of stent in large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45349\u003c/td\u003e\n              \u003ctd\u003eRemoval of large bowel tissue using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45350\u003c/td\u003e\n              \u003ctd\u003eRubber banding of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45355\u003c/td\u003e\n              \u003ctd\u003eIncisional examination of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45378\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45380\u003c/td\u003e\n              \u003ctd\u003eBiopsy of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45381\u003c/td\u003e\n              \u003ctd\u003eInjections of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45382\u003c/td\u003e\n              \u003ctd\u003eControl of bleeding in large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45383\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths in large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45384\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths in large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45385\u003c/td\u003e\n              \u003ctd\u003eRemoval of polyps or growths of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45386\u003c/td\u003e\n              \u003ctd\u003eBalloon dilation of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45387\u003c/td\u003e\n              \u003ctd\u003eInsertion of large bowel stent using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45388\u003c/td\u003e\n              \u003ctd\u003eDestruction of large bowel growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45389\u003c/td\u003e\n              \u003ctd\u003eStent placement of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45390\u003c/td\u003e\n              \u003ctd\u003eRemoval of large bowel tissue using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45391\u003c/td\u003e\n              \u003ctd\u003eUltrasound examination of lower large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45392\u003c/td\u003e\n              \u003ctd\u003eUltrasound guided needle aspiration or biopsy of lower large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45393\u003c/td\u003e\n              \u003ctd\u003eDecompression of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45398\u003c/td\u003e\n              \u003ctd\u003eTying of large bowel using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45500\u003c/td\u003e\n              \u003ctd\u003eRelease of scar tissue and repair of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e45505\u003c/td\u003e\n              \u003ctd\u003eRepair of rectal prolapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46600\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of the anus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46601\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of anus with magnification and chemical agent enhancement using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46604\u003c/td\u003e\n              \u003ctd\u003eDilation of anus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46606\u003c/td\u003e\n              \u003ctd\u003eBiopsy of anus using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46607\u003c/td\u003e\n              \u003ctd\u003eBiopsies of anus with magnification and chemical agent enhancement using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46610\u003c/td\u003e\n              \u003ctd\u003eRemoval of anal polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46611\u003c/td\u003e\n              \u003ctd\u003eRemoval of single anal polyp or growth using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46612\u003c/td\u003e\n              \u003ctd\u003eRemoval of multiple anal polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46614\u003c/td\u003e\n              \u003ctd\u003eControl of anal bleeding using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e46615\u003c/td\u003e\n              \u003ctd\u003eDestruction of anal polyps or growths using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47000\u003c/td\u003e\n              \u003ctd\u003eNeedle biopsy of liver, accessed through the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47001\u003c/td\u003e\n              \u003ctd\u003eNeedle biopsy of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47100\u003c/td\u003e\n              \u003ctd\u003ePartial removal of liver tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47135\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor liver to anatomic position\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47136\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor liver to alternate anatomic position\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47140\u003c/td\u003e\n              \u003ctd\u003ePartial removal of donor liver left segment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47141\u003c/td\u003e\n              \u003ctd\u003eRemoval of donor liver left lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47142\u003c/td\u003e\n              \u003ctd\u003eRemoval of donor liver right lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47143\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor liver for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47144\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor liver for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47145\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor liver for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47146\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor liver for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47147\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor liver for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47500\u003c/td\u003e\n              \u003ctd\u003eInjection of bile duct for X-ray imaging procedure, accessed through the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47505\u003c/td\u003e\n              \u003ctd\u003eInjection through existing gallbladder catheter for X-ray imaging procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47531\u003c/td\u003e\n              \u003ctd\u003eInjection of bile duct for X-ray imaging procedure accessed through the skin using imaging guidance including radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e47532\u003c/td\u003e\n              \u003ctd\u003eInjection of bile duct for X-ray imaging procedure accessed through the skin using imaging guidance including radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e48160\u003c/td\u003e\n              \u003ctd\u003eRemoval of pancreas with pancreatic cell transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e48551\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor pancreas for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e48552\u003c/td\u003e\n              \u003ctd\u003ePreparation of donor pancreas for transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e48554\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e49465\u003c/td\u003e\n              \u003ctd\u003eContrast injections for x-ray imaging through existing tube in stomach, small bowel or large bowel, accessed through the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50360\u003c/td\u003e\n              \u003ctd\u003eTransplantation of donor kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50365\u003c/td\u003e\n              \u003ctd\u003eRemoval of kidney and transplantation of donor kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50380\u003c/td\u003e\n              \u003ctd\u003eRemoval with relocation of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50394\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for x-ray imaging of kidney and urinary duct (ureter)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50430\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for x-ray imaging of kidney and urinary duct (ureter) using imaging guidance including radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50431\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for x-ray imaging of kidney and urinary duct (ureter) using imaging guidance including radiological supervision and interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50551\u003c/td\u003e\n              \u003ctd\u003eExamination of kidney using an endoscopy which is inserted through an already created kidney opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50553\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter into urinary duct (ureter) using an endoscopy which is inserted through an already created kidney opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50555\u003c/td\u003e\n              \u003ctd\u003eKidney biopsy using an endoscopy which is inserted through an already created kidney opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50570\u003c/td\u003e\n              \u003ctd\u003eExamination of kidney using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50574\u003c/td\u003e\n              \u003ctd\u003eKidney biopsy using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50951\u003c/td\u003e\n              \u003ctd\u003eExamination of kidney and urinary duct (ureter) using an endoscopy which is inserted through an already created urinary duct (ureter) opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50955\u003c/td\u003e\n              \u003ctd\u003eBiopsy of kidney or urinary duct (ureter) using an endoscopy which is inserted through an already created urinary duct (ureter) opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50970\u003c/td\u003e\n              \u003ctd\u003eExamination of kidney and urinary duct (ureter) using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e50974\u003c/td\u003e\n              \u003ctd\u003eBiopsy of kidney or urinary duct (ureter) using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52000\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of the bladder and bladder canal (urethra) using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52007\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter into urinary duct (ureter) and biopsy of urinary duct and/or renal pelvis using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52010\u003c/td\u003e\n              \u003ctd\u003eInsertion of catheter into sperm duct using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52204\u003c/td\u003e\n              \u003ctd\u003eBiopsy of the bladder using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52276\u003c/td\u003e\n              \u003ctd\u003eIncision of the bladder canal (urethra) using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52351\u003c/td\u003e\n              \u003ctd\u003eDiagnostic examination of the bladder, bladder canal (urethra), and urinary duct (ureter) or kidney using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e52354\u003c/td\u003e\n              \u003ctd\u003eBiopsy and/or destruction of growth of urinary duct (ureter) or kidney using an endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e53200\u003c/td\u003e\n              \u003ctd\u003eBiopsy of bladder canal (urethra)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e54150\u003c/td\u003e\n              \u003ctd\u003eRemoval of foreskin of using clamp or device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e54160\u003c/td\u003e\n              \u003ctd\u003eRemoval of foreskin, neonate (28 days of age or less)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e54161\u003c/td\u003e\n              \u003ctd\u003eRemoval of foreskin, patient older than 28 days of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e54163\u003c/td\u003e\n              \u003ctd\u003eRepair of incomplete removal of penile foreskin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e54230\u003c/td\u003e\n              \u003ctd\u003eInjection procedure for X-ray imaging of penile erection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e55300\u003c/td\u003e\n              \u003ctd\u003eIncision of sperm ducts for X-ray imaging procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e55874\u003c/td\u003e\n              \u003ctd\u003eInjection of biodegradable material next to prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59425\u003c/td\u003e\n              \u003ctd\u003ePredelivery care 4-6 visits\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59426\u003c/td\u003e\n              \u003ctd\u003ePredelivery care 7 or more visits\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59430\u003c/td\u003e\n              \u003ctd\u003ePost-delivery care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59840\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by dilation and uterine scraping\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59841\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by dilation and removal of pregnancy contents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59850\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by amniotic fluid injections with delivery of fetus and placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59851\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by amniotic fluid injections with delivery of fetus and placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59852\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by amniotic fluid injections\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59855\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by insertion of vaginal suppositories\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59856\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by insertion of vaginal suppositories\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e59857\u003c/td\u003e\n              \u003ctd\u003eInduced abortion by insertion of vaginal suppositories\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e62290\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of spine disc\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e62291\u003c/td\u003e\n              \u003ctd\u003eInjection of dye for X-ray imaging of spine disc\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65710\u003c/td\u003e\n              \u003ctd\u003eTransplantation of tissue from one cornea to other cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65730\u003c/td\u003e\n              \u003ctd\u003eTransplantation of tissue from one cornea to other cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65750\u003c/td\u003e\n              \u003ctd\u003eTransplantation of tissue from one cornea to other cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65755\u003c/td\u003e\n              \u003ctd\u003eTransplantation of tissue from one cornea to other cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65756\u003c/td\u003e\n              \u003ctd\u003eTransplant of outer layer of corneal tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65757\u003c/td\u003e\n              \u003ctd\u003ePreparation of corneal tissue for transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65780\u003c/td\u003e\n              \u003ctd\u003eTransplantation of fetal sac tissue to cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65781\u003c/td\u003e\n              \u003ctd\u003eTransplantation of stem cells to cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65782\u003c/td\u003e\n              \u003ctd\u003eTransplantation of stem cells from one cornea to other cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65820\u003c/td\u003e\n              \u003ctd\u003eIncision to improve eye fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65850\u003c/td\u003e\n              \u003ctd\u003eInsertion of eye fluid drainage tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65855\u003c/td\u003e\n              \u003ctd\u003eLaser repair to improve eye fluid flow, 1 or more sessions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e65920\u003c/td\u003e\n              \u003ctd\u003eRemoval of implanted lens in eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66150\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract with removal of iris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66155\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract with removal of iris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66160\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract with removal of sclera and iris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66165\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66170\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66172\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66174\u003c/td\u003e\n              \u003ctd\u003eDilation to improve eye fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66175\u003c/td\u003e\n              \u003ctd\u003eDilation with insertion of device or stent to improve eye fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66179\u003c/td\u003e\n              \u003ctd\u003eCreation of shunt to improve eye fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66180\u003c/td\u003e\n              \u003ctd\u003eCreation of shunt to improve eye fluid flow with graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66183\u003c/td\u003e\n              \u003ctd\u003eInsertion of eye fluid drainage device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66184\u003c/td\u003e\n              \u003ctd\u003eRevision of shunt to improve eye fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66185\u003c/td\u003e\n              \u003ctd\u003eRevision of eye fluid drainage shunt with graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66700\u003c/td\u003e\n              \u003ctd\u003eDestruction of lens tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66710\u003c/td\u003e\n              \u003ctd\u003eDestruction of lens tissue using laser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66711\u003c/td\u003e\n              \u003ctd\u003eDestruction of tissue encircling lens using endoscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66720\u003c/td\u003e\n              \u003ctd\u003eDestruction of tissue encircling lens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66740\u003c/td\u003e\n              \u003ctd\u003eDestruction of tissue of eyelid border\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66761\u003c/td\u003e\n              \u003ctd\u003eCreation of eye fluid drainage tracts in iris using laser, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66820\u003c/td\u003e\n              \u003ctd\u003eRemoval of recurring cataract in lens capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66821\u003c/td\u003e\n              \u003ctd\u003eRemoval of recurring cataract in lens capsule using laser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66825\u003c/td\u003e\n              \u003ctd\u003eRepositioning of lens prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66830\u003c/td\u003e\n              \u003ctd\u003eRemoval of recurring cataract in lens capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66840\u003c/td\u003e\n              \u003ctd\u003eAspiration removal of lens material\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66850\u003c/td\u003e\n              \u003ctd\u003eFragmenting, aspiration, and removal of lens material\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66852\u003c/td\u003e\n              \u003ctd\u003eRemoval of lens material\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66920\u003c/td\u003e\n              \u003ctd\u003eRemoval of lens material and capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66930\u003c/td\u003e\n              \u003ctd\u003eRemoval of lens material and capsule for dislocated lens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66940\u003c/td\u003e\n              \u003ctd\u003eRemoval of lens material and portion of lens capsule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66982\u003c/td\u003e\n              \u003ctd\u003eComplex removal of cataract with insertion of lens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66983\u003c/td\u003e\n              \u003ctd\u003eRemoval of cataract with insertion of lens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66984\u003c/td\u003e\n              \u003ctd\u003eRemoval of cataract with insertion of lens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66985\u003c/td\u003e\n              \u003ctd\u003eInsertion of lens prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e66986\u003c/td\u003e\n              \u003ctd\u003eExchange of lens prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e68850\u003c/td\u003e\n              \u003ctd\u003eInjection of contrast for X-ray imaging of tear sac\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70015\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of brain and spinal cord with contrast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70100\u003c/td\u003e\n              \u003ctd\u003eX-ray of mandible, less than 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70110\u003c/td\u003e\n              \u003ctd\u003eX-ray of mandible, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70120\u003c/td\u003e\n              \u003ctd\u003eX-ray of mastoid, less than 3 views per side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70130\u003c/td\u003e\n              \u003ctd\u003eX-ray of mastoid, minimum of 3 views per side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70134\u003c/td\u003e\n              \u003ctd\u003eX-ray of internal ear canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70140\u003c/td\u003e\n              \u003ctd\u003eX-ray of bones of face, less than 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70150\u003c/td\u003e\n              \u003ctd\u003eX-ray of bones of face, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70160\u003c/td\u003e\n              \u003ctd\u003eX-ray of bones of nose, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70170\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of tear drainage structure of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70190\u003c/td\u003e\n              \u003ctd\u003eX-ray of skull\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70200\u003c/td\u003e\n              \u003ctd\u003eX-ray of eye bones, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70210\u003c/td\u003e\n              \u003ctd\u003eX-ray of paranasal sinus, less than 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70220\u003c/td\u003e\n              \u003ctd\u003eX-ray of paranasal sinus, complete, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70240\u003c/td\u003e\n              \u003ctd\u003eX-ray of bone at base of skull\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70250\u003c/td\u003e\n              \u003ctd\u003eX-ray of skull, less than 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70260\u003c/td\u003e\n              \u003ctd\u003eX-ray of skull, complete, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70300\u003c/td\u003e\n              \u003ctd\u003eX-ray of teeth, single view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70310\u003c/td\u003e\n              \u003ctd\u003eX-ray of teeth, less than full mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70320\u003c/td\u003e\n              \u003ctd\u003eX-ray of teeth, full mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70328\u003c/td\u003e\n              \u003ctd\u003eX-ray of jaw joint on one side of the face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70330\u003c/td\u003e\n              \u003ctd\u003eX-ray of jaw joints on both sides of the face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70332\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of jaw joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70350\u003c/td\u003e\n              \u003ctd\u003eImaging of jaws and skull for orthodontic purposes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70355\u003c/td\u003e\n              \u003ctd\u003eX-ray imaging of teeth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70360\u003c/td\u003e\n              \u003ctd\u003eX-ray of soft tissue of neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70370\u003c/td\u003e\n              \u003ctd\u003eX-ray of voice box or throat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70371\u003c/td\u003e\n              \u003ctd\u003eImaging of voice box with speech evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70373\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of voice box with contrast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70380\u003c/td\u003e\n              \u003ctd\u003eX-ray of salivary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e70390\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of salivary structure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71023\u003c/td\u003e\n              \u003ctd\u003eX-ray of chest, 2 views, front and side with fluoroscopy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71034\u003c/td\u003e\n              \u003ctd\u003eX-ray of chest, complete, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71100\u003c/td\u003e\n              \u003ctd\u003eX-ray of ribs of one side of body, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71101\u003c/td\u003e\n              \u003ctd\u003eX-ray of ribs on one side of body including the chest, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71110\u003c/td\u003e\n              \u003ctd\u003eX-ray of both sides of the ribs, 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71111\u003c/td\u003e\n              \u003ctd\u003eX-ray of both sides of the ribs including the chest, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71120\u003c/td\u003e\n              \u003ctd\u003eX-ray of breast bone, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e71130\u003c/td\u003e\n              \u003ctd\u003eX-ray of junction of breast and collar bones, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72010\u003c/td\u003e\n              \u003ctd\u003eX-ray of entire spine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72020\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72040\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine of neck, 2 or 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72050\u003c/td\u003e\n              \u003ctd\u003eX-ray of upper spine, 4 or 5 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72052\u003c/td\u003e\n              \u003ctd\u003eX-ray of upper spine, 6 or more views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72069\u003c/td\u003e\n              \u003ctd\u003eX-ray of middle and lower spine, standing view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72070\u003c/td\u003e\n              \u003ctd\u003eX-ray of middle spine, 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72072\u003c/td\u003e\n              \u003ctd\u003eX-ray of middle spine, 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72074\u003c/td\u003e\n              \u003ctd\u003eX-ray of middle spine, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72080\u003c/td\u003e\n              \u003ctd\u003eX-ray of middle and lower spine, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72081\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72082\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, 2 or 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72083\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, 4 or 5 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72084\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, minimum of 6 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72090\u003c/td\u003e\n              \u003ctd\u003eX-ray of spine, scoliosis study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72100\u003c/td\u003e\n              \u003ctd\u003eX-ray of lower and sacral spine, 2 or 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72110\u003c/td\u003e\n              \u003ctd\u003eX-ray of lower and sacral spine, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72114\u003c/td\u003e\n              \u003ctd\u003eX-ray lower and sacral spine including bending views minimum 6 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72120\u003c/td\u003e\n              \u003ctd\u003eX-ray lower and sacral spine including bending views 2 or 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72170\u003c/td\u003e\n              \u003ctd\u003eX-ray of pelvis, 1 or 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72190\u003c/td\u003e\n              \u003ctd\u003eX-ray of pelvis, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72200\u003c/td\u003e\n              \u003ctd\u003eX-ray of sacroiliac joints, less than 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72202\u003c/td\u003e\n              \u003ctd\u003eX-ray of sacroiliac joints, 3 or more views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72220\u003c/td\u003e\n              \u003ctd\u003eX-ray of pelvis, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72275\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of covering of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72285\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of disc of vertebra, upper or middle spine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72291\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of percutaneous repair or reconstruction of vertebra (accessed through the skin) using fluoroscopic guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72292\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of repair or reconstruction of vertebra (accessed through the skin) procedure using CT guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e72295\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of disc of vertebra, lower spine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73000\u003c/td\u003e\n              \u003ctd\u003eX-ray of collar bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73010\u003c/td\u003e\n              \u003ctd\u003eX-ray of shoulder blade\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73020\u003c/td\u003e\n              \u003ctd\u003eX-ray of shoulder, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73030\u003c/td\u003e\n              \u003ctd\u003eX-ray of shoulder, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73040\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of shoulder joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73050\u003c/td\u003e\n              \u003ctd\u003eX-ray of both collar bones\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73060\u003c/td\u003e\n              \u003ctd\u003eX-ray of upper arm, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73070\u003c/td\u003e\n              \u003ctd\u003eX-ray of elbow, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73080\u003c/td\u003e\n              \u003ctd\u003eX-ray of elbow, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73085\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of elbow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73090\u003c/td\u003e\n              \u003ctd\u003eX-ray of forearm, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73092\u003c/td\u003e\n              \u003ctd\u003eX-ray of arm in infant minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73100\u003c/td\u003e\n              \u003ctd\u003eX-ray of wrist, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73110\u003c/td\u003e\n              \u003ctd\u003eX-ray of wrist, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73115\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of wrist joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73120\u003c/td\u003e\n              \u003ctd\u003eX-ray of hand, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73130\u003c/td\u003e\n              \u003ctd\u003eX-ray of hand, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73140\u003c/td\u003e\n              \u003ctd\u003eX-ray of fingers, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73500\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip on one side of body, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73501\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip with pelvis, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73502\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip with pelvis, 2-3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73503\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip with pelvis, minimum of 4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73510\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip of one side of body, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73520\u003c/td\u003e\n              \u003ctd\u003eX-ray of both hips minimum 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73521\u003c/td\u003e\n              \u003ctd\u003eX-ray of both hips with pelvis, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73522\u003c/td\u003e\n              \u003ctd\u003eX-ray of both hips with pelvis, 3-4 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73523\u003c/td\u003e\n              \u003ctd\u003eX-ray of both hips with pelvis, minimum of 5 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73525\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of hip joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73530\u003c/td\u003e\n              \u003ctd\u003eX-ray of hip during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73540\u003c/td\u003e\n              \u003ctd\u003eX-ray of pelvis and hips, infant or child, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73550\u003c/td\u003e\n              \u003ctd\u003eX-ray of thigh, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73551\u003c/td\u003e\n              \u003ctd\u003eX-ray of femur, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73552\u003c/td\u003e\n              \u003ctd\u003eX-ray of femur, minimum 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73560\u003c/td\u003e\n              \u003ctd\u003eX-ray of knee, 1 or 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73562\u003c/td\u003e\n              \u003ctd\u003eX-ray of knee, 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73564\u003c/td\u003e\n              \u003ctd\u003eX-ray of knee, 4 or more views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73565\u003c/td\u003e\n              \u003ctd\u003eX-ray of both knees, standing, front to back view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73580\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of knee joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73590\u003c/td\u003e\n              \u003ctd\u003eX-ray of lower leg, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73592\u003c/td\u003e\n              \u003ctd\u003eX-ray of leg in infant minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73600\u003c/td\u003e\n              \u003ctd\u003eX-ray of ankle, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73610\u003c/td\u003e\n              \u003ctd\u003eX-ray of ankle, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73615\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of ankle joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73620\u003c/td\u003e\n              \u003ctd\u003eX-ray of foot, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73630\u003c/td\u003e\n              \u003ctd\u003eX-ray of foot, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73650\u003c/td\u003e\n              \u003ctd\u003eX-ray of heel, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e73660\u003c/td\u003e\n              \u003ctd\u003eX-ray of toes, minimum of 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74000\u003c/td\u003e\n              \u003ctd\u003eX-ray of abdomen, single view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74010\u003c/td\u003e\n              \u003ctd\u003eImaging of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74018\u003c/td\u003e\n              \u003ctd\u003eX-ray of abdomen, 1 view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74019\u003c/td\u003e\n              \u003ctd\u003eX-ray of abdomen, 2 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74020\u003c/td\u003e\n              \u003ctd\u003eImaging of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74021\u003c/td\u003e\n              \u003ctd\u003eX-ray of abdomen, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74022\u003c/td\u003e\n              \u003ctd\u003eComplete X-ray study of abdomen with single X-ray of chest\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74190\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of lower abdominal and genital region\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74210\u003c/td\u003e\n              \u003ctd\u003eX-ray of voice box and/or esophagus in neck with contrast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74235\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of removal of foreign bodies in esophagus with balloon catheter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74290\u003c/td\u003e\n              \u003ctd\u003eImaging of gallbladder with contrast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74291\u003c/td\u003e\n              \u003ctd\u003eImaging of gallbladder with contrast, which may involve additional, repeat, or multiple-day examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74305\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of bile and/or pancreatic ducts, contrast inserted through existing catheter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74320\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of X-ray of bile duct, contrast injection (accessed through the skin)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74327\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of removal of biliary duct stone (accessed through the skin) after surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74355\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement (accessed through the skin) of small bowel tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74360\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of opening of digestive tract procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74363\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of dilation of biliary duct (accessed through the skin)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74415\u003c/td\u003e\n              \u003ctd\u003eImaging of urinary tract using infusion technique with kidney section filming\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74420\u003c/td\u003e\n              \u003ctd\u003eImaging of urinary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74425\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of urinary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74430\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of urinary bladder, minimum of 3 views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74440\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of male internal genitals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74445\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74450\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of urinary bladder and urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74455\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of urinary bladder and urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74470\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of kidney cyst, lower back contrast injection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74475\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement of catheter (accessed through the skin) into kidney procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74480\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement of catheter into ureter (accessed through the skin) procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74485\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of dilation of urinary ducts (ureters) or bladder canal (urethra)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74710\u003c/td\u003e\n              \u003ctd\u003eImaging of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74740\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation X-ray of uterine tubes and ovaries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74742\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement of catheter of uterine tube procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e74775\u003c/td\u003e\n              \u003ctd\u003eImaging of anogenital region\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75801\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of lymphatic system of one arm or leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75803\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of lymphatic system of both arms or legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75805\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of lymphatic system of one side of pelvis and abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75807\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of lymphatic system of both side of pelvis and abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75809\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of previous placed shunt\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75893\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of drawing blood via catheter procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75901\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of removal of obstructive material in catheter procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75902\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of removal of obstructive material from large vein catheter procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75952\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of repair of artery of abdomen procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75970\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of biopsy procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75980\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of drainage of biliary duct (accessed through the skin) with contrast monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75982\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement (accessed through the skin) of bile drainage catheter or stent\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75984\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of change of tube (accessed through the skin) or drainage catheter with contrast monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e75989\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of placement of catheter with drainage (accessed through the skin) procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76000\u003c/td\u003e\n              \u003ctd\u003eImaging guidance for procedure, up to 1 hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76001\u003c/td\u003e\n              \u003ctd\u003eImaging guidance for procedure, more than 1 hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76010\u003c/td\u003e\n              \u003ctd\u003eImaging from nose to rectum, single view, child\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76080\u003c/td\u003e\n              \u003ctd\u003eImaging for abscess or abnormal drainage tract procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76098\u003c/td\u003e\n              \u003ctd\u003eImaging of surgical specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76100\u003c/td\u003e\n              \u003ctd\u003eSingle plane imaging procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76101\u003c/td\u003e\n              \u003ctd\u003eComplex motion imaging procedure on one side of body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76102\u003c/td\u003e\n              \u003ctd\u003eComplex motion imaging procedure on both sides of body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76120\u003c/td\u003e\n              \u003ctd\u003eImaging of organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76125\u003c/td\u003e\n              \u003ctd\u003eImaging of organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76140\u003c/td\u003e\n              \u003ctd\u003eConsultation on X-ray imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76376\u003c/td\u003e\n              \u003ctd\u003e3D radiographic procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76377\u003c/td\u003e\n              \u003ctd\u003e3D radiographic procedure with computerized image postprocessing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76390\u003c/td\u003e\n              \u003ctd\u003eMRI study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76496\u003c/td\u003e\n              \u003ctd\u003eFluoroscopic procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76499\u003c/td\u003e\n              \u003ctd\u003eImaging procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76950\u003c/td\u003e\n              \u003ctd\u003eUltrasonic guidance for administration of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e76965\u003c/td\u003e\n              \u003ctd\u003eUltrasonic guidance for administration of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77001\u003c/td\u003e\n              \u003ctd\u003eFluoroscopic guidance for insertion, replacement or removal of central venous access device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77002\u003c/td\u003e\n              \u003ctd\u003eFluoroscopic guidance for insertion of needle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77003\u003c/td\u003e\n              \u003ctd\u003eFluoroscopic guidance for injection into spine or muscle next to spine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77051\u003c/td\u003e\n              \u003ctd\u003eComputer analysis of diagnostic mammogram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77052\u003c/td\u003e\n              \u003ctd\u003eComputer analysis of screening mammogram to assist detection of cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77053\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of breast duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77054\u003c/td\u003e\n              \u003ctd\u003eRadiological supervision and interpretation of imaging of breast ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77055\u003c/td\u003e\n              \u003ctd\u003eMammography of one breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77056\u003c/td\u003e\n              \u003ctd\u003eMammography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77057\u003c/td\u003e\n              \u003ctd\u003eScreening mammography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77061\u003c/td\u003e\n              \u003ctd\u003eDigital tomography of one breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77062\u003c/td\u003e\n              \u003ctd\u003eDigital tomography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77063\u003c/td\u003e\n              \u003ctd\u003eScreening digital tomography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77065\u003c/td\u003e\n              \u003ctd\u003eMammography of one breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77066\u003c/td\u003e\n              \u003ctd\u003eMammography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77067\u003c/td\u003e\n              \u003ctd\u003eMammography of both breasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77071\u003c/td\u003e\n              \u003ctd\u003eImaging of joint with stressing by physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77072\u003c/td\u003e\n              \u003ctd\u003eImaging for bone age assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77073\u003c/td\u003e\n              \u003ctd\u003eImaging for bone length assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77074\u003c/td\u003e\n              \u003ctd\u003eX-ray of bones\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77075\u003c/td\u003e\n              \u003ctd\u003eX-ray survey of forearm or wrist bone density\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77076\u003c/td\u003e\n              \u003ctd\u003eX-ray survey of bones, infant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77077\u003c/td\u003e\n              \u003ctd\u003eImaging of 2 or more joints, single view\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77080\u003c/td\u003e\n              \u003ctd\u003eBone density measurement using dedicated X-ray machine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77081\u003c/td\u003e\n              \u003ctd\u003eBone density measurement using dedicated X-ray machine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77082\u003c/td\u003e\n              \u003ctd\u003eSpine scanning X-ray done with bone density measurement for spine compression\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77085\u003c/td\u003e\n              \u003ctd\u003eBone density measurement using dedicated X-ray machine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77086\u003c/td\u003e\n              \u003ctd\u003eFracture assessment of spine bones using dedicated X-ray machine for bone density measurement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77261\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77262\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77263\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77280\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy simulation, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77285\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, simulation, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77290\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, simulation, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77293\u003c/td\u003e\n              \u003ctd\u003eRespiratory motion management simulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77295\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy, 3D\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77299\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77300\u003c/td\u003e\n              \u003ctd\u003eCalculation of radiation therapy dose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77301\u003c/td\u003e\n              \u003ctd\u003eManagement of modulation radiotherapy planning\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77305\u003c/td\u003e\n              \u003ctd\u003eIsodose radiation therapy plan, 1 or more ports, single area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77306\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77307\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77310\u003c/td\u003e\n              \u003ctd\u003eIsodose radiation therapy plan, 3 or more ports, single area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77315\u003c/td\u003e\n              \u003ctd\u003eIsodose radiation therapy plan, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77316\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77317\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77318\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77321\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy total body port plan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77326\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy radiation therapy plan (1 to 4 applications, 9 to 12 brachytherapy sources)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77327\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy radiation therapy plan (5 to 10 applications, 9 to 12 brachytherapy sources)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77328\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy radiation therapy plan (over 10 applications, over 12 brachytherapy sources)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77331\u003c/td\u003e\n              \u003ctd\u003eSpecial radiation therapy planning\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77332\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment devices, design and construction, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77333\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment devices, design and construction, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77334\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment devices, design and construction, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77336\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy consultation per week\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77338\u003c/td\u003e\n              \u003ctd\u003eDesign and construction of device for radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77370\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy consultation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77371\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy delivery, stereotactic radiosurgery (SRS) for cranial growths, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77372\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy delivery, stereotactic radiosurgery (SRS) for cranial growths, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77373\u003c/td\u003e\n              \u003ctd\u003eStereotactic body radiation therapy 1 or more lesions using imaging guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77385\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy delivery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77386\u003c/td\u003e\n              \u003ctd\u003eRadiation therapy delivery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77387\u003c/td\u003e\n              \u003ctd\u003eGuidance for localization of target delivery of radiation treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77399\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77401\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, superficial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77402\u003c/td\u003e\n              \u003ctd\u003eSimple radiation treatment delivery \u0026gt;/\u003d1 MeV\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77403\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77404\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77406\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77407\u003c/td\u003e\n              \u003ctd\u003eIntermediate radiation treatment delivery \u0026gt;/\u003d1 MeV\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77408\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, two treatment areas, 3 or more ports\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77409\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, two treatment areas, 3 or more ports\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77411\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, two treatment areas, 3 or more ports\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77412\u003c/td\u003e\n              \u003ctd\u003eComplex radiation treatment delivery \u0026gt;/\u003d1 MeV\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77413\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, three or more treatment areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77414\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, three or more treatment areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77416\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, three or more treatment areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77417\u003c/td\u003e\n              \u003ctd\u003eTherapeutic radiology port films\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77418\u003c/td\u003e\n              \u003ctd\u003eIntensity modulated radiation treatment delivery per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77421\u003c/td\u003e\n              \u003ctd\u003eX-ray guidance for radiation therapy delivery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77422\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, high energy, single treatment area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77423\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, high energy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77424\u003c/td\u003e\n              \u003ctd\u003eIntraoperative single X-ray radiation treatment session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77425\u003c/td\u003e\n              \u003ctd\u003eIntraoperative electrons radiation treatment single session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77427\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment management, 5 treatments\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77431\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment management, 1 or 2 treatments\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77432\u003c/td\u003e\n              \u003ctd\u003eStereotactic radiation treatment management of brain lesions, complete course of treatment consisting of 1 session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77435\u003c/td\u003e\n              \u003ctd\u003eStereotactic radiation treatment management of 1 or more lesions using imaging guidance, per treatment course\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77469\u003c/td\u003e\n              \u003ctd\u003eIntraoperative radiation treatment management\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77470\u003c/td\u003e\n              \u003ctd\u003eSpecial radiation treatment procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77499\u003c/td\u003e\n              \u003ctd\u003eManagement of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77520\u003c/td\u003e\n              \u003ctd\u003eProton treatment delivery, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77522\u003c/td\u003e\n              \u003ctd\u003eProton treatment delivery, simple with compensation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77523\u003c/td\u003e\n              \u003ctd\u003eProton treatment delivery, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77525\u003c/td\u003e\n              \u003ctd\u003eProton treatment delivery, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77600\u003c/td\u003e\n              \u003ctd\u003eExternal hyperthermia treatment depth 4 cm or less\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77605\u003c/td\u003e\n              \u003ctd\u003eExternal hyperthermia treatment depth greater than 4 cm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77610\u003c/td\u003e\n              \u003ctd\u003eHyperthermia treatment, 5 or fewer probe applications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77615\u003c/td\u003e\n              \u003ctd\u003eHyperthermia treatment, 5 or more probe applications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77620\u003c/td\u003e\n              \u003ctd\u003eHyperthermia treatment by organ cavity probes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77750\u003c/td\u003e\n              \u003ctd\u003eInfusion or instillation of radioelement solution, includes 3-month follow-up care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77761\u003c/td\u003e\n              \u003ctd\u003eApplication of organ cavity radiation source, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77762\u003c/td\u003e\n              \u003ctd\u003eApplication of organ cavity radiation source, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77763\u003c/td\u003e\n              \u003ctd\u003eApplication of organ cavity radiation source, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77767\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy through skin surface, 1 channel or up to 2.0 cm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77768\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy through skin surface, 2 channels or more than 2.0 cm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77770\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy , 1 channel\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77771\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy , 2- 12 channels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77772\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy , more than 12 channels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77776\u003c/td\u003e\n              \u003ctd\u003eApplication of radiation source, simple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77777\u003c/td\u003e\n              \u003ctd\u003eApplication of radiation source, intermediate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77778\u003c/td\u003e\n              \u003ctd\u003eApplication of radiation source, complex\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77785\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy delivery, 1 channel\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77786\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy delivery, 2-12 channels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77787\u003c/td\u003e\n              \u003ctd\u003eHigh dose brachytherapy delivery, over 12 channels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77789\u003c/td\u003e\n              \u003ctd\u003eSurface application of radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77790\u003c/td\u003e\n              \u003ctd\u003eSupervision, handling, loading of radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e77799\u003c/td\u003e\n              \u003ctd\u003eAdministration of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78012\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine imaging for thyroid uptake measurements\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78013\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine imaging of thyroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78014\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine imaging for thyroid uptake measurements\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78015\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine limited study for thyroid cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78016\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine additional studies for thyroid cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78018\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine whole body study for thyroid cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78020\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study for thyroid cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78070\u003c/td\u003e\n              \u003ctd\u003eImaging of parathyroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78071\u003c/td\u003e\n              \u003ctd\u003eImaging of parathyroid with nuclear medicine study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78072\u003c/td\u003e\n              \u003ctd\u003eImaging of parathyroid with CT and nuclear medicine study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78075\u003c/td\u003e\n              \u003ctd\u003eImaging of blood vessel of gland of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78099\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of endocrine organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78102\u003c/td\u003e\n              \u003ctd\u003eImaging of bone marrow limited area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78103\u003c/td\u003e\n              \u003ctd\u003eImaging of bone marrow multiple areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78104\u003c/td\u003e\n              \u003ctd\u003eImaging of bone marrow whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78110\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of plasma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78111\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of plasma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78120\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of red blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78121\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of red blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78122\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78130\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of red blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78135\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of red blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78140\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of red blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78185\u003c/td\u003e\n              \u003ctd\u003eImaging of spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78190\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of survival of blood cell\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78191\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of platelet\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78195\u003c/td\u003e\n              \u003ctd\u003eImaging of lymphatic tissue and lymph node\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78199\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of cardiovascular systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78201\u003c/td\u003e\n              \u003ctd\u003eImaging of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78202\u003c/td\u003e\n              \u003ctd\u003eImaging of liver blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78205\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78206\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of liver with blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78215\u003c/td\u003e\n              \u003ctd\u003eImaging of liver and spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78216\u003c/td\u003e\n              \u003ctd\u003eImaging of liver and spleen with blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78226\u003c/td\u003e\n              \u003ctd\u003eImaging of liver and bile duct system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78227\u003c/td\u003e\n              \u003ctd\u003eImaging of liver and bile duct system with use of drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78230\u003c/td\u003e\n              \u003ctd\u003eImaging of salivary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78231\u003c/td\u003e\n              \u003ctd\u003eImaging of salivary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78232\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of salivary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78258\u003c/td\u003e\n              \u003ctd\u003eImaging of esophagus using radioisotopes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78261\u003c/td\u003e\n              \u003ctd\u003eImaging of stomach lining\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78262\u003c/td\u003e\n              \u003ctd\u003eStomach and esophagus regurgitation study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78264\u003c/td\u003e\n              \u003ctd\u003eStomach emptying study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78265\u003c/td\u003e\n              \u003ctd\u003eStomach emptying and small bowel transit study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78266\u003c/td\u003e\n              \u003ctd\u003eStomach emptying and small bowel with colon transit study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78267\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of digestive tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78268\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of digestive tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78270\u003c/td\u003e\n              \u003ctd\u003eVitamin B-12 absorption study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78271\u003c/td\u003e\n              \u003ctd\u003eVitamin B-12 absorption study with factor necessary for absorption\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78272\u003c/td\u003e\n              \u003ctd\u003eVitamin B-12 absorption study without then with factor necessary for absorption\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78278\u003c/td\u003e\n              \u003ctd\u003eAcute digestive tract blood loss imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78282\u003c/td\u003e\n              \u003ctd\u003eDigestive tract protein loss\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78290\u003c/td\u003e\n              \u003ctd\u003eIntestine imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78291\u003c/td\u003e\n              \u003ctd\u003ePeritoneal-venous shunt patency test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78299\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of digestive tracts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78300\u003c/td\u003e\n              \u003ctd\u003eBone and/or joint imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78305\u003c/td\u003e\n              \u003ctd\u003eBone and/or joint imaging, multiple areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78306\u003c/td\u003e\n              \u003ctd\u003eBone and/or joint imaging, whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78315\u003c/td\u003e\n              \u003ctd\u003eBone and/or joint imaging, 3 phase study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78320\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of bone and/or joint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78350\u003c/td\u003e\n              \u003ctd\u003eBone density (bone mineral content) study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78351\u003c/td\u003e\n              \u003ctd\u003eBone density (bone mineral content) study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78399\u003c/td\u003e\n              \u003ctd\u003eDiagnostic musculoskeletal nuclear medicine studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78414\u003c/td\u003e\n              \u003ctd\u003eNon-imaging determination of cardiovascular function\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78428\u003c/td\u003e\n              \u003ctd\u003eCardiac shunt detection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78445\u003c/td\u003e\n              \u003ctd\u003eNon-cardiac vascular flow imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78451\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of vessels of heart using drugs or exercise single study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78452\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of vessels of heart using drugs or exercise multiple studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78453\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine single study of vessels of heart using drugs or exercise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78454\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine multiple studies of vessels of heart at rest, using drugs, or exercise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78456\u003c/td\u003e\n              \u003ctd\u003eDiagnostic nuclear imaging of platelet proteins for blood clot assessment in vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78457\u003c/td\u003e\n              \u003ctd\u003eVenography for blood clot in vein, one leg or arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78458\u003c/td\u003e\n              \u003ctd\u003eVenography for blood clot in veins, both legs or arms\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78459\u003c/td\u003e\n              \u003ctd\u003eSingle nuclear medicine study of heart muscle with metabolic evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78466\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart muscle following heart attack\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78468\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart muscle following heart attack with evaluation of blood ejection from heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78469\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart muscle following heart attack\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78472\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78473\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart function wall motion at rest and stress with evaluation of blood ejection from heart, multiple studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78481\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78483\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart wall motion at rest and stress with evaluation of blood ejection from heart, multiple studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78491\u003c/td\u003e\n              \u003ctd\u003eSingle nuclear medicine study of blood flow in heart muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78492\u003c/td\u003e\n              \u003ctd\u003eMultiple nuclear medicine studies of blood flow in heart muscle at rest and with stress\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78494\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart wall motion at rest with evaluation of blood ejection from heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78496\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of heart function at rest or stress with evaluation of blood ejection from heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78499\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of cardiovascular systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78579\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of lung ventilation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78580\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of blood circulation in the lungs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78582\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of lung ventilation and blood circulation in the lungs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78597\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study with measurement of blood circulation in the lungs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78598\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study with measurement of blood circulation in the lungs and ventilation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78599\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of respiratory systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78600\u003c/td\u003e\n              \u003ctd\u003eImaging of brain, less than 4 static views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78601\u003c/td\u003e\n              \u003ctd\u003eImaging of brain with blood flow, less than 4 static views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78605\u003c/td\u003e\n              \u003ctd\u003eImaging of brain with blood flow, minimum of 4 static views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78606\u003c/td\u003e\n              \u003ctd\u003eImaging of brain with blood flow, minimum of 4 static views\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78607\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78608\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study brain with metabolic evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78609\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study brain with blood circulation evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78610\u003c/td\u003e\n              \u003ctd\u003eImaging of brain, blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78630\u003c/td\u003e\n              \u003ctd\u003eImaging of brain and spinal cord fluid flow at base of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78635\u003c/td\u003e\n              \u003ctd\u003eImaging of brain and spinal cord fluid flow in brain compartments (ventricles)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78645\u003c/td\u003e\n              \u003ctd\u003eImaging of brain and spinal cord fluid flow shunt evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78647\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of brain and spinal cord fluid flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78650\u003c/td\u003e\n              \u003ctd\u003eImaging of brain and spinal cord fluid leakage detection and localization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78660\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of tear drainage structure of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78699\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of nervous systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78700\u003c/td\u003e\n              \u003ctd\u003eImaging of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78701\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of kidney with assessment of blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78707\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of kidney with assessment of blood flow and function\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78708\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of kidney with assessment of blood flow and function\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78709\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of kidney with assessment of blood flow and function\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78710\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78725\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine kidney function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78730\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of remaining urine in bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78740\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine backwash of urine into kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78761\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of testicles and blood vessel flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78799\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of urogenital systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78800\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78801\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78802\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in whole body, single day imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78803\u003c/td\u003e\n              \u003ctd\u003eSPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78804\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in whole body, 2 or more days imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78805\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of radioactive material distribution at site of inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78806\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of radioactive material distribution at sites of inflammation in whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78807\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study of radioactive material distribution at site of inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78808\u003c/td\u003e\n              \u003ctd\u003eInjection of radioactive contrast material into a vein for non-imaging gamma probe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78811\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study limited area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78812\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine imaging from skull base to mid-thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78813\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine imaging whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78814\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study with CT imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78815\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study with CT imaging skull base to mid-thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78816\u003c/td\u003e\n              \u003ctd\u003eNuclear medicine study with CT imaging whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78830\u003c/td\u003e\n              \u003ctd\u003eSPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, with concurrently acquired CT transmission scan, 1 day of imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78831\u003c/td\u003e\n              \u003ctd\u003eSPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78832\u003c/td\u003e\n              \u003ctd\u003eSPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days, with concurrently acquired CT transmission scan, 1 day of imaging\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78835\u003c/td\u003e\n              \u003ctd\u003eQuantification of radioactive tracer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e78999\u003c/td\u003e\n              \u003ctd\u003eDiagnostic nuclear medicine procedures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e79101\u003c/td\u003e\n              \u003ctd\u003eRadioactive material therapy into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e79200\u003c/td\u003e\n              \u003ctd\u003eRadioactive material therapy into body space or cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e79300\u003c/td\u003e\n              \u003ctd\u003eRadioactive material therapy into tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e79403\u003c/td\u003e\n              \u003ctd\u003eRadioactive material therapy into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80100\u003c/td\u003e\n              \u003ctd\u003eDrug screen, multiple drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80101\u003c/td\u003e\n              \u003ctd\u003eDrug screen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80102\u003c/td\u003e\n              \u003ctd\u003eDrug confirmation test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80103\u003c/td\u003e\n              \u003ctd\u003eTissue preparation for drug analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80104\u003c/td\u003e\n              \u003ctd\u003eDrug screen, multiple drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80500\u003c/td\u003e\n              \u003ctd\u003eClinical pathology consultation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e80502\u003c/td\u003e\n              \u003ctd\u003eComprehensive, clinical pathology consultation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81000\u003c/td\u003e\n              \u003ctd\u003eManual urinalysis test with examination using microscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81001\u003c/td\u003e\n              \u003ctd\u003eManual urinalysis test with examination using microscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81007\u003c/td\u003e\n              \u003ctd\u003eUrinalysis for bacteria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81015\u003c/td\u003e\n              \u003ctd\u003eUrinalysis using microscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81020\u003c/td\u003e\n              \u003ctd\u003eUrinalysis, 2 or 3 glass test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81105\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 1) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81106\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 2) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81107\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 3) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81108\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 4) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81109\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 5) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81110\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 6) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81111\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 9) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81112\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Human Platelet Antigen 15) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81120\u003c/td\u003e\n              \u003ctd\u003eGene analysis (isocitrate dehydrogenase 1 [NADP+], soluble) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81121\u003c/td\u003e\n              \u003ctd\u003eGene analysis (isocitrate dehydrogenase 2 [NADP+], mitochondrial) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81161\u003c/td\u003e\n              \u003ctd\u003eGene analysis (dystrophin)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81162\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81163\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81164\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) for duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81165\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81166\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1) for duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81167\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 2) for duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81170\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ABL proto-oncogene 1, non-receptor tyrosine kinase)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81171\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fragile X mental retardation 2) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81172\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fragile X mental retardation 2) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81173\u003c/td\u003e\n              \u003ctd\u003eGene analysis (androgen receptor) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81174\u003c/td\u003e\n              \u003ctd\u003eGene analysis (androgen receptor) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81175\u003c/td\u003e\n              \u003ctd\u003eGene analysis (additional sex combs like 1, transcriptional regulator) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81176\u003c/td\u003e\n              \u003ctd\u003eGene analysis (additional sex combs like 1, transcriptional regulator) targeted sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81177\u003c/td\u003e\n              \u003ctd\u003eGene analysis (atropin 1) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81178\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 1) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81179\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 2) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81180\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 3) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81181\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 7) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81182\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 8 opposite strand [non-protein coding]) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81183\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ataxin 10) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81184\u003c/td\u003e\n              \u003ctd\u003eGene analysis (calcium voltage-gated channel subunit alpha1 A) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81185\u003c/td\u003e\n              \u003ctd\u003eGene analysis (calcium voltage-gated channel subunit alpha1 A) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81186\u003c/td\u003e\n              \u003ctd\u003eGene analysis (calcium voltage-gated channel subunit alpha1 A) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81187\u003c/td\u003e\n              \u003ctd\u003eGene analysis (CCH-type zinc finger nucleic acid binding protein) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81188\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystatin B) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81189\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystatin B) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81190\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystatin B) for known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81200\u003c/td\u003e\n              \u003ctd\u003eGene analysis (aspartoacylase)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81201\u003c/td\u003e\n              \u003ctd\u003eGene analysis (adenomatous polyposis coli), full gene sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81202\u003c/td\u003e\n              \u003ctd\u003eGene analysis (adenomatous polyposis coli), known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81203\u003c/td\u003e\n              \u003ctd\u003eGene analysis (adenomatous polyposis coli), duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81204\u003c/td\u003e\n              \u003ctd\u003eGene analysis (androgen receptor) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81205\u003c/td\u003e\n              \u003ctd\u003eGene analysis (branched-chain keto acid dehydrogenase E1, beta polypeptide)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81206\u003c/td\u003e\n              \u003ctd\u003eTranslocation analysis (BCR/ABL1) minor breakpoint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81207\u003c/td\u003e\n              \u003ctd\u003eTranslocation analysis (BCR/ABL1) major breakpoint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81208\u003c/td\u003e\n              \u003ctd\u003eTranslocation analysis (BCR/ABL1) other breakpoint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81209\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Bloom syndrome, RecQ helicase-like)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81210\u003c/td\u003e\n              \u003ctd\u003eGene analysis (v-raf murine sarcoma viral oncogene homolog B1)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81211\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81212\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) for 185delAG, 5385insC, 6174delT variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81213\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1 and 2) uncommon duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81214\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1) full sequence and common duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81215\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 1) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81216\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 2) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81217\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast cancer 2) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81218\u003c/td\u003e\n              \u003ctd\u003eGene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81219\u003c/td\u003e\n              \u003ctd\u003eGene analysis (calreticulin), common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81220\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystic fibrosis transmembrane conductance regular) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81221\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystic fibrosis transmembrane conductance regular) known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81222\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystic fibrosis transmembrane conductance regular) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81223\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81224\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cystic fibrosis transmembrane conductance regular) intron 8 poly-T\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81225\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily C, polypeptide 19) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81226\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81227\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450, family 2, subfamily C, polypeptide 9) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81228\u003c/td\u003e\n              \u003ctd\u003eGenome-wide microarray analysis for copy number variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81229\u003c/td\u003e\n              \u003ctd\u003eGenome-wide microarray analysis for copy number and single nucleotide polymorphism variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81230\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450 family 3 subfamily A member 4) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81231\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cytochrome P450 family 3 subfamily A member 5) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81232\u003c/td\u003e\n              \u003ctd\u003eGene analysis (dihydropyrimidine dehydrogenase) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81233\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Bruton\u0027s tyrosine kinase) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81234\u003c/td\u003e\n              \u003ctd\u003eGene analysis (DM1 protein kinase) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81235\u003c/td\u003e\n              \u003ctd\u003eGene analysis (epidermal growth factor receptor), common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81236\u003c/td\u003e\n              \u003ctd\u003eGene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81237\u003c/td\u003e\n              \u003ctd\u003eGene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81238\u003c/td\u003e\n              \u003ctd\u003eGene analysis (coagulation factor IX) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81239\u003c/td\u003e\n              \u003ctd\u003eGene analysis (DM1 protein kinase) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81240\u003c/td\u003e\n              \u003ctd\u003eGene analysis (prothrombin, coagulation factor II) A variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81241\u003c/td\u003e\n              \u003ctd\u003eGene analysis (coagulation factor V) Leiden variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81242\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Fanconi anemia, complementation group C) common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81243\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fragile X mental retardation) abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81244\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fragile X mental retardation 1) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81245\u003c/td\u003e\n              \u003ctd\u003eGene analysis (fms-related tyrosine kinase 3) internal tandem duplication variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81246\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with blood cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81247\u003c/td\u003e\n              \u003ctd\u003eGene analysis (glucose-6-phosphate dehydrogenase) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81248\u003c/td\u003e\n              \u003ctd\u003eGene analysis (glucose-6-phosphate dehydrogenase) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81249\u003c/td\u003e\n              \u003ctd\u003eGene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81250\u003c/td\u003e\n              \u003ctd\u003eGene analysis (glucose-6-phosphatase, catalytic subunit) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81251\u003c/td\u003e\n              \u003ctd\u003eGene analysis (glucosidase, beta, acid) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81252\u003c/td\u003e\n              \u003ctd\u003eGene analysis (gap junction protein, beta 2, 26kda, connexin 26), full gene sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81253\u003c/td\u003e\n              \u003ctd\u003eGene analysis (gap junction protein, beta 2, 26kda, connexin 26), known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81254\u003c/td\u003e\n              \u003ctd\u003eGene analysis (gap junction protein, beta 6, 30kda, connexin 30), common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81255\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hexosaminidase A) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81256\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hemochromatosis) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81257\u003c/td\u003e\n              \u003ctd\u003eGene analysis (alpha globin 1 and alpha globin 2) for common deletions or variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81258\u003c/td\u003e\n              \u003ctd\u003eGene analysis (alpha globin 1 and alpha globin 2) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81259\u003c/td\u003e\n              \u003ctd\u003eGene analysis (alpha globin 1 and alpha globin 2) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81260\u003c/td\u003e\n              \u003ctd\u003eGene analysis (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81261\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population amplified methodology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81262\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population direct probe methodology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81263\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81264\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis (immunoglobulin kappa light chain locus) to detect abnormal clonal population\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81265\u003c/td\u003e\n              \u003ctd\u003eComparative analysis using Short Tandem Repeat (STR) markers of patient and specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81266\u003c/td\u003e\n              \u003ctd\u003eComparative analysis using Short Tandem Repeat (STR) markers of patient and specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81267\u003c/td\u003e\n              \u003ctd\u003eChimerism analysis post transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81268\u003c/td\u003e\n              \u003ctd\u003eChimerism analysis post transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81269\u003c/td\u003e\n              \u003ctd\u003eGene analysis (alpha globin 1 and alpha globin 2) for duplication/deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81270\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Janus kinase 2) variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81271\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Huntingtin) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81272\u003c/td\u003e\n              \u003ctd\u003eGene analysis (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81273\u003c/td\u003e\n              \u003ctd\u003eGene analysis (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog), D816 variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81274\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Huntingtin) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81275\u003c/td\u003e\n              \u003ctd\u003eGene analysis (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) variants in codons 12 and 13\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81276\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Kirsten rat sarcoma viral oncogene homolog), additional variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81277\u003c/td\u003e\n              \u003ctd\u003eCancer cytogenomic array gene analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81280\u003c/td\u003e\n              \u003ctd\u003eGene analysis (long QT syndrome) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81281\u003c/td\u003e\n              \u003ctd\u003eGene analysis (long QT syndrome) known familial sequence variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81282\u003c/td\u003e\n              \u003ctd\u003eGene analysis (long QT syndrome) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81283\u003c/td\u003e\n              \u003ctd\u003eGene analysis (interferon, lambda 3) for rs12979860 variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81284\u003c/td\u003e\n              \u003ctd\u003eGene analysis (frataxin) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81285\u003c/td\u003e\n              \u003ctd\u003eGene analysis (frataxin) for characterization of alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81286\u003c/td\u003e\n              \u003ctd\u003eGene analysis (frataxin) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81287\u003c/td\u003e\n              \u003ctd\u003eGene analysis (O-6-methylguanine-DNA methyltransferase) for promoter methylation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81288\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with colon cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81289\u003c/td\u003e\n              \u003ctd\u003eGene analysis (frataxin) for known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81290\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mucolipin 1) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81291\u003c/td\u003e\n              \u003ctd\u003eGene analysis (5, 10-methylenetetrahydrofolate reductase) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81292\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81293\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81294\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81295\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81296\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81297\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81298\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 6 [E coli]) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81299\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 6 [E coli]) known familial variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81300\u003c/td\u003e\n              \u003ctd\u003eGene analysis (mutS homolog 6 [E coli]) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81301\u003c/td\u003e\n              \u003ctd\u003eMicrosatellite instability analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81302\u003c/td\u003e\n              \u003ctd\u003eGene analysis (methyl CpG binding protein 2) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81303\u003c/td\u003e\n              \u003ctd\u003eGene analysis (methyl CpG binding protein 2) known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81304\u003c/td\u003e\n              \u003ctd\u003eGene analysis (methyl CpG binding protein 2) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81305\u003c/td\u003e\n              \u003ctd\u003eGene analysis (myeloid differentiation primary response 88) for p.Leu265Pro variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81306\u003c/td\u003e\n              \u003ctd\u003eGene analysis (nudix hydrolase 15) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81307\u003c/td\u003e\n              \u003ctd\u003eGene analysis (partner and localizer of BRCA2) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81308\u003c/td\u003e\n              \u003ctd\u003eGene analysis (partner and localizer of BRCA2) for detection of known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81309\u003c/td\u003e\n              \u003ctd\u003eGene analysis (partner and localizer of BRCA2) targeted sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81310\u003c/td\u003e\n              \u003ctd\u003eGene analysis (nucleophosmin) exon 12 variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81311\u003c/td\u003e\n              \u003ctd\u003eGene analysis for cancer (neuroblastoma)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81312\u003c/td\u003e\n              \u003ctd\u003eGene analysis (poly[A] binding protein nuclear 1) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81313\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with prostate cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81314\u003c/td\u003e\n              \u003ctd\u003eGene analysis ((platelet-derived growth factor receptor, alpha polypeptide) targeted sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81315\u003c/td\u003e\n              \u003ctd\u003eTranslocation analysis (PML-RARA regulated adaptor molecule 1) common breakpoint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81316\u003c/td\u003e\n              \u003ctd\u003eTranslocation analysis (PML-RARA regulated adaptor molecule 1) single breakpoint\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81317\u003c/td\u003e\n              \u003ctd\u003eGene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81318\u003c/td\u003e\n              \u003ctd\u003eGene analysis (postmeiotic segregation increased 2 [S cerevisiae]) known familiar variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81319\u003c/td\u003e\n              \u003ctd\u003eGene analysis (postmeiotic segregation increased 2 [S cerevisiae]) duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81320\u003c/td\u003e\n              \u003ctd\u003eGene analysis (phospholipase C gamma 2) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81325\u003c/td\u003e\n              \u003ctd\u003eGene analysis (peripheral myelin protein 22), full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81326\u003c/td\u003e\n              \u003ctd\u003eGene analysis (peripheral myelin protein 22), known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81327\u003c/td\u003e\n              \u003ctd\u003eGene analysis (Septin9) for promoter methylation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81328\u003c/td\u003e\n              \u003ctd\u003eGene analysis (solute carrier organic anion transporter family, member 1B1) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81329\u003c/td\u003e\n              \u003ctd\u003eGene analysis (survival of motor neuron 1, telomeric) for dosage/deletion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81330\u003c/td\u003e\n              \u003ctd\u003eGene analysis (sphingomyelin phosphodiesterase 1, acid lysosomal) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81331\u003c/td\u003e\n              \u003ctd\u003eMethylation analysis (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81332\u003c/td\u003e\n              \u003ctd\u003eGene analysis (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81333\u003c/td\u003e\n              \u003ctd\u003eGene analysis (transforming growth factor beta-induced) for common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81334\u003c/td\u003e\n              \u003ctd\u003eGene analysis (runt related transcription factor 1) targeted sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81335\u003c/td\u003e\n              \u003ctd\u003eGene analysis (thiopurine S-methyltransferase) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81336\u003c/td\u003e\n              \u003ctd\u003eGene analysis (survival of motor neuron 1, telomeric) of full sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81337\u003c/td\u003e\n              \u003ctd\u003eGene analysis (survival of motor neuron 1, telomeric) for known familial sequence variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81340\u003c/td\u003e\n              \u003ctd\u003eGene analysis (T cell antigen receptor beta) amplification methodology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81341\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis detection abnormal clonal population (T cell antigen receptor beta) direct probe methodology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81342\u003c/td\u003e\n              \u003ctd\u003eGene rearrangement analysis detection abnormal clonal population (T cell antigen receptor gamma)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81343\u003c/td\u003e\n              \u003ctd\u003eGene analysis (protein phosphatase 2 regulatory subunit Bbeta) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81344\u003c/td\u003e\n              \u003ctd\u003eGene analysis (TATA box binding protein) for abnormal alleles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81345\u003c/td\u003e\n              \u003ctd\u003eGene analysis (telomerase reverse transcriptase) targeted sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81346\u003c/td\u003e\n              \u003ctd\u003eGene analysis (thymidylate synthetase) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81350\u003c/td\u003e\n              \u003ctd\u003eGene analysis (UDP glucuronosyltransferase 1 family, polypeptide A1) for detection of common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81355\u003c/td\u003e\n              \u003ctd\u003eGene analysis (vitamin K epoxide reductase complex subunit 1) common variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81361\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hemoglobin, subunit beta) for common variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81362\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hemoglobin, subunit beta) for known familial variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81363\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hemoglobin, subunit beta) for duplication/deletion variant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81364\u003c/td\u003e\n              \u003ctd\u003eGene analysis (hemoglobin, subunit beta) full sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81370\u003c/td\u003e\n              \u003ctd\u003eHLA class I and II typing low resolution HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81371\u003c/td\u003e\n              \u003ctd\u003eHLA class I and II typing, low resolution HLA-A, -B, and -DRB1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81372\u003c/td\u003e\n              \u003ctd\u003eHLA class I typing low resolution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81373\u003c/td\u003e\n              \u003ctd\u003eHLA class I typing low resolution one locus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81374\u003c/td\u003e\n              \u003ctd\u003eHLA class I typing, low resolution one antigen equivalent\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81375\u003c/td\u003e\n              \u003ctd\u003eHLA class II typing low resolution HLA-DRB1/3/4/5 and -DQB1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81376\u003c/td\u003e\n              \u003ctd\u003eHLA class II typing low resolution one locus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81377\u003c/td\u003e\n              \u003ctd\u003eHLA class II typing low resolution one antigen equivalent\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81378\u003c/td\u003e\n              \u003ctd\u003eHLA class I and II typing high resolution HLA-A, -B, -C, and -DRB1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81379\u003c/td\u003e\n              \u003ctd\u003eHLA Class I typing high resolution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81380\u003c/td\u003e\n              \u003ctd\u003eHLA class I typing high resolution one locus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81381\u003c/td\u003e\n              \u003ctd\u003eHLA class I typing high resolution one allele or allele group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81382\u003c/td\u003e\n              \u003ctd\u003eHLA class II typing high resolution one locus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81383\u003c/td\u003e\n              \u003ctd\u003eHLA class II typing high resolution one allele or allele group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81400\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81401\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81402\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 3\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81403\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 4\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81404\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 5\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81405\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81406\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 7\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81407\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 8\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81408\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure level 9\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81410\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81411\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81412\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes for disorders related to Ashkenazi Jews\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81413\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81414\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81415\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81416\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81417\u003c/td\u003e\n              \u003ctd\u003eReevaluation test for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81420\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with fetal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81422\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with fetal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81425\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81426\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81427\u003c/td\u003e\n              \u003ctd\u003eReevaluation test for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81430\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes causing hearing loss\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81431\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes causing hearing loss\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81432\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with inherited breast cancer-related disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81433\u003c/td\u003e\n              \u003ctd\u003eGene analysis (breast and related cancers), duplication or deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81434\u003c/td\u003e\n              \u003ctd\u003eGene analysis (retinal disorders), genomic sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81435\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with colon cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81436\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with colon cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81437\u003c/td\u003e\n              \u003ctd\u003eGene analysis (neuroendocrine tumors), genomic sequence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81438\u003c/td\u003e\n              \u003ctd\u003eGene analysis (neuroendocrine tumors), duplication and deletion variants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81439\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with inherited disease of heart muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81440\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81442\u003c/td\u003e\n              \u003ctd\u003eGene analysis (noonan syndrome) genomic sequence analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81443\u003c/td\u003e\n              \u003ctd\u003eGenomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81445\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with cancer of body organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81448\u003c/td\u003e\n              \u003ctd\u003eGene analysis panel for hereditary disorders of the peripheral nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81450\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with blood related cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81455\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81460\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81465\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81470\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with intellectual disability\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81471\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with intellectual disability\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81479\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81490\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with rheumatoid arthritis using immunoassay technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81493\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart vessels diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81500\u003c/td\u003e\n              \u003ctd\u003eGenetic profiling on oncology biopsy of ovarian lesions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81503\u003c/td\u003e\n              \u003ctd\u003eGenetic profiling on oncology biopsy of ovarian lesions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81504\u003c/td\u003e\n              \u003ctd\u003eGenetic profiling on oncology biopsy lesions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81506\u003c/td\u003e\n              \u003ctd\u003eEndocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, hba1c, insulin, hs-crp, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81507\u003c/td\u003e\n              \u003ctd\u003eDNA analysis using maternal plasma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81508\u003c/td\u003e\n              \u003ctd\u003eFetal congenital abnormalities, biochemical assays of two proteins (papp-a, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81509\u003c/td\u003e\n              \u003ctd\u003eFetal congenital abnormalities, biochemical assays of three proteins (papp-a, hcg [any form], dia), utilizing maternal serum, algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81510\u003c/td\u003e\n              \u003ctd\u003eFetal congenital abnormalities, biochemical assays of three analytes (afp, ue3, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81511\u003c/td\u003e\n              \u003ctd\u003eFetal congenital abnormalities, biochemical assays of four analytes (afp, ue3, hcg [any form], dia) utilizing maternal serum, algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81512\u003c/td\u003e\n              \u003ctd\u003eFetal congenital abnormalities, biochemical assays of five analytes (afp, ue3, total hcg, hyperglycosylated hcg, dia) utilizing maternal serum, algorithm reported as a risk score\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81518\u003c/td\u003e\n              \u003ctd\u003emRNA gene analysis of 11 genes in breast tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81519\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with breast cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81520\u003c/td\u003e\n              \u003ctd\u003eGene analysis of breast tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81521\u003c/td\u003e\n              \u003ctd\u003eGene analysis of breast tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81522\u003c/td\u003e\n              \u003ctd\u003emRNA gene expression analysis of 12 genes in breast tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81525\u003c/td\u003e\n              \u003ctd\u003eGene analysis (colon related cancer)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81528\u003c/td\u003e\n              \u003ctd\u003eGene analysis (colorectal cancer)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81535\u003c/td\u003e\n              \u003ctd\u003eCulture of live tumor cells and chemotherapy drug response by staining\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81536\u003c/td\u003e\n              \u003ctd\u003eCulture of live tumor cells and chemotherapy drug response by staining\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81538\u003c/td\u003e\n              \u003ctd\u003eTesting of lung tumor cells for prediction of survival\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81539\u003c/td\u003e\n              \u003ctd\u003eMeasurement of proteins associated with prostate cancer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81540\u003c/td\u003e\n              \u003ctd\u003eGene analysis (cancer)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81541\u003c/td\u003e\n              \u003ctd\u003eGene analysis of prostate tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81542\u003c/td\u003e\n              \u003ctd\u003emRNA gene expression analysis of 22 genes in prostate tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81545\u003c/td\u003e\n              \u003ctd\u003eGene analysis (thyroid cancer)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81551\u003c/td\u003e\n              \u003ctd\u003eGene analysis of prostate tumor tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81552\u003c/td\u003e\n              \u003ctd\u003emRNA gene expression analysis of 15 genes in eye melanoma o tissue or fine needle aspirate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81595\u003c/td\u003e\n              \u003ctd\u003eTest for detecting genes associated with heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81596\u003c/td\u003e\n              \u003ctd\u003eBiochemical assays for evaluation of chronic Hepatitis C virus infection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e81599\u003c/td\u003e\n              \u003ctd\u003eMultianalyte assay procedure with algorithmic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82003\u003c/td\u003e\n              \u003ctd\u003eAcetaminophen level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82043\u003c/td\u003e\n              \u003ctd\u003eUrine microalbumin (protein) level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82044\u003c/td\u003e\n              \u003ctd\u003eUrine microalbumin (protein) analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82045\u003c/td\u003e\n              \u003ctd\u003eAlbumin (protein) level related to restricted heart blood flow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82055\u003c/td\u003e\n              \u003ctd\u003eAlcohol (ethanol) level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82120\u003c/td\u003e\n              \u003ctd\u003eVaginal fluid chemical analysis for bacteria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82127\u003c/td\u003e\n              \u003ctd\u003eAmino acid analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82128\u003c/td\u003e\n              \u003ctd\u003eAmino acid analysis, multiple amino acids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e82175\u003c/td\u003e\n              \u003ctd\u003eArsenic level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83015\u003c/td\u003e\n              \u003ctd\u003eHeavy metal screening test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83018\u003c/td\u003e\n              \u003ctd\u003eHeavy metal level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83805\u003c/td\u003e\n              \u003ctd\u003eMeprobamate (sedative) level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83885\u003c/td\u003e\n              \u003ctd\u003eNickel level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83887\u003c/td\u003e\n              \u003ctd\u003eNicotine level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e83925\u003c/td\u003e\n              \u003ctd\u003eOpiates (drug) measurement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e84022\u003c/td\u003e\n              \u003ctd\u003ePhenothiazine (drug) level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e85097\u003c/td\u003e\n              \u003ctd\u003eBone marrow, smear interpretation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86077\u003c/td\u003e\n              \u003ctd\u003eBlood bank physician services for cross match and/or evaluation and written report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86078\u003c/td\u003e\n              \u003ctd\u003eBlood bank physician services for investigation of transfusion reaction with written report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86079\u003c/td\u003e\n              \u003ctd\u003eBlood bank physician services with written report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86812\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86813\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86816\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86817\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86821\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86822\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for autoimmune disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86825\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e86826\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87015\u003c/td\u003e\n              \u003ctd\u003eConcentration of specimen for infectious agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87040\u003c/td\u003e\n              \u003ctd\u003eBacterial blood culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87045\u003c/td\u003e\n              \u003ctd\u003eStool culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87046\u003c/td\u003e\n              \u003ctd\u003eStool culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87070\u003c/td\u003e\n              \u003ctd\u003eBacterial culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87071\u003c/td\u003e\n              \u003ctd\u003eBacterial culture and colony count\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87073\u003c/td\u003e\n              \u003ctd\u003eBacterial culture and colony count for anaerobic bacteria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87075\u003c/td\u003e\n              \u003ctd\u003eBacterial culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87076\u003c/td\u003e\n              \u003ctd\u003eBacterial culture for anaerobic isolates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87077\u003c/td\u003e\n              \u003ctd\u003eBacterial culture for aerobic isolates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87081\u003c/td\u003e\n              \u003ctd\u003eScreening test for pathogenic organisms\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87084\u003c/td\u003e\n              \u003ctd\u003eScreening test for pathogenic organisms with colony count\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87086\u003c/td\u003e\n              \u003ctd\u003eBacterial colony count, urine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87088\u003c/td\u003e\n              \u003ctd\u003eBacterial urine culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87101\u003c/td\u003e\n              \u003ctd\u003eFungal culture (mold or yeast) of skin, hair, or nail\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87102\u003c/td\u003e\n              \u003ctd\u003eFungal culture (mold or yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87103\u003c/td\u003e\n              \u003ctd\u003eFungal blood culture (mold or yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87106\u003c/td\u003e\n              \u003ctd\u003eFungal culture, yeast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87107\u003c/td\u003e\n              \u003ctd\u003eCulture for identification of yeast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87109\u003c/td\u003e\n              \u003ctd\u003eMycoplasma culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87110\u003c/td\u003e\n              \u003ctd\u003eCulture for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87116\u003c/td\u003e\n              \u003ctd\u003eCulture for acid-fast bacilli\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87118\u003c/td\u003e\n              \u003ctd\u003eIdentification of mycobacteria (TB or TB like organism)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87140\u003c/td\u003e\n              \u003ctd\u003eIdentification of organisms by immunologic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87143\u003c/td\u003e\n              \u003ctd\u003eIdentification of organism using chromatography\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87147\u003c/td\u003e\n              \u003ctd\u003eIdentification of organisms by immunologic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87149\u003c/td\u003e\n              \u003ctd\u003eIdentification of organisms by genetic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87150\u003c/td\u003e\n              \u003ctd\u003eIdentification of organisms by genetic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87152\u003c/td\u003e\n              \u003ctd\u003eIdentification of organism by pulse field gel typing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87153\u003c/td\u003e\n              \u003ctd\u003eIdentification of organisms by genetic analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87158\u003c/td\u003e\n              \u003ctd\u003eMicrobial identification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87164\u003c/td\u003e\n              \u003ctd\u003eDark field microscopic examination for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87166\u003c/td\u003e\n              \u003ctd\u003eDark field microscopic examination for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87168\u003c/td\u003e\n              \u003ctd\u003eMacroscopic examination (visual inspection) of insect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87169\u003c/td\u003e\n              \u003ctd\u003eMacroscopic examination (visual inspection) of parasite\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87172\u003c/td\u003e\n              \u003ctd\u003ePinworm test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87176\u003c/td\u003e\n              \u003ctd\u003eTissue preparation for culture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87177\u003c/td\u003e\n              \u003ctd\u003eSmear for parasites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87181\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87184\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87185\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87186\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87187\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87188\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antimicrobial drug (antibiotic, antifungal, antiviral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87190\u003c/td\u003e\n              \u003ctd\u003eAntimicrobial study, mycobacteria (TB organism family)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87197\u003c/td\u003e\n              \u003ctd\u003eEvaluation of antibiotic therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87205\u003c/td\u003e\n              \u003ctd\u003eSpecial stain for microorganism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87206\u003c/td\u003e\n              \u003ctd\u003eSpecial stain for microorganism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87207\u003c/td\u003e\n              \u003ctd\u003eSpecial stain for microorganism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87210\u003c/td\u003e\n              \u003ctd\u003eSmear for infectious agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87220\u003c/td\u003e\n              \u003ctd\u003eTissue fungi or parasites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87230\u003c/td\u003e\n              \u003ctd\u003eMicrobial toxin or antitoxin assay\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87250\u003c/td\u003e\n              \u003ctd\u003eInoculation of embryonated eggs, or small animal for virus isolation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87252\u003c/td\u003e\n              \u003ctd\u003eTissue culture inoculation for virus isolation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87253\u003c/td\u003e\n              \u003ctd\u003eTissue culture for virus isolation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87254\u003c/td\u003e\n              \u003ctd\u003eVirus isolation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87255\u003c/td\u003e\n              \u003ctd\u003eVirus isolation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87260\u003c/td\u003e\n              \u003ctd\u003eDetection test for adenovirus (virus)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87265\u003c/td\u003e\n              \u003ctd\u003eDetection test for bordetella pertussis or parapertussis (respiratory bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87267\u003c/td\u003e\n              \u003ctd\u003eDetection test for enterovirus (intestinal virus)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87269\u003c/td\u003e\n              \u003ctd\u003eDetection test for giardia (intestinal parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87270\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87271\u003c/td\u003e\n              \u003ctd\u003eDetection test for cytomegalovirus (CMV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87272\u003c/td\u003e\n              \u003ctd\u003eDetection test for cryptosporidium (parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87273\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes simplex virus type 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87274\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes simplex virus type 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87275\u003c/td\u003e\n              \u003ctd\u003eDetection test for influenza B virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87276\u003c/td\u003e\n              \u003ctd\u003eDetection test for influenza A virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87277\u003c/td\u003e\n              \u003ctd\u003eDetection test for legionella micdadei (water borne bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87278\u003c/td\u003e\n              \u003ctd\u003eDetection test for legionella pneumophila (water borne bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87279\u003c/td\u003e\n              \u003ctd\u003eDetection test for parainfluenza virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87280\u003c/td\u003e\n              \u003ctd\u003eDetection test for respiratory syncytial virus (RSV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87281\u003c/td\u003e\n              \u003ctd\u003eDetection test for pneumocystis carinii (respiratory parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87283\u003c/td\u003e\n              \u003ctd\u003eDetection test for rubeola (measles virus)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87285\u003c/td\u003e\n              \u003ctd\u003eDetection test for treponema pallidum (syphilis organism)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87290\u003c/td\u003e\n              \u003ctd\u003eDetection test for varicella (chicken pox) zoster virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87299\u003c/td\u003e\n              \u003ctd\u003eDetection test for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87300\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple organisms\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87301\u003c/td\u003e\n              \u003ctd\u003eDetection test for adenovirus enteric types 40/41\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87305\u003c/td\u003e\n              \u003ctd\u003eDetection test for aspergillus (fungus)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87320\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87324\u003c/td\u003e\n              \u003ctd\u003eDetection test for clostridium difficile toxins (stool pathogen)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87327\u003c/td\u003e\n              \u003ctd\u003eDetection test for cryptococcus neoformans (yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87328\u003c/td\u003e\n              \u003ctd\u003eDetection test for cryptosporidium (parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87329\u003c/td\u003e\n              \u003ctd\u003eDetection test for giardia (intestinal parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87332\u003c/td\u003e\n              \u003ctd\u003eDetection test for cytomegalovirus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87335\u003c/td\u003e\n              \u003ctd\u003eDetection test for E. coli, (escherichia coli 0157)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87336\u003c/td\u003e\n              \u003ctd\u003eDetection test for entamoeba histolytica dispar group (parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87337\u003c/td\u003e\n              \u003ctd\u003eDetection test for entamoeba histolytica group (parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87338\u003c/td\u003e\n              \u003ctd\u003eQualitative or semiquantitative detection test for helicobacter pylori in stool, multiple-step method\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87339\u003c/td\u003e\n              \u003ctd\u003eDetection test for helicobacter pylori (GI tract bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87340\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis B surface antigen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87341\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis B surface antigen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87350\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis Be surface antigen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87380\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis D\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87385\u003c/td\u003e\n              \u003ctd\u003eDetection test for histoplasma capsulatum (parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87389\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1 and HIV-2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87390\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87391\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87400\u003c/td\u003e\n              \u003ctd\u003eDetection test for Influenza virus, A or B\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87420\u003c/td\u003e\n              \u003ctd\u003eDetection test for respiratory syncytial virus (RSV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87425\u003c/td\u003e\n              \u003ctd\u003eDetection test for Rotavirus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87430\u003c/td\u003e\n              \u003ctd\u003eDetection test for Strep (Streptococcus, group A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87449\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for detection of organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87450\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for detection of organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87451\u003c/td\u003e\n              \u003ctd\u003eImmunologic analysis for detection of organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87470\u003c/td\u003e\n              \u003ctd\u003eDetection test for Bartonella henselae and Bartonella quintana (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87471\u003c/td\u003e\n              \u003ctd\u003eDetection Bartonella henselae and Bartonella quintana (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87472\u003c/td\u003e\n              \u003ctd\u003eDetection test for Bartonella henselae and Bartonella quintana (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87475\u003c/td\u003e\n              \u003ctd\u003eDetection test for borrelia burgdorferi, (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87476\u003c/td\u003e\n              \u003ctd\u003eDetection test for borrelia burgdorferi (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87477\u003c/td\u003e\n              \u003ctd\u003eDetection test for borrelia burgdorferi (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87480\u003c/td\u003e\n              \u003ctd\u003eDetection test for candida species (yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87481\u003c/td\u003e\n              \u003ctd\u003eDetection test for candida species (yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87482\u003c/td\u003e\n              \u003ctd\u003eDetection test for candida species (yeast)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87483\u003c/td\u003e\n              \u003ctd\u003eTest for detecting nucleic acid of organism causing infection of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87485\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia pneumoniae\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87486\u003c/td\u003e\n              \u003ctd\u003eDetection test for Chlamydia pneumoniae\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87487\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia pneumoniae\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87490\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87491\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87492\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87495\u003c/td\u003e\n              \u003ctd\u003eDetection test for cytomegalovirus (CMV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87496\u003c/td\u003e\n              \u003ctd\u003eDetection test for Cytomegalovirus (CMV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87497\u003c/td\u003e\n              \u003ctd\u003eDetection test for cytomegalovirus, quantification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87498\u003c/td\u003e\n              \u003ctd\u003eDetection test for enterovirus (intestinal virus)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87500\u003c/td\u003e\n              \u003ctd\u003eDetection test for Vancomycin resistance strep (VRE)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87501\u003c/td\u003e\n              \u003ctd\u003eDetection test for influenza virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87502\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple types influenza virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87503\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple types of influenza virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87505\u003c/td\u003e\n              \u003ctd\u003eDetection test for digestive tract pathogen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87506\u003c/td\u003e\n              \u003ctd\u003eDetection test for digestive tract pathogen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87507\u003c/td\u003e\n              \u003ctd\u003eDetection test for digestive tract pathogen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87510\u003c/td\u003e\n              \u003ctd\u003eDetection test for gardnerella vaginalis (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87511\u003c/td\u003e\n              \u003ctd\u003eDetection test for gardnerella vaginalis (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87512\u003c/td\u003e\n              \u003ctd\u003eDetection test for gardnerella vaginalis (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87515\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis B virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87516\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis B virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87517\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis B virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87520\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis C virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87521\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis C virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87522\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis C virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87525\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis G virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87526\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis G virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87527\u003c/td\u003e\n              \u003ctd\u003eDetection test for Hepatitis G virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87528\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes simplex virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87529\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes simplex virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87530\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes simplex virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87531\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes virus-6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87532\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes virus-6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87533\u003c/td\u003e\n              \u003ctd\u003eDetection test for herpes virus-6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87534\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87535\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87536\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87537\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-2 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87538\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-2 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87539\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-2 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87540\u003c/td\u003e\n              \u003ctd\u003eDetection test for legionella pneumophila (water borne bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87541\u003c/td\u003e\n              \u003ctd\u003eDetection test for legionella pneumophila (water borne bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87542\u003c/td\u003e\n              \u003ctd\u003eDetection test for legionella pneumophila (water borne bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87550\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria species (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87551\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria species (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87552\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria species (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87555\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria tuberculosis (TB bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87556\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria tuberculosis (TB bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87557\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria tuberculosis (TB bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87560\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria avium-intracellulare (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87561\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria avium-intracellulare (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87562\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycobacteria avium-intracellulare (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87563\u003c/td\u003e\n              \u003ctd\u003eDetection of Mycoplasma genitalium by DNA or RNA probe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87580\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycoplasma pneumoniae (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87581\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycoplasma pneumoniae (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87582\u003c/td\u003e\n              \u003ctd\u003eDetection test for Mycoplasma pneumoniae (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87590\u003c/td\u003e\n              \u003ctd\u003eDetection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87591\u003c/td\u003e\n              \u003ctd\u003eDetection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87592\u003c/td\u003e\n              \u003ctd\u003eDetection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87620\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (HPV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87621\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (HPV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87622\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (HPV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87623\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (hpv)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87624\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (hpv)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87625\u003c/td\u003e\n              \u003ctd\u003eDetection test for human papillomavirus (hpv)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87631\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple types of respiratory virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87632\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple types of respiratory virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87633\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple types of respiratory virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87640\u003c/td\u003e\n              \u003ctd\u003eDetection test for Staphylococcus aureus (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87641\u003c/td\u003e\n              \u003ctd\u003eDetection test for Staphylococcus aureus, methicillin resistant (MRSA bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87650\u003c/td\u003e\n              \u003ctd\u003eDetection test for Strep (Streptococcus, group A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87651\u003c/td\u003e\n              \u003ctd\u003eDetection test for Strep (Streptococcus, group A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87652\u003c/td\u003e\n              \u003ctd\u003eDetection test for Strep (Streptococcus, group A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87653\u003c/td\u003e\n              \u003ctd\u003eDetection test for Strep (Streptococcus, group B)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87660\u003c/td\u003e\n              \u003ctd\u003eDetection test for Trichomonas vaginalis (genital parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87661\u003c/td\u003e\n              \u003ctd\u003eInfectious agent detection by nucleic acid (dna or rna); trichomonas vaginalis, amplified probe technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87797\u003c/td\u003e\n              \u003ctd\u003eDetection test for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87798\u003c/td\u003e\n              \u003ctd\u003eDetection test for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87799\u003c/td\u003e\n              \u003ctd\u003eDetection test for organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87800\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple organisms\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87801\u003c/td\u003e\n              \u003ctd\u003eDetection test for multiple organisms\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87802\u003c/td\u003e\n              \u003ctd\u003eDetection test for Streptococcus, group B (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87803\u003c/td\u003e\n              \u003ctd\u003eDetection test for clostridium difficile toxin A (bacteria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87804\u003c/td\u003e\n              \u003ctd\u003eDetection test for influenza virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87806\u003c/td\u003e\n              \u003ctd\u003eDetection test for HIV-1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87807\u003c/td\u003e\n              \u003ctd\u003eDetection test for respiratory syncytial virus (RSV)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87808\u003c/td\u003e\n              \u003ctd\u003eDetection test for Trichomonas vaginal (genital parasite)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87809\u003c/td\u003e\n              \u003ctd\u003eDetection test for adenovirus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87810\u003c/td\u003e\n              \u003ctd\u003eDetection test for chlamydia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87850\u003c/td\u003e\n              \u003ctd\u003eDetection test for Neisseria gonorrhoeae (gonorrhoeae)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87880\u003c/td\u003e\n              \u003ctd\u003eStrep test (Streptococcus, group A)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87899\u003c/td\u003e\n              \u003ctd\u003eDetection test for identification of organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87900\u003c/td\u003e\n              \u003ctd\u003eInfectious agent drug susceptibility analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87901\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87902\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for Hepatitis C virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87903\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87904\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87905\u003c/td\u003e\n              \u003ctd\u003eInfectious agent enzymatic activity to detect organism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87906\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for HIV-1 virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87910\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for cytomegalovirus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87912\u003c/td\u003e\n              \u003ctd\u003eAnalysis test for hepatitis b virus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e87999\u003c/td\u003e\n              \u003ctd\u003eMicrobiology procedures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88000\u003c/td\u003e\n              \u003ctd\u003eAutopsy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88005\u003c/td\u003e\n              \u003ctd\u003eAutopsy with of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88007\u003c/td\u003e\n              \u003ctd\u003eAutopsy with examination of brain and spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88012\u003c/td\u003e\n              \u003ctd\u003eAutopsy of infant with examination of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88014\u003c/td\u003e\n              \u003ctd\u003eAutopsy of stillborn or newborn infant with examination of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88016\u003c/td\u003e\n              \u003ctd\u003eAutopsy of stillborn infant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88020\u003c/td\u003e\n              \u003ctd\u003eAutopsy with microscopic examination of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88025\u003c/td\u003e\n              \u003ctd\u003eAutopsy with examination of brain and microscopic examination of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88027\u003c/td\u003e\n              \u003ctd\u003eAutopsy with examination of brain and spinal cord and microscopic examination of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88028\u003c/td\u003e\n              \u003ctd\u003eAutopsy of infant including brain and microscopic examination of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88029\u003c/td\u003e\n              \u003ctd\u003eAutopsy of stillborn or newborn infant with examination of brain and microscopic examination of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88036\u003c/td\u003e\n              \u003ctd\u003eLimited, gross and/or microscopic autopsy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88037\u003c/td\u003e\n              \u003ctd\u003eLimited, gross and/or microscopic autopsy, single organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88040\u003c/td\u003e\n              \u003ctd\u003eAutopsy for forensic (investigative) examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88045\u003c/td\u003e\n              \u003ctd\u003eCoroner\u0027s services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88099\u003c/td\u003e\n              \u003ctd\u003eAutopsy services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88104\u003c/td\u003e\n              \u003ctd\u003eCell examination of body fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88106\u003c/td\u003e\n              \u003ctd\u003eCell examination of body fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88108\u003c/td\u003e\n              \u003ctd\u003eCell examination of specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88112\u003c/td\u003e\n              \u003ctd\u003eCell examination of specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88120\u003c/td\u003e\n              \u003ctd\u003eCell examination of urine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88121\u003c/td\u003e\n              \u003ctd\u003eCell examination of urine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88125\u003c/td\u003e\n              \u003ctd\u003eForensic (investigation) examination of specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88130\u003c/td\u003e\n              \u003ctd\u003eSex identification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88140\u003c/td\u003e\n              \u003ctd\u003eSex identification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88141\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88142\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88143\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88147\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88148\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88150\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88152\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88153\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88154\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88155\u003c/td\u003e\n              \u003ctd\u003eExamination of cervical or vaginal slide for hormonal evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88160\u003c/td\u003e\n              \u003ctd\u003eScreening examination of specimen cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88161\u003c/td\u003e\n              \u003ctd\u003eScreening examination of specimen cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88162\u003c/td\u003e\n              \u003ctd\u003eScreening examination of specimen cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88164\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88165\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88166\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88167\u003c/td\u003e\n              \u003ctd\u003ePap test (Pap smear)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88172\u003c/td\u003e\n              \u003ctd\u003eEvaluation of fine needle aspirate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88173\u003c/td\u003e\n              \u003ctd\u003eEvaluation of fine needle aspirate with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88174\u003c/td\u003e\n              \u003ctd\u003ePap test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88175\u003c/td\u003e\n              \u003ctd\u003ePap test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88177\u003c/td\u003e\n              \u003ctd\u003ePap test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88182\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88184\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88185\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88187\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88188\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88189\u003c/td\u003e\n              \u003ctd\u003eFlow cytometry technique for DNA or cell analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88199\u003c/td\u003e\n              \u003ctd\u003eCytopathology procedures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88230\u003c/td\u003e\n              \u003ctd\u003eTissue culture to identify white blood cell disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88233\u003c/td\u003e\n              \u003ctd\u003eTissue culture to identify skin disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88235\u003c/td\u003e\n              \u003ctd\u003eTissue culture for disorders of amniotic fluid or placenta cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88237\u003c/td\u003e\n              \u003ctd\u003eTissue culture for tumor disorders of bone marrow and blood cells\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88239\u003c/td\u003e\n              \u003ctd\u003eTissue culture for tumor disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88245\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88248\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88249\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88261\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88262\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88263\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88264\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88267\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis of amniotic fluid or placenta for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88269\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis of amniotic fluid for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88280\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88283\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88285\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88289\u003c/td\u003e\n              \u003ctd\u003eChromosome analysis for genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88291\u003c/td\u003e\n              \u003ctd\u003eInterpretation and report of genetic testing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88299\u003c/td\u003e\n              \u003ctd\u003eGenetic studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88300\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope, limited examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88302\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88304\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope, moderately low complexity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88305\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope, intermediate complexity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88307\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope, moderately high complexity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88309\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue using a microscope, high complexity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88311\u003c/td\u003e\n              \u003ctd\u003ePreparation of tissue for examination by removing any calcium present\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88312\u003c/td\u003e\n              \u003ctd\u003eSpecial stained specimen slides to identify organisms including interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88313\u003c/td\u003e\n              \u003ctd\u003eSpecial stained specimen slides to examine tissue including interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88314\u003c/td\u003e\n              \u003ctd\u003eSpecial stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88321\u003c/td\u003e\n              \u003ctd\u003eSurgical pathology consultation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88323\u003c/td\u003e\n              \u003ctd\u003eSurgical pathology consultation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88325\u003c/td\u003e\n              \u003ctd\u003eComprehensive surgical pathology consultation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88329\u003c/td\u003e\n              \u003ctd\u003ePathology examination of specimen during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88331\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88332\u003c/td\u003e\n              \u003ctd\u003ePathology examination of specimen during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88333\u003c/td\u003e\n              \u003ctd\u003ePathology examination of tissue specimen during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88334\u003c/td\u003e\n              \u003ctd\u003ePathology examination of specimen during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88341\u003c/td\u003e\n              \u003ctd\u003eSpecial stained specimen slides to examine tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88342\u003c/td\u003e\n              \u003ctd\u003eTissue or cell analysis by immunologic technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88343\u003c/td\u003e\n              \u003ctd\u003eImmunohistochemistry or immunocytochemistry, each separately identifiable antibody per block, cytologic preparation, or hematologic smear; each additional separately identifiable antibody per slide (list separately in addition to code for primary procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88344\u003c/td\u003e\n              \u003ctd\u003eSpecial stained specimen slides to examine tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88346\u003c/td\u003e\n              \u003ctd\u003eAntibody evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88347\u003c/td\u003e\n              \u003ctd\u003eAntibody evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88348\u003c/td\u003e\n              \u003ctd\u003eElectron microscopy for diagnosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88349\u003c/td\u003e\n              \u003ctd\u003eAssessment using electron microscopy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88350\u003c/td\u003e\n              \u003ctd\u003eAntibody evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88355\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88356\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of nerve tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88358\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tumor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88360\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tumor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88361\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tumor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88362\u003c/td\u003e\n              \u003ctd\u003eNerve teasing preparation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88363\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88364\u003c/td\u003e\n              \u003ctd\u003eCell examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88365\u003c/td\u003e\n              \u003ctd\u003eAnalysis of genetic material\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88366\u003c/td\u003e\n              \u003ctd\u003eCell examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88367\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88368\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic analysis of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88369\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic examination manual\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88371\u003c/td\u003e\n              \u003ctd\u003eProtein analysis of tissue with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88372\u003c/td\u003e\n              \u003ctd\u003eProtein analysis of tissue by western blot, with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88373\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic examination using computer-assisted technology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88374\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic examination using computer-assisted technology\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88375\u003c/td\u003e\n              \u003ctd\u003eMicroscopic imaging using an endoscope, interpretation and report, real-time or referred, each session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88377\u003c/td\u003e\n              \u003ctd\u003eMicroscopic genetic examination manual\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88380\u003c/td\u003e\n              \u003ctd\u003ePreparation of specimen using laser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88381\u003c/td\u003e\n              \u003ctd\u003ePreparation of specimen, manual\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88387\u003c/td\u003e\n              \u003ctd\u003ePathologist examination, dissection, and preparation of tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88388\u003c/td\u003e\n              \u003ctd\u003ePathologist examination, dissection, and preparation of tissue during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e88399\u003c/td\u003e\n              \u003ctd\u003eSurgical pathology procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89060\u003c/td\u003e\n              \u003ctd\u003eCrystal identification from tissue or body fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89125\u003c/td\u003e\n              \u003ctd\u003eFat stain of stool, urine, or respiratory secretions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89160\u003c/td\u003e\n              \u003ctd\u003eExamination of stool for meat fibers\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89190\u003c/td\u003e\n              \u003ctd\u003eNasal smear for eosinophils (allergy related white blood cells)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89240\u003c/td\u003e\n              \u003ctd\u003ePathology tests\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89250\u003c/td\u003e\n              \u003ctd\u003eCulture of eggs or embryos, less than 4 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89251\u003c/td\u003e\n              \u003ctd\u003eCulture of eggs or embryos, less than 4 days, with co-culture of eggs or embryos\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89253\u003c/td\u003e\n              \u003ctd\u003eAssisted embryo hatching (fertility procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89254\u003c/td\u003e\n              \u003ctd\u003eEgg identification from ovarian fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89255\u003c/td\u003e\n              \u003ctd\u003ePreparation of embryo for transfer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89257\u003c/td\u003e\n              \u003ctd\u003eSperm identification from aspiration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89260\u003c/td\u003e\n              \u003ctd\u003eSperm isolation with semen analysis for fertilization or diagnosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89261\u003c/td\u003e\n              \u003ctd\u003eSperm isolation and semen analysis for fertilization or diagnosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89264\u003c/td\u003e\n              \u003ctd\u003eSperm identification from testis tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89268\u003c/td\u003e\n              \u003ctd\u003eFertilizing of eggs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89272\u003c/td\u003e\n              \u003ctd\u003eExtended culture of eggs or embryos, 4-7 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89280\u003c/td\u003e\n              \u003ctd\u003eAssisted oocyte fertilization (fertility procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89281\u003c/td\u003e\n              \u003ctd\u003eAssisted oocyte fertilization (fertility procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89290\u003c/td\u003e\n              \u003ctd\u003eBiopsy of egg or embryo for pre-implantation genetic diagnosis, less than or equal to 5 embryos\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89291\u003c/td\u003e\n              \u003ctd\u003eBiopsy of egg or embryo for pre-implantation genetic diagnosis, greater than 5 embryos\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89300\u003c/td\u003e\n              \u003ctd\u003eSemen analysis presence and/or motility of sperm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89310\u003c/td\u003e\n              \u003ctd\u003eSemen analysis motility and count\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89320\u003c/td\u003e\n              \u003ctd\u003eSemen evaluation volume, sperm count, motility and analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89321\u003c/td\u003e\n              \u003ctd\u003eSemen analysis for sperm presence\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89322\u003c/td\u003e\n              \u003ctd\u003eSemen evaluation, volume, sperm count, motility, and analysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89325\u003c/td\u003e\n              \u003ctd\u003eSperm antibody measurement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89329\u003c/td\u003e\n              \u003ctd\u003eSperm evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89330\u003c/td\u003e\n              \u003ctd\u003eSperm evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e89331\u003c/td\u003e\n              \u003ctd\u003eSperm evaluation, for reverse ejaculation, urine specimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90281\u003c/td\u003e\n              \u003ctd\u003eHuman immune globulin for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90283\u003c/td\u003e\n              \u003ctd\u003eHuman immune globulin for infusion into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90284\u003c/td\u003e\n              \u003ctd\u003eHuman immune globulin for infusions beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90287\u003c/td\u003e\n              \u003ctd\u003eBotulinum equine antitoxin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90288\u003c/td\u003e\n              \u003ctd\u003eBotulinum human antitoxin for infusion into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90291\u003c/td\u003e\n              \u003ctd\u003eCytomegalovirus immune globulin for infusion into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90296\u003c/td\u003e\n              \u003ctd\u003eDiphtheria equine antitoxin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90371\u003c/td\u003e\n              \u003ctd\u003eHepatitis B immune globulin for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90375\u003c/td\u003e\n              \u003ctd\u003eRabies immune globulin for injection beneath the skin and/or into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90376\u003c/td\u003e\n              \u003ctd\u003eRabies immune globulin for injection beneath the skin and/or into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90378\u003c/td\u003e\n              \u003ctd\u003eRespiratory syncytial virus antibody for injection into tissue or muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90384\u003c/td\u003e\n              \u003ctd\u003eRho(D) immune globulin (full dose) for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90385\u003c/td\u003e\n              \u003ctd\u003eRho(D) immune globulin (mini dose) for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90386\u003c/td\u003e\n              \u003ctd\u003eRho (D) immune globulin for infusion into vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90389\u003c/td\u003e\n              \u003ctd\u003eTetanus immune globulin for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90393\u003c/td\u003e\n              \u003ctd\u003eVaccinia immune globulin for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90396\u003c/td\u003e\n              \u003ctd\u003eVaricella (chicken pox) zoster immune globulin for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90399\u003c/td\u003e\n              \u003ctd\u003eImmune globulin injection or infusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90460\u003c/td\u003e\n              \u003ctd\u003eAdministration of first vaccine or toxoid component through 18 years of age with counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90461\u003c/td\u003e\n              \u003ctd\u003eAdministration of vaccine or toxoid component through 18 years of age with counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90471\u003c/td\u003e\n              \u003ctd\u003eAdministration of 1 vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90472\u003c/td\u003e\n              \u003ctd\u003eAdministration of vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90473\u003c/td\u003e\n              \u003ctd\u003eAdministration of 1 nasal or oral vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90474\u003c/td\u003e\n              \u003ctd\u003eAdministration of nasal or oral vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90476\u003c/td\u003e\n              \u003ctd\u003eVaccine for adenovirus oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90477\u003c/td\u003e\n              \u003ctd\u003eVaccine for adenovirus oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90581\u003c/td\u003e\n              \u003ctd\u003eVaccine for anthrax injection beneath the skin or into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90585\u003c/td\u003e\n              \u003ctd\u003eVaccine for tuberculosis injection into skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90586\u003c/td\u003e\n              \u003ctd\u003eVaccine for bladder cancer injection into urinary bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90587\u003c/td\u003e\n              \u003ctd\u003eVaccine for dengue for injection under skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90619\u003c/td\u003e\n              \u003ctd\u003eMeningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT) for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90620\u003c/td\u003e\n              \u003ctd\u003eVaccine for meningococcus for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90621\u003c/td\u003e\n              \u003ctd\u003eVaccine for meningococcus for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90625\u003c/td\u003e\n              \u003ctd\u003eVaccine for cholera for oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90630\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90632\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis A injection into muscle, adult dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90633\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis A (2 dose schedule) injection into muscle, pediatric or adolescent dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90634\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis A (3 dose schedule) injection into muscle, pediatric or adolescent dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90636\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis A and Hepatitis B injection into muscle, adult dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90644\u003c/td\u003e\n              \u003ctd\u003eVaccine for meningococcal and Haemophilus influenza B (4 dose schedule) injection into muscle, children 6 weeks-18 months of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90645\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hemophilus influenza B (4 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90646\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hemophilus influenza B (booster) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90647\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hemophilus influenza B (3 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90648\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hemophilus influenza B (4 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90649\u003c/td\u003e\n              \u003ctd\u003eVaccine for human papilloma virus (3 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90650\u003c/td\u003e\n              \u003ctd\u003eVaccine for human papilloma virus (3 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90651\u003c/td\u003e\n              \u003ctd\u003eVaccine for human papilloma virus (3 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90653\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90654\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza injection into skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90655\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.25 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90656\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90657\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.25 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90658\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90660\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for nasal administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90661\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90662\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90664\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for nasal administration, pandemic formulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90666\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle, pandemic formulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90667\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle, pandemic formulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90668\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle, pandemic formulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90669\u003c/td\u003e\n              \u003ctd\u003ePneumococcal vaccine for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90670\u003c/td\u003e\n              \u003ctd\u003ePneumococcal vaccine for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90672\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for nasal administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90673\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza administered into muscle, preservative and antibiotic free\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90674\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90675\u003c/td\u003e\n              \u003ctd\u003eVaccine for rabies injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90676\u003c/td\u003e\n              \u003ctd\u003eVaccine for rabies injection into skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90680\u003c/td\u003e\n              \u003ctd\u003eVaccine for Rotavirus (3 dose schedule) for oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90681\u003c/td\u003e\n              \u003ctd\u003eVaccine for Rotavirus (2 dose schedule) for oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90682\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90685\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.25 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90686\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90687\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.25 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90688\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for administration into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90689\u003c/td\u003e\n              \u003ctd\u003eInactivated quadrivalent influenza vaccine for injection into muscle, 0.25 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90690\u003c/td\u003e\n              \u003ctd\u003eOral typhoid vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90691\u003c/td\u003e\n              \u003ctd\u003eVaccine for typhoid for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90692\u003c/td\u003e\n              \u003ctd\u003eVaccine for typhoid injection beneath or within skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90693\u003c/td\u003e\n              \u003ctd\u003eVaccine for typhoid injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90694\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90696\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), and polio for injection into muscle, patient 4 through 6 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90697\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), haemophilus influenza type B, hepatitis B and polio for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90698\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), haemophilus influenza type B, and polio for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90700\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus, and acellular pertussis (whooping cough) injection into muscle, child younger than 7 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90702\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria and tetanus toxoids injection into muscle, patient younger than 7 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90703\u003c/td\u003e\n              \u003ctd\u003eTetanus toxoid injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90704\u003c/td\u003e\n              \u003ctd\u003eMumps vaccine injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90705\u003c/td\u003e\n              \u003ctd\u003eVaccine for measles injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90706\u003c/td\u003e\n              \u003ctd\u003eVaccine for rubella (German measles) injection, beneath the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90707\u003c/td\u003e\n              \u003ctd\u003eVaccine for measles, mumps, and rubella (German measles) injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90708\u003c/td\u003e\n              \u003ctd\u003eMeasles and rubella (German measles) vaccine injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90710\u003c/td\u003e\n              \u003ctd\u003eVaccine for measles, mumps, rubella (German measles), and varicella (chicken pox) injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90712\u003c/td\u003e\n              \u003ctd\u003eVaccine for polio vaccine for oral administration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90713\u003c/td\u003e\n              \u003ctd\u003eVaccine for polio injection beneath the skin or into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90714\u003c/td\u003e\n              \u003ctd\u003eVaccine for tetanus and diphtheria toxoids injection into muscle, patient 7 years or older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90715\u003c/td\u003e\n              \u003ctd\u003eVaccine for tetanus, diphtheria toxoids and acellular pertussis (whooping cough) for injection into muscle, patient 7 years or older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90716\u003c/td\u003e\n              \u003ctd\u003eVaccine for varicella (chicken pox) injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90717\u003c/td\u003e\n              \u003ctd\u003eVaccine for yellow fever injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90719\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria toxoid injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90720\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, whole cell pertussis (whooping cough), and Hemophilus influenza B injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90721\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), and Hemophilus influenza B injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90723\u003c/td\u003e\n              \u003ctd\u003eVaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), Hepatitis B, and polio for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90725\u003c/td\u003e\n              \u003ctd\u003eVaccine for cholera injection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90727\u003c/td\u003e\n              \u003ctd\u003eVaccine for plague injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90732\u003c/td\u003e\n              \u003ctd\u003eVaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90733\u003c/td\u003e\n              \u003ctd\u003eVaccine for meningococcus for injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90734\u003c/td\u003e\n              \u003ctd\u003eVaccine for meningococcus for administration into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90735\u003c/td\u003e\n              \u003ctd\u003eVaccine for Japanese encephalitis virus injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90736\u003c/td\u003e\n              \u003ctd\u003eVaccine for shingles injection beneath skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90738\u003c/td\u003e\n              \u003ctd\u003eVaccine for Japanese encephalitis virus injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90739\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B adult dosage (2 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90740\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B (3 dose schedule) for injection into muscle, dialysis or immunosuppressed patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90743\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B (2 dose schedule) for injection into muscle, adolescent patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90744\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B (3 dose schedule) for injection into muscle, pediatric and adolescent patients\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90746\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B adult dosage (3 dose schedule) injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90747\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B (4 dose schedule) for injection into muscle, dialysis or immunosuppressed patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90748\u003c/td\u003e\n              \u003ctd\u003eVaccine for Hepatitis B and Hemophilus influenza B for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90749\u003c/td\u003e\n              \u003ctd\u003eVaccine or toxoid injection or infusion procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90750\u003c/td\u003e\n              \u003ctd\u003eVaccine for shingles for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90756\u003c/td\u003e\n              \u003ctd\u003eVaccine for influenza for injection into muscle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90785\u003c/td\u003e\n              \u003ctd\u003eInteractive complexity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90791\u003c/td\u003e\n              \u003ctd\u003ePsychiatric diagnostic evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90792\u003c/td\u003e\n              \u003ctd\u003ePsychiatric diagnostic evaluation with medical services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90832\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90833\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90834\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90836\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90837\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90838\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy, 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90839\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy for crisis, first 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90840\u003c/td\u003e\n              \u003ctd\u003ePsychotherapy for crisis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90845\u003c/td\u003e\n              \u003ctd\u003ePsychoanalysis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90846\u003c/td\u003e\n              \u003ctd\u003eFamily psychotherapy, 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90847\u003c/td\u003e\n              \u003ctd\u003eFamily psychotherapy including patient, 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90849\u003c/td\u003e\n              \u003ctd\u003eMultiple-family group psychotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90853\u003c/td\u003e\n              \u003ctd\u003eGroup psychotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90863\u003c/td\u003e\n              \u003ctd\u003eManagement of prescriptions and review of medication\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90865\u003c/td\u003e\n              \u003ctd\u003eInjection of hypnotic drug for psychiatric diagnosis or therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90867\u003c/td\u003e\n              \u003ctd\u003eTranscranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90868\u003c/td\u003e\n              \u003ctd\u003eTranscranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90869\u003c/td\u003e\n              \u003ctd\u003eTranscranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90870\u003c/td\u003e\n              \u003ctd\u003eShock treatment and monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90875\u003c/td\u003e\n              \u003ctd\u003eIndividual psychophysiological therapy incorporating biofeedback training with psychotherapy, 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90876\u003c/td\u003e\n              \u003ctd\u003eIndividual psychophysiological therapy incorporating biofeedback training with psychotherapy, 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90880\u003c/td\u003e\n              \u003ctd\u003eHypnotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90882\u003c/td\u003e\n              \u003ctd\u003eEnvironmental intervention for management of medical conditions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90885\u003c/td\u003e\n              \u003ctd\u003ePsychiatric evaluation of hospital records, reports, testing, or data for diagnosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90887\u003c/td\u003e\n              \u003ctd\u003eExplanation of psychiatric, medical examinations, procedures, and data to other than patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90889\u003c/td\u003e\n              \u003ctd\u003ePreparation of report of patient\u0027s psychiatric status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90899\u003c/td\u003e\n              \u003ctd\u003ePsychiatric service or procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90901\u003c/td\u003e\n              \u003ctd\u003eBiofeedback training\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90911\u003c/td\u003e\n              \u003ctd\u003eBiofeedback training, perineal muscles, anorectal or urethral sphincter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90912\u003c/td\u003e\n              \u003ctd\u003eBiofeedback training for bowel or bladder control, initial 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90913\u003c/td\u003e\n              \u003ctd\u003eBiofeedback training for bowel or bladder control, additional 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90951\u003c/td\u003e\n              \u003ctd\u003eDialysis services (4 or more physician visits per month), patient younger than 2 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90952\u003c/td\u003e\n              \u003ctd\u003eDialysis services (2-3 physician visits per month), patient younger than 2 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90953\u003c/td\u003e\n              \u003ctd\u003eDialysis services (1 physician visit per month), patient younger than 2 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90954\u003c/td\u003e\n              \u003ctd\u003eDialysis services (4 or more physician visits per month), patient 2-11 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90955\u003c/td\u003e\n              \u003ctd\u003eDialysis services (2-3 physician visits per month), patient 2-11 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90956\u003c/td\u003e\n              \u003ctd\u003eDialysis services (1 physician visit per month), patient 2-11 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90957\u003c/td\u003e\n              \u003ctd\u003eDialysis services (4 or more physician visits per month), patient 12-19 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90958\u003c/td\u003e\n              \u003ctd\u003eDialysis services (2-3 physician visits per month), patient 12-19 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90959\u003c/td\u003e\n              \u003ctd\u003eDialysis services (1 physician visit per month), patient 12-19 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90960\u003c/td\u003e\n              \u003ctd\u003eDialysis services (4 or more physician visits per month), patient 20 years of age and older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90961\u003c/td\u003e\n              \u003ctd\u003eDialysis services (2-3 physician visits per month), patient 20 years of age and older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90962\u003c/td\u003e\n              \u003ctd\u003eDialysis services (1 physician visit per month), patient 20 years of age and older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90963\u003c/td\u003e\n              \u003ctd\u003eHome dialysis services per month, patient younger than 2 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90964\u003c/td\u003e\n              \u003ctd\u003eHome dialysis services per month, patient 2-11 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90965\u003c/td\u003e\n              \u003ctd\u003eHome dialysis services per month, patient 12-19 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90966\u003c/td\u003e\n              \u003ctd\u003eHome dialysis services per month, patient 20 years of age or older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90967\u003c/td\u003e\n              \u003ctd\u003eDialysis services, per day (less than full month service), patient younger than 2 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90968\u003c/td\u003e\n              \u003ctd\u003eDialysis services, per day (less than full month service), patient 2-11 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90969\u003c/td\u003e\n              \u003ctd\u003eDialysis services, per day (less than full month service), patient 12-19 years of age\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e90970\u003c/td\u003e\n              \u003ctd\u003eDialysis services, per day (less than full month service), patient 20 years of age or older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92507\u003c/td\u003e\n              \u003ctd\u003eTreatment of speech, language, voice, communication, and/or hearing processing disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92508\u003c/td\u003e\n              \u003ctd\u003eGroup treatment of speech, language, voice, communication, and/or hearing processing disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92521\u003c/td\u003e\n              \u003ctd\u003eEvaluation of speech fluency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92522\u003c/td\u003e\n              \u003ctd\u003eEvaluation of speech sound production\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92523\u003c/td\u003e\n              \u003ctd\u003eEvaluation of speech sound production with evaluation of language comprehension and expression\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92524\u003c/td\u003e\n              \u003ctd\u003eBehavioral and qualitative analysis of voice and resonance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92548\u003c/td\u003e\n              \u003ctd\u003eComputerized dynamic assessment of balance and postural instability\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e92597\u003c/td\u003e\n              \u003ctd\u003eEvaluation for use and/or fitting of voice prosthetic device to supplement oral speech\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93000\u003c/td\u003e\n              \u003ctd\u003eRoutine EKG using at least 12 leads including interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93005\u003c/td\u003e\n              \u003ctd\u003eRoutine electrocardiogram (EKG) with tracing using at least 12 leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93010\u003c/td\u003e\n              \u003ctd\u003eRoutine electrocardiogram (EKG) using at least 12 leads with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93015\u003c/td\u003e\n              \u003ctd\u003eExercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93016\u003c/td\u003e\n              \u003ctd\u003eExercise or drug-induced heart and blood vessel stress test with EKG monitoring and physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93017\u003c/td\u003e\n              \u003ctd\u003eExercise or drug-induced heart and blood vessel stress test with EKG tracing and monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93018\u003c/td\u003e\n              \u003ctd\u003eExercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93025\u003c/td\u003e\n              \u003ctd\u003eMeasurement of height of heart beats on EKG\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93040\u003c/td\u003e\n              \u003ctd\u003eTracing of electrical activity of heart using 1-3 leads with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93041\u003c/td\u003e\n              \u003ctd\u003eTracing of electrical activity of the heart using 1-3 leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93042\u003c/td\u003e\n              \u003ctd\u003eInterpretation and report of electrical activity of heart using 1-3 leads\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93224\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm tracing, analysis, and interpretation of 48-hour EKG\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93225\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm tracing of 48-hour EKG\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93226\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm analysis, interpretation and report of 48-hour EKG\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93227\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm tracing, analysis, and interpretation of 48-hour EKG\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93228\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour EKG up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93229\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour EKG up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93268\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm symptom-related tracing and interpretation of 24-hour EKG monitoring up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93270\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm symptom-related tracing of 24-hour EKG monitoring up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93271\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm symptom-related transmission and analysis of 24-hour EKG monitoring up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93272\u003c/td\u003e\n              \u003ctd\u003eHeart rhythm symptom-related interpretation of 24-hour EKG monitoring up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93278\u003c/td\u003e\n              \u003ctd\u003eRecording to evaluate height and duration of heart beats through damaged heart tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93279\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93280\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93281\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of permanent multiple lead pacemaker system with physician analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93282\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing and programming adjustment of defibrillator with analysis, review and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93283\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing and programming adjustment of defibrillator with analysis, review and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93284\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing and programming adjustment of defibrillator with analysis, review and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93285\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of heart rhythm monitor system system implanted under skin with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93286\u003c/td\u003e\n              \u003ctd\u003eEvaluation, testing, and programming adjustment of single, dual, or multiple lead pacemaker system before or after surgery, procedure, or test with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93287\u003c/td\u003e\n              \u003ctd\u003eEvaluation and programming adjustment of defibrillator with analysis, review and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93288\u003c/td\u003e\n              \u003ctd\u003eEvaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93289\u003c/td\u003e\n              \u003ctd\u003eEvaluation of defibrillator including connection, recording and disconnection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93290\u003c/td\u003e\n              \u003ctd\u003eEvaluation of parameters of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93291\u003c/td\u003e\n              \u003ctd\u003eEvaluation of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93292\u003c/td\u003e\n              \u003ctd\u003eEvaluation of wearable defibrillator system including connection, disconnection, recording, physician analysis, review, and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93293\u003c/td\u003e\n              \u003ctd\u003eTelephonic evaluation of single, dual, or multiple lead pacemaker heart rhythm strips up to 90 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93294\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93295\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of defibrillator up to 90 days with analysis, review and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93296\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93297\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93298\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93299\u003c/td\u003e\n              \u003ctd\u003eRemote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93660\u003c/td\u003e\n              \u003ctd\u003eEvaluation of heart function using tilt table\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93668\u003c/td\u003e\n              \u003ctd\u003ePeripheral arterial disease (PAD) rehabilitation per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93724\u003c/td\u003e\n              \u003ctd\u003eElectronic analysis of pacemaker to correct rapid heart rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93745\u003c/td\u003e\n              \u003ctd\u003eSetup and programming of wearable cardioverter-defibrillator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93792\u003c/td\u003e\n              \u003ctd\u003eTraining for home international normalized ratio (INR) monitoring of blood thinner therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93793\u003c/td\u003e\n              \u003ctd\u003eAnti-clotting management for patient taking warfarin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93797\u003c/td\u003e\n              \u003ctd\u003ePhysician services for outpatient heart cardiac rehabilitation per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e93798\u003c/td\u003e\n              \u003ctd\u003ePhysician services for outpatient heart rehabilitation with continuous EKG monitoring per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e94772\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of breathing pattern over 12-24 hours, infant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e94780\u003c/td\u003e\n              \u003ctd\u003eCar seat or bed airway testing of infant 1 year or less, 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e94781\u003c/td\u003e\n              \u003ctd\u003eCar seat or bed airway testing of infant 1 year or less, additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95115\u003c/td\u003e\n              \u003ctd\u003eInjection of incremental dosages of allergen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95117\u003c/td\u003e\n              \u003ctd\u003eInjection of incremental dosages of allergen, 2 or more injections\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95120\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of allergen extract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95125\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision and injection of allergen extract, 2 or more injections\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95130\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of one stinging insect venom\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95131\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of two stinging insect venom\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95132\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of three stinging insect venom\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95133\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of four stinging insect venom\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95134\u003c/td\u003e\n              \u003ctd\u003ePreparation, provision, and injection of five stinging insect venom\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95144\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of single-dose vials of allergen antigens for allergy immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95145\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of single stinging insect venom for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95146\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of 2 single stinging insect venom for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95147\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of 3 single stinging insect venom for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95148\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of 4 single stinging insect venom for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95149\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of 5 single stinging insect venom for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95165\u003c/td\u003e\n              \u003ctd\u003ePreparation and provision of single or multiple antigens for allergen immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95782\u003c/td\u003e\n              \u003ctd\u003eSleep monitoring of patient (younger than 6 years) in sleep lab\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95783\u003c/td\u003e\n              \u003ctd\u003eSleep monitoring of patient (younger than 6 years) in sleep lab with continued pressured respiratory assistance by mask or breathing tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95800\u003c/td\u003e\n              \u003ctd\u003eStudy of sleep patterns\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95801\u003c/td\u003e\n              \u003ctd\u003eStudy of sleep patterns\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95803\u003c/td\u003e\n              \u003ctd\u003eStudy of sleep and wake patterns including interpretation and report, minimum of 72 hours to 14 consecutive days of recording\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95805\u003c/td\u003e\n              \u003ctd\u003eDiagnostic test for sleep disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95806\u003c/td\u003e\n              \u003ctd\u003eUnattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95807\u003c/td\u003e\n              \u003ctd\u003eSleep study attended by a technician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95808\u003c/td\u003e\n              \u003ctd\u003eSleep monitoring of patient in sleep lab\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95810\u003c/td\u003e\n              \u003ctd\u003eSleep monitoring of patient (6 years or older) in sleep lab\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95811\u003c/td\u003e\n              \u003ctd\u003eSleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95812\u003c/td\u003e\n              \u003ctd\u003eMeasurement of brain wave (EEG) activity, 41-60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95813\u003c/td\u003e\n              \u003ctd\u003eMeasurement of brain wave activity (EEG) extended monitoring, 61-119 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95816\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of brain wave (EEG) activity, awake and drowsy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95819\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of brain wave (EEG) activity, awake and asleep\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95822\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of brain wave (EEG) activity, in coma or asleep\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95824\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of brain wave (EEG) activity, cerebral death evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95827\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of brain wave (EEG) activity, overnight\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95829\u003c/td\u003e\n              \u003ctd\u003eMeasurement of brain activity (EEG) during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95830\u003c/td\u003e\n              \u003ctd\u003eInsertion of electrodes in bone for measurement and recording of brain wave activity (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95831\u003c/td\u003e\n              \u003ctd\u003eManual muscle testing of arm, leg or trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95832\u003c/td\u003e\n              \u003ctd\u003eManual muscle testing of hand\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95833\u003c/td\u003e\n              \u003ctd\u003eManual muscle testing of whole body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95834\u003c/td\u003e\n              \u003ctd\u003eManual muscle testing of whole body including hands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95851\u003c/td\u003e\n              \u003ctd\u003eRange of motion testing of arm, leg or each spine section\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95852\u003c/td\u003e\n              \u003ctd\u003eRange of motion testing of hand\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95950\u003c/td\u003e\n              \u003ctd\u003eMonitoring and localization of seizure activity over 24-hour period using electroencephalograph (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95951\u003c/td\u003e\n              \u003ctd\u003eMonitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95953\u003c/td\u003e\n              \u003ctd\u003eMonitoring and localization of seizure activity over 24-hour period using portable 16-channel electroencephalograph (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95954\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of electrical activity (EEG) of the brain including stimulation by medication or physical activity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95955\u003c/td\u003e\n              \u003ctd\u003eMeasurement of electrical activity (EEG) outside the brain during surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95956\u003c/td\u003e\n              \u003ctd\u003eMonitoring and localization of seizure activity over 24-hour period using electroencephalograph (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95957\u003c/td\u003e\n              \u003ctd\u003eDigital analysis of electrical brain wave activity (EEG)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95958\u003c/td\u003e\n              \u003ctd\u003eMeasurement and recording of electrical brain wave activity (EEG) in a specific area of the brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95961\u003c/td\u003e\n              \u003ctd\u003eMapping of electrical brain wave activity (EEG) using electrodes on brain surface to provoke seizure activity or assess brain function, first hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e95962\u003c/td\u003e\n              \u003ctd\u003eMapping of electrical brain wave activity (EEG) to provoke seizure activity or assess brain function\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96004\u003c/td\u003e\n              \u003ctd\u003ePhysician review interpretation and report of motion analysis during walking or functional activity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96040\u003c/td\u003e\n              \u003ctd\u003eMedical genetic patient or family counseling services each 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96101\u003c/td\u003e\n              \u003ctd\u003ePsychological testing with interpretation and report by psychologist or physician per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96102\u003c/td\u003e\n              \u003ctd\u003ePsychological testing with interpretation and report by technician per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96103\u003c/td\u003e\n              \u003ctd\u003ePsychological testing with interpretation and report by computer\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96116\u003c/td\u003e\n              \u003ctd\u003eNeurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96118\u003c/td\u003e\n              \u003ctd\u003eNeuropsychological testing, interpretation, and report by psychologist or physician per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96119\u003c/td\u003e\n              \u003ctd\u003eNeuropsychological testing by technician with interpretation and report by a qualified healthcare professional per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96120\u003c/td\u003e\n              \u003ctd\u003eNeuropsychological testing by a computer with interpretation and report by a qualified healthcare professional\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96121\u003c/td\u003e\n              \u003ctd\u003eNeurobehavioral status examination by qualified health care professional with interpretation and report, additional 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96125\u003c/td\u003e\n              \u003ctd\u003eStandardized thought processing testing, interpretation, and report per hour\u0026quot;\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96127\u003c/td\u003e\n              \u003ctd\u003eBrief emotional or behavioral assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96130\u003c/td\u003e\n              \u003ctd\u003ePsychological testing evaluation by qualified health care professional, first 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96131\u003c/td\u003e\n              \u003ctd\u003ePsychological testing evaluation by qualified health care professional, additional 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96132\u003c/td\u003e\n              \u003ctd\u003eNeuropsychological testing evaluation by qualified health care professional, first 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96133\u003c/td\u003e\n              \u003ctd\u003eNeuropsychological testing evaluation by qualified health care professional, additional 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96136\u003c/td\u003e\n              \u003ctd\u003ePsychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96137\u003c/td\u003e\n              \u003ctd\u003ePsychological or neuropsychological test administration and scoring by qualified health care professional, additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96138\u003c/td\u003e\n              \u003ctd\u003ePsychological or neuropsychological test administration and scoring by technician, first 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96139\u003c/td\u003e\n              \u003ctd\u003ePsychological or neuropsychological test administration and scoring by technician, additional 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96146\u003c/td\u003e\n              \u003ctd\u003ePsychological or neuropsychological test administration and scoring by single standardized instrument via electronic platform with automated result\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96150\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior assessment each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96151\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior re-assessment each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96152\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior intervention, individual each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96153\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior intervention, group each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96154\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior intervention, family and patient each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96155\u003c/td\u003e\n              \u003ctd\u003eHealth and behavior intervention, family each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96156\u003c/td\u003e\n              \u003ctd\u003eHealth behavior assessment, or re-assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96158\u003c/td\u003e\n              \u003ctd\u003eHealth behavior intervention, individual, face-to-face; initial 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96159\u003c/td\u003e\n              \u003ctd\u003eHealth behavior intervention, individual, face-to-face; each additional 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96160\u003c/td\u003e\n              \u003ctd\u003eAdministration and interpretation of patient-focused health risk assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96161\u003c/td\u003e\n              \u003ctd\u003eAdministration and interpretation of caregiver-focused health risk assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e96902\u003c/td\u003e\n              \u003ctd\u003eMicroscopic examination of hairs to detect hair shaft abnormality\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97001\u003c/td\u003e\n              \u003ctd\u003ePhysical therapy evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97002\u003c/td\u003e\n              \u003ctd\u003ePhysical therapy re-evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97003\u003c/td\u003e\n              \u003ctd\u003eOccupational therapy evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97004\u003c/td\u003e\n              \u003ctd\u003eOccupational therapy re-evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97005\u003c/td\u003e\n              \u003ctd\u003eAthletic training evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97006\u003c/td\u003e\n              \u003ctd\u003eAthletic training re-evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97010\u003c/td\u003e\n              \u003ctd\u003eApplication of hot or cold packs to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97014\u003c/td\u003e\n              \u003ctd\u003eApplication of electrical stimulation to 1 or more areas, unattended by physical therapist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97016\u003c/td\u003e\n              \u003ctd\u003eApplication of blood vessel compression or decompression device to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97018\u003c/td\u003e\n              \u003ctd\u003eApplication of hot wax bath to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97022\u003c/td\u003e\n              \u003ctd\u003eApplication of whirlpool therapy to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97024\u003c/td\u003e\n              \u003ctd\u003eApplication of heat wave therapy to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97026\u003c/td\u003e\n              \u003ctd\u003eApplication of low energy heat (infrared) to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97028\u003c/td\u003e\n              \u003ctd\u003eApplication of ultraviolet light to 1 or more areas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97032\u003c/td\u003e\n              \u003ctd\u003eApplication of electrical stimulation to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97033\u003c/td\u003e\n              \u003ctd\u003eApplication of medication through skin using electrical current, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97034\u003c/td\u003e\n              \u003ctd\u003eTherapeutic hot and cold baths to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97035\u003c/td\u003e\n              \u003ctd\u003eApplication of ultrasound to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97039\u003c/td\u003e\n              \u003ctd\u003ePhysical medicine service or procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97110\u003c/td\u003e\n              \u003ctd\u003eTherapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97112\u003c/td\u003e\n              \u003ctd\u003eTherapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97113\u003c/td\u003e\n              \u003ctd\u003eWater pool therapy with therapeutic exercises to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97116\u003c/td\u003e\n              \u003ctd\u003eWalking training to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97124\u003c/td\u003e\n              \u003ctd\u003eTherapeutic massage to 1 or more areas, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97127\u003c/td\u003e\n              \u003ctd\u003eOne-on-one therapeutic interventions focused on thought processing and strategies to manage activities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97139\u003c/td\u003e\n              \u003ctd\u003eTherapeutic procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97140\u003c/td\u003e\n              \u003ctd\u003eManual (physical) therapy techniques to 1 or more regions, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97150\u003c/td\u003e\n              \u003ctd\u003eTherapeutic procedures in a group setting\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97151\u003c/td\u003e\n              \u003ctd\u003eBehavior identification assessment by qualified health care professional, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97152\u003c/td\u003e\n              \u003ctd\u003eBehavior identification assessment by technician under direction of qualified health care professional, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97153\u003c/td\u003e\n              \u003ctd\u003eAdaptive behavior treatment by protocol, administered by technician under direction of qualified health care professional to one patient, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97154\u003c/td\u003e\n              \u003ctd\u003eAdaptive behavior treatment by protocol, administered by technician under direction of qualified health care professional to multiple patients, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97155\u003c/td\u003e\n              \u003ctd\u003eAdaptive behavior treatment with protocol modification administered by qualified health care professional to one patient, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97156\u003c/td\u003e\n              \u003ctd\u003eFamily adaptive behavior treatment guidance by qualified health care professional (with or without patient present), each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97157\u003c/td\u003e\n              \u003ctd\u003eFamily adaptive behavior treatment guidance by qualified health care professional without patient present, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97158\u003c/td\u003e\n              \u003ctd\u003eGroup adaptive behavior treatment with protocol modification administered by qualified health care professional to multiple patients, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97161\u003c/td\u003e\n              \u003ctd\u003eEvaluation of physical therapy, typically 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97162\u003c/td\u003e\n              \u003ctd\u003eEvaluation of physical therapy, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97163\u003c/td\u003e\n              \u003ctd\u003eEvaluation of physical therapy, typically 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97164\u003c/td\u003e\n              \u003ctd\u003eRe-evaluation of physical therapy, typically 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97165\u003c/td\u003e\n              \u003ctd\u003eEvaluation of occupational therapy, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97166\u003c/td\u003e\n              \u003ctd\u003eEvaluation of occupational therapy, typically 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97167\u003c/td\u003e\n              \u003ctd\u003eEvaluation of occupational therapy established plan of care, typically 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97168\u003c/td\u003e\n              \u003ctd\u003eRe-evaluation of occupational therapy established plan of care, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97169\u003c/td\u003e\n              \u003ctd\u003eEvaluation of athletic training, typically 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97170\u003c/td\u003e\n              \u003ctd\u003eEvaluation of athletic training, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97171\u003c/td\u003e\n              \u003ctd\u003eEvaluation of athletic training, typically 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97172\u003c/td\u003e\n              \u003ctd\u003eRe-evaluation of athletic training, typically 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97530\u003c/td\u003e\n              \u003ctd\u003eTherapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97532\u003c/td\u003e\n              \u003ctd\u003eDevelopment of cognitive skills to improve attention, memory, or problem solving, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97533\u003c/td\u003e\n              \u003ctd\u003eSensory technique to enhance processing and adaptation to environmental demands, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97535\u003c/td\u003e\n              \u003ctd\u003eSelf-care or home management training, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97537\u003c/td\u003e\n              \u003ctd\u003eCommunity or work reintegration training, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97542\u003c/td\u003e\n              \u003ctd\u003eWheelchair management, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97545\u003c/td\u003e\n              \u003ctd\u003eWork hardening or conditioning, first 2 hours\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97546\u003c/td\u003e\n              \u003ctd\u003eWork hardening or conditioning\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97750\u003c/td\u003e\n              \u003ctd\u003ePhysical performance test or measurement with report, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97755\u003c/td\u003e\n              \u003ctd\u003eAssistive technology assessment to enhance functional performance, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97760\u003c/td\u003e\n              \u003ctd\u003eTraining in use of orthotics (supports, braces, or splints) for arms, legs and/or trunk, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97761\u003c/td\u003e\n              \u003ctd\u003eTraining in use of prosthesis for arms and/or legs, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97762\u003c/td\u003e\n              \u003ctd\u003eEvaluation of orthotic or prosthetic use, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97763\u003c/td\u003e\n              \u003ctd\u003eManagement and/or training in use of orthotics (supports, braces, or splints) for arms, legs, and/or trunk, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97799\u003c/td\u003e\n              \u003ctd\u003ePhysical medicine or rehabilitation service or procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97810\u003c/td\u003e\n              \u003ctd\u003eAcupuncture 1 or more needles, first 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97811\u003c/td\u003e\n              \u003ctd\u003eAcupuncture 1 or more needles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97813\u003c/td\u003e\n              \u003ctd\u003eAcupuncture 1 or more needles with electrical stimulation, first 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e97814\u003c/td\u003e\n              \u003ctd\u003eAcupuncture 1 or more needles with electrical stimulation and re-insertion of needles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e98925\u003c/td\u003e\n              \u003ctd\u003eOsteopathic manipulative treatment to 1-2 body regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e98926\u003c/td\u003e\n              \u003ctd\u003eOsteopathic manipulative treatment to 3-4 body regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e98927\u003c/td\u003e\n              \u003ctd\u003eOsteopathic manipulative treatment to 5-6 body regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e98928\u003c/td\u003e\n              \u003ctd\u003eOsteopathic manipulative treatment to 7-8 body regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e98929\u003c/td\u003e\n              \u003ctd\u003eOsteopathic manipulative treatment to 9-10 body regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99026\u003c/td\u003e\n              \u003ctd\u003eHospital mandated on-call service in the hospital, each hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99027\u003c/td\u003e\n              \u003ctd\u003eHospital mandated on-call service outside the hospital, each hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99050\u003c/td\u003e\n              \u003ctd\u003eServices provided in the office when the office is normally closed\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99056\u003c/td\u003e\n              \u003ctd\u003eServices provided out of the office at patient request\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99058\u003c/td\u003e\n              \u003ctd\u003eServices provided on an emergency basis in the office\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99090\u003c/td\u003e\n              \u003ctd\u003eAnalysis of clinical data stored in computers\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99091\u003c/td\u003e\n              \u003ctd\u003eCollection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99170\u003c/td\u003e\n              \u003ctd\u003eExamination of genital and anal region of child using an endoscope, suspected trauma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99201\u003c/td\u003e\n              \u003ctd\u003eNew patient office or other outpatient visit, typically 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99202\u003c/td\u003e\n              \u003ctd\u003eNew patient office or other outpatient visit, typically 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99203\u003c/td\u003e\n              \u003ctd\u003eNew patient office or other outpatient visit, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99204\u003c/td\u003e\n              \u003ctd\u003eNew patient office or other outpatient visit, typically 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99205\u003c/td\u003e\n              \u003ctd\u003eNew patient office or other outpatient visit, typically 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99211\u003c/td\u003e\n              \u003ctd\u003eEstablished patient office or other outpatient visit, typically 5 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99212\u003c/td\u003e\n              \u003ctd\u003eEstablished patient office or other outpatient visit, typically 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99213\u003c/td\u003e\n              \u003ctd\u003eEstablished patient office or other outpatient visit, typically 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99214\u003c/td\u003e\n              \u003ctd\u003eEstablished patient office or other outpatient, visit typically 25 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99215\u003c/td\u003e\n              \u003ctd\u003eEstablished patient office or other outpatient, visit typically 40 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99217\u003c/td\u003e\n              \u003ctd\u003eHospital observation care on day of discharge\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99218\u003c/td\u003e\n              \u003ctd\u003eHospital observation care, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99219\u003c/td\u003e\n              \u003ctd\u003eHospital observation care, typically 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99220\u003c/td\u003e\n              \u003ctd\u003eHospital observation care, typically 70 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99221\u003c/td\u003e\n              \u003ctd\u003eInitial hospital inpatient care, typically 30 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99222\u003c/td\u003e\n              \u003ctd\u003eInitial hospital inpatient care, typically 50 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99223\u003c/td\u003e\n              \u003ctd\u003eInitial hospital inpatient care, typically 70 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99224\u003c/td\u003e\n              \u003ctd\u003eSubsequent observation care, typically 15 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99225\u003c/td\u003e\n              \u003ctd\u003eSubsequent observation care, typically 25 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99226\u003c/td\u003e\n              \u003ctd\u003eSubsequent observation care, typically 35 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99231\u003c/td\u003e\n              \u003ctd\u003eSubsequent hospital inpatient care, typically 15 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99232\u003c/td\u003e\n              \u003ctd\u003eSubsequent hospital inpatient care, typically 25 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99233\u003c/td\u003e\n              \u003ctd\u003eSubsequent hospital inpatient care, typically 35 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99234\u003c/td\u003e\n              \u003ctd\u003eHospital observation or inpatient care low severity, 40 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99235\u003c/td\u003e\n              \u003ctd\u003eHospital observation or inpatient care moderate severity, 50 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99236\u003c/td\u003e\n              \u003ctd\u003eHospital observation or inpatient care high severity, 55 minutes per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99238\u003c/td\u003e\n              \u003ctd\u003eHospital discharge day management, 30 minutes or less\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99239\u003c/td\u003e\n              \u003ctd\u003eHospital discharge day management, more than 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99241\u003c/td\u003e\n              \u003ctd\u003ePatient office consultation, typically 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99242\u003c/td\u003e\n              \u003ctd\u003ePatient office consultation, typically 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99243\u003c/td\u003e\n              \u003ctd\u003ePatient office consultation, typically 40 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99244\u003c/td\u003e\n              \u003ctd\u003ePatient office consultation, typically 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99245\u003c/td\u003e\n              \u003ctd\u003ePatient office consultation, typically 80 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99251\u003c/td\u003e\n              \u003ctd\u003eInpatient hospital consultation, typically 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99252\u003c/td\u003e\n              \u003ctd\u003eInpatient hospital consultation, typically 40 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99253\u003c/td\u003e\n              \u003ctd\u003eInpatient hospital consultation, typically 55 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99254\u003c/td\u003e\n              \u003ctd\u003eInpatient hospital consultation, typically 80 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99255\u003c/td\u003e\n              \u003ctd\u003eInpatient hospital consultation, typically 110 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99281\u003c/td\u003e\n              \u003ctd\u003eEmergency department visit, self limited or minor problem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99282\u003c/td\u003e\n              \u003ctd\u003eEmergency department visit, low to moderately severe problem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99283\u003c/td\u003e\n              \u003ctd\u003eEmergency department visit, moderately severe problem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99284\u003c/td\u003e\n              \u003ctd\u003eEmergency department visit, problem of high severity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99291\u003c/td\u003e\n              \u003ctd\u003eCritical care delivery critically ill or injured patient, first 30-74 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99363\u003c/td\u003e\n              \u003ctd\u003eAnti-clotting management for patient taking blood thinner, first 90 day therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99364\u003c/td\u003e\n              \u003ctd\u003eAnti-clotting management for patient taking blood thinner\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99366\u003c/td\u003e\n              \u003ctd\u003eMedical team conference with patient and/or family, and nonphysician health care professionals, 30 minutes or more\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99367\u003c/td\u003e\n              \u003ctd\u003eMedical team conference with physician, 30 minutes or more\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99368\u003c/td\u003e\n              \u003ctd\u003eMedical team conference with nonphysician health care professionals, 30 minutes or more\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99374\u003c/td\u003e\n              \u003ctd\u003ePhysician supervision of patient home health agency services, 15-29 minutes per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99375\u003c/td\u003e\n              \u003ctd\u003ePhysician supervision of patient home health agency services, 30 minutes or more per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99377\u003c/td\u003e\n              \u003ctd\u003ePhysician supervision of patient hospice services, 15-29 minutes per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99378\u003c/td\u003e\n              \u003ctd\u003ePhysician supervision of patient hospice services, 30 minutes or more per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99379\u003c/td\u003e\n              \u003ctd\u003eSupervision of nursing facility patient services, 15-29 minutes per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99380\u003c/td\u003e\n              \u003ctd\u003eSupervision of nursing facility patient services, 30 minutes or more per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99381\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation infant younger than 1 year\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99382\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation, age 1 through 4 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99383\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation, age 5 through 11 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99384\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation, age 12 through 17 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99385\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation age 18-39 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99386\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation age 40-64 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99387\u003c/td\u003e\n              \u003ctd\u003eInitial new patient preventive medicine evaluation, age 65 years and older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99391\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination infant younger than 1 year\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99392\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination, age 1 through 4 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99393\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination, age 5 through 11 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99394\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination, age 12 through 17 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99395\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination age 18-39 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99396\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination age 40-64 years\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99397\u003c/td\u003e\n              \u003ctd\u003eEstablished patient periodic preventive medicine examination, age 65 years and older\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99401\u003c/td\u003e\n              \u003ctd\u003ePreventive medicine counseling, approximately 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99402\u003c/td\u003e\n              \u003ctd\u003ePreventive medicine counseling, approximately 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99403\u003c/td\u003e\n              \u003ctd\u003ePreventive medicine counseling, approximately 45 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99404\u003c/td\u003e\n              \u003ctd\u003ePreventive medicine counseling, approximately 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99406\u003c/td\u003e\n              \u003ctd\u003eSmoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99407\u003c/td\u003e\n              \u003ctd\u003eSmoking and tobacco use intensive counseling, greater than 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99408\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance abuse screening and intervention, 15-30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99409\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance abuse screening and intervention, greater than 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99411\u003c/td\u003e\n              \u003ctd\u003eGroup preventive medicine counseling, approximately 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99412\u003c/td\u003e\n              \u003ctd\u003eGroup preventive medicine counseling, approximately 60 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99420\u003c/td\u003e\n              \u003ctd\u003eAdministration and interpretation of health risk assessment instrument\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99421\u003c/td\u003e\n              \u003ctd\u003eOnline digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99422\u003c/td\u003e\n              \u003ctd\u003eOnline digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99423\u003c/td\u003e\n              \u003ctd\u003eOnline digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99429\u003c/td\u003e\n              \u003ctd\u003ePreventive medicine service\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99441\u003c/td\u003e\n              \u003ctd\u003ePhysician telephone patient service, 5-10 minutes of medical discussion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99442\u003c/td\u003e\n              \u003ctd\u003ePhysician telephone patient service, 11-20 minutes of medical discussion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99443\u003c/td\u003e\n              \u003ctd\u003ePhysician telephone patient service, 21-30 minutes of medical discussion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99444\u003c/td\u003e\n              \u003ctd\u003ePhysician or health care professional evaluation and management of patient care by internet (email) related to visit within previous 7 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99446\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet assessment and management service provided byconsultative physician with verbal and written report, 5-10 minutes of medical consultative discussion and review\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99447\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet assessment and management service provided by consultative physician with verbal and written report, 11-20 minutes of medical consultative discussion and review\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99448\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99449\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99450\u003c/td\u003e\n              \u003ctd\u003eBasic life and/or disability examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99451\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99452\u003c/td\u003e\n              \u003ctd\u003eTelephone or internet referral service, 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99453\u003c/td\u003e\n              \u003ctd\u003eRemote monitoring of physiologic parameters, initial set-up and patient education on use of equipment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99454\u003c/td\u003e\n              \u003ctd\u003eRemote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99455\u003c/td\u003e\n              \u003ctd\u003eWork-related or medical disability examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99456\u003c/td\u003e\n              \u003ctd\u003eWork-related or medical disability examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99457\u003c/td\u003e\n              \u003ctd\u003eRemote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99458\u003c/td\u003e\n              \u003ctd\u003eRemote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99460\u003c/td\u003e\n              \u003ctd\u003eInitial hospital or birthing center newborn infant evaluation and management per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99461\u003c/td\u003e\n              \u003ctd\u003eInitial newborn infant evaluation and management per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99462\u003c/td\u003e\n              \u003ctd\u003eSubsequent inpatient hospital care of newborn per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99463\u003c/td\u003e\n              \u003ctd\u003eInitial inpatient hospital or birthing center same date care and discharge of newborn\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99468\u003c/td\u003e\n              \u003ctd\u003eInitial inpatient hospital critical care of newborn, 28 days of age or younger, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99469\u003c/td\u003e\n              \u003ctd\u003eSubsequent inpatient hospital critical care of newborn, 28 days of age or younger, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99471\u003c/td\u003e\n              \u003ctd\u003eInitial inpatient hospital critical care of infant or young child, 29 days through 24 months of age, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99472\u003c/td\u003e\n              \u003ctd\u003eSubsequent inpatient hospital critical care of infant or young child, 29 days through 24 months of age, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99473\u003c/td\u003e\n              \u003ctd\u003eSelf-measured blood pressure; patient education/training and device calibration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99474\u003c/td\u003e\n              \u003ctd\u003eSelf-measured blood pressure measurements\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99475\u003c/td\u003e\n              \u003ctd\u003eInitial inpatient hospital critical care of infant or young child, 2 through 5 years of age, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99476\u003c/td\u003e\n              \u003ctd\u003eSubsequent inpatient hospital critical care of infant or young child, 2 through 5 years of age, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99477\u003c/td\u003e\n              \u003ctd\u003eInitial intensive care of newborn, 28 days of age or younger, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99478\u003c/td\u003e\n              \u003ctd\u003eSubsequent intensive care of recovering low birth weight infant, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99479\u003c/td\u003e\n              \u003ctd\u003eSubsequent intensive care of recovering low birth weight infant, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99480\u003c/td\u003e\n              \u003ctd\u003eSubsequent intensive care of recovering low birth weight infant, per day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99483\u003c/td\u003e\n              \u003ctd\u003eAssessment of and care planning for patient with impaired thought processing, typically 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99484\u003c/td\u003e\n              \u003ctd\u003eCare management services for behavioral health conditions, at least 20 minutes clinical staff time\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99487\u003c/td\u003e\n              \u003ctd\u003eComplex chronic care management services 60 minutes clinical staff time\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99488\u003c/td\u003e\n              \u003ctd\u003eComplex chronic care coordination services, first hour with 1 face-to-face visit, per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99489\u003c/td\u003e\n              \u003ctd\u003eComplex chronic care management services each additional 30 minutes clinical staff time\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99490\u003c/td\u003e\n              \u003ctd\u003eChronic care management services at least 20 minutes per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99491\u003c/td\u003e\n              \u003ctd\u003eChronic care management services by qualified health care professional, 30 minutes or more per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99492\u003c/td\u003e\n              \u003ctd\u003eInitial psychiatric collaborative care management, first 70 minutes in the first calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99493\u003c/td\u003e\n              \u003ctd\u003eSubsequent psychiatric collaborative care management, first 60 minutes in subsequent month of behavioral health care manager activities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99494\u003c/td\u003e\n              \u003ctd\u003eInitial or subsequent psychiatric collaborative care management, additional 30 minutes in the first calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99495\u003c/td\u003e\n              \u003ctd\u003eTransitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99496\u003c/td\u003e\n              \u003ctd\u003eTransitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99497\u003c/td\u003e\n              \u003ctd\u003eAdvance care planning by the physician or other qualified health care professional\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99498\u003c/td\u003e\n              \u003ctd\u003eAdvance care planning by the physician or other qualified health care professional\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99499\u003c/td\u003e\n              \u003ctd\u003eEvaluation and management service\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99605\u003c/td\u003e\n              \u003ctd\u003eMedication therapy management services to a new patient provided by a pharmacist 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99606\u003c/td\u003e\n              \u003ctd\u003eMedication therapy management services to an established patient provided by a pharmacist 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e99607\u003c/td\u003e\n              \u003ctd\u003eMedication therapy management services provided by a pharmacist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC1749\u003c/td\u003e\n              \u003ctd\u003eEndoscope, retrograde imaging/illumination colonoscope device (implantable)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2638\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, stranded, iodine-125, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2639\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, non-stranded, iodine-125, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2640\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, stranded, palladium-103, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2641\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, non-stranded, palladium-103, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2642\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, stranded, cesium-131, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2643\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, non-stranded, cesium-131, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2644\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, cesium-131 chloride solution, per millicurie\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2645\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy planar source, palladium-103, per square millimeter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2698\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, stranded, not otherwise specified, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC2699\u003c/td\u003e\n              \u003ctd\u003eBrachytherapy source, non-stranded, not otherwise specified, per source\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC8937\u003c/td\u003e\n              \u003ctd\u003eComputer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9724\u003c/td\u003e\n              \u003ctd\u003eEndoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9725\u003c/td\u003e\n              \u003ctd\u003ePlacement of endorectal intracavitary applicator for high intensity brachytherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9726\u003c/td\u003e\n              \u003ctd\u003ePlacement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9727\u003c/td\u003e\n              \u003ctd\u003eInsertion of implants into the soft palate; minimum of three implants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9728\u003c/td\u003e\n              \u003ctd\u003ePlacement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9733\u003c/td\u003e\n              \u003ctd\u003eNon-ophthalmic fluorescent vascular angiography\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9734\u003c/td\u003e\n              \u003ctd\u003eFocused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9735\u003c/td\u003e\n              \u003ctd\u003eAnoscopy; with directed submucosal injection(s), any substance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC9738\u003c/td\u003e\n              \u003ctd\u003eAdjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0008\u003c/td\u003e\n              \u003ctd\u003eAdministration of influenza virus vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0009\u003c/td\u003e\n              \u003ctd\u003eAdministration of pneumococcal vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0010\u003c/td\u003e\n              \u003ctd\u003eAdministration of hepatitis b vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0071\u003c/td\u003e\n              \u003ctd\u003ePayment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0104\u003c/td\u003e\n              \u003ctd\u003eColorectal cancer screening; flexible sigmoidoscopy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0105\u003c/td\u003e\n              \u003ctd\u003eColorectal cancer screening; colonoscopy on individual at high risk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0121\u003c/td\u003e\n              \u003ctd\u003eColorectal cancer screening; colonoscopy on individual not meeting criteria for high risk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0124\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0129\u003c/td\u003e\n              \u003ctd\u003eOccupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization treatment program, per session (45 minutes or more)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0130\u003c/td\u003e\n              \u003ctd\u003eSingle energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0141\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0143\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0144\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0145\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0147\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0148\u003c/td\u003e\n              \u003ctd\u003eScreening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0163\u003c/td\u003e\n              \u003ctd\u003eSkilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient\u0027s condition, each 15 minutes (the change in the patient\u0027s condition requires skilled nursing personnel to identify and evaluate the patient\u0027s need for possible modification of treatment in the home health or hospice setting)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0164\u003c/td\u003e\n              \u003ctd\u003eSkilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0202\u003c/td\u003e\n              \u003ctd\u003eScreening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0204\u003c/td\u003e\n              \u003ctd\u003eDiagnostic mammography, including computer-aided detection (cad) when performed; bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0206\u003c/td\u003e\n              \u003ctd\u003eDiagnostic mammography, including computer-aided detection (cad) when performed; unilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0219\u003c/td\u003e\n              \u003ctd\u003ePet imaging whole body; melanoma for non-covered indications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0235\u003c/td\u003e\n              \u003ctd\u003ePet imaging, any site, not otherwise specified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0246\u003c/td\u003e\n              \u003ctd\u003eFollow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0250\u003c/td\u003e\n              \u003ctd\u003ePhysician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0251\u003c/td\u003e\n              \u003ctd\u003eLinear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0252\u003c/td\u003e\n              \u003ctd\u003ePet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0289\u003c/td\u003e\n              \u003ctd\u003eArthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0296\u003c/td\u003e\n              \u003ctd\u003eCounseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0339\u003c/td\u003e\n              \u003ctd\u003eImage-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0340\u003c/td\u003e\n              \u003ctd\u003eImage-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0341\u003c/td\u003e\n              \u003ctd\u003ePercutaneous islet cell transplant, includes portal vein catheterization and infusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0342\u003c/td\u003e\n              \u003ctd\u003eLaparoscopy for islet cell transplant, includes portal vein catheterization and infusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0343\u003c/td\u003e\n              \u003ctd\u003eLaparotomy for islet cell transplant, includes portal vein catheterization and infusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0364\u003c/td\u003e\n              \u003ctd\u003eBone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0380\u003c/td\u003e\n              \u003ctd\u003eLevel 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0381\u003c/td\u003e\n              \u003ctd\u003eLevel 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0382\u003c/td\u003e\n              \u003ctd\u003eLevel 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0383\u003c/td\u003e\n              \u003ctd\u003eLevel 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0384\u003c/td\u003e\n              \u003ctd\u003eLevel 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0390\u003c/td\u003e\n              \u003ctd\u003eTrauma response team associated with hospital critical care service\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0396\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0397\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0398\u003c/td\u003e\n              \u003ctd\u003eHome sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0399\u003c/td\u003e\n              \u003ctd\u003eHome sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0400\u003c/td\u003e\n              \u003ctd\u003eHome sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0402\u003c/td\u003e\n              \u003ctd\u003eInitial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0403\u003c/td\u003e\n              \u003ctd\u003eElectrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0404\u003c/td\u003e\n              \u003ctd\u003eElectrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0405\u003c/td\u003e\n              \u003ctd\u003eElectrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0406\u003c/td\u003e\n              \u003ctd\u003eFollow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0407\u003c/td\u003e\n              \u003ctd\u003eFollow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0408\u003c/td\u003e\n              \u003ctd\u003eFollow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0409\u003c/td\u003e\n              \u003ctd\u003eSocial work and psychological services, directly relating to and/or furthering the patient\u0027s rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0410\u003c/td\u003e\n              \u003ctd\u003eGroup psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0411\u003c/td\u003e\n              \u003ctd\u003eInteractive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0422\u003c/td\u003e\n              \u003ctd\u003eIntensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0423\u003c/td\u003e\n              \u003ctd\u003eIntensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0425\u003c/td\u003e\n              \u003ctd\u003eTelehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0426\u003c/td\u003e\n              \u003ctd\u003eTelehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0427\u003c/td\u003e\n              \u003ctd\u003eTelehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0428\u003c/td\u003e\n              \u003ctd\u003eCollagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0431\u003c/td\u003e\n              \u003ctd\u003eDrug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0434\u003c/td\u003e\n              \u003ctd\u003eDrug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0436\u003c/td\u003e\n              \u003ctd\u003eSmoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0437\u003c/td\u003e\n              \u003ctd\u003eSmoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0438\u003c/td\u003e\n              \u003ctd\u003eAnnual wellness visit; includes a personalized prevention plan of service (pps), initial visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0439\u003c/td\u003e\n              \u003ctd\u003eAnnual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0442\u003c/td\u003e\n              \u003ctd\u003eAnnual alcohol misuse screening, 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0443\u003c/td\u003e\n              \u003ctd\u003eBrief face-to-face behavioral counseling for alcohol misuse, 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0444\u003c/td\u003e\n              \u003ctd\u003eAnnual depression screening, 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0445\u003c/td\u003e\n              \u003ctd\u003eHigh intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0446\u003c/td\u003e\n              \u003ctd\u003eAnnual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0447\u003c/td\u003e\n              \u003ctd\u003eFace-to-face behavioral counseling for obesity, 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0448\u003c/td\u003e\n              \u003ctd\u003eInsertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0451\u003c/td\u003e\n              \u003ctd\u003eDevelopment testing, with interpretation and report, per standardized instrument form\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0452\u003c/td\u003e\n              \u003ctd\u003eMolecular pathology procedure; physician interpretation and report\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0454\u003c/td\u003e\n              \u003ctd\u003ePhysician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0458\u003c/td\u003e\n              \u003ctd\u003eLow dose rate (ldr) prostate brachytherapy services, composite rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0459\u003c/td\u003e\n              \u003ctd\u003eInpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0461\u003c/td\u003e\n              \u003ctd\u003eImmunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0462\u003c/td\u003e\n              \u003ctd\u003eImmunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0463\u003c/td\u003e\n              \u003ctd\u003eHospital outpatient clinic visit for assessment and management of a patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0466\u003c/td\u003e\n              \u003ctd\u003eFederally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0467\u003c/td\u003e\n              \u003ctd\u003eFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0468\u003c/td\u003e\n              \u003ctd\u003eFederally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0469\u003c/td\u003e\n              \u003ctd\u003eFederally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0470\u003c/td\u003e\n              \u003ctd\u003eFederally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0473\u003c/td\u003e\n              \u003ctd\u003eFace-to-face behavioral counseling for obesity, group (2-10), 30 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0475\u003c/td\u003e\n              \u003ctd\u003eHiv antigen/antibody, combination assay, screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0476\u003c/td\u003e\n              \u003ctd\u003eInfectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0501\u003c/td\u003e\n              \u003ctd\u003eResource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0502\u003c/td\u003e\n              \u003ctd\u003eInitial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0503\u003c/td\u003e\n              \u003ctd\u003eSubsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient\u0027s mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0504\u003c/td\u003e\n              \u003ctd\u003eInitial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure); (use g0504 in conjunction with g0502, g0503)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0505\u003c/td\u003e\n              \u003ctd\u003eCognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0506\u003c/td\u003e\n              \u003ctd\u003eComprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0507\u003c/td\u003e\n              \u003ctd\u003eCare management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0508\u003c/td\u003e\n              \u003ctd\u003eTelehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0509\u003c/td\u003e\n              \u003ctd\u003eTelehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0511\u003c/td\u003e\n              \u003ctd\u003eRural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0512\u003c/td\u003e\n              \u003ctd\u003eRural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0513\u003c/td\u003e\n              \u003ctd\u003eProlonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0514\u003c/td\u003e\n              \u003ctd\u003eProlonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG0515\u003c/td\u003e\n              \u003ctd\u003eDevelopment of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG2010\u003c/td\u003e\n              \u003ctd\u003eRemote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG2011\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG2012\u003c/td\u003e\n              \u003ctd\u003eBrief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6001\u003c/td\u003e\n              \u003ctd\u003eUltrasonic guidance for placement of radiation therapy fields\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6002\u003c/td\u003e\n              \u003ctd\u003eStereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6003\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6004\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6005\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6006\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6007\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6008\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6009\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6010\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6011\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6012\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6013\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6014\u003c/td\u003e\n              \u003ctd\u003eRadiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6015\u003c/td\u003e\n              \u003ctd\u003eIntensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6016\u003c/td\u003e\n              \u003ctd\u003eCompensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6017\u003c/td\u003e\n              \u003ctd\u003eIntra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6018\u003c/td\u003e\n              \u003ctd\u003eIleoscopy, through stoma; with transendoscopic stent placement (includes predilation)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6019\u003c/td\u003e\n              \u003ctd\u003eColonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6020\u003c/td\u003e\n              \u003ctd\u003eColonoscopy through stoma; with transendoscopic stent placement (includes predilation)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6022\u003c/td\u003e\n              \u003ctd\u003eSigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6023\u003c/td\u003e\n              \u003ctd\u003eSigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6024\u003c/td\u003e\n              \u003ctd\u003eColonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6025\u003c/td\u003e\n              \u003ctd\u003eColonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6027\u003c/td\u003e\n              \u003ctd\u003eAnoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG6028\u003c/td\u003e\n              \u003ctd\u003eAnoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG9156\u003c/td\u003e\n              \u003ctd\u003eEvaluation for wheelchair requiring face to face visit with physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG9157\u003c/td\u003e\n              \u003ctd\u003eTransesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0001\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0002\u003c/td\u003e\n              \u003ctd\u003eBehavioral health screening to determine eligibility for admission to treatment program\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0003\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0004\u003c/td\u003e\n              \u003ctd\u003eBehavioral health counseling and therapy, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0005\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; group counseling by a clinician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0006\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; case management\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0007\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; crisis intervention (outpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0008\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; sub-acute detoxification (hospital inpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0009\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; acute detoxification (hospital inpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0010\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0011\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; acute detoxification (residential addiction program inpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0012\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0013\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; acute detoxification (residential addiction program outpatient)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0014\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; ambulatory detoxification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0015\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0016\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0017\u003c/td\u003e\n              \u003ctd\u003eBehavioral health; residential (hospital residential treatment program), without room and board, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0018\u003c/td\u003e\n              \u003ctd\u003eBehavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0019\u003c/td\u003e\n              \u003ctd\u003eBehavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0020\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0021\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug training service (for staff and personnel not employed by providers)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0022\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug intervention service (planned facilitation)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0023\u003c/td\u003e\n              \u003ctd\u003eBehavioral health outreach service (planned approach to reach a targeted population)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0024\u003c/td\u003e\n              \u003ctd\u003eBehavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0025\u003c/td\u003e\n              \u003ctd\u003eBehavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0026\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0027\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0028\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0029\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0030\u003c/td\u003e\n              \u003ctd\u003eBehavioral health hotline service\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0031\u003c/td\u003e\n              \u003ctd\u003eMental health assessment, by non-physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0032\u003c/td\u003e\n              \u003ctd\u003eMental health service plan development by non-physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0033\u003c/td\u003e\n              \u003ctd\u003eOral medication administration, direct observation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0034\u003c/td\u003e\n              \u003ctd\u003eMedication training and support, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0035\u003c/td\u003e\n              \u003ctd\u003eMental health partial hospitalization, treatment, less than 24 hours\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0036\u003c/td\u003e\n              \u003ctd\u003eCommunity psychiatric supportive treatment, face-to-face, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0037\u003c/td\u003e\n              \u003ctd\u003eCommunity psychiatric supportive treatment program, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0038\u003c/td\u003e\n              \u003ctd\u003eSelf-help/peer services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0039\u003c/td\u003e\n              \u003ctd\u003eAssertive community treatment, face-to-face, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0040\u003c/td\u003e\n              \u003ctd\u003eAssertive community treatment program, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0045\u003c/td\u003e\n              \u003ctd\u003eRespite care services, not in the home, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0046\u003c/td\u003e\n              \u003ctd\u003eMental health services, not otherwise specified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0047\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or other drug abuse services, not otherwise specified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0048\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or other drug testing: collection and handling only, specimens other than blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0049\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH0050\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug services, brief intervention, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1000\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at-risk assessment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1001\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at-risk enhanced service; antepartum management\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1002\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at risk enhanced service; care coordination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1003\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at-risk enhanced service; education\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1004\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at-risk enhanced service; follow-up home visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1005\u003c/td\u003e\n              \u003ctd\u003ePrenatal care, at-risk enhanced service package (includes h1001-h1004)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1010\u003c/td\u003e\n              \u003ctd\u003eNon-medical family planning education, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH1011\u003c/td\u003e\n              \u003ctd\u003eFamily assessment by licensed behavioral health professional for state defined purposes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2000\u003c/td\u003e\n              \u003ctd\u003eComprehensive multidisciplinary evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2001\u003c/td\u003e\n              \u003ctd\u003eRehabilitation program, per 1/2 day\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2010\u003c/td\u003e\n              \u003ctd\u003eComprehensive medication services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2011\u003c/td\u003e\n              \u003ctd\u003eCrisis intervention service, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2012\u003c/td\u003e\n              \u003ctd\u003eBehavioral health day treatment, per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2013\u003c/td\u003e\n              \u003ctd\u003ePsychiatric health facility service, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2014\u003c/td\u003e\n              \u003ctd\u003eSkills training and development, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2015\u003c/td\u003e\n              \u003ctd\u003eComprehensive community support services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2016\u003c/td\u003e\n              \u003ctd\u003eComprehensive community support services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2017\u003c/td\u003e\n              \u003ctd\u003ePsychosocial rehabilitation services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2018\u003c/td\u003e\n              \u003ctd\u003ePsychosocial rehabilitation services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2019\u003c/td\u003e\n              \u003ctd\u003eTherapeutic behavioral services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2020\u003c/td\u003e\n              \u003ctd\u003eTherapeutic behavioral services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2025\u003c/td\u003e\n              \u003ctd\u003eOngoing support to maintain employment, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2026\u003c/td\u003e\n              \u003ctd\u003eOngoing support to maintain employment, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2027\u003c/td\u003e\n              \u003ctd\u003ePsychoeducational service, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2028\u003c/td\u003e\n              \u003ctd\u003eSexual offender treatment service, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2029\u003c/td\u003e\n              \u003ctd\u003eSexual offender treatment service, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2030\u003c/td\u003e\n              \u003ctd\u003eMental health clubhouse services, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2031\u003c/td\u003e\n              \u003ctd\u003eMental health clubhouse services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2032\u003c/td\u003e\n              \u003ctd\u003eActivity therapy, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2033\u003c/td\u003e\n              \u003ctd\u003eMultisystemic therapy for juveniles, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2034\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or drug abuse halfway house services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2035\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or other drug treatment program, per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2036\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or other drug treatment program, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eH2037\u003c/td\u003e\n              \u003ctd\u003eDevelopmental delay prevention activities, dependent child of client, per 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eM0064\u003c/td\u003e\n              \u003ctd\u003eBrief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eP3000\u003c/td\u003e\n              \u003ctd\u003eScreening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eP3001\u003c/td\u003e\n              \u003ctd\u003eScreening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eP7001\u003c/td\u003e\n              \u003ctd\u003eCulture, bacterial, urine; quantitative, sensitivity study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0035\u003c/td\u003e\n              \u003ctd\u003eCardiokymography\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0091\u003c/td\u003e\n              \u003ctd\u003eScreening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0092\u003c/td\u003e\n              \u003ctd\u003eSet-up portable x-ray equipment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0111\u003c/td\u003e\n              \u003ctd\u003eWet mounts, including preparations of vaginal, cervical or skin specimens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0112\u003c/td\u003e\n              \u003ctd\u003eAll potassium hydroxide (koh) preparations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0113\u003c/td\u003e\n              \u003ctd\u003ePinworm examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ0115\u003c/td\u003e\n              \u003ctd\u003ePost-coital direct, qualitative examinations of vaginal or cervical mucous\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2034\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, split virus, for intramuscular use (agriflu)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2035\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2036\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2037\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2038\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ2039\u003c/td\u003e\n              \u003ctd\u003eInfluenza virus vaccine, not otherwise specified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eQ5010\u003c/td\u003e\n              \u003ctd\u003eHospice home care provided in a hospice facility\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0195\u003c/td\u003e\n              \u003ctd\u003ePneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0199\u003c/td\u003e\n              \u003ctd\u003eMedically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0260\u003c/td\u003e\n              \u003ctd\u003eHistory and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0302\u003c/td\u003e\n              \u003ctd\u003eCompleted early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0311\u003c/td\u003e\n              \u003ctd\u003eComprehensive management and care coordination for advanced illness, per calendar month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0353\u003c/td\u003e\n              \u003ctd\u003eTreatment planning and care coordination management for cancer, initial treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0354\u003c/td\u003e\n              \u003ctd\u003eTreatment planning and care coordination management for cancer, established patient with a change of regimen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0601\u003c/td\u003e\n              \u003ctd\u003eScreening proctoscopy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0610\u003c/td\u003e\n              \u003ctd\u003eAnnual gynecological examination, new patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0612\u003c/td\u003e\n              \u003ctd\u003eAnnual gynecological examination, established patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0613\u003c/td\u003e\n              \u003ctd\u003eAnnual gynecological examination; clinical breast examination without pelvic evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS0622\u003c/td\u003e\n              \u003ctd\u003ePhysical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2053\u003c/td\u003e\n              \u003ctd\u003eTransplantation of small intestine and liver allografts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2054\u003c/td\u003e\n              \u003ctd\u003eTransplantation of multivisceral organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2055\u003c/td\u003e\n              \u003ctd\u003eHarvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2060\u003c/td\u003e\n              \u003ctd\u003eLobar lung transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2065\u003c/td\u003e\n              \u003ctd\u003eSimultaneous pancreas kidney transplantation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2102\u003c/td\u003e\n              \u003ctd\u003eIslet cell tissue transplant from pancreas; allogeneic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2103\u003c/td\u003e\n              \u003ctd\u003eAdrenal tissue transplant to brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2117\u003c/td\u003e\n              \u003ctd\u003eArthroereisis, subtalar\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2140\u003c/td\u003e\n              \u003ctd\u003eCord blood harvesting for transplantation, allogeneic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2152\u003c/td\u003e\n              \u003ctd\u003eSolid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2260\u003c/td\u003e\n              \u003ctd\u003eInduced abortion, 17 to 24 weeks\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2265\u003c/td\u003e\n              \u003ctd\u003eInduced abortion, 25 to 28 weeks\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2266\u003c/td\u003e\n              \u003ctd\u003eInduced abortion, 29 to 31 weeks\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2267\u003c/td\u003e\n              \u003ctd\u003eInduced abortion, 32 weeks or greater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS2300\u003c/td\u003e\n              \u003ctd\u003eArthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS3904\u003c/td\u003e\n              \u003ctd\u003eMasters two step\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4011\u003c/td\u003e\n              \u003ctd\u003eIn vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4013\u003c/td\u003e\n              \u003ctd\u003eComplete cycle, gamete intrafallopian transfer (gift), case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4014\u003c/td\u003e\n              \u003ctd\u003eComplete cycle, zygote intrafallopian transfer (zift), case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4015\u003c/td\u003e\n              \u003ctd\u003eComplete in vitro fertilization cycle, not otherwise specified, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4016\u003c/td\u003e\n              \u003ctd\u003eFrozen in vitro fertilization cycle, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4017\u003c/td\u003e\n              \u003ctd\u003eIncomplete cycle, treatment cancelled prior to stimulation, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4018\u003c/td\u003e\n              \u003ctd\u003eFrozen embryo transfer procedure cancelled before transfer, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4020\u003c/td\u003e\n              \u003ctd\u003eIn vitro fertilization procedure cancelled before aspiration, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4021\u003c/td\u003e\n              \u003ctd\u003eIn vitro fertilization procedure cancelled after aspiration, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4022\u003c/td\u003e\n              \u003ctd\u003eAssisted oocyte fertilization, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4023\u003c/td\u003e\n              \u003ctd\u003eDonor egg cycle, incomplete, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4025\u003c/td\u003e\n              \u003ctd\u003eDonor services for in vitro fertilization (sperm or embryo), case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4026\u003c/td\u003e\n              \u003ctd\u003eProcurement of donor sperm from sperm bank\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4028\u003c/td\u003e\n              \u003ctd\u003eMicrosurgical epididymal sperm aspiration (mesa)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4035\u003c/td\u003e\n              \u003ctd\u003eStimulated intrauterine insemination (iui), case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4037\u003c/td\u003e\n              \u003ctd\u003eCryopreserved embryo transfer, case rate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4040\u003c/td\u003e\n              \u003ctd\u003eMonitoring and storage of cryopreserved embryos, per 30 days\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS4042\u003c/td\u003e\n              \u003ctd\u003eManagement of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS5190\u003c/td\u003e\n              \u003ctd\u003eWellness assessment, performed by non-physician\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8030\u003c/td\u003e\n              \u003ctd\u003eScleral application of tantalum ring(s) for localization of lesions for proton beam therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8055\u003c/td\u003e\n              \u003ctd\u003eUltrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8080\u003c/td\u003e\n              \u003ctd\u003eScintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8085\u003c/td\u003e\n              \u003ctd\u003eFluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8930\u003c/td\u003e\n              \u003ctd\u003eElectrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8940\u003c/td\u003e\n              \u003ctd\u003eEquestrian/hippotherapy, per session\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8950\u003c/td\u003e\n              \u003ctd\u003eComplex lymphedema therapy, each 15 minutes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS8990\u003c/td\u003e\n              \u003ctd\u003ePhysical or manipulative therapy performed for maintenance rather than restoration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9015\u003c/td\u003e\n              \u003ctd\u003eAutomated eeg monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9025\u003c/td\u003e\n              \u003ctd\u003eOmnicardiogram/cardiointegram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9110\u003c/td\u003e\n              \u003ctd\u003eTelemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9117\u003c/td\u003e\n              \u003ctd\u003eBack school, per visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9152\u003c/td\u003e\n              \u003ctd\u003eSpeech therapy, re-evaluation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9472\u003c/td\u003e\n              \u003ctd\u003eCardiac rehabilitation program, non-physician provider, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9473\u003c/td\u003e\n              \u003ctd\u003ePulmonary rehabilitation program, non-physician provider, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9475\u003c/td\u003e\n              \u003ctd\u003eAmbulatory setting substance abuse treatment or detoxification services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9476\u003c/td\u003e\n              \u003ctd\u003eVestibular rehabilitation program, non-physician provider, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9480\u003c/td\u003e\n              \u003ctd\u003eIntensive outpatient psychiatric services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9484\u003c/td\u003e\n              \u003ctd\u003eCrisis intervention mental health services, per hour\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eS9485\u003c/td\u003e\n              \u003ctd\u003eCrisis intervention mental health services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1006\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance abuse services, family/couple counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1007\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance abuse services, treatment plan development and/or modification\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1009\u003c/td\u003e\n              \u003ctd\u003eChild sitting services for children of the individual receiving alcohol and/or substance abuse services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1010\u003c/td\u003e\n              \u003ctd\u003eMeals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1012\u003c/td\u003e\n              \u003ctd\u003eAlcohol and/or substance abuse services, skills development\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1015\u003c/td\u003e\n              \u003ctd\u003eClinic visit/encounter, all-inclusive\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1040\u003c/td\u003e\n              \u003ctd\u003eMedicaid certified community behavioral health clinic services, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT1041\u003c/td\u003e\n              \u003ctd\u003eMedicaid certified community behavioral health clinic services, per month\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT2048\u003c/td\u003e\n              \u003ctd\u003eBehavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eV5362\u003c/td\u003e\n              \u003ctd\u003eSpeech screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eV5363\u003c/td\u003e\n              \u003ctd\u003eLanguage screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eV5364\u003c/td\u003e\n              \u003ctd\u003eDysphagia screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n          \u003c/table\u003e\n        \u003c/li\u003e\n      \u003c/ul\u003e\n    \u003c/div\u003e"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.399","version":"20200623","name":"Elective Procedure","status":"active","date":"2020-06-23T01:00:22-04:00","publisher":"Change Healthcare Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"0001M","display":"Infectious disease, hcv, six biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver"},{"code":"0001U","display":"Red blood cell typing"},{"code":"0002M","display":"Liver disease, ten biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, haptoglobin, ast, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and alcoholic steatohepatitis (ash)"},{"code":"0003M","display":"Liver disease, ten biochemical assays (alt, a2-macroglobulin, apolipoprotein a-1, total bilirubin, ggt, haptoglobin, ast, glucose, total cholesterol and triglycerides) utilizing serum, prognostic algorithm reported as quantitative scores for fibrosis, steatosis and nonalcoholic steatohepatitis (nash)"},{"code":"0003U","display":"Measurement of proteins associated with ovarian cancer in serum"},{"code":"0004M","display":"Scoliosis, dna analysis of 53 single nucleotide polymorphisms (snps), using saliva, prognostic algorithm reported as a risk score"},{"code":"0004U","display":"Test for detecting genes associated with antibiotic resistance in bacterial culture"},{"code":"0005U","display":"Test for detecting genes associated with prostate cancer in urine"},{"code":"0006M","display":"Oncology (hepatic), mrna expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier"},{"code":"0007M","display":"Oncology (gastrointestinal neuroendocrine tumors), real-time pcr expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index"},{"code":"0008M","display":"Oncology (breast), mrna analysis of 58 genes using hybrid capture, on formalin-fixed paraffin-embedded (ffpe) tissue, prognostic algorithm reported as a risk score"},{"code":"0008U","display":"Test for detecting Helicobacter pylori genes associated with antibiotic resistance in tissue sample"},{"code":"0009M","display":"Fetal aneuploidy (trisomy 21, and 18) dna sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy"},{"code":"0009U","display":"Gene analysis of breast tumor tissue"},{"code":"0010M","display":"Oncology (high-grade prostate cancer), biochemical assay of four proteins (total psa, free psa, intact psa and human kallidrein 2 (hk2)) plus patient age, digital rectal examination status, and no history of positive prostate biopsy, utilizing plasma, prognostic algorithm reported as a probability score"},{"code":"0010U","display":"Typing of bacterial strain"},{"code":"0011M","display":"Oncology, prostate cancer, mrna expression assay of 12 genes (10 content and 2 housekeeping), rt-pcr test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk"},{"code":"0012M","display":"Oncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma"},{"code":"0012U","display":"Gene analysis for germline disorder"},{"code":"0013M","display":"Oncology (urothelial), mrna, gene expression profiling by real-time quantitative pcr of five genes (mdk, hoxa13, cdc2 [cdk1], igfbp5, and cxcr2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma"},{"code":"0013U","display":"Gene analysis of solid organ tumor tissue"},{"code":"0014U","display":"Test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow"},{"code":"0015U","display":"Test for detecting genes associated with drug metabolism in blood or cheek swab"},{"code":"0016U","display":"Test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow"},{"code":"0017U","display":"Test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow"},{"code":"0018U","display":"MicroRNA gene analysis of thyroid nodule tissue"},{"code":"0019U","display":"RNA gene analysis of tumor tissue"},{"code":"0021U","display":"Detection of 8 autoantibodies in prostate tissue"},{"code":"0022U","display":"DNA and RNA gene analysis for non-small cell lung cancer"},{"code":"0023U","display":"DNA gene analysis for acute myelogenous leukemia"},{"code":"0026U","display":"DNA and microRNA gene analysis of thyroid nodule tissue"},{"code":"0027U","display":"Gene analysis (Janus kinase 2) of targeted sequence exons 12-15"},{"code":"0028U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) for copy number variants and common variants with follow-up targeted sequence analysis"},{"code":"0029U","display":"Gene analysis of targeted sequences for adverse drug reactions and drug response"},{"code":"0030U","display":"Gene analysis of targeted sequences for warfarin drug response"},{"code":"0031U","display":"Gene analysis (cytochrome P450 family 1, subfamily A, member 2) for common variants"},{"code":"0032U","display":"Gene analysis (catechol-O-methyltransferase) for c.472G\u003eA (rs4680) variant"},{"code":"0033U","display":"Gene analysis (5-hydroxytryptamine receptor 2A) for common variants"},{"code":"0034U","display":"Gene analysis (thiopurine S-methyltransferase) for common variants"},{"code":"0035U","display":"Testing for presence of prion protein in cerebrospinal fluid"},{"code":"0036U","display":"Exome gene analysis for somatic mutation in tumor tissue"},{"code":"0037U","display":"DNA gene analysis of 324 genes in solid organ tumor tissue"},{"code":"0040U","display":"Gene analysis (t(9;22)) for translocation analysis"},{"code":"0041U","display":"IgM antibody detection test for Borrelia burgdorferi"},{"code":"0042U","display":"IgG antibody detection test for Borrelia burgdorferi"},{"code":"0043U","display":"IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group"},{"code":"0044U","display":"IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group"},{"code":"0045U","display":"mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue"},{"code":"0046U","display":"Gene analysis (fms-related tyrosine kinase 3) for internal tandem duplication variants"},{"code":"0047U","display":"mRNA gene analysis of 17 genes in prostate tumor tissue"},{"code":"0048U","display":"DNA gene analysis of 468 genes in solid organ tumor tissue"},{"code":"0049U","display":"Gene analysis (nucleophosmin)"},{"code":"0050U","display":"DNA gene analysis of targeted sequences in 194 genes for acute myelogenous leukemia"},{"code":"0053U","display":"FISH analysis of 4 genes in prostate needle biopsy specimen"},{"code":"0054T","display":"Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation"},{"code":"0055T","display":"Musculoskeletal surgical navigational orthopedic operation using imaging guidance"},{"code":"0055U","display":"DNA gene analysis of 96 target sequences in plasma for heart transplant"},{"code":"0056U","display":"Whole genome sequencing in blood or bone marrow for acute myelogenous leukemia"},{"code":"0057U","display":"mRNA gene analysis of 51 genes in solid organ tumor tissue"},{"code":"0060U","display":"Gene analysis for identical twins in maternal blood"},{"code":"0062U","display":"IgG and IgM analysis of 80 biomarkers of systemic lupus erythematosus in serum"},{"code":"0063U","display":"Testing for amines associated with autism spectrum disorder in plasma"},{"code":"0067U","display":"Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue"},{"code":"0068U","display":"Detection of Candida species by amplified probe"},{"code":"0069U","display":"mRNA expression profiling of miR-31-3 in colon tumor tissue"},{"code":"0070U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) for common and select rare variants"},{"code":"0071U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) full sequence analysis"},{"code":"0072U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D7 hybrid gene"},{"code":"0073T","display":"Compensator-based beam modulation radiation treatment delivery per session"},{"code":"0073U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for CYP2D6-2D6 hybrid gene"},{"code":"0074U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for non-duplicated gene when duplication/multiplication is trans"},{"code":"0075U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 5 gene duplication/multiplication"},{"code":"0076U","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) targeted sequence analysis for 3 gene duplication/multiplication"},{"code":"0078U","display":"Gene analysis of 16 genes to evaluate risk of opioid-use disorder"},{"code":"0079U","display":"DNA analysis of urine and cheek swabs for specimen identity verification"},{"code":"0080U","display":"Analysis of galectin-3-binding protein and scavenger receptor cysteine-rich type 1 protein M130 in plasma, with clinical risk factors, to evaluate probability of lung cancer"},{"code":"0081U","display":"Oncology (uveal melanoma), mrna, gene-expression profiling by real-time rt-pcr of 15 genes (12 content and 3 housekeeping genes), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis"},{"code":"0083U","display":"Evaluation of response to chemotherapy drugs using motility contrast tomography of fresh or frozen tissue"},{"code":"0092T","display":"Insertion of upper spine artificial disc with decompression of nerve roots"},{"code":"0123T","display":"Surgical creation of drainage tract to relieve increased eye pressure"},{"code":"0178T","display":"Electrocardiogram (ECG) 64 leads or greater with graphic presentation, analysis interpretation, and report"},{"code":"0179T","display":"Tracing of electrocardiogram (ECG) 64 leads or greater with graphic presentation"},{"code":"0180T","display":"Interpretation and report of electrocardiogram (ECG) 64 leads or greater with graphic presentation"},{"code":"0182T","display":"High dose rate electronic brachytherapy"},{"code":"0188T","display":"Remote real-time interactive video-conferenced critical care, 30-74 minutes"},{"code":"0189T","display":"Remote real-time interactive video-conferenced critical care"},{"code":"0191T","display":"Internal insertion of eye fluid drainage device"},{"code":"0197T","display":"Localization and tracking of target or patient motion during radiation therapy delivery"},{"code":"0206T","display":"Remote analysis of ECG-derived data with computer assessment and report"},{"code":"0223T","display":"Acoustic ECG analysis"},{"code":"0224T","display":"Acoustic multiple interval ECG analysis"},{"code":"0226T","display":"Diagnostic anal examination using an endoscope"},{"code":"0227T","display":"Examination and biopsy of anus using an endoscope"},{"code":"0253T","display":"Insertion of eye fluid drainage device"},{"code":"0286T","display":"Near-infrared spectroscopy studies of wounds of legs"},{"code":"0287T","display":"Near-infrared guidance to assess patency of potential vascular access sites"},{"code":"0289T","display":"Corneal incisions in the donor cornea created using a laser in preparation for penetrating or lamellar keratoplasty"},{"code":"0290T","display":"Corneal incisions in the recipient cornea created using a laser in preparation for penetrating or lamellar keratoplasty"},{"code":"0293T","display":"Insertion of left upper heart monitor with communication module and pressure sensor, with radiological supervision and interpretation"},{"code":"0294T","display":"Insertion of left upper heart monitor and pacing defibrillator pulse generator, with radiological supervision and interpretation"},{"code":"0295T","display":"External EKG recording for more than 48 hours up to 21 days with analysis, report, review and interpretation"},{"code":"0296T","display":"External EKG recording for more than 48 hours up to 21 days"},{"code":"0297T","display":"Analysis and report of external EKG recording for more than 48 hours up to 21 days"},{"code":"0301T","display":"Destruction or reduction of malignant breast tumor with externally applied microwave therapy, including placement of catheter and monitoring probe under ultrasound heat guidance"},{"code":"0308T","display":"Insertion of prosthetic telescope in eye for the treatment of central vision"},{"code":"0312T","display":"Implantation of neurostimulator electrodes and pulse generator for vagus nerve blocking therapy for obesity using an endoscope"},{"code":"0313T","display":"Revision or replacement of neurostimulator electrodes for vagus nerve blocking therapy for obesity using an endoscope"},{"code":"0314T","display":"Removal of neurostimulator electrodes and pulse generator for vagus nerve blocking therapy for obesity using an endoscope"},{"code":"0315T","display":"Removal of pulse generator for vagus nerve blocking therapy for treatment of obesity"},{"code":"0316T","display":"Replacement of pulse generator for vagus nerve blocking therapy for treatment of obesity"},{"code":"0319T","display":"Insertion or replacement of electrode and defibrillator generator implantable beneath the skin"},{"code":"0320T","display":"Insertion of electrode beneath the skin for defibrillator device"},{"code":"0321T","display":"Insertion of defibrillator generator implantable beneath the skin"},{"code":"0322T","display":"Removal of defibrillator device accessed beneath the skin"},{"code":"0323T","display":"Replacement of defibrillator device accessed beneath the skin"},{"code":"0324T","display":"Removal of electrode of defibrillator device accessed beneath the skin"},{"code":"0331T","display":"Imaging of heart muscle"},{"code":"0332T","display":"Imaging of heart muscle with SPECT"},{"code":"0347T","display":"Insertion of devices in bone for visualization and measurement using radiostereometric analysis (RSA)"},{"code":"0348T","display":"X-ray of spine with radiostereometric analysis (RSA)"},{"code":"0349T","display":"X-ray of arms with radiostereometric analysis (RSA)"},{"code":"0358T","display":"Whole body composition tissue and fluid measurements with interpretation and report"},{"code":"0359T","display":"Behavior identification assessment"},{"code":"0360T","display":"Observational behavioral follow-up assessment first 30 minutes"},{"code":"0361T","display":"Observational behavioral follow-up assessment additional 30 minutes"},{"code":"0362T","display":"Behavior identification supporting assessment for patient exhibiting destructive behavior, each 15 minutes of technicians\u0027 face-to-face time"},{"code":"0363T","display":"Exposure behavioral follow-up assessment each additional 30 minutes"},{"code":"0364T","display":"Behavior treatment by protocol administered by technician first 30 minutes"},{"code":"0365T","display":"Behavior treatment by protocol administered by technician each additional 30 minutes"},{"code":"0366T","display":"Group behavior treatment by protocol administered by technician first 30 minutes"},{"code":"0367T","display":"Group behavior treatment by protocol administered by technician each additional 30 minutes"},{"code":"0368T","display":"Behavior treatment with protocol modification administered by physician or other qualified health care professional first 30 minutes"},{"code":"0369T","display":"Behavior treatment with protocol modification administered by physician or other qualified health care professional each additional 30 minutes"},{"code":"0370T","display":"Family behavior treatment guidance administered by physician"},{"code":"0371T","display":"Multiple-family group behavior treatment guidance administered by physician or other qualified health care professional"},{"code":"0372T","display":"Behavior treatment social skills group administered by physician or other qualified health care professional"},{"code":"0373T","display":"Adaptive behavior treatment with protocol modification for patient exhibiting destructive behavior, each 15 minutes of technicians\u0027 face-to-face time"},{"code":"0375T","display":"Insertion of artificial upper spine discs anterior approach"},{"code":"0387T","display":"Transcatheter insertion or replacement of permanent leadless pacemaker, ventricular"},{"code":"0388T","display":"Transcatheter removal of permanent leadless pacemaker, ventricular"},{"code":"0389T","display":"Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report, leadless pacemaker system"},{"code":"0390T","display":"Peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure or test with analysis, review and report, leadless pacemaker system"},{"code":"0394T","display":"High dose rate electronic brachytherapy"},{"code":"0395T","display":"High dose rate electronic brachytherapy"},{"code":"0396T","display":"Intra-operative use of kinetic balance sensor for joint implant stability during knee replacement surgery"},{"code":"0408T","display":"Insertion or replacement of pulse generator and electrodes of heart contractility modulator system"},{"code":"0409T","display":"Insertion or replacement of pulse generator of heart contractility modulator system"},{"code":"0410T","display":"Insertion or replacement of electrodes in upper chamber of heart for heart contractility modulator system"},{"code":"0411T","display":"Insertion or replacement of electrodes in lower chamber of heart for heart contractility modulator system"},{"code":"0412T","display":"Removal of pulse generator for heart contractility modulator system"},{"code":"0413T","display":"Removal of electrode for heart contractility modulator system"},{"code":"0414T","display":"Replacement of pulse generator of heart contractility modulator system"},{"code":"0415T","display":"Repositioning of electrode of heart contractility modulator system"},{"code":"0417T","display":"Programming evaluation of heart contractility modulator system"},{"code":"0418T","display":"Interrogation evaluation of heart contractility modulator system"},{"code":"0422T","display":"Tactile imaging of one or both breasts"},{"code":"0438T","display":"Injection of biodegradable material adjacent to prostate, accessed by perineal region using imaging guidance"},{"code":"0449T","display":"Insertion of aqueous fluid drainage device into eye"},{"code":"0450T","display":"Insertion of aqueous fluid drainage device into eye"},{"code":"0479T","display":"Laser destruction of scar tissue"},{"code":"0480T","display":"Laser destruction of scar tissue"},{"code":"0482T","display":"Measurement of blood flow in heart muscle at rest and under stress"},{"code":"0494T","display":"Preparation and storage of donor lung"},{"code":"0495T","display":"Initiation and monitoring of circulation in donor lung"},{"code":"0497T","display":"Connection of external patient-activated EKG event recorder"},{"code":"0498T","display":"Review and interpretation of external patient-activated EKG event recordings"},{"code":"0500T","display":"Infectious agent detection by nucleic acid (DNA or RNA); human papillomavirus (HPV)"},{"code":"0515T","display":"Insertion of complete wireless heart stimulator system for pacing of lower left chamber of heart"},{"code":"0516T","display":"Insertion of electrode of wireless heart stimulator system for pacing of lower left chamber of heart"},{"code":"0517T","display":"Insertion of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart"},{"code":"0518T","display":"Removal of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart"},{"code":"0519T","display":"Removal and replacement of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart"},{"code":"0521T","display":"Evaluation of parameters of wireless heart stimulator system for pacing of lower left chamber of heart including connection, recording, disconnection, and analysis"},{"code":"0522T","display":"Evaluation, testing, and programming adjustment of wireless heart stimulator system for pacing of lower left chamber of heart with qualified health care professional analysis, review, and report"},{"code":"0528T","display":"Evaluation, testing, and programming adjustment of monitoring system for deficient blood flow in heart muscle with analysis, review, and report"},{"code":"0529T","display":"Evaluation of parameters of monitoring system for deficient blood flow in heart muscle with analysis, review, and report"},{"code":"10160","display":"Aspiration of abscess, blood accumulation, blister, or cyst"},{"code":"11055","display":"Removal of single thickened skin growth"},{"code":"11056","display":"Removal of 2 to 4 thickened skin growths"},{"code":"11057","display":"Removal of more than 4 thickened skin growths"},{"code":"11200","display":"Removal of up to and including 15 skin tags"},{"code":"11201","display":"Removal of skin tags"},{"code":"11300","display":"Shaving of 0.5 centimeters or less skin growth of the trunk, arms, or legs"},{"code":"11301","display":"Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs"},{"code":"11302","display":"Shaving of 1.1 to 2.0 centimeters skin growth of the trunk, arms, or legs"},{"code":"11303","display":"Shaving of over 2.0 centimeters skin growth of the trunk, arms, or legs"},{"code":"11305","display":"Shaving of 0.5 centimeters or less skin growth of scalp, neck, hands, feet, or genitals"},{"code":"11306","display":"Shaving of 0.6 centimeters to 1.0 centimeters skin growth of scalp, neck, hands, feet, or genitals"},{"code":"11307","display":"Shaving of 1.1 to 2.0 centimeters skin growth of scalp, neck, hands, feet, or genitals"},{"code":"11308","display":"Shaving of over 2.0 centimeters skin growth of scalp, neck, hands, feet, or genitals"},{"code":"11310","display":"Shaving of 0.5 centimeters or less skin growth of face, ears, eyelids, nose, lips, or mouth"},{"code":"11311","display":"Shaving of 0.6 centimeters to 1.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth"},{"code":"11312","display":"Shaving of 1.1 to 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth"},{"code":"11313","display":"Shaving of over 2.0 centimeters skin growth of face, ears, eyelids, nose, lips, or mouth"},{"code":"11400","display":"Removal of growth (0.5 centimeters or less) of the trunk, arms or legs"},{"code":"11401","display":"Removal of growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs"},{"code":"11402","display":"Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs"},{"code":"11403","display":"Removal of growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs"},{"code":"11404","display":"Removal of growth (3.1 to 4.0 centimeters) of the trunk, arms, or legs"},{"code":"11406","display":"Removal of growth (4.0 centimeters) of the trunk, arms, or legs"},{"code":"11420","display":"Removal of growth (0.5 centimeters or less) of the scalp, neck, hands, feet, or genitals"},{"code":"11421","display":"Removal of growth (0.6 to 1.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11422","display":"Removal of growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11423","display":"Removal of growth (2.1 to 3.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11424","display":"Removal of growth (3.1 to 4.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11426","display":"Removal of growth (over 4.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11440","display":"Removal of growth (0.5 centimeters or less) of the face, ears, eyelids, nose, lips, or mouth"},{"code":"11441","display":"Removal of growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth"},{"code":"11442","display":"Removal of growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, lips, or mouth"},{"code":"11443","display":"Removal of growth (2.1 to 3.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"11444","display":"Removal (3.1 to 4.0 centimeters) growth of face, ears, eyelids, nose, lips, or mouth"},{"code":"11446","display":"Removal (over 4.0 centimeters) growth of the face, ears, eyelids, nose, lips, or mouth"},{"code":"11450","display":"Removal of skin and tissue beneath the skin of underarms for excessive sweating"},{"code":"11451","display":"Removal of skin and tissue beneath the skin of underarms for excessive sweating"},{"code":"11462","display":"Removal of skin and tissue beneath the skin of groin for excessive sweating"},{"code":"11463","display":"Removal of skin and tissue beneath the skin of groin for excessive sweating"},{"code":"11470","display":"Removal of skin and tissue beneath the skin of anus or navel for excessive sweating"},{"code":"11471","display":"Removal of skin and tissue beneath the skin of anus or navel for excessive sweating"},{"code":"11600","display":"Removal of malignant growth (0.5 centimeters or less) of the trunk, arms, or legs"},{"code":"11601","display":"Removal of malignant growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs"},{"code":"11602","display":"Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs"},{"code":"11603","display":"Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs"},{"code":"11604","display":"Removal of malignant growth (3.1 to 4 centimeters) of the trunk, arms, or legs"},{"code":"11606","display":"Removal of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs"},{"code":"11620","display":"Removal of malignant growth (0.5 centimeters or less) of the scalp, neck, hands, feet, or genitals"},{"code":"11621","display":"Removal of malignant growth (0.6 to 1.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11622","display":"Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11623","display":"Removal of malignant growth (2.1 to 3.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11624","display":"Removal of malignant growth (3.1 to 4 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11626","display":"Removal of malignant growth (over 4.0 centimeters) of the scalp, neck, hands, feet, or genitals"},{"code":"11640","display":"Removal of malignant growth (0.5 centimeters or less) of the face, ears, eyelids, nose, or lips"},{"code":"11641","display":"Removal of malignant growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, or lips"},{"code":"11642","display":"Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips"},{"code":"11643","display":"Removal of malignant growth (2.1 to 3.0 centimeters) of the face, ears, eyelids, nose, or lips"},{"code":"11644","display":"Removal of malignant growth (3.1 to 4.0 centimeters) of the face, ears, eyelids, nose, or lips"},{"code":"11646","display":"Removal of malignant growth (over 4.0 centimeters) of the face, ears, eyelids, nose, or lips"},{"code":"15931","display":"Removal of pressure sore of sacrum"},{"code":"15934","display":"Removal of pressure sore at sacrum with skin graft"},{"code":"15936","display":"Removal of pressure sore at sacrum in preparation of muscle flap or skin graft"},{"code":"15940","display":"Removal of pressure sore at lower pelvic bone"},{"code":"15944","display":"Removal of pressure sore with skin graft at lower pelvic bone"},{"code":"15950","display":"Removal of pressure sore at hip bone"},{"code":"15952","display":"Removal of pressure sore at hip bone with skin graft"},{"code":"15956","display":"Removal of pressure sore at hip bone in preparation of muscle flap or skin graft"},{"code":"15999","display":"Removal of pressure sore"},{"code":"17000","display":"Destruction of skin growth"},{"code":"17003","display":"Destruction of 2-14 skin growths"},{"code":"17004","display":"Destruction of 15 or more skin growths"},{"code":"17106","display":"Destruction of skin growth (less than 10 sq centimeters)"},{"code":"17107","display":"Destruction of skin growth (10.0 to 50.0 sq centimeters)"},{"code":"17108","display":"Destruction of skin growth (over 50.0 sq centimeters)"},{"code":"17110","display":"Destruction of up to 14 skin growths"},{"code":"17111","display":"Destruction of 15 or more skin growths"},{"code":"17250","display":"Application of chemical agent to excessive wound tissue"},{"code":"17260","display":"Destruction of malignant growth (0.5 centimeters or less) of trunk, arms, or legs"},{"code":"17261","display":"Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs"},{"code":"17262","display":"Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs"},{"code":"17263","display":"Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs"},{"code":"17264","display":"Destruction of malignant growth (3.1 to 4.0 centimeters) of trunk, arms, or legs"},{"code":"17266","display":"Destruction of malignant growth (over 4.0 centimeters) of trunk, arms, or legs"},{"code":"17270","display":"Destruction of malignant growth (0.5 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17271","display":"Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17272","display":"Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17273","display":"Destruction of malignant growth (2.1 to 3.0 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17274","display":"Destruction of malignant growth (3.1 to 4.0 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17276","display":"Destruction of malignant growth (over 4.0 centimeters) of scalp, neck, hands, feet, or genitals"},{"code":"17280","display":"Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17281","display":"Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17282","display":"Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17283","display":"Destruction of malignant growth (2.1 to 3.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17284","display":"Destruction of malignant growth (3.1 to 4.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17286","display":"Destruction of malignant growth (over 4.0 centimeters) of face, ears, eyelids, nose, lips, or mouth"},{"code":"17311","display":"Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)"},{"code":"17312","display":"Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals"},{"code":"17313","display":"Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks)"},{"code":"17314","display":"Removal and microscopic examination of growth of the trunk, arms, or legs"},{"code":"17315","display":"Removal and microscopic examination of growth of the trunk, arms, or legs"},{"code":"17340","display":"Chemical treatment of acne"},{"code":"17360","display":"Chemical treatment of acne"},{"code":"17380","display":"Hair removal by electrolysis, each 30 minutes"},{"code":"19000","display":"Aspiration of breast cyst"},{"code":"19001","display":"Puncture aspiration of breast cyst"},{"code":"19030","display":"Injection for X-ray imaging of breast duct"},{"code":"19120","display":"Removal of 1 or more breast growth, open procedure"},{"code":"19125","display":"Removal of breast growth, open procedure"},{"code":"19126","display":"Removal of growth of chest wall and ribs, open procedure"},{"code":"19281","display":"Placement of breast localization devices accessed through the skin with mammographic guidance"},{"code":"19282","display":"Placement of breast localization devices accessed through the skin with mammographic guidance"},{"code":"19283","display":"Placement of breast localization devices accessed through the skin with stereotactic guidance"},{"code":"19284","display":"Placement of breast localization devices accessed through the skin with stereotactic guidance"},{"code":"19285","display":"Placement of breast localization devices accessed through the skin with ultrasound guidance"},{"code":"19286","display":"Placement of breast localization devices accessed through the skin with ultrasound guidance"},{"code":"19287","display":"Placement of breast localization devices accessed through the skin with MRI guidance"},{"code":"19288","display":"Placement of breast localization devices accessed through the skin with MRI guidance"},{"code":"19294","display":"Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal"},{"code":"19297","display":"Insertion of catheter into breast for radiation therapy concurrent with partial breast removal using imaging guidance"},{"code":"19301","display":"Partial removal of breast"},{"code":"19302","display":"Partial removal of breast and underarm lymph nodes"},{"code":"21011","display":"Removal of (less than 2 centimeter) tissue growth beneath the skin of face and scalp"},{"code":"21012","display":"Removal of (2 centimeters or greater) tissue growth beneath the skin of face and scalp"},{"code":"21116","display":"Injection for X-ray imaging of hinged joint of upper and lower jaw bones"},{"code":"21240","display":"Repair of hinged joint of upper and lower jaw bones"},{"code":"21242","display":"Repair of hinged joint of upper and lower jaw bones with donor graft"},{"code":"21243","display":"Repair of hinged joint of upper and lower jaw bones with prosthesis"},{"code":"21552","display":"Removal of (3 centimeters or greater) tissue growth beneath the skin of neck or front of chest"},{"code":"21555","display":"Removal of (less than 3 centimeters) tissue growth beneath the skin of neck or front of chest"},{"code":"21931","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of back or flank"},{"code":"22902","display":"Removal (less than 3 centimeters) tissue growth beneath the skin in abdominal wall"},{"code":"22903","display":"Removal (3 centimeters or greater) tissue growth beneath the skin in abdominal wall"},{"code":"23071","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of shoulder area"},{"code":"23075","display":"Removal (less than 3 centimeters) tissue growth beneath the skin of shoulder area"},{"code":"23350","display":"Injection of dye for X-ray imaging of shoulder joint"},{"code":"23420","display":"Repair of torn shoulder tendons"},{"code":"23470","display":"Prosthetic repair of shoulder joint"},{"code":"23472","display":"Prosthetic repair of shoulder joint"},{"code":"23473","display":"Revision of total shoulder repair"},{"code":"23474","display":"Revision of total shoulder repair"},{"code":"24071","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of upper arm or elbow"},{"code":"24075","display":"Removal (less than 3 centimeters) tissue growth beneath the skin of upper arm or elbow"},{"code":"24220","display":"Injection of dye for X-ray imaging of elbow joint"},{"code":"24360","display":"Repair of elbow joint"},{"code":"24361","display":"Repair of elbow joint"},{"code":"24362","display":"Repair of elbow joint"},{"code":"24363","display":"Prosthetic repair of elbow joint"},{"code":"24365","display":"Repair of forearm bone at elbow"},{"code":"24366","display":"Repair of forearm bone at elbow"},{"code":"24370","display":"Revision of total elbow repair"},{"code":"24371","display":"Revision of total elbow repair"},{"code":"25071","display":"Removal (3 centimeters or greater) tissue growth beneath the skin at forearm and/or wrist"},{"code":"25075","display":"Removal (less than 3 centimeters) tissue growth beneath the skin at forearm and/or wrist"},{"code":"25246","display":"Injection of dye for X-ray imaging of wrist joint"},{"code":"25332","display":"Repair of wrist joint"},{"code":"25441","display":"Removal of forearm bone at wrist"},{"code":"25442","display":"Removal of forearm bone at wrist"},{"code":"25443","display":"Removal of wrist bone"},{"code":"25444","display":"Removal of wrist bone"},{"code":"25445","display":"Removal of wrist bone"},{"code":"25446","display":"Removal of forearm bone at wrist"},{"code":"25447","display":"Removal of bone joints between wrist and fingers"},{"code":"25449","display":"Removal and reinsertion of implant at wrist joint"},{"code":"26111","display":"Removal (1.5 centimeters or greater) tissue beneath the skin growth of hand or finger"},{"code":"26115","display":"Removal (less than 1.5 centimeters) tissue beneath the skin growth of hand or finger"},{"code":"26530","display":"Repair of joint of hand bone and finger"},{"code":"26531","display":"Repair of joint of hand bone and finger"},{"code":"26535","display":"Repair of finger joint"},{"code":"26536","display":"Repair of finger joint"},{"code":"27043","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of pelvis or hip"},{"code":"27047","display":"Removal (less than 3 centimeters) tissue growth of pelvis or hip"},{"code":"27093","display":"Injection of dye for X-ray imaging of hip joint"},{"code":"27095","display":"Injection procedure for X-ray imaging of hip under anesthesia"},{"code":"27096","display":"Injection procedure into sacroiliac joint for anesthetic or steroid"},{"code":"27327","display":"Removal (less than 3 centimeters) tissue growth beneath the skin of thigh or knee"},{"code":"27332","display":"Removal of knee cartilage"},{"code":"27333","display":"Removal of knee cartilage"},{"code":"27337","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of thigh or knee"},{"code":"27347","display":"Removal of growth of knee cartilage or capsule"},{"code":"27369","display":"Injection of contrast for imaging of knee joint"},{"code":"27370","display":"Injection of contract for X-ray imaging of knee"},{"code":"27403","display":"Incision and repair of knee cartilage"},{"code":"27405","display":"Repair of torn collateral ligament and/or knee joint capsule"},{"code":"27407","display":"Repair of torn cruciate ligament and/or knee joint capsule"},{"code":"27409","display":"Repair of torn collateral and cruciate ligaments or knee joint capsule"},{"code":"27420","display":"Repair of dislocating knee cap"},{"code":"27422","display":"Repair of dislocating knee cap"},{"code":"27424","display":"Reconstruction of dislocating knee cap"},{"code":"27427","display":"Reconstruction of knee joint ligaments"},{"code":"27428","display":"Reconstruction of knee joint ligaments, open procedure"},{"code":"27429","display":"Reconstruction of knee joint ligaments, open procedure"},{"code":"27437","display":"Repair of knee cap"},{"code":"27438","display":"Repair of knee cap with insertion of prosthesis"},{"code":"27440","display":"Repair of knee joint"},{"code":"27441","display":"Repair of knee joint"},{"code":"27442","display":"Repair of knee joint"},{"code":"27443","display":"Repair of knee joint"},{"code":"27445","display":"Repair of knee joint with hinged prosthesis"},{"code":"27446","display":"Repair of knee joint"},{"code":"27447","display":"Repair of knee joint"},{"code":"27486","display":"Revision of one component of total knee joint prosthesis"},{"code":"27487","display":"Revision of lower thigh bone and both shin bone components of total knee joint prosthesis"},{"code":"27618","display":"Removal (less than 3 centimeters) tissue growth beneath the skin of leg or ankle"},{"code":"27632","display":"Removal (3 centimeters or greater) tissue growth beneath the skin of leg or ankle"},{"code":"27648","display":"Injection for X-ray imaging of ankle"},{"code":"27700","display":"Repair of ankle joint"},{"code":"27702","display":"Repair of ankle joint with prosthesis"},{"code":"27703","display":"Repair of ankle joint with revision of prosthesis"},{"code":"28039","display":"Removal (1.5 centimeters or greater) tissue growth beneath the skin of foot or toe"},{"code":"28043","display":"Removal (less than 1.5 centimeters) tissue growth beneath the skin of foot or toe"},{"code":"28285","display":"Correction of toe joint deformity"},{"code":"28286","display":"Correction of fifth toe joint deformity"},{"code":"28289","display":"Correction of rigid deformity of first joint of big toe"},{"code":"28290","display":"Correction of bunion"},{"code":"28291","display":"Correction of rigid deformity of first joint of big toe using implant"},{"code":"28292","display":"Correction of bunion"},{"code":"28293","display":"Correction of bunion"},{"code":"28294","display":"Correction of bunion"},{"code":"28295","display":"Correction of bunion"},{"code":"28296","display":"Correction of bunion"},{"code":"28297","display":"Correction of bunion"},{"code":"28298","display":"Correction of bunion"},{"code":"28299","display":"Correction of bunion"},{"code":"28313","display":"Reconstruction of soft tissue angular deformity of toe"},{"code":"28340","display":"Reconstruction of abnormal toe"},{"code":"28341","display":"Reconstruction of abnormal toe"},{"code":"28345","display":"Removal of congenital web space deformity of toes"},{"code":"28755","display":"Fusion of great toe"},{"code":"28760","display":"Fusion of great toe"},{"code":"29800","display":"Diagnostic examination of jaw joint using an endoscope"},{"code":"29804","display":"Examination of jaw joint using an endoscope"},{"code":"29805","display":"Diagnostic examination of shoulder using an endoscope"},{"code":"29819","display":"Removal of loose or foreign body of shoulder using an endoscope"},{"code":"29826","display":"Shaving of shoulder bone using an endoscope"},{"code":"29830","display":"Diagnostic examination of elbow joint using an endoscope"},{"code":"29834","display":"Removal of loose or foreign body of elbow using an endoscope"},{"code":"29840","display":"Diagnostic examination of the wrist using an endoscope"},{"code":"29843","display":"Diagnostic examination of the wrist using an endoscope for infection, irrigation, and drainage"},{"code":"29860","display":"Diagnostic examination of hip using an endoscope"},{"code":"29870","display":"Diagnostic examination of knee using an endoscope"},{"code":"29871","display":"Irrigation and drainage of knee joint for infection using an endoscope"},{"code":"29880","display":"Removal of both knee cartilages using an endoscope"},{"code":"29881","display":"Removal of one knee cartilage using an endoscope"},{"code":"29882","display":"Repair of knee joint using an endoscope"},{"code":"29883","display":"Repair of knee joint using an endoscope"},{"code":"29888","display":"Repair of anterior cruciate ligament of knee with assistance of an endoscope"},{"code":"29889","display":"Repair of posterior cruciate ligament of knee with assistance of an endoscope"},{"code":"29893","display":"Repair of fibrous tissue of foot using an endoscope"},{"code":"29900","display":"Biopsy of lining of joint of finger using an endoscope"},{"code":"29999","display":"Joint procedure using an endoscope"},{"code":"30400","display":"Reshaping of tip of nose"},{"code":"30410","display":"Reshaping of bone, cartilage, or tip of nose"},{"code":"30420","display":"Reshaping of bony cartilage dividing nasal passages"},{"code":"30430","display":"Revision to reshape nose or tip of nose after previous repair"},{"code":"30435","display":"Revision to reshape nasal bones after previous repair"},{"code":"30450","display":"Revision to reshape nasal bones and tip of nose after previous repair"},{"code":"30460","display":"Repair of congenital nasal defect to lengthen tip of nose"},{"code":"30462","display":"Repair of congenital nasal defect with lengthening of tip of nose"},{"code":"30465","display":"Widening of nasal passage"},{"code":"30520","display":"Reshaping of nasal cartilage"},{"code":"30540","display":"Reconstruction to create nasal passages"},{"code":"30545","display":"Reconstruction to create nasal passages"},{"code":"30620","display":"Repair of mucous lining of nasal passage with graft"},{"code":"30630","display":"Repair of openings in nasal cartilage"},{"code":"31505","display":"Diagnostic examination of voice box using an endoscope"},{"code":"31510","display":"Biopsy of voice box using an endoscope"},{"code":"31515","display":"Aspiration of voice box using an endoscope"},{"code":"31520","display":"Diagnostic examination of voice box using an endoscope, newborn"},{"code":"31525","display":"Diagnostic examination of voice box using an endoscope"},{"code":"31526","display":"Diagnostic examination of voice box using an endoscope with operating microscope or telescope"},{"code":"31535","display":"Biopsy of voice box using an endoscope"},{"code":"31536","display":"Biopsy of voice box using an endoscope with operating microscope or telescope"},{"code":"31575","display":"Diagnostic examination of voice box using flexible endoscope"},{"code":"31576","display":"Biopsy of voice box using a flexible endoscope"},{"code":"31579","display":"Examination to assess movement of vocal cord flaps using an endoscope"},{"code":"31615","display":"Examination of windpipe and lung airways through permanent skin opening to windpipe using an endoscope"},{"code":"31622","display":"Diagnostic examination of lung airways using an endoscope"},{"code":"31623","display":"Examination of lung airways using an endoscope"},{"code":"31624","display":"Irrigation and suction of lung airways to obtain cells using an endoscope"},{"code":"31625","display":"Biopsy of lung airways using an endoscope"},{"code":"31626","display":"Insertion of radiation therapy markers into lung airways using an endoscope"},{"code":"31627","display":"Computer-assisted image-guided navigation of lung airways using an endoscope"},{"code":"31628","display":"Biopsy of one lobe of lung using an endoscope"},{"code":"31629","display":"Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope"},{"code":"31632","display":"Biopsy of lung using an endoscope"},{"code":"31633","display":"Needle biopsy of lung using an endoscope"},{"code":"31652","display":"Examination of lung airways using an endoscope with imaging guidance and ultrasound"},{"code":"31653","display":"Examination of lung airways using an endoscope with imaging guidance and ultrasound"},{"code":"31717","display":"Insertion of catheter into airway of lung for brush biopsy"},{"code":"31830","display":"Revision of permanent windpipe opening scar"},{"code":"32851","display":"Transplant of lung"},{"code":"32852","display":"Transplant of lung on heart-lung machine"},{"code":"32853","display":"Transplant of both lungs"},{"code":"32854","display":"Transplant of both lungs on heart-lung machine"},{"code":"32855","display":"Preparation of one lung from a cadaver"},{"code":"32856","display":"Preparation of two cadaver lungs for transplantation"},{"code":"33202","display":"Insertion of electrodes to outer layer of heart, open procedure"},{"code":"33203","display":"Insertion of electrodes to outer layer of heart using an endoscope"},{"code":"33206","display":"Insertion or replacement of permanent pacemaker and upper chamber electrodes"},{"code":"33207","display":"Insertion or replacement of permanent pacemaker and lower chamber electrodes"},{"code":"33208","display":"Insertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes"},{"code":"33210","display":"Placement of temporary pacemaker leads"},{"code":"33211","display":"Placement of temporary pacemaker leads"},{"code":"33212","display":"Insertion of pacemaker pulse generator with existing single lead"},{"code":"33213","display":"Insertion of pacemaker pulse generator with existing dual leads"},{"code":"33214","display":"Conversion to two chamber pacemaker system"},{"code":"33215","display":"Repositioning of implanted pacemaker or defibrillator device"},{"code":"33216","display":"Insertion of electrode for permanent pacemaker or pacing defibrillator device"},{"code":"33217","display":"Insertion of electrodes for permanent pacemaker or pacing defibrillator device"},{"code":"33218","display":"Repair of electrode for permanent pacemaker or defibrillator device"},{"code":"33220","display":"Repair of 2 electrodes for permanent pacemaker or defibrillator device"},{"code":"33221","display":"Insertion of pacemaker pulse generator with existing multiple leads"},{"code":"33222","display":"Relocation of pacemaker generator skin pocket"},{"code":"33223","display":"Relocation of defibrillator device skin pocket"},{"code":"33224","display":"Insertion of left heart electrode with attachment to pacemaker or pacing defibrillator device"},{"code":"33225","display":"Insertion of left heart electrode for pacing defibrillator device"},{"code":"33226","display":"Repositioning of implanted left heart electrode"},{"code":"33227","display":"Removal and replacement of single lead permanent pacemaker pulse generator"},{"code":"33228","display":"Removal and replacement of dual lead permanent pacemaker pulse generator"},{"code":"33229","display":"Removal and replacement of multiple lead permanent pacemaker pulse generator"},{"code":"33230","display":"Insertion of pacing defibrillator pulse generator with existing dual leads"},{"code":"33231","display":"Insertion of pacing defibrillator pulse generator with existing multiple leads"},{"code":"33233","display":"Removal of permanent pacemaker pulse generator"},{"code":"33234","display":"Removal of electrode from right heart"},{"code":"33235","display":"Removal of electrodes from right heart"},{"code":"33236","display":"Removal of permanent right heart electrodes and pacemaker"},{"code":"33237","display":"Removal of permanent right heart electrodes and pacemaker"},{"code":"33238","display":"Removal of permanent pacemaker venous electrodes"},{"code":"33240","display":"Insertion of pacing defibrillator pulse generator with existing single lead"},{"code":"33241","display":"Removal of defibrillator pulse generator"},{"code":"33243","display":"Removal of defibrillator electrodes"},{"code":"33244","display":"Removal of defibrillator electrodes"},{"code":"33249","display":"Insertion or replacement of single or dual chamber pacing defibrillator leads"},{"code":"33262","display":"Removal and replacement of defibrillator pulse generator"},{"code":"33263","display":"Removal and replacement of defibrillator pulse generator"},{"code":"33264","display":"Removal and replacement of defibrillator pulse generator"},{"code":"33270","display":"Insertion or replacement of defibrillator with electrode"},{"code":"33271","display":"Insertion of defibrillator electrode"},{"code":"33272","display":"Removal of defibrillator electrode"},{"code":"33273","display":"Repositioning of previously implanted defibrillator electrode"},{"code":"33274","display":"Insertion or replacement of permanent leadless pacemaker into lower right chamber of heart via catheter using imaging guidance"},{"code":"33275","display":"Removal of permanent leadless pacemaker from lower right chamber of heart via catheter using imaging guidance"},{"code":"33930","display":"Harvest of donor heart and lung"},{"code":"33933","display":"Preparation of donor heart and lung for transplantation"},{"code":"33935","display":"Transplantation of donor heart and lung"},{"code":"33944","display":"Preparation of donor heart for transplantation"},{"code":"33945","display":"Transplantation of donor heart"},{"code":"36598","display":"Contrast injections for X-ray imaging procedure to evaluate central venous access device"},{"code":"38200","display":"Injection procedure for X-ray imaging of the spleen and portal (liver) vein"},{"code":"38205","display":"Collection of donor stem cells for transplantation"},{"code":"38206","display":"Collection of stem cells for transplantation"},{"code":"38207","display":"Freezing, preservation, and storage of stem cells for transplantation"},{"code":"38208","display":"Thawing of previously frozen stem cells for transplantation"},{"code":"38209","display":"Thawing and washing of previously frozen stem cells for transplantation"},{"code":"38210","display":"Preparation of stem cells for transplantation with removal of T cells"},{"code":"38211","display":"Preparation of stem cells for transplantation with removal of tumor cells"},{"code":"38212","display":"Preparation of stem cells for transplantation with red blood cell removal"},{"code":"38213","display":"Preparation of stem cells for transplantation with removal of platelets"},{"code":"38214","display":"Preparation of stem cells for transplantation with reduction of excessive opening blood fluid (plasma) volume"},{"code":"38215","display":"Preparation of stem cells for transplantation with cell concentration"},{"code":"38220","display":"Diagnostic bone marrow aspiration"},{"code":"38221","display":"Bone marrow biopsy"},{"code":"38222","display":"Bone marrow biopsy and aspiration"},{"code":"38240","display":"Transplantation of donor bone marrow or blood-derived stem cells"},{"code":"38241","display":"Transplantation of patient\u0027s bone marrow or blood-derived stem cells"},{"code":"38242","display":"Transplantation of donor stem cells from bone marrow or blood with infusion of donor white blood cells"},{"code":"38243","display":"Transplantation of donor bone marrow or blood-derived stem cells"},{"code":"38790","display":"Injection procedure for X-ray imaging of the lymphatic system"},{"code":"38792","display":"Injection of radioactive dye for X-ray identification of lymph node"},{"code":"41019","display":"Insertion of needles, catheters, or devices into head and/or neck for radiation delivery"},{"code":"42550","display":"Injection of dye for X-ray of salivary glands"},{"code":"42820","display":"Removal of tonsils and adenoid glands patient younger than age 12"},{"code":"42821","display":"Removal of tonsils and adenoid glands patient age 12 or over"},{"code":"42825","display":"Removal of tonsils patient younger than age 12"},{"code":"42826","display":"Removal of tonsils patient age 12 or over"},{"code":"42830","display":"Removal of adenoids patient younger than age 12"},{"code":"42831","display":"Removal of adenoids patient age 12 or over"},{"code":"42835","display":"Removal of adenoids patient younger than age 12"},{"code":"42836","display":"Removal of adenoids patient age 12 or over"},{"code":"42860","display":"Removal of remaining tonsil tissue"},{"code":"42870","display":"Removal or destruction of growth of tongue lymph node"},{"code":"43180","display":"Removal of esophagus tissue using an endoscope"},{"code":"43191","display":"Diagnostic examination of esophagus using an endoscope"},{"code":"43192","display":"Injections of substance in tissue lining of esophagus using an endoscope"},{"code":"43193","display":"Biopsy of esophagus using an endoscope"},{"code":"43197","display":"Diagnostic examination of esophagus using an endoscope"},{"code":"43198","display":"Biopsy of esophagus using an endoscope"},{"code":"43200","display":"Diagnostic examination of esophagus using an endoscope"},{"code":"43201","display":"Injections into esophagus using an endoscope"},{"code":"43202","display":"Biopsy of esophagus using an endoscope"},{"code":"43204","display":"Injection of dilated esophageal veins using an endoscope"},{"code":"43205","display":"Tying of esophageal veins using an endoscope"},{"code":"43206","display":"Microscopic examination of esophagus using an endoscope"},{"code":"43210","display":"Diagnostic examination of esophagus, stomach, and/or upper small bowel with repair of muscle at esophagus and stomach using an endoscope"},{"code":"43211","display":"Removal of tissue lining of esophagus using an endoscope"},{"code":"43212","display":"Placement of stent on esophagus using an endoscope"},{"code":"43217","display":"Removal of esophageal polyps or growths using an endoscope"},{"code":"43229","display":"Destruction of growths of esophagus using an endoscope"},{"code":"43231","display":"Ultrasound examination of esophagus using an endoscope"},{"code":"43232","display":"Ultrasound guided fine needle aspiration or biopsy of esophagus using an endoscope"},{"code":"43235","display":"Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43236","display":"Injections of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43237","display":"Ultrasound examination of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43238","display":"Ultrasound guided needle aspiration or biopsies of esophagus using an endoscope"},{"code":"43239","display":"Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43240","display":"Drainage of cyst of the esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43241","display":"Insertion of catheter or tube in esophagus stomach and/or upper small bowel using an endoscope"},{"code":"43242","display":"Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43247","display":"Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43250","display":"Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43251","display":"Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43252","display":"Microscopic examination of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43253","display":"Injection of diagnostic or therapeutic substances or markers in esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43254","display":"Removal of tissue lining of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43255","display":"Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43257","display":"Heat delivery to muscle at esophagus and/or stomach to treat gastric reflux using an endoscope"},{"code":"43259","display":"Ultrasound examination of esophagus, stomach and/or upper small bowel using an endoscope"},{"code":"43266","display":"Placement of stent in esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43270","display":"Destruction of growths on esophagus, stomach, and/or upper small bowel using an endoscope"},{"code":"43644","display":"Bypass operation of stomach using an endoscope"},{"code":"43645","display":"Bypass operation of stomach with reconstruction of small bowel using an endoscope"},{"code":"43770","display":"Insertion of adjustable stomach reduction device using an endoscope"},{"code":"43771","display":"Revision of stomach reduction device using an endoscope"},{"code":"43772","display":"Removal of stomach reduction device using an endoscope"},{"code":"43773","display":"Replacement of stomach reduction device using an endoscope"},{"code":"43774","display":"Removal of stomach reduction device and port beneath the skin using an endoscope"},{"code":"43775","display":"Stomach reduction procedure with partial removal of stomach using an endoscope"},{"code":"43842","display":"Banding of upper stomach to reduce size"},{"code":"43843","display":"Reduction of size of upper stomach"},{"code":"43845","display":"Partial removal of stomach"},{"code":"43846","display":"Partial removal of stomach"},{"code":"43847","display":"Partial removal of stomach"},{"code":"43848","display":"Revision of upper stomach bypass, open procedure"},{"code":"43886","display":"Revision of skin level port of stomach banding device, open procedure"},{"code":"43887","display":"Removal of skin level port of stomach banding device, open procedure"},{"code":"43888","display":"Removal and replacement of skin level port of stomach banding device, open procedure"},{"code":"44135","display":"Transplantation of small bowel from cadaver donor"},{"code":"44136","display":"Transplantation of donor small bowel"},{"code":"44360","display":"Examination of small bowel using an endoscope"},{"code":"44361","display":"Biopsy of small bowel using an endoscope"},{"code":"44376","display":"Diagnostic examination of small bowel using an endoscope"},{"code":"44377","display":"Biopsy of small bowel using an endoscope"},{"code":"44379","display":"Insertion of small bowel stent using an endoscope"},{"code":"44380","display":"Diagnostic examination of small bowel using an endoscope which is inserted through abdominal opening"},{"code":"44381","display":"Balloon dilation of small bowel using an endoscope which is inserted through abdominal opening"},{"code":"44382","display":"Biopsy of small bowel using an endoscope which is inserted through abdominal opening"},{"code":"44383","display":"Insertion of small bowel stent using an endoscope which is inserted through abdominal opening into small bowel"},{"code":"44384","display":"Placement of stent in small bowel using an endoscope which is inserted through abdominal opening"},{"code":"44385","display":"Diagnostic examination of defect in wall of small bowel using an endoscope"},{"code":"44386","display":"Biopsy of small bowel using an endoscope"},{"code":"44388","display":"Diagnostic examination of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44389","display":"Biopsies of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44391","display":"Control of bleeding in large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44392","display":"Removal of polyps or growths of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44393","display":"Destruction of large bowel polyps or growths using an endoscope"},{"code":"44394","display":"Removal of large bowel polyps or growths using an endoscope"},{"code":"44397","display":"Insertion of large bowel stent using an endoscope"},{"code":"44401","display":"Destruction of large bowel growths using an endoscope which is inserted through abdominal opening"},{"code":"44402","display":"Stent placement in large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44403","display":"Resection of large bowel tissue using an endoscope which is inserted through abdominal opening"},{"code":"44404","display":"Injections of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44405","display":"Balloon dilation of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44406","display":"Ultrasound examination of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44407","display":"Ultrasound guided fine needle aspiration/biopsies of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44408","display":"Decompression of large bowel using an endoscope which is inserted through abdominal opening"},{"code":"44715","display":"Preparation of donor small bowel for transplantation"},{"code":"44720","display":"Reconstruction of donor small bowel for transplantation"},{"code":"44721","display":"Reconstruction of donor small bowel for transplantation"},{"code":"45100","display":"Biopsy of rectum"},{"code":"45300","display":"Diagnostic examination of rectum and large bowel using an endoscope"},{"code":"45303","display":"Dilation of rectum and large bowel using an endoscope"},{"code":"45305","display":"Biopsy of rectum and large bowel using an endoscope"},{"code":"45308","display":"Removal of polyp or growth of rectum and large bowel using an endoscope"},{"code":"45309","display":"Removal of polyp or growth of rectum and large bowel using an endoscope"},{"code":"45315","display":"Removal of multiple polyps or growths in rectum and large bowel using an endoscope"},{"code":"45317","display":"Control of bleeding in rectum and large bowel using an endoscope"},{"code":"45320","display":"Destruction of polyps or growths of the rectum and large bowel using an endoscope"},{"code":"45321","display":"Release of twisted bowel in rectum and large bowel using an endoscope"},{"code":"45327","display":"Insertion of rectal or large bowel stent using an endoscope"},{"code":"45330","display":"Diagnostic examination of large bowel using an endoscope"},{"code":"45331","display":"Biopsy of large bowel using an endoscope"},{"code":"45333","display":"Removal of polyps or growths of large bowel using an endoscope"},{"code":"45334","display":"Control of bleeding in large bowel using an endoscope"},{"code":"45335","display":"Injections into large bowel using an endoscope"},{"code":"45337","display":"Release of twisted large bowel using an endoscope"},{"code":"45338","display":"Removal of polyps or growths of large bowel using an endoscope"},{"code":"45339","display":"Destruction of polyps or growths of large bowel using an endoscope"},{"code":"45340","display":"Dilation of large bowel stricture using an endoscope"},{"code":"45341","display":"Ultrasound examination of large bowel using an endoscope"},{"code":"45342","display":"Ultrasound guided needle aspiration or biopsy of large bowel using an endoscope"},{"code":"45345","display":"Insertion of stent in lower large bowel using an endoscope"},{"code":"45346","display":"Destruction of polyps or growths of large bowel using an endoscope"},{"code":"45347","display":"Placement of stent in large bowel using an endoscope"},{"code":"45349","display":"Removal of large bowel tissue using an endoscope"},{"code":"45350","display":"Rubber banding of large bowel using an endoscope"},{"code":"45355","display":"Incisional examination of large bowel using an endoscope"},{"code":"45378","display":"Diagnostic examination of large bowel using an endoscope"},{"code":"45380","display":"Biopsy of large bowel using an endoscope"},{"code":"45381","display":"Injections of large bowel using an endoscope"},{"code":"45382","display":"Control of bleeding in large bowel using an endoscope"},{"code":"45383","display":"Removal of polyps or growths in large bowel using an endoscope"},{"code":"45384","display":"Removal of polyps or growths in large bowel using an endoscope"},{"code":"45385","display":"Removal of polyps or growths of large bowel using an endoscope"},{"code":"45386","display":"Balloon dilation of large bowel using an endoscope"},{"code":"45387","display":"Insertion of large bowel stent using an endoscope"},{"code":"45388","display":"Destruction of large bowel growths using an endoscope"},{"code":"45389","display":"Stent placement of large bowel using an endoscope"},{"code":"45390","display":"Removal of large bowel tissue using an endoscope"},{"code":"45391","display":"Ultrasound examination of lower large bowel using an endoscope"},{"code":"45392","display":"Ultrasound guided needle aspiration or biopsy of lower large bowel using an endoscope"},{"code":"45393","display":"Decompression of large bowel using an endoscope"},{"code":"45398","display":"Tying of large bowel using an endoscope"},{"code":"45500","display":"Release of scar tissue and repair of rectum"},{"code":"45505","display":"Repair of rectal prolapse"},{"code":"46600","display":"Diagnostic examination of the anus using an endoscope"},{"code":"46601","display":"Diagnostic examination of anus with magnification and chemical agent enhancement using an endoscope"},{"code":"46604","display":"Dilation of anus using an endoscope"},{"code":"46606","display":"Biopsy of anus using an endoscope"},{"code":"46607","display":"Biopsies of anus with magnification and chemical agent enhancement using an endoscope"},{"code":"46610","display":"Removal of anal polyps or growths using an endoscope"},{"code":"46611","display":"Removal of single anal polyp or growth using an endoscope"},{"code":"46612","display":"Removal of multiple anal polyps or growths using an endoscope"},{"code":"46614","display":"Control of anal bleeding using an endoscope"},{"code":"46615","display":"Destruction of anal polyps or growths using an endoscope"},{"code":"47000","display":"Needle biopsy of liver, accessed through the skin"},{"code":"47001","display":"Needle biopsy of liver"},{"code":"47100","display":"Partial removal of liver tissue"},{"code":"47135","display":"Transplantation of donor liver to anatomic position"},{"code":"47136","display":"Transplantation of donor liver to alternate anatomic position"},{"code":"47140","display":"Partial removal of donor liver left segment"},{"code":"47141","display":"Removal of donor liver left lobe"},{"code":"47142","display":"Removal of donor liver right lobe"},{"code":"47143","display":"Preparation of donor liver for transplantation"},{"code":"47144","display":"Preparation of donor liver for transplantation"},{"code":"47145","display":"Preparation of donor liver for transplantation"},{"code":"47146","display":"Preparation of donor liver for transplantation"},{"code":"47147","display":"Preparation of donor liver for transplantation"},{"code":"47500","display":"Injection of bile duct for X-ray imaging procedure, accessed through the skin"},{"code":"47505","display":"Injection through existing gallbladder catheter for X-ray imaging procedure"},{"code":"47531","display":"Injection of bile duct for X-ray imaging procedure accessed through the skin using imaging guidance including radiological supervision and interpretation"},{"code":"47532","display":"Injection of bile duct for X-ray imaging procedure accessed through the skin using imaging guidance including radiological supervision and interpretation"},{"code":"48160","display":"Removal of pancreas with pancreatic cell transplantation"},{"code":"48551","display":"Preparation of donor pancreas for transplantation"},{"code":"48552","display":"Preparation of donor pancreas for transplantation"},{"code":"48554","display":"Transplantation of donor pancreas"},{"code":"49465","display":"Contrast injections for x-ray imaging through existing tube in stomach, small bowel or large bowel, accessed through the skin"},{"code":"50360","display":"Transplantation of donor kidney"},{"code":"50365","display":"Removal of kidney and transplantation of donor kidney"},{"code":"50380","display":"Removal with relocation of kidney"},{"code":"50394","display":"Injection procedure for x-ray imaging of kidney and urinary duct (ureter)"},{"code":"50430","display":"Injection procedure for x-ray imaging of kidney and urinary duct (ureter) using imaging guidance including radiological supervision and interpretation"},{"code":"50431","display":"Injection procedure for x-ray imaging of kidney and urinary duct (ureter) using imaging guidance including radiological supervision and interpretation"},{"code":"50551","display":"Examination of kidney using an endoscopy which is inserted through an already created kidney opening"},{"code":"50553","display":"Insertion of catheter into urinary duct (ureter) using an endoscopy which is inserted through an already created kidney opening"},{"code":"50555","display":"Kidney biopsy using an endoscopy which is inserted through an already created kidney opening"},{"code":"50570","display":"Examination of kidney using an endoscope"},{"code":"50574","display":"Kidney biopsy using an endoscope"},{"code":"50951","display":"Examination of kidney and urinary duct (ureter) using an endoscopy which is inserted through an already created urinary duct (ureter) opening"},{"code":"50955","display":"Biopsy of kidney or urinary duct (ureter) using an endoscopy which is inserted through an already created urinary duct (ureter) opening"},{"code":"50970","display":"Examination of kidney and urinary duct (ureter) using an endoscope"},{"code":"50974","display":"Biopsy of kidney or urinary duct (ureter) using an endoscope"},{"code":"52000","display":"Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope"},{"code":"52007","display":"Insertion of catheter into urinary duct (ureter) and biopsy of urinary duct and/or renal pelvis using an endoscope"},{"code":"52010","display":"Insertion of catheter into sperm duct using an endoscope"},{"code":"52204","display":"Biopsy of the bladder using an endoscope"},{"code":"52276","display":"Incision of the bladder canal (urethra) using an endoscope"},{"code":"52351","display":"Diagnostic examination of the bladder, bladder canal (urethra), and urinary duct (ureter) or kidney using an endoscope"},{"code":"52354","display":"Biopsy and/or destruction of growth of urinary duct (ureter) or kidney using an endoscope"},{"code":"53200","display":"Biopsy of bladder canal (urethra)"},{"code":"54150","display":"Removal of foreskin of using clamp or device"},{"code":"54160","display":"Removal of foreskin, neonate (28 days of age or less)"},{"code":"54161","display":"Removal of foreskin, patient older than 28 days of age"},{"code":"54163","display":"Repair of incomplete removal of penile foreskin"},{"code":"54230","display":"Injection procedure for X-ray imaging of penile erection"},{"code":"55300","display":"Incision of sperm ducts for X-ray imaging procedure"},{"code":"55874","display":"Injection of biodegradable material next to prostate"},{"code":"59425","display":"Predelivery care 4-6 visits"},{"code":"59426","display":"Predelivery care 7 or more visits"},{"code":"59430","display":"Post-delivery care"},{"code":"59840","display":"Induced abortion by dilation and uterine scraping"},{"code":"59841","display":"Induced abortion by dilation and removal of pregnancy contents"},{"code":"59850","display":"Induced abortion by amniotic fluid injections with delivery of fetus and placenta"},{"code":"59851","display":"Induced abortion by amniotic fluid injections with delivery of fetus and placenta"},{"code":"59852","display":"Induced abortion by amniotic fluid injections"},{"code":"59855","display":"Induced abortion by insertion of vaginal suppositories"},{"code":"59856","display":"Induced abortion by insertion of vaginal suppositories"},{"code":"59857","display":"Induced abortion by insertion of vaginal suppositories"},{"code":"62290","display":"Injection of dye for X-ray imaging of spine disc"},{"code":"62291","display":"Injection of dye for X-ray imaging of spine disc"},{"code":"65710","display":"Transplantation of tissue from one cornea to other cornea"},{"code":"65730","display":"Transplantation of tissue from one cornea to other cornea"},{"code":"65750","display":"Transplantation of tissue from one cornea to other cornea"},{"code":"65755","display":"Transplantation of tissue from one cornea to other cornea"},{"code":"65756","display":"Transplant of outer layer of corneal tissue"},{"code":"65757","display":"Preparation of corneal tissue for transplant"},{"code":"65780","display":"Transplantation of fetal sac tissue to cornea"},{"code":"65781","display":"Transplantation of stem cells to cornea"},{"code":"65782","display":"Transplantation of stem cells from one cornea to other cornea"},{"code":"65820","display":"Incision to improve eye fluid flow"},{"code":"65850","display":"Insertion of eye fluid drainage tube"},{"code":"65855","display":"Laser repair to improve eye fluid flow, 1 or more sessions"},{"code":"65920","display":"Removal of implanted lens in eye"},{"code":"66150","display":"Creation of eye fluid drainage tract with removal of iris"},{"code":"66155","display":"Creation of eye fluid drainage tract with removal of iris"},{"code":"66160","display":"Creation of eye fluid drainage tract with removal of sclera and iris"},{"code":"66165","display":"Creation of eye fluid drainage tract"},{"code":"66170","display":"Creation of eye fluid drainage tract"},{"code":"66172","display":"Creation of eye fluid drainage tract"},{"code":"66174","display":"Dilation to improve eye fluid flow"},{"code":"66175","display":"Dilation with insertion of device or stent to improve eye fluid flow"},{"code":"66179","display":"Creation of shunt to improve eye fluid flow"},{"code":"66180","display":"Creation of shunt to improve eye fluid flow with graft"},{"code":"66183","display":"Insertion of eye fluid drainage device"},{"code":"66184","display":"Revision of shunt to improve eye fluid flow"},{"code":"66185","display":"Revision of eye fluid drainage shunt with graft"},{"code":"66700","display":"Destruction of lens tissue"},{"code":"66710","display":"Destruction of lens tissue using laser"},{"code":"66711","display":"Destruction of tissue encircling lens using endoscope"},{"code":"66720","display":"Destruction of tissue encircling lens"},{"code":"66740","display":"Destruction of tissue of eyelid border"},{"code":"66761","display":"Creation of eye fluid drainage tracts in iris using laser, per session"},{"code":"66820","display":"Removal of recurring cataract in lens capsule"},{"code":"66821","display":"Removal of recurring cataract in lens capsule using laser"},{"code":"66825","display":"Repositioning of lens prosthesis"},{"code":"66830","display":"Removal of recurring cataract in lens capsule"},{"code":"66840","display":"Aspiration removal of lens material"},{"code":"66850","display":"Fragmenting, aspiration, and removal of lens material"},{"code":"66852","display":"Removal of lens material"},{"code":"66920","display":"Removal of lens material and capsule"},{"code":"66930","display":"Removal of lens material and capsule for dislocated lens"},{"code":"66940","display":"Removal of lens material and portion of lens capsule"},{"code":"66982","display":"Complex removal of cataract with insertion of lens"},{"code":"66983","display":"Removal of cataract with insertion of lens"},{"code":"66984","display":"Removal of cataract with insertion of lens"},{"code":"66985","display":"Insertion of lens prosthesis"},{"code":"66986","display":"Exchange of lens prosthesis"},{"code":"68850","display":"Injection of contrast for X-ray imaging of tear sac"},{"code":"70015","display":"Radiological supervision and interpretation X-ray of brain and spinal cord with contrast"},{"code":"70100","display":"X-ray of mandible, less than 4 views"},{"code":"70110","display":"X-ray of mandible, minimum of 4 views"},{"code":"70120","display":"X-ray of mastoid, less than 3 views per side"},{"code":"70130","display":"X-ray of mastoid, minimum of 3 views per side"},{"code":"70134","display":"X-ray of internal ear canal"},{"code":"70140","display":"X-ray of bones of face, less than 3 views"},{"code":"70150","display":"X-ray of bones of face, minimum of 3 views"},{"code":"70160","display":"X-ray of bones of nose, minimum of 3 views"},{"code":"70170","display":"Radiological supervision and interpretation X-ray of tear drainage structure of eye"},{"code":"70190","display":"X-ray of skull"},{"code":"70200","display":"X-ray of eye bones, minimum of 4 views"},{"code":"70210","display":"X-ray of paranasal sinus, less than 3 views"},{"code":"70220","display":"X-ray of paranasal sinus, complete, minimum of 3 views"},{"code":"70240","display":"X-ray of bone at base of skull"},{"code":"70250","display":"X-ray of skull, less than 4 views"},{"code":"70260","display":"X-ray of skull, complete, minimum of 4 views"},{"code":"70300","display":"X-ray of teeth, single view"},{"code":"70310","display":"X-ray of teeth, less than full mouth"},{"code":"70320","display":"X-ray of teeth, full mouth"},{"code":"70328","display":"X-ray of jaw joint on one side of the face"},{"code":"70330","display":"X-ray of jaw joints on both sides of the face"},{"code":"70332","display":"Radiological supervision and interpretation X-ray of jaw joint"},{"code":"70350","display":"Imaging of jaws and skull for orthodontic purposes"},{"code":"70355","display":"X-ray imaging of teeth"},{"code":"70360","display":"X-ray of soft tissue of neck"},{"code":"70370","display":"X-ray of voice box or throat"},{"code":"70371","display":"Imaging of voice box with speech evaluation"},{"code":"70373","display":"Radiological supervision and interpretation X-ray of voice box with contrast"},{"code":"70380","display":"X-ray of salivary gland"},{"code":"70390","display":"Radiological supervision and interpretation X-ray of salivary structure"},{"code":"71023","display":"X-ray of chest, 2 views, front and side with fluoroscopy"},{"code":"71034","display":"X-ray of chest, complete, minimum of 4 views"},{"code":"71100","display":"X-ray of ribs of one side of body, 2 views"},{"code":"71101","display":"X-ray of ribs on one side of body including the chest, minimum of 3 views"},{"code":"71110","display":"X-ray of both sides of the ribs, 3 views"},{"code":"71111","display":"X-ray of both sides of the ribs including the chest, minimum of 4 views"},{"code":"71120","display":"X-ray of breast bone, minimum of 2 views"},{"code":"71130","display":"X-ray of junction of breast and collar bones, minimum of 2 views"},{"code":"72010","display":"X-ray of entire spine"},{"code":"72020","display":"X-ray of spine, 1 view"},{"code":"72040","display":"X-ray of spine of neck, 2 or 3 views"},{"code":"72050","display":"X-ray of upper spine, 4 or 5 views"},{"code":"72052","display":"X-ray of upper spine, 6 or more views"},{"code":"72069","display":"X-ray of middle and lower spine, standing view"},{"code":"72070","display":"X-ray of middle spine, 3 views"},{"code":"72072","display":"X-ray of middle spine, 3 views"},{"code":"72074","display":"X-ray of middle spine, minimum of 4 views"},{"code":"72080","display":"X-ray of middle and lower spine, 2 views"},{"code":"72081","display":"X-ray of spine, 1 view"},{"code":"72082","display":"X-ray of spine, 2 or 3 views"},{"code":"72083","display":"X-ray of spine, 4 or 5 views"},{"code":"72084","display":"X-ray of spine, minimum of 6 views"},{"code":"72090","display":"X-ray of spine, scoliosis study"},{"code":"72100","display":"X-ray of lower and sacral spine, 2 or 3 views"},{"code":"72110","display":"X-ray of lower and sacral spine, minimum of 4 views"},{"code":"72114","display":"X-ray lower and sacral spine including bending views minimum 6 views"},{"code":"72120","display":"X-ray lower and sacral spine including bending views 2 or 3 views"},{"code":"72170","display":"X-ray of pelvis, 1 or 2 views"},{"code":"72190","display":"X-ray of pelvis, minimum of 3 views"},{"code":"72200","display":"X-ray of sacroiliac joints, less than 3 views"},{"code":"72202","display":"X-ray of sacroiliac joints, 3 or more views"},{"code":"72220","display":"X-ray of pelvis, minimum of 2 views"},{"code":"72275","display":"Radiological supervision and interpretation X-ray of covering of spinal cord"},{"code":"72285","display":"Radiological supervision and interpretation X-ray of disc of vertebra, upper or middle spine"},{"code":"72291","display":"Radiological supervision and interpretation of percutaneous repair or reconstruction of vertebra (accessed through the skin) using fluoroscopic guidance"},{"code":"72292","display":"Radiological supervision and interpretation of repair or reconstruction of vertebra (accessed through the skin) procedure using CT guidance"},{"code":"72295","display":"Radiological supervision and interpretation X-ray of disc of vertebra, lower spine"},{"code":"73000","display":"X-ray of collar bone"},{"code":"73010","display":"X-ray of shoulder blade"},{"code":"73020","display":"X-ray of shoulder, 1 view"},{"code":"73030","display":"X-ray of shoulder, minimum of 2 views"},{"code":"73040","display":"Radiological supervision and interpretation X-ray of shoulder joint"},{"code":"73050","display":"X-ray of both collar bones"},{"code":"73060","display":"X-ray of upper arm, minimum of 2 views"},{"code":"73070","display":"X-ray of elbow, 2 views"},{"code":"73080","display":"X-ray of elbow, minimum of 3 views"},{"code":"73085","display":"Radiological supervision and interpretation X-ray of elbow"},{"code":"73090","display":"X-ray of forearm, 2 views"},{"code":"73092","display":"X-ray of arm in infant minimum of 2 views"},{"code":"73100","display":"X-ray of wrist, 2 views"},{"code":"73110","display":"X-ray of wrist, minimum of 3 views"},{"code":"73115","display":"Radiological supervision and interpretation X-ray of wrist joint"},{"code":"73120","display":"X-ray of hand, 2 views"},{"code":"73130","display":"X-ray of hand, minimum of 3 views"},{"code":"73140","display":"X-ray of fingers, minimum of 2 views"},{"code":"73500","display":"X-ray of hip on one side of body, 1 view"},{"code":"73501","display":"X-ray of hip with pelvis, 1 view"},{"code":"73502","display":"X-ray of hip with pelvis, 2-3 views"},{"code":"73503","display":"X-ray of hip with pelvis, minimum of 4 views"},{"code":"73510","display":"X-ray of hip of one side of body, minimum of 2 views"},{"code":"73520","display":"X-ray of both hips minimum 2 views"},{"code":"73521","display":"X-ray of both hips with pelvis, 2 views"},{"code":"73522","display":"X-ray of both hips with pelvis, 3-4 views"},{"code":"73523","display":"X-ray of both hips with pelvis, minimum of 5 views"},{"code":"73525","display":"Radiological supervision and interpretation X-ray of hip joint"},{"code":"73530","display":"X-ray of hip during surgery"},{"code":"73540","display":"X-ray of pelvis and hips, infant or child, minimum of 2 views"},{"code":"73550","display":"X-ray of thigh, 2 views"},{"code":"73551","display":"X-ray of femur, 1 view"},{"code":"73552","display":"X-ray of femur, minimum 2 views"},{"code":"73560","display":"X-ray of knee, 1 or 2 views"},{"code":"73562","display":"X-ray of knee, 3 views"},{"code":"73564","display":"X-ray of knee, 4 or more views"},{"code":"73565","display":"X-ray of both knees, standing, front to back view"},{"code":"73580","display":"Radiological supervision and interpretation X-ray of knee joint"},{"code":"73590","display":"X-ray of lower leg, 2 views"},{"code":"73592","display":"X-ray of leg in infant minimum of 2 views"},{"code":"73600","display":"X-ray of ankle, 2 views"},{"code":"73610","display":"X-ray of ankle, minimum of 3 views"},{"code":"73615","display":"Radiological supervision and interpretation X-ray of ankle joint"},{"code":"73620","display":"X-ray of foot, 2 views"},{"code":"73630","display":"X-ray of foot, minimum of 3 views"},{"code":"73650","display":"X-ray of heel, minimum of 2 views"},{"code":"73660","display":"X-ray of toes, minimum of 2 views"},{"code":"74000","display":"X-ray of abdomen, single view"},{"code":"74010","display":"Imaging of abdomen"},{"code":"74018","display":"X-ray of abdomen, 1 view"},{"code":"74019","display":"X-ray of abdomen, 2 views"},{"code":"74020","display":"Imaging of abdomen"},{"code":"74021","display":"X-ray of abdomen, minimum of 3 views"},{"code":"74022","display":"Complete X-ray study of abdomen with single X-ray of chest"},{"code":"74190","display":"Radiological supervision and interpretation X-ray of lower abdominal and genital region"},{"code":"74210","display":"X-ray of voice box and/or esophagus in neck with contrast"},{"code":"74235","display":"Radiological supervision and interpretation of removal of foreign bodies in esophagus with balloon catheter"},{"code":"74290","display":"Imaging of gallbladder with contrast"},{"code":"74291","display":"Imaging of gallbladder with contrast, which may involve additional, repeat, or multiple-day examination"},{"code":"74305","display":"Radiological supervision and interpretation X-ray of bile and/or pancreatic ducts, contrast inserted through existing catheter"},{"code":"74320","display":"Radiological supervision and interpretation of X-ray of bile duct, contrast injection (accessed through the skin)"},{"code":"74327","display":"Radiological supervision and interpretation of removal of biliary duct stone (accessed through the skin) after surgery"},{"code":"74355","display":"Radiological supervision and interpretation of placement (accessed through the skin) of small bowel tube"},{"code":"74360","display":"Radiological supervision and interpretation of opening of digestive tract procedure"},{"code":"74363","display":"Radiological supervision and interpretation of dilation of biliary duct (accessed through the skin)"},{"code":"74415","display":"Imaging of urinary tract using infusion technique with kidney section filming"},{"code":"74420","display":"Imaging of urinary tract"},{"code":"74425","display":"Radiological supervision and interpretation X-ray of urinary tract"},{"code":"74430","display":"Radiological supervision and interpretation X-ray of urinary bladder, minimum of 3 views"},{"code":"74440","display":"Radiological supervision and interpretation X-ray of male internal genitals"},{"code":"74445","display":"Radiological supervision and interpretation X-ray of penis"},{"code":"74450","display":"Radiological supervision and interpretation X-ray of urinary bladder and urethra"},{"code":"74455","display":"Radiological supervision and interpretation X-ray of urinary bladder and urethra"},{"code":"74470","display":"Radiological supervision and interpretation X-ray of kidney cyst, lower back contrast injection"},{"code":"74475","display":"Radiological supervision and interpretation of placement of catheter (accessed through the skin) into kidney procedure"},{"code":"74480","display":"Radiological supervision and interpretation of placement of catheter into ureter (accessed through the skin) procedure"},{"code":"74485","display":"Radiological supervision and interpretation of dilation of urinary ducts (ureters) or bladder canal (urethra)"},{"code":"74710","display":"Imaging of pelvis"},{"code":"74740","display":"Radiological supervision and interpretation X-ray of uterine tubes and ovaries"},{"code":"74742","display":"Radiological supervision and interpretation of placement of catheter of uterine tube procedure"},{"code":"74775","display":"Imaging of anogenital region"},{"code":"75801","display":"Radiological supervision and interpretation of imaging of lymphatic system of one arm or leg"},{"code":"75803","display":"Radiological supervision and interpretation of imaging of lymphatic system of both arms or legs"},{"code":"75805","display":"Radiological supervision and interpretation of imaging of lymphatic system of one side of pelvis and abdomen"},{"code":"75807","display":"Radiological supervision and interpretation of imaging of lymphatic system of both side of pelvis and abdomen"},{"code":"75809","display":"Radiological supervision and interpretation of imaging of previous placed shunt"},{"code":"75893","display":"Radiological supervision and interpretation of drawing blood via catheter procedure"},{"code":"75901","display":"Radiological supervision and interpretation of removal of obstructive material in catheter procedure"},{"code":"75902","display":"Radiological supervision and interpretation of removal of obstructive material from large vein catheter procedure"},{"code":"75952","display":"Radiological supervision and interpretation of repair of artery of abdomen procedure"},{"code":"75970","display":"Radiological supervision and interpretation of biopsy procedure"},{"code":"75980","display":"Radiological supervision and interpretation of drainage of biliary duct (accessed through the skin) with contrast monitoring"},{"code":"75982","display":"Radiological supervision and interpretation of placement (accessed through the skin) of bile drainage catheter or stent"},{"code":"75984","display":"Radiological supervision and interpretation of change of tube (accessed through the skin) or drainage catheter with contrast monitoring"},{"code":"75989","display":"Radiological supervision and interpretation of placement of catheter with drainage (accessed through the skin) procedure"},{"code":"76000","display":"Imaging guidance for procedure, up to 1 hour"},{"code":"76001","display":"Imaging guidance for procedure, more than 1 hour"},{"code":"76010","display":"Imaging from nose to rectum, single view, child"},{"code":"76080","display":"Imaging for abscess or abnormal drainage tract procedure"},{"code":"76098","display":"Imaging of surgical specimen"},{"code":"76100","display":"Single plane imaging procedure"},{"code":"76101","display":"Complex motion imaging procedure on one side of body"},{"code":"76102","display":"Complex motion imaging procedure on both sides of body"},{"code":"76120","display":"Imaging of organ"},{"code":"76125","display":"Imaging of organ"},{"code":"76140","display":"Consultation on X-ray imaging"},{"code":"76376","display":"3D radiographic procedure"},{"code":"76377","display":"3D radiographic procedure with computerized image postprocessing"},{"code":"76390","display":"MRI study"},{"code":"76496","display":"Fluoroscopic procedure"},{"code":"76499","display":"Imaging procedure"},{"code":"76950","display":"Ultrasonic guidance for administration of radiation therapy"},{"code":"76965","display":"Ultrasonic guidance for administration of radiation therapy"},{"code":"77001","display":"Fluoroscopic guidance for insertion, replacement or removal of central venous access device"},{"code":"77002","display":"Fluoroscopic guidance for insertion of needle"},{"code":"77003","display":"Fluoroscopic guidance for injection into spine or muscle next to spine"},{"code":"77051","display":"Computer analysis of diagnostic mammogram"},{"code":"77052","display":"Computer analysis of screening mammogram to assist detection of cancer"},{"code":"77053","display":"Radiological supervision and interpretation of imaging of breast duct"},{"code":"77054","display":"Radiological supervision and interpretation of imaging of breast ducts"},{"code":"77055","display":"Mammography of one breast"},{"code":"77056","display":"Mammography of both breasts"},{"code":"77057","display":"Screening mammography of both breasts"},{"code":"77061","display":"Digital tomography of one breast"},{"code":"77062","display":"Digital tomography of both breasts"},{"code":"77063","display":"Screening digital tomography of both breasts"},{"code":"77065","display":"Mammography of one breast"},{"code":"77066","display":"Mammography of both breasts"},{"code":"77067","display":"Mammography of both breasts"},{"code":"77071","display":"Imaging of joint with stressing by physician"},{"code":"77072","display":"Imaging for bone age assessment"},{"code":"77073","display":"Imaging for bone length assessment"},{"code":"77074","display":"X-ray of bones"},{"code":"77075","display":"X-ray survey of forearm or wrist bone density"},{"code":"77076","display":"X-ray survey of bones, infant"},{"code":"77077","display":"Imaging of 2 or more joints, single view"},{"code":"77080","display":"Bone density measurement using dedicated X-ray machine"},{"code":"77081","display":"Bone density measurement using dedicated X-ray machine"},{"code":"77082","display":"Spine scanning X-ray done with bone density measurement for spine compression"},{"code":"77085","display":"Bone density measurement using dedicated X-ray machine"},{"code":"77086","display":"Fracture assessment of spine bones using dedicated X-ray machine for bone density measurement"},{"code":"77261","display":"Management of radiation therapy, simple"},{"code":"77262","display":"Management of radiation therapy, intermediate"},{"code":"77263","display":"Management of radiation therapy, complex"},{"code":"77280","display":"Management of radiation therapy simulation, simple"},{"code":"77285","display":"Management of radiation therapy, simulation, intermediate"},{"code":"77290","display":"Management of radiation therapy, simulation, complex"},{"code":"77293","display":"Respiratory motion management simulation"},{"code":"77295","display":"Management of radiation therapy, 3D"},{"code":"77299","display":"Management of radiation therapy"},{"code":"77300","display":"Calculation of radiation therapy dose"},{"code":"77301","display":"Management of modulation radiotherapy planning"},{"code":"77305","display":"Isodose radiation therapy plan, 1 or more ports, single area"},{"code":"77306","display":"Radiation therapy plan"},{"code":"77307","display":"Radiation therapy plan"},{"code":"77310","display":"Isodose radiation therapy plan, 3 or more ports, single area"},{"code":"77315","display":"Isodose radiation therapy plan, complex"},{"code":"77316","display":"Radiation therapy plan"},{"code":"77317","display":"Radiation therapy plan"},{"code":"77318","display":"Radiation therapy plan"},{"code":"77321","display":"Radiation therapy total body port plan"},{"code":"77326","display":"Brachytherapy radiation therapy plan (1 to 4 applications, 9 to 12 brachytherapy sources)"},{"code":"77327","display":"Brachytherapy radiation therapy plan (5 to 10 applications, 9 to 12 brachytherapy sources)"},{"code":"77328","display":"Brachytherapy radiation therapy plan (over 10 applications, over 12 brachytherapy sources)"},{"code":"77331","display":"Special radiation therapy planning"},{"code":"77332","display":"Radiation treatment devices, design and construction, simple"},{"code":"77333","display":"Radiation treatment devices, design and construction, intermediate"},{"code":"77334","display":"Radiation treatment devices, design and construction, complex"},{"code":"77336","display":"Radiation therapy consultation per week"},{"code":"77338","display":"Design and construction of device for radiation therapy"},{"code":"77370","display":"Radiation therapy consultation"},{"code":"77371","display":"Radiation therapy delivery, stereotactic radiosurgery (SRS) for cranial growths, per session"},{"code":"77372","display":"Radiation therapy delivery, stereotactic radiosurgery (SRS) for cranial growths, per session"},{"code":"77373","display":"Stereotactic body radiation therapy 1 or more lesions using imaging guidance"},{"code":"77385","display":"Radiation therapy delivery"},{"code":"77386","display":"Radiation therapy delivery"},{"code":"77387","display":"Guidance for localization of target delivery of radiation treatment"},{"code":"77399","display":"Management of radiation therapy"},{"code":"77401","display":"Radiation treatment delivery, superficial"},{"code":"77402","display":"Simple radiation treatment delivery \u003e/\u003d1 MeV"},{"code":"77403","display":"Radiation treatment delivery, single treatment area"},{"code":"77404","display":"Radiation treatment delivery, single treatment area"},{"code":"77406","display":"Radiation treatment delivery, single treatment area"},{"code":"77407","display":"Intermediate radiation treatment delivery \u003e/\u003d1 MeV"},{"code":"77408","display":"Radiation treatment delivery, two treatment areas, 3 or more ports"},{"code":"77409","display":"Radiation treatment delivery, two treatment areas, 3 or more ports"},{"code":"77411","display":"Radiation treatment delivery, two treatment areas, 3 or more ports"},{"code":"77412","display":"Complex radiation treatment delivery \u003e/\u003d1 MeV"},{"code":"77413","display":"Radiation treatment delivery, three or more treatment areas"},{"code":"77414","display":"Radiation treatment delivery, three or more treatment areas"},{"code":"77416","display":"Radiation treatment delivery, three or more treatment areas"},{"code":"77417","display":"Therapeutic radiology port films"},{"code":"77418","display":"Intensity modulated radiation treatment delivery per session"},{"code":"77421","display":"X-ray guidance for radiation therapy delivery"},{"code":"77422","display":"Radiation treatment delivery, high energy, single treatment area"},{"code":"77423","display":"Radiation treatment delivery, high energy"},{"code":"77424","display":"Intraoperative single X-ray radiation treatment session"},{"code":"77425","display":"Intraoperative electrons radiation treatment single session"},{"code":"77427","display":"Radiation treatment management, 5 treatments"},{"code":"77431","display":"Radiation treatment management, 1 or 2 treatments"},{"code":"77432","display":"Stereotactic radiation treatment management of brain lesions, complete course of treatment consisting of 1 session"},{"code":"77435","display":"Stereotactic radiation treatment management of 1 or more lesions using imaging guidance, per treatment course"},{"code":"77469","display":"Intraoperative radiation treatment management"},{"code":"77470","display":"Special radiation treatment procedure"},{"code":"77499","display":"Management of radiation therapy"},{"code":"77520","display":"Proton treatment delivery, simple"},{"code":"77522","display":"Proton treatment delivery, simple with compensation"},{"code":"77523","display":"Proton treatment delivery, intermediate"},{"code":"77525","display":"Proton treatment delivery, complex"},{"code":"77600","display":"External hyperthermia treatment depth 4 cm or less"},{"code":"77605","display":"External hyperthermia treatment depth greater than 4 cm"},{"code":"77610","display":"Hyperthermia treatment, 5 or fewer probe applications"},{"code":"77615","display":"Hyperthermia treatment, 5 or more probe applications"},{"code":"77620","display":"Hyperthermia treatment by organ cavity probes"},{"code":"77750","display":"Infusion or instillation of radioelement solution, includes 3-month follow-up care"},{"code":"77761","display":"Application of organ cavity radiation source, simple"},{"code":"77762","display":"Application of organ cavity radiation source, intermediate"},{"code":"77763","display":"Application of organ cavity radiation source, complex"},{"code":"77767","display":"High dose brachytherapy through skin surface, 1 channel or up to 2.0 cm"},{"code":"77768","display":"High dose brachytherapy through skin surface, 2 channels or more than 2.0 cm"},{"code":"77770","display":"High dose brachytherapy , 1 channel"},{"code":"77771","display":"High dose brachytherapy , 2- 12 channels"},{"code":"77772","display":"High dose brachytherapy , more than 12 channels"},{"code":"77776","display":"Application of radiation source, simple"},{"code":"77777","display":"Application of radiation source, intermediate"},{"code":"77778","display":"Application of radiation source, complex"},{"code":"77785","display":"High dose brachytherapy delivery, 1 channel"},{"code":"77786","display":"High dose brachytherapy delivery, 2-12 channels"},{"code":"77787","display":"High dose brachytherapy delivery, over 12 channels"},{"code":"77789","display":"Surface application of radiation"},{"code":"77790","display":"Supervision, handling, loading of radiation"},{"code":"77799","display":"Administration of radiation therapy"},{"code":"78012","display":"Nuclear medicine imaging for thyroid uptake measurements"},{"code":"78013","display":"Nuclear medicine imaging of thyroid"},{"code":"78014","display":"Nuclear medicine imaging for thyroid uptake measurements"},{"code":"78015","display":"Nuclear medicine limited study for thyroid cancer"},{"code":"78016","display":"Nuclear medicine additional studies for thyroid cancer"},{"code":"78018","display":"Nuclear medicine whole body study for thyroid cancer"},{"code":"78020","display":"Nuclear medicine study for thyroid cancer"},{"code":"78070","display":"Imaging of parathyroid"},{"code":"78071","display":"Imaging of parathyroid with nuclear medicine study"},{"code":"78072","display":"Imaging of parathyroid with CT and nuclear medicine study"},{"code":"78075","display":"Imaging of blood vessel of gland of kidney"},{"code":"78099","display":"Nuclear medicine study of endocrine organs"},{"code":"78102","display":"Imaging of bone marrow limited area"},{"code":"78103","display":"Imaging of bone marrow multiple areas"},{"code":"78104","display":"Imaging of bone marrow whole body"},{"code":"78110","display":"Nuclear medicine study of plasma"},{"code":"78111","display":"Nuclear medicine study of plasma"},{"code":"78120","display":"Nuclear medicine study of red blood cell"},{"code":"78121","display":"Nuclear medicine study of red blood cell"},{"code":"78122","display":"Nuclear medicine study of blood"},{"code":"78130","display":"Nuclear medicine study of red blood cell"},{"code":"78135","display":"Nuclear medicine study of red blood cell"},{"code":"78140","display":"Nuclear medicine study of red blood cell"},{"code":"78185","display":"Imaging of spleen"},{"code":"78190","display":"Nuclear medicine study of survival of blood cell"},{"code":"78191","display":"Nuclear medicine study of platelet"},{"code":"78195","display":"Imaging of lymphatic tissue and lymph node"},{"code":"78199","display":"Nuclear medicine study of cardiovascular systems"},{"code":"78201","display":"Imaging of liver"},{"code":"78202","display":"Imaging of liver blood flow"},{"code":"78205","display":"Nuclear medicine study of liver"},{"code":"78206","display":"Nuclear medicine study of liver with blood flow"},{"code":"78215","display":"Imaging of liver and spleen"},{"code":"78216","display":"Imaging of liver and spleen with blood flow"},{"code":"78226","display":"Imaging of liver and bile duct system"},{"code":"78227","display":"Imaging of liver and bile duct system with use of drugs"},{"code":"78230","display":"Imaging of salivary gland"},{"code":"78231","display":"Imaging of salivary gland"},{"code":"78232","display":"Nuclear medicine study of salivary gland"},{"code":"78258","display":"Imaging of esophagus using radioisotopes"},{"code":"78261","display":"Imaging of stomach lining"},{"code":"78262","display":"Stomach and esophagus regurgitation study"},{"code":"78264","display":"Stomach emptying study"},{"code":"78265","display":"Stomach emptying and small bowel transit study"},{"code":"78266","display":"Stomach emptying and small bowel with colon transit study"},{"code":"78267","display":"Nuclear medicine study of digestive tract"},{"code":"78268","display":"Nuclear medicine study of digestive tract"},{"code":"78270","display":"Vitamin B-12 absorption study"},{"code":"78271","display":"Vitamin B-12 absorption study with factor necessary for absorption"},{"code":"78272","display":"Vitamin B-12 absorption study without then with factor necessary for absorption"},{"code":"78278","display":"Acute digestive tract blood loss imaging"},{"code":"78282","display":"Digestive tract protein loss"},{"code":"78290","display":"Intestine imaging"},{"code":"78291","display":"Peritoneal-venous shunt patency test"},{"code":"78299","display":"Nuclear medicine study of digestive tracts"},{"code":"78300","display":"Bone and/or joint imaging"},{"code":"78305","display":"Bone and/or joint imaging, multiple areas"},{"code":"78306","display":"Bone and/or joint imaging, whole body"},{"code":"78315","display":"Bone and/or joint imaging, 3 phase study"},{"code":"78320","display":"Nuclear medicine study of bone and/or joint"},{"code":"78350","display":"Bone density (bone mineral content) study"},{"code":"78351","display":"Bone density (bone mineral content) study"},{"code":"78399","display":"Diagnostic musculoskeletal nuclear medicine studies"},{"code":"78414","display":"Non-imaging determination of cardiovascular function"},{"code":"78428","display":"Cardiac shunt detection"},{"code":"78445","display":"Non-cardiac vascular flow imaging"},{"code":"78451","display":"Nuclear medicine study of vessels of heart using drugs or exercise single study"},{"code":"78452","display":"Nuclear medicine study of vessels of heart using drugs or exercise multiple studies"},{"code":"78453","display":"Nuclear medicine single study of vessels of heart using drugs or exercise"},{"code":"78454","display":"Nuclear medicine multiple studies of vessels of heart at rest, using drugs, or exercise"},{"code":"78456","display":"Diagnostic nuclear imaging of platelet proteins for blood clot assessment in vein"},{"code":"78457","display":"Venography for blood clot in vein, one leg or arm"},{"code":"78458","display":"Venography for blood clot in veins, both legs or arms"},{"code":"78459","display":"Single nuclear medicine study of heart muscle with metabolic evaluation"},{"code":"78466","display":"Nuclear medicine study of heart muscle following heart attack"},{"code":"78468","display":"Nuclear medicine study of heart muscle following heart attack with evaluation of blood ejection from heart"},{"code":"78469","display":"Nuclear medicine study of heart muscle following heart attack"},{"code":"78472","display":"Nuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study"},{"code":"78473","display":"Nuclear medicine study of heart function wall motion at rest and stress with evaluation of blood ejection from heart, multiple studies"},{"code":"78481","display":"Nuclear medicine study of heart wall motion at rest or stress with evaluation of blood ejection from heart, single study"},{"code":"78483","display":"Nuclear medicine study of heart wall motion at rest and stress with evaluation of blood ejection from heart, multiple studies"},{"code":"78491","display":"Single nuclear medicine study of blood flow in heart muscle"},{"code":"78492","display":"Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress"},{"code":"78494","display":"Nuclear medicine study of heart wall motion at rest with evaluation of blood ejection from heart"},{"code":"78496","display":"Nuclear medicine study of heart function at rest or stress with evaluation of blood ejection from heart"},{"code":"78499","display":"Nuclear medicine study of cardiovascular systems"},{"code":"78579","display":"Nuclear medicine study of lung ventilation"},{"code":"78580","display":"Nuclear medicine study of blood circulation in the lungs"},{"code":"78582","display":"Nuclear medicine study of lung ventilation and blood circulation in the lungs"},{"code":"78597","display":"Nuclear medicine study with measurement of blood circulation in the lungs"},{"code":"78598","display":"Nuclear medicine study with measurement of blood circulation in the lungs and ventilation"},{"code":"78599","display":"Nuclear medicine study of respiratory systems"},{"code":"78600","display":"Imaging of brain, less than 4 static views"},{"code":"78601","display":"Imaging of brain with blood flow, less than 4 static views"},{"code":"78605","display":"Imaging of brain with blood flow, minimum of 4 static views"},{"code":"78606","display":"Imaging of brain with blood flow, minimum of 4 static views"},{"code":"78607","display":"Nuclear medicine study of brain"},{"code":"78608","display":"Nuclear medicine study brain with metabolic evaluation"},{"code":"78609","display":"Nuclear medicine study brain with blood circulation evaluation"},{"code":"78610","display":"Imaging of brain, blood flow"},{"code":"78630","display":"Imaging of brain and spinal cord fluid flow at base of brain"},{"code":"78635","display":"Imaging of brain and spinal cord fluid flow in brain compartments (ventricles)"},{"code":"78645","display":"Imaging of brain and spinal cord fluid flow shunt evaluation"},{"code":"78647","display":"Nuclear medicine study of brain and spinal cord fluid flow"},{"code":"78650","display":"Imaging of brain and spinal cord fluid leakage detection and localization"},{"code":"78660","display":"Nuclear medicine study of tear drainage structure of eye"},{"code":"78699","display":"Nuclear medicine study of nervous systems"},{"code":"78700","display":"Imaging of kidney"},{"code":"78701","display":"Nuclear medicine study of kidney with assessment of blood flow"},{"code":"78707","display":"Nuclear medicine study of kidney with assessment of blood flow and function"},{"code":"78708","display":"Nuclear medicine study of kidney with assessment of blood flow and function"},{"code":"78709","display":"Nuclear medicine study of kidney with assessment of blood flow and function"},{"code":"78710","display":"Nuclear medicine study of kidney"},{"code":"78725","display":"Nuclear medicine kidney function study"},{"code":"78730","display":"Nuclear medicine study of remaining urine in bladder"},{"code":"78740","display":"Nuclear medicine backwash of urine into kidney"},{"code":"78761","display":"Nuclear medicine study of testicles and blood vessel flow"},{"code":"78799","display":"Nuclear medicine study of urogenital systems"},{"code":"78800","display":"Nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging"},{"code":"78801","display":"Nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days"},{"code":"78802","display":"Nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in whole body, single day imaging"},{"code":"78803","display":"SPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging"},{"code":"78804","display":"Nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in whole body, 2 or more days imaging"},{"code":"78805","display":"Nuclear medicine study of radioactive material distribution at site of inflammation"},{"code":"78806","display":"Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body"},{"code":"78807","display":"Nuclear medicine study of radioactive material distribution at site of inflammation"},{"code":"78808","display":"Injection of radioactive contrast material into a vein for non-imaging gamma probe"},{"code":"78811","display":"Nuclear medicine study limited area"},{"code":"78812","display":"Nuclear medicine imaging from skull base to mid-thigh"},{"code":"78813","display":"Nuclear medicine imaging whole body"},{"code":"78814","display":"Nuclear medicine study with CT imaging"},{"code":"78815","display":"Nuclear medicine study with CT imaging skull base to mid-thigh"},{"code":"78816","display":"Nuclear medicine study with CT imaging whole body"},{"code":"78830","display":"SPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, with concurrently acquired CT transmission scan, 1 day of imaging"},{"code":"78831","display":"SPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days"},{"code":"78832","display":"SPECT nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in multiple areas, or in single area with imaging over multiple days, with concurrently acquired CT transmission scan, 1 day of imaging"},{"code":"78835","display":"Quantification of radioactive tracer"},{"code":"78999","display":"Diagnostic nuclear medicine procedures"},{"code":"79101","display":"Radioactive material therapy into vein"},{"code":"79200","display":"Radioactive material therapy into body space or cavity"},{"code":"79300","display":"Radioactive material therapy into tissue"},{"code":"79403","display":"Radioactive material therapy into vein"},{"code":"80100","display":"Drug screen, multiple drugs"},{"code":"80101","display":"Drug screen"},{"code":"80102","display":"Drug confirmation test"},{"code":"80103","display":"Tissue preparation for drug analysis"},{"code":"80104","display":"Drug screen, multiple drugs"},{"code":"80500","display":"Clinical pathology consultation"},{"code":"80502","display":"Comprehensive, clinical pathology consultation"},{"code":"81000","display":"Manual urinalysis test with examination using microscope"},{"code":"81001","display":"Manual urinalysis test with examination using microscope"},{"code":"81007","display":"Urinalysis for bacteria"},{"code":"81015","display":"Urinalysis using microscope"},{"code":"81020","display":"Urinalysis, 2 or 3 glass test"},{"code":"81105","display":"Gene analysis (Human Platelet Antigen 1) for common variant"},{"code":"81106","display":"Gene analysis (Human Platelet Antigen 2) for common variant"},{"code":"81107","display":"Gene analysis (Human Platelet Antigen 3) for common variant"},{"code":"81108","display":"Gene analysis (Human Platelet Antigen 4) for common variant"},{"code":"81109","display":"Gene analysis (Human Platelet Antigen 5) for common variant"},{"code":"81110","display":"Gene analysis (Human Platelet Antigen 6) for common variant"},{"code":"81111","display":"Gene analysis (Human Platelet Antigen 9) for common variant"},{"code":"81112","display":"Gene analysis (Human Platelet Antigen 15) for common variant"},{"code":"81120","display":"Gene analysis (isocitrate dehydrogenase 1 [NADP+], soluble) for common variants"},{"code":"81121","display":"Gene analysis (isocitrate dehydrogenase 2 [NADP+], mitochondrial) for common variants"},{"code":"81161","display":"Gene analysis (dystrophin)"},{"code":"81162","display":"Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants"},{"code":"81163","display":"Gene analysis (breast cancer 1 and 2) of full sequence"},{"code":"81164","display":"Gene analysis (breast cancer 1 and 2) for duplication or deletion variants"},{"code":"81165","display":"Gene analysis (breast cancer 1) of full sequence"},{"code":"81166","display":"Gene analysis (breast cancer 1) for duplication or deletion variants"},{"code":"81167","display":"Gene analysis (breast cancer 2) for duplication or deletion variants"},{"code":"81170","display":"Gene analysis (ABL proto-oncogene 1, non-receptor tyrosine kinase)"},{"code":"81171","display":"Gene analysis (fragile X mental retardation 2) for abnormal alleles"},{"code":"81172","display":"Gene analysis (fragile X mental retardation 2) for characterization of alleles"},{"code":"81173","display":"Gene analysis (androgen receptor) of full sequence"},{"code":"81174","display":"Gene analysis (androgen receptor) for known familial variant"},{"code":"81175","display":"Gene analysis (additional sex combs like 1, transcriptional regulator) full sequence analysis"},{"code":"81176","display":"Gene analysis (additional sex combs like 1, transcriptional regulator) targeted sequence analysis"},{"code":"81177","display":"Gene analysis (atropin 1) for abnormal alleles"},{"code":"81178","display":"Gene analysis (ataxin 1) for abnormal alleles"},{"code":"81179","display":"Gene analysis (ataxin 2) for abnormal alleles"},{"code":"81180","display":"Gene analysis (ataxin 3) for abnormal alleles"},{"code":"81181","display":"Gene analysis (ataxin 7) for abnormal alleles"},{"code":"81182","display":"Gene analysis (ataxin 8 opposite strand [non-protein coding]) for abnormal alleles"},{"code":"81183","display":"Gene analysis (ataxin 10) for abnormal alleles"},{"code":"81184","display":"Gene analysis (calcium voltage-gated channel subunit alpha1 A) for abnormal alleles"},{"code":"81185","display":"Gene analysis (calcium voltage-gated channel subunit alpha1 A) of full sequence"},{"code":"81186","display":"Gene analysis (calcium voltage-gated channel subunit alpha1 A) for known familial variant"},{"code":"81187","display":"Gene analysis (CCH-type zinc finger nucleic acid binding protein) for abnormal alleles"},{"code":"81188","display":"Gene analysis (cystatin B) for abnormal alleles"},{"code":"81189","display":"Gene analysis (cystatin B) of full sequence"},{"code":"81190","display":"Gene analysis (cystatin B) for known familial variants"},{"code":"81200","display":"Gene analysis (aspartoacylase)"},{"code":"81201","display":"Gene analysis (adenomatous polyposis coli), full gene sequence"},{"code":"81202","display":"Gene analysis (adenomatous polyposis coli), known familial variants"},{"code":"81203","display":"Gene analysis (adenomatous polyposis coli), duplication or deletion variants"},{"code":"81204","display":"Gene analysis (androgen receptor) for characterization of alleles"},{"code":"81205","display":"Gene analysis (branched-chain keto acid dehydrogenase E1, beta polypeptide)"},{"code":"81206","display":"Translocation analysis (BCR/ABL1) minor breakpoint"},{"code":"81207","display":"Translocation analysis (BCR/ABL1) major breakpoint"},{"code":"81208","display":"Translocation analysis (BCR/ABL1) other breakpoint"},{"code":"81209","display":"Gene analysis (Bloom syndrome, RecQ helicase-like)"},{"code":"81210","display":"Gene analysis (v-raf murine sarcoma viral oncogene homolog B1)"},{"code":"81211","display":"Gene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants"},{"code":"81212","display":"Gene analysis (breast cancer 1 and 2) for 185delAG, 5385insC, 6174delT variants"},{"code":"81213","display":"Gene analysis (breast cancer 1 and 2) uncommon duplication or deletion variants"},{"code":"81214","display":"Gene analysis (breast cancer 1) full sequence and common duplication or deletion variants"},{"code":"81215","display":"Gene analysis (breast cancer 1) for known familial variant"},{"code":"81216","display":"Gene analysis (breast cancer 2) of full sequence"},{"code":"81217","display":"Gene analysis (breast cancer 2) for known familial variant"},{"code":"81218","display":"Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence"},{"code":"81219","display":"Gene analysis (calreticulin), common variants"},{"code":"81220","display":"Gene analysis (cystic fibrosis transmembrane conductance regular) common variants"},{"code":"81221","display":"Gene analysis (cystic fibrosis transmembrane conductance regular) known familial variants"},{"code":"81222","display":"Gene analysis (cystic fibrosis transmembrane conductance regular) duplication or deletion variants"},{"code":"81223","display":"Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence"},{"code":"81224","display":"Gene analysis (cystic fibrosis transmembrane conductance regular) intron 8 poly-T"},{"code":"81225","display":"Gene analysis (cytochrome P450, family 2, subfamily C, polypeptide 19) common variants"},{"code":"81226","display":"Gene analysis (cytochrome P450, family 2, subfamily D, polypeptide 6) common variants"},{"code":"81227","display":"Gene analysis (cytochrome P450, family 2, subfamily C, polypeptide 9) common variants"},{"code":"81228","display":"Genome-wide microarray analysis for copy number variants"},{"code":"81229","display":"Genome-wide microarray analysis for copy number and single nucleotide polymorphism variants"},{"code":"81230","display":"Gene analysis (cytochrome P450 family 3 subfamily A member 4) for common variant"},{"code":"81231","display":"Gene analysis (cytochrome P450 family 3 subfamily A member 5) for common variant"},{"code":"81232","display":"Gene analysis (dihydropyrimidine dehydrogenase) for common variant"},{"code":"81233","display":"Gene analysis (Bruton\u0027s tyrosine kinase) for common variants"},{"code":"81234","display":"Gene analysis (DM1 protein kinase) for abnormal alleles"},{"code":"81235","display":"Gene analysis (epidermal growth factor receptor), common variants"},{"code":"81236","display":"Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) of full sequence"},{"code":"81237","display":"Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) for common variants"},{"code":"81238","display":"Gene analysis (coagulation factor IX) full sequence analysis"},{"code":"81239","display":"Gene analysis (DM1 protein kinase) for characterization of alleles"},{"code":"81240","display":"Gene analysis (prothrombin, coagulation factor II) A variant"},{"code":"81241","display":"Gene analysis (coagulation factor V) Leiden variant"},{"code":"81242","display":"Gene analysis (Fanconi anemia, complementation group C) common variant"},{"code":"81243","display":"Gene analysis (fragile X mental retardation) abnormal alleles"},{"code":"81244","display":"Gene analysis (fragile X mental retardation 1) for characterization of alleles"},{"code":"81245","display":"Gene analysis (fms-related tyrosine kinase 3) internal tandem duplication variants"},{"code":"81246","display":"Test for detecting genes associated with blood cancer"},{"code":"81247","display":"Gene analysis (glucose-6-phosphate dehydrogenase) for common variant"},{"code":"81248","display":"Gene analysis (glucose-6-phosphate dehydrogenase) for known familial variant"},{"code":"81249","display":"Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis"},{"code":"81250","display":"Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants"},{"code":"81251","display":"Gene analysis (glucosidase, beta, acid) common variants"},{"code":"81252","display":"Gene analysis (gap junction protein, beta 2, 26kda, connexin 26), full gene sequence"},{"code":"81253","display":"Gene analysis (gap junction protein, beta 2, 26kda, connexin 26), known familial variants"},{"code":"81254","display":"Gene analysis (gap junction protein, beta 6, 30kda, connexin 30), common variants"},{"code":"81255","display":"Gene analysis (hexosaminidase A) common variants"},{"code":"81256","display":"Gene analysis (hemochromatosis) common variants"},{"code":"81257","display":"Gene analysis (alpha globin 1 and alpha globin 2) for common deletions or variant"},{"code":"81258","display":"Gene analysis (alpha globin 1 and alpha globin 2) for known familial variant"},{"code":"81259","display":"Gene analysis (alpha globin 1 and alpha globin 2) full sequence analysis"},{"code":"81260","display":"Gene analysis (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) common variants"},{"code":"81261","display":"Gene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population amplified methodology"},{"code":"81262","display":"Gene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population direct probe methodology"},{"code":"81263","display":"Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis"},{"code":"81264","display":"Gene rearrangement analysis (immunoglobulin kappa light chain locus) to detect abnormal clonal population"},{"code":"81265","display":"Comparative analysis using Short Tandem Repeat (STR) markers of patient and specimen"},{"code":"81266","display":"Comparative analysis using Short Tandem Repeat (STR) markers of patient and specimen"},{"code":"81267","display":"Chimerism analysis post transplantation"},{"code":"81268","display":"Chimerism analysis post transplantation"},{"code":"81269","display":"Gene analysis (alpha globin 1 and alpha globin 2) for duplication/deletion variants"},{"code":"81270","display":"Gene analysis (Janus kinase 2) variant"},{"code":"81271","display":"Gene analysis (Huntingtin) for abnormal alleles"},{"code":"81272","display":"Gene analysis (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence"},{"code":"81273","display":"Gene analysis (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog), D816 variants"},{"code":"81274","display":"Gene analysis (Huntingtin) for characterization of alleles"},{"code":"81275","display":"Gene analysis (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) variants in codons 12 and 13"},{"code":"81276","display":"Gene analysis (Kirsten rat sarcoma viral oncogene homolog), additional variants"},{"code":"81277","display":"Cancer cytogenomic array gene analysis"},{"code":"81280","display":"Gene analysis (long QT syndrome) full sequence analysis"},{"code":"81281","display":"Gene analysis (long QT syndrome) known familial sequence variant"},{"code":"81282","display":"Gene analysis (long QT syndrome) duplication or deletion variants"},{"code":"81283","display":"Gene analysis (interferon, lambda 3) for rs12979860 variant"},{"code":"81284","display":"Gene analysis (frataxin) for abnormal alleles"},{"code":"81285","display":"Gene analysis (frataxin) for characterization of alleles"},{"code":"81286","display":"Gene analysis (frataxin) of full sequence"},{"code":"81287","display":"Gene analysis (O-6-methylguanine-DNA methyltransferase) for promoter methylation"},{"code":"81288","display":"Test for detecting genes associated with colon cancer"},{"code":"81289","display":"Gene analysis (frataxin) for known familial variants"},{"code":"81290","display":"Gene analysis (mucolipin 1) common variants"},{"code":"81291","display":"Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants"},{"code":"81292","display":"Gene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis"},{"code":"81293","display":"Gene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) known familial variants"},{"code":"81294","display":"Gene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) duplication or deletion variants"},{"code":"81295","display":"Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis"},{"code":"81296","display":"Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) known familial variants"},{"code":"81297","display":"Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) duplication or deletion variants"},{"code":"81298","display":"Gene analysis (mutS homolog 6 [E coli]) full sequence analysis"},{"code":"81299","display":"Gene analysis (mutS homolog 6 [E coli]) known familial variants"},{"code":"81300","display":"Gene analysis (mutS homolog 6 [E coli]) duplication or deletion variants"},{"code":"81301","display":"Microsatellite instability analysis"},{"code":"81302","display":"Gene analysis (methyl CpG binding protein 2) full sequence analysis"},{"code":"81303","display":"Gene analysis (methyl CpG binding protein 2) known familial variant"},{"code":"81304","display":"Gene analysis (methyl CpG binding protein 2) duplication or deletion variants"},{"code":"81305","display":"Gene analysis (myeloid differentiation primary response 88) for p.Leu265Pro variant"},{"code":"81306","display":"Gene analysis (nudix hydrolase 15) for common variants"},{"code":"81307","display":"Gene analysis (partner and localizer of BRCA2) full sequence analysis"},{"code":"81308","display":"Gene analysis (partner and localizer of BRCA2) for detection of known familial variant"},{"code":"81309","display":"Gene analysis (partner and localizer of BRCA2) targeted sequence analysis"},{"code":"81310","display":"Gene analysis (nucleophosmin) exon 12 variants"},{"code":"81311","display":"Gene analysis for cancer (neuroblastoma)"},{"code":"81312","display":"Gene analysis (poly[A] binding protein nuclear 1) for abnormal alleles"},{"code":"81313","display":"Test for detecting genes associated with prostate cancer"},{"code":"81314","display":"Gene analysis ((platelet-derived growth factor receptor, alpha polypeptide) targeted sequence"},{"code":"81315","display":"Translocation analysis (PML-RARA regulated adaptor molecule 1) common breakpoint"},{"code":"81316","display":"Translocation analysis (PML-RARA regulated adaptor molecule 1) single breakpoint"},{"code":"81317","display":"Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis"},{"code":"81318","display":"Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) known familiar variants"},{"code":"81319","display":"Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) duplication or deletion variants"},{"code":"81320","display":"Gene analysis (phospholipase C gamma 2) for common variants"},{"code":"81325","display":"Gene analysis (peripheral myelin protein 22), full sequence analysis"},{"code":"81326","display":"Gene analysis (peripheral myelin protein 22), known familial variant"},{"code":"81327","display":"Gene analysis (Septin9) for promoter methylation"},{"code":"81328","display":"Gene analysis (solute carrier organic anion transporter family, member 1B1) for common variant"},{"code":"81329","display":"Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion"},{"code":"81330","display":"Gene analysis (sphingomyelin phosphodiesterase 1, acid lysosomal) common variants"},{"code":"81331","display":"Methylation analysis (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A)"},{"code":"81332","display":"Gene analysis (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) common variants"},{"code":"81333","display":"Gene analysis (transforming growth factor beta-induced) for common variants"},{"code":"81334","display":"Gene analysis (runt related transcription factor 1) targeted sequence analysis"},{"code":"81335","display":"Gene analysis (thiopurine S-methyltransferase) for common variant"},{"code":"81336","display":"Gene analysis (survival of motor neuron 1, telomeric) of full sequence"},{"code":"81337","display":"Gene analysis (survival of motor neuron 1, telomeric) for known familial sequence variants"},{"code":"81340","display":"Gene analysis (T cell antigen receptor beta) amplification methodology"},{"code":"81341","display":"Gene rearrangement analysis detection abnormal clonal population (T cell antigen receptor beta) direct probe methodology"},{"code":"81342","display":"Gene rearrangement analysis detection abnormal clonal population (T cell antigen receptor gamma)"},{"code":"81343","display":"Gene analysis (protein phosphatase 2 regulatory subunit Bbeta) for abnormal alleles"},{"code":"81344","display":"Gene analysis (TATA box binding protein) for abnormal alleles"},{"code":"81345","display":"Gene analysis (telomerase reverse transcriptase) targeted sequence analysis"},{"code":"81346","display":"Gene analysis (thymidylate synthetase) for common variant"},{"code":"81350","display":"Gene analysis (UDP glucuronosyltransferase 1 family, polypeptide A1) for detection of common variants"},{"code":"81355","display":"Gene analysis (vitamin K epoxide reductase complex subunit 1) common variants"},{"code":"81361","display":"Gene analysis (hemoglobin, subunit beta) for common variant"},{"code":"81362","display":"Gene analysis (hemoglobin, subunit beta) for known familial variant"},{"code":"81363","display":"Gene analysis (hemoglobin, subunit beta) for duplication/deletion variant"},{"code":"81364","display":"Gene analysis (hemoglobin, subunit beta) full sequence analysis"},{"code":"81370","display":"HLA class I and II typing low resolution HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1"},{"code":"81371","display":"HLA class I and II typing, low resolution HLA-A, -B, and -DRB1"},{"code":"81372","display":"HLA class I typing low resolution"},{"code":"81373","display":"HLA class I typing low resolution one locus"},{"code":"81374","display":"HLA class I typing, low resolution one antigen equivalent"},{"code":"81375","display":"HLA class II typing low resolution HLA-DRB1/3/4/5 and -DQB1"},{"code":"81376","display":"HLA class II typing low resolution one locus"},{"code":"81377","display":"HLA class II typing low resolution one antigen equivalent"},{"code":"81378","display":"HLA class I and II typing high resolution HLA-A, -B, -C, and -DRB1"},{"code":"81379","display":"HLA Class I typing high resolution"},{"code":"81380","display":"HLA class I typing high resolution one locus"},{"code":"81381","display":"HLA class I typing high resolution one allele or allele group"},{"code":"81382","display":"HLA class II typing high resolution one locus"},{"code":"81383","display":"HLA class II typing high resolution one allele or allele group"},{"code":"81400","display":"Molecular pathology procedure level 1"},{"code":"81401","display":"Molecular pathology procedure level 2"},{"code":"81402","display":"Molecular pathology procedure level 3"},{"code":"81403","display":"Molecular pathology procedure level 4"},{"code":"81404","display":"Molecular pathology procedure level 5"},{"code":"81405","display":"Molecular pathology procedure level 6"},{"code":"81406","display":"Molecular pathology procedure level 7"},{"code":"81407","display":"Molecular pathology procedure level 8"},{"code":"81408","display":"Molecular pathology procedure level 9"},{"code":"81410","display":"Test for detecting genes associated with heart disease"},{"code":"81411","display":"Test for detecting genes associated with heart disease"},{"code":"81412","display":"Test for detecting genes for disorders related to Ashkenazi Jews"},{"code":"81413","display":"Test for detecting genes associated with heart disease"},{"code":"81414","display":"Test for detecting genes associated with heart disease"},{"code":"81415","display":"Test for detecting genes associated with diseases"},{"code":"81416","display":"Test for detecting genes associated with disease"},{"code":"81417","display":"Reevaluation test for detecting genes associated with disease"},{"code":"81420","display":"Test for detecting genes associated with fetal disease"},{"code":"81422","display":"Test for detecting genes associated with fetal disease"},{"code":"81425","display":"Test for detecting genes associated with disease"},{"code":"81426","display":"Test for detecting genes associated with disease"},{"code":"81427","display":"Reevaluation test for detecting genes associated with disease"},{"code":"81430","display":"Test for detecting genes causing hearing loss"},{"code":"81431","display":"Test for detecting genes causing hearing loss"},{"code":"81432","display":"Test for detecting genes associated with inherited breast cancer-related disorders"},{"code":"81433","display":"Gene analysis (breast and related cancers), duplication or deletion variants"},{"code":"81434","display":"Gene analysis (retinal disorders), genomic sequence"},{"code":"81435","display":"Test for detecting genes associated with colon cancer"},{"code":"81436","display":"Test for detecting genes associated with colon cancer"},{"code":"81437","display":"Gene analysis (neuroendocrine tumors), genomic sequence"},{"code":"81438","display":"Gene analysis (neuroendocrine tumors), duplication and deletion variants"},{"code":"81439","display":"Test for detecting genes associated with inherited disease of heart muscle"},{"code":"81440","display":"Test for detecting genes"},{"code":"81442","display":"Gene analysis (noonan syndrome) genomic sequence analysis"},{"code":"81443","display":"Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes"},{"code":"81445","display":"Test for detecting genes associated with cancer of body organ"},{"code":"81448","display":"Gene analysis panel for hereditary disorders of the peripheral nervous system"},{"code":"81450","display":"Test for detecting genes associated with blood related cancer"},{"code":"81455","display":"Test for detecting genes associated with cancer"},{"code":"81460","display":"Test for detecting genes associated with disease"},{"code":"81465","display":"Test for detecting genes associated with disease"},{"code":"81470","display":"Test for detecting genes associated with intellectual disability"},{"code":"81471","display":"Test for detecting genes associated with intellectual disability"},{"code":"81479","display":"Molecular pathology procedure"},{"code":"81490","display":"Test for detecting genes associated with rheumatoid arthritis using immunoassay technique"},{"code":"81493","display":"Test for detecting genes associated with heart vessels diseases"},{"code":"81500","display":"Genetic profiling on oncology biopsy of ovarian lesions"},{"code":"81503","display":"Genetic profiling on oncology biopsy of ovarian lesions"},{"code":"81504","display":"Genetic profiling on oncology biopsy lesions"},{"code":"81506","display":"Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, hba1c, insulin, hs-crp, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score"},{"code":"81507","display":"DNA analysis using maternal plasma"},{"code":"81508","display":"Fetal congenital abnormalities, biochemical assays of two proteins (papp-a, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score"},{"code":"81509","display":"Fetal congenital abnormalities, biochemical assays of three proteins (papp-a, hcg [any form], dia), utilizing maternal serum, algorithm reported as a risk score"},{"code":"81510","display":"Fetal congenital abnormalities, biochemical assays of three analytes (afp, ue3, hcg [any form]), utilizing maternal serum, algorithm reported as a risk score"},{"code":"81511","display":"Fetal congenital abnormalities, biochemical assays of four analytes (afp, ue3, hcg [any form], dia) utilizing maternal serum, algorithm reported as a risk score"},{"code":"81512","display":"Fetal congenital abnormalities, biochemical assays of five analytes (afp, ue3, total hcg, hyperglycosylated hcg, dia) utilizing maternal serum, algorithm reported as a risk score"},{"code":"81518","display":"mRNA gene analysis of 11 genes in breast tumor tissue"},{"code":"81519","display":"Test for detecting genes associated with breast cancer"},{"code":"81520","display":"Gene analysis of breast tumor tissue"},{"code":"81521","display":"Gene analysis of breast tumor tissue"},{"code":"81522","display":"mRNA gene expression analysis of 12 genes in breast tumor tissue"},{"code":"81525","display":"Gene analysis (colon related cancer)"},{"code":"81528","display":"Gene analysis (colorectal cancer)"},{"code":"81535","display":"Culture of live tumor cells and chemotherapy drug response by staining"},{"code":"81536","display":"Culture of live tumor cells and chemotherapy drug response by staining"},{"code":"81538","display":"Testing of lung tumor cells for prediction of survival"},{"code":"81539","display":"Measurement of proteins associated with prostate cancer"},{"code":"81540","display":"Gene analysis (cancer)"},{"code":"81541","display":"Gene analysis of prostate tumor tissue"},{"code":"81542","display":"mRNA gene expression analysis of 22 genes in prostate tumor tissue"},{"code":"81545","display":"Gene analysis (thyroid cancer)"},{"code":"81551","display":"Gene analysis of prostate tumor tissue"},{"code":"81552","display":"mRNA gene expression analysis of 15 genes in eye melanoma o tissue or fine needle aspirate"},{"code":"81595","display":"Test for detecting genes associated with heart diseases"},{"code":"81596","display":"Biochemical assays for evaluation of chronic Hepatitis C virus infection"},{"code":"81599","display":"Multianalyte assay procedure with algorithmic analysis"},{"code":"82003","display":"Acetaminophen level"},{"code":"82043","display":"Urine microalbumin (protein) level"},{"code":"82044","display":"Urine microalbumin (protein) analysis"},{"code":"82045","display":"Albumin (protein) level related to restricted heart blood flow"},{"code":"82055","display":"Alcohol (ethanol) level"},{"code":"82120","display":"Vaginal fluid chemical analysis for bacteria"},{"code":"82127","display":"Amino acid analysis"},{"code":"82128","display":"Amino acid analysis, multiple amino acids"},{"code":"82175","display":"Arsenic level"},{"code":"83015","display":"Heavy metal screening test"},{"code":"83018","display":"Heavy metal level"},{"code":"83805","display":"Meprobamate (sedative) level"},{"code":"83885","display":"Nickel level"},{"code":"83887","display":"Nicotine level"},{"code":"83925","display":"Opiates (drug) measurement"},{"code":"84022","display":"Phenothiazine (drug) level"},{"code":"85097","display":"Bone marrow, smear interpretation"},{"code":"86077","display":"Blood bank physician services for cross match and/or evaluation and written report"},{"code":"86078","display":"Blood bank physician services for investigation of transfusion reaction with written report"},{"code":"86079","display":"Blood bank physician services with written report"},{"code":"86812","display":"Immunologic analysis for autoimmune disease"},{"code":"86813","display":"Immunologic analysis for autoimmune disease"},{"code":"86816","display":"Immunologic analysis for autoimmune disease"},{"code":"86817","display":"Immunologic analysis for autoimmune disease"},{"code":"86821","display":"Immunologic analysis for autoimmune disease"},{"code":"86822","display":"Immunologic analysis for autoimmune disease"},{"code":"86825","display":"Immunologic analysis for organ transplant"},{"code":"86826","display":"Immunologic analysis for organ transplant"},{"code":"87015","display":"Concentration of specimen for infectious agents"},{"code":"87040","display":"Bacterial blood culture"},{"code":"87045","display":"Stool culture"},{"code":"87046","display":"Stool culture"},{"code":"87070","display":"Bacterial culture"},{"code":"87071","display":"Bacterial culture and colony count"},{"code":"87073","display":"Bacterial culture and colony count for anaerobic bacteria"},{"code":"87075","display":"Bacterial culture"},{"code":"87076","display":"Bacterial culture for anaerobic isolates"},{"code":"87077","display":"Bacterial culture for aerobic isolates"},{"code":"87081","display":"Screening test for pathogenic organisms"},{"code":"87084","display":"Screening test for pathogenic organisms with colony count"},{"code":"87086","display":"Bacterial colony count, urine"},{"code":"87088","display":"Bacterial urine culture"},{"code":"87101","display":"Fungal culture (mold or yeast) of skin, hair, or nail"},{"code":"87102","display":"Fungal culture (mold or yeast)"},{"code":"87103","display":"Fungal blood culture (mold or yeast)"},{"code":"87106","display":"Fungal culture, yeast"},{"code":"87107","display":"Culture for identification of yeast"},{"code":"87109","display":"Mycoplasma culture"},{"code":"87110","display":"Culture for chlamydia"},{"code":"87116","display":"Culture for acid-fast bacilli"},{"code":"87118","display":"Identification of mycobacteria (TB or TB like organism)"},{"code":"87140","display":"Identification of organisms by immunologic analysis"},{"code":"87143","display":"Identification of organism using chromatography"},{"code":"87147","display":"Identification of organisms by immunologic analysis"},{"code":"87149","display":"Identification of organisms by genetic analysis"},{"code":"87150","display":"Identification of organisms by genetic analysis"},{"code":"87152","display":"Identification of organism by pulse field gel typing"},{"code":"87153","display":"Identification of organisms by genetic analysis"},{"code":"87158","display":"Microbial identification"},{"code":"87164","display":"Dark field microscopic examination for organism"},{"code":"87166","display":"Dark field microscopic examination for organism"},{"code":"87168","display":"Macroscopic examination (visual inspection) of insect"},{"code":"87169","display":"Macroscopic examination (visual inspection) of parasite"},{"code":"87172","display":"Pinworm test"},{"code":"87176","display":"Tissue preparation for culture"},{"code":"87177","display":"Smear for parasites"},{"code":"87181","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87184","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87185","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87186","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87187","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87188","display":"Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral)"},{"code":"87190","display":"Antimicrobial study, mycobacteria (TB organism family)"},{"code":"87197","display":"Evaluation of antibiotic therapy"},{"code":"87205","display":"Special stain for microorganism"},{"code":"87206","display":"Special stain for microorganism"},{"code":"87207","display":"Special stain for microorganism"},{"code":"87210","display":"Smear for infectious agents"},{"code":"87220","display":"Tissue fungi or parasites"},{"code":"87230","display":"Microbial toxin or antitoxin assay"},{"code":"87250","display":"Inoculation of embryonated eggs, or small animal for virus isolation"},{"code":"87252","display":"Tissue culture inoculation for virus isolation"},{"code":"87253","display":"Tissue culture for virus isolation"},{"code":"87254","display":"Virus isolation"},{"code":"87255","display":"Virus isolation"},{"code":"87260","display":"Detection test for adenovirus (virus)"},{"code":"87265","display":"Detection test for bordetella pertussis or parapertussis (respiratory bacteria)"},{"code":"87267","display":"Detection test for enterovirus (intestinal virus)"},{"code":"87269","display":"Detection test for giardia (intestinal parasite)"},{"code":"87270","display":"Detection test for chlamydia"},{"code":"87271","display":"Detection test for cytomegalovirus (CMV)"},{"code":"87272","display":"Detection test for cryptosporidium (parasite)"},{"code":"87273","display":"Detection test for herpes simplex virus type 2"},{"code":"87274","display":"Detection test for herpes simplex virus type 1"},{"code":"87275","display":"Detection test for influenza B virus"},{"code":"87276","display":"Detection test for influenza A virus"},{"code":"87277","display":"Detection test for legionella micdadei (water borne bacteria)"},{"code":"87278","display":"Detection test for legionella pneumophila (water borne bacteria)"},{"code":"87279","display":"Detection test for parainfluenza virus"},{"code":"87280","display":"Detection test for respiratory syncytial virus (RSV)"},{"code":"87281","display":"Detection test for pneumocystis carinii (respiratory parasite)"},{"code":"87283","display":"Detection test for rubeola (measles virus)"},{"code":"87285","display":"Detection test for treponema pallidum (syphilis organism)"},{"code":"87290","display":"Detection test for varicella (chicken pox) zoster virus"},{"code":"87299","display":"Detection test for organism"},{"code":"87300","display":"Detection test for multiple organisms"},{"code":"87301","display":"Detection test for adenovirus enteric types 40/41"},{"code":"87305","display":"Detection test for aspergillus (fungus)"},{"code":"87320","display":"Detection test for chlamydia"},{"code":"87324","display":"Detection test for clostridium difficile toxins (stool pathogen)"},{"code":"87327","display":"Detection test for cryptococcus neoformans (yeast)"},{"code":"87328","display":"Detection test for cryptosporidium (parasite)"},{"code":"87329","display":"Detection test for giardia (intestinal parasite)"},{"code":"87332","display":"Detection test for cytomegalovirus"},{"code":"87335","display":"Detection test for E. coli, (escherichia coli 0157)"},{"code":"87336","display":"Detection test for entamoeba histolytica dispar group (parasite)"},{"code":"87337","display":"Detection test for entamoeba histolytica group (parasite)"},{"code":"87338","display":"Qualitative or semiquantitative detection test for helicobacter pylori in stool, multiple-step method"},{"code":"87339","display":"Detection test for helicobacter pylori (GI tract bacteria)"},{"code":"87340","display":"Detection test for Hepatitis B surface antigen"},{"code":"87341","display":"Detection test for Hepatitis B surface antigen"},{"code":"87350","display":"Detection test for Hepatitis Be surface antigen"},{"code":"87380","display":"Detection test for Hepatitis D"},{"code":"87385","display":"Detection test for histoplasma capsulatum (parasite)"},{"code":"87389","display":"Detection test for HIV-1 and HIV-2"},{"code":"87390","display":"Detection test for HIV-1"},{"code":"87391","display":"Detection test for HIV-2"},{"code":"87400","display":"Detection test for Influenza virus, A or B"},{"code":"87420","display":"Detection test for respiratory syncytial virus (RSV)"},{"code":"87425","display":"Detection test for Rotavirus"},{"code":"87430","display":"Detection test for Strep (Streptococcus, group A)"},{"code":"87449","display":"Immunologic analysis for detection of organism"},{"code":"87450","display":"Immunologic analysis for detection of organism"},{"code":"87451","display":"Immunologic analysis for detection of organism"},{"code":"87470","display":"Detection test for Bartonella henselae and Bartonella quintana (bacteria)"},{"code":"87471","display":"Detection Bartonella henselae and Bartonella quintana (bacteria)"},{"code":"87472","display":"Detection test for Bartonella henselae and Bartonella quintana (bacteria)"},{"code":"87475","display":"Detection test for borrelia burgdorferi, (bacteria)"},{"code":"87476","display":"Detection test for borrelia burgdorferi (bacteria)"},{"code":"87477","display":"Detection test for borrelia burgdorferi (bacteria)"},{"code":"87480","display":"Detection test for candida species (yeast)"},{"code":"87481","display":"Detection test for candida species (yeast)"},{"code":"87482","display":"Detection test for candida species (yeast)"},{"code":"87483","display":"Test for detecting nucleic acid of organism causing infection of central nervous system"},{"code":"87485","display":"Detection test for chlamydia pneumoniae"},{"code":"87486","display":"Detection test for Chlamydia pneumoniae"},{"code":"87487","display":"Detection test for chlamydia pneumoniae"},{"code":"87490","display":"Detection test for chlamydia"},{"code":"87491","display":"Detection test for chlamydia"},{"code":"87492","display":"Detection test for chlamydia"},{"code":"87495","display":"Detection test for cytomegalovirus (CMV)"},{"code":"87496","display":"Detection test for Cytomegalovirus (CMV)"},{"code":"87497","display":"Detection test for cytomegalovirus, quantification"},{"code":"87498","display":"Detection test for enterovirus (intestinal virus)"},{"code":"87500","display":"Detection test for Vancomycin resistance strep (VRE)"},{"code":"87501","display":"Detection test for influenza virus"},{"code":"87502","display":"Detection test for multiple types influenza virus"},{"code":"87503","display":"Detection test for multiple types of influenza virus"},{"code":"87505","display":"Detection test for digestive tract pathogen"},{"code":"87506","display":"Detection test for digestive tract pathogen"},{"code":"87507","display":"Detection test for digestive tract pathogen"},{"code":"87510","display":"Detection test for gardnerella vaginalis (bacteria)"},{"code":"87511","display":"Detection test for gardnerella vaginalis (bacteria)"},{"code":"87512","display":"Detection test for gardnerella vaginalis (bacteria)"},{"code":"87515","display":"Detection test for Hepatitis B virus"},{"code":"87516","display":"Detection test for Hepatitis B virus"},{"code":"87517","display":"Detection test for Hepatitis B virus"},{"code":"87520","display":"Detection test for Hepatitis C virus"},{"code":"87521","display":"Detection test for Hepatitis C virus"},{"code":"87522","display":"Detection test for Hepatitis C virus"},{"code":"87525","display":"Detection test for Hepatitis G virus"},{"code":"87526","display":"Detection test for Hepatitis G virus"},{"code":"87527","display":"Detection test for Hepatitis G virus"},{"code":"87528","display":"Detection test for herpes simplex virus"},{"code":"87529","display":"Detection test for herpes simplex virus"},{"code":"87530","display":"Detection test for herpes simplex virus"},{"code":"87531","display":"Detection test for herpes virus-6"},{"code":"87532","display":"Detection test for herpes virus-6"},{"code":"87533","display":"Detection test for herpes virus-6"},{"code":"87534","display":"Detection test for HIV-1 virus"},{"code":"87535","display":"Detection test for HIV-1 virus"},{"code":"87536","display":"Detection test for HIV-1 virus"},{"code":"87537","display":"Detection test for HIV-2 virus"},{"code":"87538","display":"Detection test for HIV-2 virus"},{"code":"87539","display":"Detection test for HIV-2 virus"},{"code":"87540","display":"Detection test for legionella pneumophila (water borne bacteria)"},{"code":"87541","display":"Detection test for legionella pneumophila (water borne bacteria)"},{"code":"87542","display":"Detection test for legionella pneumophila (water borne bacteria)"},{"code":"87550","display":"Detection test for Mycobacteria species (bacteria)"},{"code":"87551","display":"Detection test for Mycobacteria species (bacteria)"},{"code":"87552","display":"Detection test for Mycobacteria species (bacteria)"},{"code":"87555","display":"Detection test for Mycobacteria tuberculosis (TB bacteria)"},{"code":"87556","display":"Detection test for Mycobacteria tuberculosis (TB bacteria)"},{"code":"87557","display":"Detection test for Mycobacteria tuberculosis (TB bacteria)"},{"code":"87560","display":"Detection test for Mycobacteria avium-intracellulare (bacteria)"},{"code":"87561","display":"Detection test for Mycobacteria avium-intracellulare (bacteria)"},{"code":"87562","display":"Detection test for Mycobacteria avium-intracellulare (bacteria)"},{"code":"87563","display":"Detection of Mycoplasma genitalium by DNA or RNA probe"},{"code":"87580","display":"Detection test for Mycoplasma pneumoniae (bacteria)"},{"code":"87581","display":"Detection test for Mycoplasma pneumoniae (bacteria)"},{"code":"87582","display":"Detection test for Mycoplasma pneumoniae (bacteria)"},{"code":"87590","display":"Detection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)"},{"code":"87591","display":"Detection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)"},{"code":"87592","display":"Detection test for Neisseria gonorrhoeae (gonorrhoeae bacteria)"},{"code":"87620","display":"Detection test for human papillomavirus (HPV)"},{"code":"87621","display":"Detection test for human papillomavirus (HPV)"},{"code":"87622","display":"Detection test for human papillomavirus (HPV)"},{"code":"87623","display":"Detection test for human papillomavirus (hpv)"},{"code":"87624","display":"Detection test for human papillomavirus (hpv)"},{"code":"87625","display":"Detection test for human papillomavirus (hpv)"},{"code":"87631","display":"Detection test for multiple types of respiratory virus"},{"code":"87632","display":"Detection test for multiple types of respiratory virus"},{"code":"87633","display":"Detection test for multiple types of respiratory virus"},{"code":"87640","display":"Detection test for Staphylococcus aureus (bacteria)"},{"code":"87641","display":"Detection test for Staphylococcus aureus, methicillin resistant (MRSA bacteria)"},{"code":"87650","display":"Detection test for Strep (Streptococcus, group A)"},{"code":"87651","display":"Detection test for Strep (Streptococcus, group A)"},{"code":"87652","display":"Detection test for Strep (Streptococcus, group A)"},{"code":"87653","display":"Detection test for Strep (Streptococcus, group B)"},{"code":"87660","display":"Detection test for Trichomonas vaginalis (genital parasite)"},{"code":"87661","display":"Infectious agent detection by nucleic acid (dna or rna); trichomonas vaginalis, amplified probe technique"},{"code":"87797","display":"Detection test for organism"},{"code":"87798","display":"Detection test for organism"},{"code":"87799","display":"Detection test for organism"},{"code":"87800","display":"Detection test for multiple organisms"},{"code":"87801","display":"Detection test for multiple organisms"},{"code":"87802","display":"Detection test for Streptococcus, group B (bacteria)"},{"code":"87803","display":"Detection test for clostridium difficile toxin A (bacteria)"},{"code":"87804","display":"Detection test for influenza virus"},{"code":"87806","display":"Detection test for HIV-1"},{"code":"87807","display":"Detection test for respiratory syncytial virus (RSV)"},{"code":"87808","display":"Detection test for Trichomonas vaginal (genital parasite)"},{"code":"87809","display":"Detection test for adenovirus"},{"code":"87810","display":"Detection test for chlamydia"},{"code":"87850","display":"Detection test for Neisseria gonorrhoeae (gonorrhoeae)"},{"code":"87880","display":"Strep test (Streptococcus, group A)"},{"code":"87899","display":"Detection test for identification of organism"},{"code":"87900","display":"Infectious agent drug susceptibility analysis"},{"code":"87901","display":"Analysis test for HIV-1 virus"},{"code":"87902","display":"Analysis test for Hepatitis C virus"},{"code":"87903","display":"Analysis test for HIV-1 virus"},{"code":"87904","display":"Analysis test for HIV-1 virus"},{"code":"87905","display":"Infectious agent enzymatic activity to detect organism"},{"code":"87906","display":"Analysis test for HIV-1 virus"},{"code":"87910","display":"Analysis test for cytomegalovirus"},{"code":"87912","display":"Analysis test for hepatitis b virus"},{"code":"87999","display":"Microbiology procedures"},{"code":"88000","display":"Autopsy"},{"code":"88005","display":"Autopsy with of brain"},{"code":"88007","display":"Autopsy with examination of brain and spinal cord"},{"code":"88012","display":"Autopsy of infant with examination of brain"},{"code":"88014","display":"Autopsy of stillborn or newborn infant with examination of brain"},{"code":"88016","display":"Autopsy of stillborn infant"},{"code":"88020","display":"Autopsy with microscopic examination of tissue"},{"code":"88025","display":"Autopsy with examination of brain and microscopic examination of tissue"},{"code":"88027","display":"Autopsy with examination of brain and spinal cord and microscopic examination of tissue"},{"code":"88028","display":"Autopsy of infant including brain and microscopic examination of tissue"},{"code":"88029","display":"Autopsy of stillborn or newborn infant with examination of brain and microscopic examination of tissue"},{"code":"88036","display":"Limited, gross and/or microscopic autopsy"},{"code":"88037","display":"Limited, gross and/or microscopic autopsy, single organ"},{"code":"88040","display":"Autopsy for forensic (investigative) examination"},{"code":"88045","display":"Coroner\u0027s services"},{"code":"88099","display":"Autopsy services"},{"code":"88104","display":"Cell examination of body fluid"},{"code":"88106","display":"Cell examination of body fluid"},{"code":"88108","display":"Cell examination of specimen"},{"code":"88112","display":"Cell examination of specimen"},{"code":"88120","display":"Cell examination of urine"},{"code":"88121","display":"Cell examination of urine"},{"code":"88125","display":"Forensic (investigation) examination of specimen"},{"code":"88130","display":"Sex identification"},{"code":"88140","display":"Sex identification"},{"code":"88141","display":"Pap test (Pap smear)"},{"code":"88142","display":"Pap test (Pap smear)"},{"code":"88143","display":"Pap test (Pap smear)"},{"code":"88147","display":"Pap test (Pap smear)"},{"code":"88148","display":"Pap test (Pap smear)"},{"code":"88150","display":"Pap test (Pap smear)"},{"code":"88152","display":"Pap test (Pap smear)"},{"code":"88153","display":"Pap test (Pap smear)"},{"code":"88154","display":"Pap test (Pap smear)"},{"code":"88155","display":"Examination of cervical or vaginal slide for hormonal evaluation"},{"code":"88160","display":"Screening examination of specimen cells"},{"code":"88161","display":"Screening examination of specimen cells"},{"code":"88162","display":"Screening examination of specimen cells"},{"code":"88164","display":"Pap test (Pap smear)"},{"code":"88165","display":"Pap test (Pap smear)"},{"code":"88166","display":"Pap test (Pap smear)"},{"code":"88167","display":"Pap test (Pap smear)"},{"code":"88172","display":"Evaluation of fine needle aspirate"},{"code":"88173","display":"Evaluation of fine needle aspirate with interpretation and report"},{"code":"88174","display":"Pap test"},{"code":"88175","display":"Pap test"},{"code":"88177","display":"Pap test"},{"code":"88182","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88184","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88185","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88187","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88188","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88189","display":"Flow cytometry technique for DNA or cell analysis"},{"code":"88199","display":"Cytopathology procedures"},{"code":"88230","display":"Tissue culture to identify white blood cell disorders"},{"code":"88233","display":"Tissue culture to identify skin disorders"},{"code":"88235","display":"Tissue culture for disorders of amniotic fluid or placenta cells"},{"code":"88237","display":"Tissue culture for tumor disorders of bone marrow and blood cells"},{"code":"88239","display":"Tissue culture for tumor disorders"},{"code":"88245","display":"Chromosome analysis for genetic defects"},{"code":"88248","display":"Chromosome analysis for genetic defects"},{"code":"88249","display":"Chromosome analysis for genetic defects"},{"code":"88261","display":"Chromosome analysis for genetic defects"},{"code":"88262","display":"Chromosome analysis for genetic defects"},{"code":"88263","display":"Chromosome analysis for genetic defects"},{"code":"88264","display":"Chromosome analysis for genetic defects"},{"code":"88267","display":"Chromosome analysis of amniotic fluid or placenta for genetic defects"},{"code":"88269","display":"Chromosome analysis of amniotic fluid for genetic defects"},{"code":"88280","display":"Chromosome analysis for genetic defects"},{"code":"88283","display":"Chromosome analysis for genetic defects"},{"code":"88285","display":"Chromosome analysis for genetic defects"},{"code":"88289","display":"Chromosome analysis for genetic defects"},{"code":"88291","display":"Interpretation and report of genetic testing"},{"code":"88299","display":"Genetic studies"},{"code":"88300","display":"Pathology examination of tissue using a microscope, limited examination"},{"code":"88302","display":"Pathology examination of tissue using a microscope"},{"code":"88304","display":"Pathology examination of tissue using a microscope, moderately low complexity"},{"code":"88305","display":"Pathology examination of tissue using a microscope, intermediate complexity"},{"code":"88307","display":"Pathology examination of tissue using a microscope, moderately high complexity"},{"code":"88309","display":"Pathology examination of tissue using a microscope, high complexity"},{"code":"88311","display":"Preparation of tissue for examination by removing any calcium present"},{"code":"88312","display":"Special stained specimen slides to identify organisms including interpretation and report"},{"code":"88313","display":"Special stained specimen slides to examine tissue including interpretation and report"},{"code":"88314","display":"Special stained specimen slides to examine tissue and frozen preparation of specimen including interpretation and report"},{"code":"88321","display":"Surgical pathology consultation and report"},{"code":"88323","display":"Surgical pathology consultation and report"},{"code":"88325","display":"Comprehensive surgical pathology consultation and report"},{"code":"88329","display":"Pathology examination of specimen during surgery"},{"code":"88331","display":"Pathology examination of tissue during surgery"},{"code":"88332","display":"Pathology examination of specimen during surgery"},{"code":"88333","display":"Pathology examination of tissue specimen during surgery"},{"code":"88334","display":"Pathology examination of specimen during surgery"},{"code":"88341","display":"Special stained specimen slides to examine tissue"},{"code":"88342","display":"Tissue or cell analysis by immunologic technique"},{"code":"88343","display":"Immunohistochemistry or immunocytochemistry, each separately identifiable antibody per block, cytologic preparation, or hematologic smear; each additional separately identifiable antibody per slide (list separately in addition to code for primary procedure)"},{"code":"88344","display":"Special stained specimen slides to examine tissue"},{"code":"88346","display":"Antibody evaluation"},{"code":"88347","display":"Antibody evaluation"},{"code":"88348","display":"Electron microscopy for diagnosis"},{"code":"88349","display":"Assessment using electron microscopy"},{"code":"88350","display":"Antibody evaluation"},{"code":"88355","display":"Microscopic genetic analysis of muscle"},{"code":"88356","display":"Microscopic genetic analysis of nerve tissue"},{"code":"88358","display":"Microscopic genetic analysis of tumor"},{"code":"88360","display":"Microscopic genetic analysis of tumor"},{"code":"88361","display":"Microscopic genetic analysis of tumor"},{"code":"88362","display":"Nerve teasing preparation"},{"code":"88363","display":"Microscopic genetic analysis of tissue"},{"code":"88364","display":"Cell examination"},{"code":"88365","display":"Analysis of genetic material"},{"code":"88366","display":"Cell examination"},{"code":"88367","display":"Microscopic genetic analysis of tissue"},{"code":"88368","display":"Microscopic genetic analysis of tissue"},{"code":"88369","display":"Microscopic genetic examination manual"},{"code":"88371","display":"Protein analysis of tissue with interpretation and report"},{"code":"88372","display":"Protein analysis of tissue by western blot, with interpretation and report"},{"code":"88373","display":"Microscopic genetic examination using computer-assisted technology"},{"code":"88374","display":"Microscopic genetic examination using computer-assisted technology"},{"code":"88375","display":"Microscopic imaging using an endoscope, interpretation and report, real-time or referred, each session"},{"code":"88377","display":"Microscopic genetic examination manual"},{"code":"88380","display":"Preparation of specimen using laser"},{"code":"88381","display":"Preparation of specimen, manual"},{"code":"88387","display":"Pathologist examination, dissection, and preparation of tissue"},{"code":"88388","display":"Pathologist examination, dissection, and preparation of tissue during surgery"},{"code":"88399","display":"Surgical pathology procedure"},{"code":"89060","display":"Crystal identification from tissue or body fluid"},{"code":"89125","display":"Fat stain of stool, urine, or respiratory secretions"},{"code":"89160","display":"Examination of stool for meat fibers"},{"code":"89190","display":"Nasal smear for eosinophils (allergy related white blood cells)"},{"code":"89240","display":"Pathology tests"},{"code":"89250","display":"Culture of eggs or embryos, less than 4 days"},{"code":"89251","display":"Culture of eggs or embryos, less than 4 days, with co-culture of eggs or embryos"},{"code":"89253","display":"Assisted embryo hatching (fertility procedure)"},{"code":"89254","display":"Egg identification from ovarian fluid"},{"code":"89255","display":"Preparation of embryo for transfer"},{"code":"89257","display":"Sperm identification from aspiration"},{"code":"89260","display":"Sperm isolation with semen analysis for fertilization or diagnosis"},{"code":"89261","display":"Sperm isolation and semen analysis for fertilization or diagnosis"},{"code":"89264","display":"Sperm identification from testis tissue"},{"code":"89268","display":"Fertilizing of eggs"},{"code":"89272","display":"Extended culture of eggs or embryos, 4-7 days"},{"code":"89280","display":"Assisted oocyte fertilization (fertility procedure)"},{"code":"89281","display":"Assisted oocyte fertilization (fertility procedure)"},{"code":"89290","display":"Biopsy of egg or embryo for pre-implantation genetic diagnosis, less than or equal to 5 embryos"},{"code":"89291","display":"Biopsy of egg or embryo for pre-implantation genetic diagnosis, greater than 5 embryos"},{"code":"89300","display":"Semen analysis presence and/or motility of sperm"},{"code":"89310","display":"Semen analysis motility and count"},{"code":"89320","display":"Semen evaluation volume, sperm count, motility and analysis"},{"code":"89321","display":"Semen analysis for sperm presence"},{"code":"89322","display":"Semen evaluation, volume, sperm count, motility, and analysis"},{"code":"89325","display":"Sperm antibody measurement"},{"code":"89329","display":"Sperm evaluation"},{"code":"89330","display":"Sperm evaluation"},{"code":"89331","display":"Sperm evaluation, for reverse ejaculation, urine specimen"},{"code":"90281","display":"Human immune globulin for injection into muscle"},{"code":"90283","display":"Human immune globulin for infusion into vein"},{"code":"90284","display":"Human immune globulin for infusions beneath skin"},{"code":"90287","display":"Botulinum equine antitoxin"},{"code":"90288","display":"Botulinum human antitoxin for infusion into vein"},{"code":"90291","display":"Cytomegalovirus immune globulin for infusion into vein"},{"code":"90296","display":"Diphtheria equine antitoxin"},{"code":"90371","display":"Hepatitis B immune globulin for injection into muscle"},{"code":"90375","display":"Rabies immune globulin for injection beneath the skin and/or into muscle"},{"code":"90376","display":"Rabies immune globulin for injection beneath the skin and/or into muscle"},{"code":"90378","display":"Respiratory syncytial virus antibody for injection into tissue or muscle"},{"code":"90384","display":"Rho(D) immune globulin (full dose) for injection into muscle"},{"code":"90385","display":"Rho(D) immune globulin (mini dose) for injection into muscle"},{"code":"90386","display":"Rho (D) immune globulin for infusion into vein"},{"code":"90389","display":"Tetanus immune globulin for injection into muscle"},{"code":"90393","display":"Vaccinia immune globulin for injection into muscle"},{"code":"90396","display":"Varicella (chicken pox) zoster immune globulin for injection into muscle"},{"code":"90399","display":"Immune globulin injection or infusion"},{"code":"90460","display":"Administration of first vaccine or toxoid component through 18 years of age with counseling"},{"code":"90461","display":"Administration of vaccine or toxoid component through 18 years of age with counseling"},{"code":"90471","display":"Administration of 1 vaccine"},{"code":"90472","display":"Administration of vaccine"},{"code":"90473","display":"Administration of 1 nasal or oral vaccine"},{"code":"90474","display":"Administration of nasal or oral vaccine"},{"code":"90476","display":"Vaccine for adenovirus oral administration"},{"code":"90477","display":"Vaccine for adenovirus oral administration"},{"code":"90581","display":"Vaccine for anthrax injection beneath the skin or into muscle"},{"code":"90585","display":"Vaccine for tuberculosis injection into skin"},{"code":"90586","display":"Vaccine for bladder cancer injection into urinary bladder"},{"code":"90587","display":"Vaccine for dengue for injection under skin"},{"code":"90619","display":"Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT) for injection into muscle"},{"code":"90620","display":"Vaccine for meningococcus for injection into muscle"},{"code":"90621","display":"Vaccine for meningococcus for injection into muscle"},{"code":"90625","display":"Vaccine for cholera for oral administration"},{"code":"90630","display":"Vaccine for influenza for injection into skin"},{"code":"90632","display":"Vaccine for Hepatitis A injection into muscle, adult dosage"},{"code":"90633","display":"Vaccine for Hepatitis A (2 dose schedule) injection into muscle, pediatric or adolescent dosage"},{"code":"90634","display":"Vaccine for Hepatitis A (3 dose schedule) injection into muscle, pediatric or adolescent dosage"},{"code":"90636","display":"Vaccine for Hepatitis A and Hepatitis B injection into muscle, adult dosage"},{"code":"90644","display":"Vaccine for meningococcal and Haemophilus influenza B (4 dose schedule) injection into muscle, children 6 weeks-18 months of age"},{"code":"90645","display":"Vaccine for Hemophilus influenza B (4 dose schedule) injection into muscle"},{"code":"90646","display":"Vaccine for Hemophilus influenza B (booster) injection into muscle"},{"code":"90647","display":"Vaccine for Hemophilus influenza B (3 dose schedule) injection into muscle"},{"code":"90648","display":"Vaccine for Hemophilus influenza B (4 dose schedule) injection into muscle"},{"code":"90649","display":"Vaccine for human papilloma virus (3 dose schedule) injection into muscle"},{"code":"90650","display":"Vaccine for human papilloma virus (3 dose schedule) injection into muscle"},{"code":"90651","display":"Vaccine for human papilloma virus (3 dose schedule) injection into muscle"},{"code":"90653","display":"Vaccine for influenza for injection into muscle"},{"code":"90654","display":"Vaccine for influenza injection into skin"},{"code":"90655","display":"Vaccine for influenza for administration into muscle, 0.25 ml dosage"},{"code":"90656","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90657","display":"Vaccine for influenza for administration into muscle, 0.25 ml dosage"},{"code":"90658","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90660","display":"Vaccine for influenza for nasal administration"},{"code":"90661","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90662","display":"Vaccine for influenza for injection into muscle"},{"code":"90664","display":"Vaccine for influenza for nasal administration, pandemic formulation"},{"code":"90666","display":"Vaccine for influenza for injection into muscle, pandemic formulation"},{"code":"90667","display":"Vaccine for influenza for injection into muscle, pandemic formulation"},{"code":"90668","display":"Vaccine for influenza for injection into muscle, pandemic formulation"},{"code":"90669","display":"Pneumococcal vaccine for injection into muscle"},{"code":"90670","display":"Pneumococcal vaccine for injection into muscle"},{"code":"90672","display":"Vaccine for influenza for nasal administration"},{"code":"90673","display":"Vaccine for influenza administered into muscle, preservative and antibiotic free"},{"code":"90674","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90675","display":"Vaccine for rabies injection into muscle"},{"code":"90676","display":"Vaccine for rabies injection into skin"},{"code":"90680","display":"Vaccine for Rotavirus (3 dose schedule) for oral administration"},{"code":"90681","display":"Vaccine for Rotavirus (2 dose schedule) for oral administration"},{"code":"90682","display":"Vaccine for influenza for injection into muscle"},{"code":"90685","display":"Vaccine for influenza for administration into muscle, 0.25 ml dosage"},{"code":"90686","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90687","display":"Vaccine for influenza for administration into muscle, 0.25 ml dosage"},{"code":"90688","display":"Vaccine for influenza for administration into muscle, 0.5 ml dosage"},{"code":"90689","display":"Inactivated quadrivalent influenza vaccine for injection into muscle, 0.25 ml dosage"},{"code":"90690","display":"Oral typhoid vaccine"},{"code":"90691","display":"Vaccine for typhoid for injection into muscle"},{"code":"90692","display":"Vaccine for typhoid injection beneath or within skin"},{"code":"90693","display":"Vaccine for typhoid injection beneath skin"},{"code":"90694","display":"Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage"},{"code":"90696","display":"Vaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), and polio for injection into muscle, patient 4 through 6 years of age"},{"code":"90697","display":"Vaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), haemophilus influenza type B, hepatitis B and polio for injection into muscle"},{"code":"90698","display":"Vaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), haemophilus influenza type B, and polio for injection into muscle"},{"code":"90700","display":"Vaccine for diphtheria, tetanus, and acellular pertussis (whooping cough) injection into muscle, child younger than 7 years"},{"code":"90702","display":"Vaccine for diphtheria and tetanus toxoids injection into muscle, patient younger than 7 years of age"},{"code":"90703","display":"Tetanus toxoid injection into muscle"},{"code":"90704","display":"Mumps vaccine injection beneath skin"},{"code":"90705","display":"Vaccine for measles injection beneath skin"},{"code":"90706","display":"Vaccine for rubella (German measles) injection, beneath the skin"},{"code":"90707","display":"Vaccine for measles, mumps, and rubella (German measles) injection beneath skin"},{"code":"90708","display":"Measles and rubella (German measles) vaccine injection beneath skin"},{"code":"90710","display":"Vaccine for measles, mumps, rubella (German measles), and varicella (chicken pox) injection beneath skin"},{"code":"90712","display":"Vaccine for polio vaccine for oral administration"},{"code":"90713","display":"Vaccine for polio injection beneath the skin or into muscle"},{"code":"90714","display":"Vaccine for tetanus and diphtheria toxoids injection into muscle, patient 7 years or older"},{"code":"90715","display":"Vaccine for tetanus, diphtheria toxoids and acellular pertussis (whooping cough) for injection into muscle, patient 7 years or older"},{"code":"90716","display":"Vaccine for varicella (chicken pox) injection beneath skin"},{"code":"90717","display":"Vaccine for yellow fever injection beneath skin"},{"code":"90719","display":"Vaccine for diphtheria toxoid injection into muscle"},{"code":"90720","display":"Vaccine for diphtheria, tetanus toxoids, whole cell pertussis (whooping cough), and Hemophilus influenza B injection into muscle"},{"code":"90721","display":"Vaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), and Hemophilus influenza B injection into muscle"},{"code":"90723","display":"Vaccine for diphtheria, tetanus toxoids, acellular pertussis (whooping cough), Hepatitis B, and polio for injection into muscle"},{"code":"90725","display":"Vaccine for cholera injection"},{"code":"90727","display":"Vaccine for plague injection into muscle"},{"code":"90732","display":"Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older"},{"code":"90733","display":"Vaccine for meningococcus for injection beneath skin"},{"code":"90734","display":"Vaccine for meningococcus for administration into muscle"},{"code":"90735","display":"Vaccine for Japanese encephalitis virus injection beneath skin"},{"code":"90736","display":"Vaccine for shingles injection beneath skin"},{"code":"90738","display":"Vaccine for Japanese encephalitis virus injection into muscle"},{"code":"90739","display":"Vaccine for Hepatitis B adult dosage (2 dose schedule) injection into muscle"},{"code":"90740","display":"Vaccine for Hepatitis B (3 dose schedule) for injection into muscle, dialysis or immunosuppressed patient"},{"code":"90743","display":"Vaccine for Hepatitis B (2 dose schedule) for injection into muscle, adolescent patient"},{"code":"90744","display":"Vaccine for Hepatitis B (3 dose schedule) for injection into muscle, pediatric and adolescent patients"},{"code":"90746","display":"Vaccine for Hepatitis B adult dosage (3 dose schedule) injection into muscle"},{"code":"90747","display":"Vaccine for Hepatitis B (4 dose schedule) for injection into muscle, dialysis or immunosuppressed patient"},{"code":"90748","display":"Vaccine for Hepatitis B and Hemophilus influenza B for injection into muscle"},{"code":"90749","display":"Vaccine or toxoid injection or infusion procedure"},{"code":"90750","display":"Vaccine for shingles for injection into muscle"},{"code":"90756","display":"Vaccine for influenza for injection into muscle"},{"code":"90785","display":"Interactive complexity"},{"code":"90791","display":"Psychiatric diagnostic evaluation"},{"code":"90792","display":"Psychiatric diagnostic evaluation with medical services"},{"code":"90832","display":"Psychotherapy, 30 minutes"},{"code":"90833","display":"Psychotherapy, 30 minutes"},{"code":"90834","display":"Psychotherapy, 45 minutes"},{"code":"90836","display":"Psychotherapy, 45 minutes"},{"code":"90837","display":"Psychotherapy, 60 minutes"},{"code":"90838","display":"Psychotherapy, 60 minutes"},{"code":"90839","display":"Psychotherapy for crisis, first 60 minutes"},{"code":"90840","display":"Psychotherapy for crisis"},{"code":"90845","display":"Psychoanalysis"},{"code":"90846","display":"Family psychotherapy, 50 minutes"},{"code":"90847","display":"Family psychotherapy including patient, 50 minutes"},{"code":"90849","display":"Multiple-family group psychotherapy"},{"code":"90853","display":"Group psychotherapy"},{"code":"90863","display":"Management of prescriptions and review of medication"},{"code":"90865","display":"Injection of hypnotic drug for psychiatric diagnosis or therapy"},{"code":"90867","display":"Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression)"},{"code":"90868","display":"Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session"},{"code":"90869","display":"Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression)"},{"code":"90870","display":"Shock treatment and monitoring"},{"code":"90875","display":"Individual psychophysiological therapy incorporating biofeedback training with psychotherapy, 30 minutes"},{"code":"90876","display":"Individual psychophysiological therapy incorporating biofeedback training with psychotherapy, 45 minutes"},{"code":"90880","display":"Hypnotherapy"},{"code":"90882","display":"Environmental intervention for management of medical conditions"},{"code":"90885","display":"Psychiatric evaluation of hospital records, reports, testing, or data for diagnosis"},{"code":"90887","display":"Explanation of psychiatric, medical examinations, procedures, and data to other than patient"},{"code":"90889","display":"Preparation of report of patient\u0027s psychiatric status"},{"code":"90899","display":"Psychiatric service or procedure"},{"code":"90901","display":"Biofeedback training"},{"code":"90911","display":"Biofeedback training, perineal muscles, anorectal or urethral sphincter"},{"code":"90912","display":"Biofeedback training for bowel or bladder control, initial 15 minutes"},{"code":"90913","display":"Biofeedback training for bowel or bladder control, additional 15 minutes"},{"code":"90951","display":"Dialysis services (4 or more physician visits per month), patient younger than 2 years of age"},{"code":"90952","display":"Dialysis services (2-3 physician visits per month), patient younger than 2 years of age"},{"code":"90953","display":"Dialysis services (1 physician visit per month), patient younger than 2 years of age"},{"code":"90954","display":"Dialysis services (4 or more physician visits per month), patient 2-11 years of age"},{"code":"90955","display":"Dialysis services (2-3 physician visits per month), patient 2-11 years of age"},{"code":"90956","display":"Dialysis services (1 physician visit per month), patient 2-11 years of age"},{"code":"90957","display":"Dialysis services (4 or more physician visits per month), patient 12-19 years of age"},{"code":"90958","display":"Dialysis services (2-3 physician visits per month), patient 12-19 years of age"},{"code":"90959","display":"Dialysis services (1 physician visit per month), patient 12-19 years of age"},{"code":"90960","display":"Dialysis services (4 or more physician visits per month), patient 20 years of age and older"},{"code":"90961","display":"Dialysis services (2-3 physician visits per month), patient 20 years of age and older"},{"code":"90962","display":"Dialysis services (1 physician visit per month), patient 20 years of age and older"},{"code":"90963","display":"Home dialysis services per month, patient younger than 2 years of age"},{"code":"90964","display":"Home dialysis services per month, patient 2-11 years of age"},{"code":"90965","display":"Home dialysis services per month, patient 12-19 years of age"},{"code":"90966","display":"Home dialysis services per month, patient 20 years of age or older"},{"code":"90967","display":"Dialysis services, per day (less than full month service), patient younger than 2 years of age"},{"code":"90968","display":"Dialysis services, per day (less than full month service), patient 2-11 years of age"},{"code":"90969","display":"Dialysis services, per day (less than full month service), patient 12-19 years of age"},{"code":"90970","display":"Dialysis services, per day (less than full month service), patient 20 years of age or older"},{"code":"92507","display":"Treatment of speech, language, voice, communication, and/or hearing processing disorder"},{"code":"92508","display":"Group treatment of speech, language, voice, communication, and/or hearing processing disorder"},{"code":"92521","display":"Evaluation of speech fluency"},{"code":"92522","display":"Evaluation of speech sound production"},{"code":"92523","display":"Evaluation of speech sound production with evaluation of language comprehension and expression"},{"code":"92524","display":"Behavioral and qualitative analysis of voice and resonance"},{"code":"92548","display":"Computerized dynamic assessment of balance and postural instability"},{"code":"92597","display":"Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech"},{"code":"93000","display":"Routine EKG using at least 12 leads including interpretation and report"},{"code":"93005","display":"Routine electrocardiogram (EKG) with tracing using at least 12 leads"},{"code":"93010","display":"Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report"},{"code":"93015","display":"Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician supervision, interpretation, and report"},{"code":"93016","display":"Exercise or drug-induced heart and blood vessel stress test with EKG monitoring and physician supervision"},{"code":"93017","display":"Exercise or drug-induced heart and blood vessel stress test with EKG tracing and monitoring"},{"code":"93018","display":"Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician interpretation and report"},{"code":"93025","display":"Measurement of height of heart beats on EKG"},{"code":"93040","display":"Tracing of electrical activity of heart using 1-3 leads with interpretation and report"},{"code":"93041","display":"Tracing of electrical activity of the heart using 1-3 leads"},{"code":"93042","display":"Interpretation and report of electrical activity of heart using 1-3 leads"},{"code":"93224","display":"Heart rhythm tracing, analysis, and interpretation of 48-hour EKG"},{"code":"93225","display":"Heart rhythm tracing of 48-hour EKG"},{"code":"93226","display":"Heart rhythm analysis, interpretation and report of 48-hour EKG"},{"code":"93227","display":"Heart rhythm tracing, analysis, and interpretation of 48-hour EKG"},{"code":"93228","display":"Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour EKG up to 30 days"},{"code":"93229","display":"Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour EKG up to 30 days"},{"code":"93268","display":"Heart rhythm symptom-related tracing and interpretation of 24-hour EKG monitoring up to 30 days"},{"code":"93270","display":"Heart rhythm symptom-related tracing of 24-hour EKG monitoring up to 30 days"},{"code":"93271","display":"Heart rhythm symptom-related transmission and analysis of 24-hour EKG monitoring up to 30 days"},{"code":"93272","display":"Heart rhythm symptom-related interpretation of 24-hour EKG monitoring up to 30 days"},{"code":"93278","display":"Recording to evaluate height and duration of heart beats through damaged heart tissue"},{"code":"93279","display":"Evaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report"},{"code":"93280","display":"Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report"},{"code":"93281","display":"Evaluation, testing, and programming adjustment of permanent multiple lead pacemaker system with physician analysis, review, and report"},{"code":"93282","display":"Evaluation, testing and programming adjustment of defibrillator with analysis, review and report"},{"code":"93283","display":"Evaluation, testing and programming adjustment of defibrillator with analysis, review and report"},{"code":"93284","display":"Evaluation, testing and programming adjustment of defibrillator with analysis, review and report"},{"code":"93285","display":"Evaluation, testing, and programming adjustment of heart rhythm monitor system system implanted under skin with qualified health care professional analysis, review, and report"},{"code":"93286","display":"Evaluation, testing, and programming adjustment of single, dual, or multiple lead pacemaker system before or after surgery, procedure, or test with qualified health care professional analysis, review, and report"},{"code":"93287","display":"Evaluation and programming adjustment of defibrillator with analysis, review and report"},{"code":"93288","display":"Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report"},{"code":"93289","display":"Evaluation of defibrillator including connection, recording and disconnection"},{"code":"93290","display":"Evaluation of parameters of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report"},{"code":"93291","display":"Evaluation of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report"},{"code":"93292","display":"Evaluation of wearable defibrillator system including connection, disconnection, recording, physician analysis, review, and report"},{"code":"93293","display":"Telephonic evaluation of single, dual, or multiple lead pacemaker heart rhythm strips up to 90 days"},{"code":"93294","display":"Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days"},{"code":"93295","display":"Remote evaluations of defibrillator up to 90 days with analysis, review and report"},{"code":"93296","display":"Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days"},{"code":"93297","display":"Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days"},{"code":"93298","display":"Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days"},{"code":"93299","display":"Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days"},{"code":"93660","display":"Evaluation of heart function using tilt table"},{"code":"93668","display":"Peripheral arterial disease (PAD) rehabilitation per session"},{"code":"93724","display":"Electronic analysis of pacemaker to correct rapid heart rate"},{"code":"93745","display":"Setup and programming of wearable cardioverter-defibrillator"},{"code":"93792","display":"Training for home international normalized ratio (INR) monitoring of blood thinner therapy"},{"code":"93793","display":"Anti-clotting management for patient taking warfarin"},{"code":"93797","display":"Physician services for outpatient heart cardiac rehabilitation per session"},{"code":"93798","display":"Physician services for outpatient heart rehabilitation with continuous EKG monitoring per session"},{"code":"94772","display":"Measurement and recording of breathing pattern over 12-24 hours, infant"},{"code":"94780","display":"Car seat or bed airway testing of infant 1 year or less, 60 minutes"},{"code":"94781","display":"Car seat or bed airway testing of infant 1 year or less, additional 30 minutes"},{"code":"95115","display":"Injection of incremental dosages of allergen"},{"code":"95117","display":"Injection of incremental dosages of allergen, 2 or more injections"},{"code":"95120","display":"Preparation, provision, and injection of allergen extract"},{"code":"95125","display":"Preparation, provision and injection of allergen extract, 2 or more injections"},{"code":"95130","display":"Preparation, provision, and injection of one stinging insect venom"},{"code":"95131","display":"Preparation, provision, and injection of two stinging insect venom"},{"code":"95132","display":"Preparation, provision, and injection of three stinging insect venom"},{"code":"95133","display":"Preparation, provision, and injection of four stinging insect venom"},{"code":"95134","display":"Preparation, provision, and injection of five stinging insect venom"},{"code":"95144","display":"Preparation and provision of single-dose vials of allergen antigens for allergy immunotherapy"},{"code":"95145","display":"Preparation and provision of single stinging insect venom for allergen immunotherapy"},{"code":"95146","display":"Preparation and provision of 2 single stinging insect venom for allergen immunotherapy"},{"code":"95147","display":"Preparation and provision of 3 single stinging insect venom for allergen immunotherapy"},{"code":"95148","display":"Preparation and provision of 4 single stinging insect venom for allergen immunotherapy"},{"code":"95149","display":"Preparation and provision of 5 single stinging insect venom for allergen immunotherapy"},{"code":"95165","display":"Preparation and provision of single or multiple antigens for allergen immunotherapy"},{"code":"95782","display":"Sleep monitoring of patient (younger than 6 years) in sleep lab"},{"code":"95783","display":"Sleep monitoring of patient (younger than 6 years) in sleep lab with continued pressured respiratory assistance by mask or breathing tube"},{"code":"95800","display":"Study of sleep patterns"},{"code":"95801","display":"Study of sleep patterns"},{"code":"95803","display":"Study of sleep and wake patterns including interpretation and report, minimum of 72 hours to 14 consecutive days of recording"},{"code":"95805","display":"Diagnostic test for sleep disorder"},{"code":"95806","display":"Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort"},{"code":"95807","display":"Sleep study attended by a technician"},{"code":"95808","display":"Sleep monitoring of patient in sleep lab"},{"code":"95810","display":"Sleep monitoring of patient (6 years or older) in sleep lab"},{"code":"95811","display":"Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube"},{"code":"95812","display":"Measurement of brain wave (EEG) activity, 41-60 minutes"},{"code":"95813","display":"Measurement of brain wave activity (EEG) extended monitoring, 61-119 minutes"},{"code":"95816","display":"Measurement and recording of brain wave (EEG) activity, awake and drowsy"},{"code":"95819","display":"Measurement and recording of brain wave (EEG) activity, awake and asleep"},{"code":"95822","display":"Measurement and recording of brain wave (EEG) activity, in coma or asleep"},{"code":"95824","display":"Measurement and recording of brain wave (EEG) activity, cerebral death evaluation"},{"code":"95827","display":"Measurement and recording of brain wave (EEG) activity, overnight"},{"code":"95829","display":"Measurement of brain activity (EEG) during surgery"},{"code":"95830","display":"Insertion of electrodes in bone for measurement and recording of brain wave activity (EEG)"},{"code":"95831","display":"Manual muscle testing of arm, leg or trunk"},{"code":"95832","display":"Manual muscle testing of hand"},{"code":"95833","display":"Manual muscle testing of whole body"},{"code":"95834","display":"Manual muscle testing of whole body including hands"},{"code":"95851","display":"Range of motion testing of arm, leg or each spine section"},{"code":"95852","display":"Range of motion testing of hand"},{"code":"95950","display":"Monitoring and localization of seizure activity over 24-hour period using electroencephalograph (EEG)"},{"code":"95951","display":"Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG)"},{"code":"95953","display":"Monitoring and localization of seizure activity over 24-hour period using portable 16-channel electroencephalograph (EEG)"},{"code":"95954","display":"Measurement and recording of electrical activity (EEG) of the brain including stimulation by medication or physical activity"},{"code":"95955","display":"Measurement of electrical activity (EEG) outside the brain during surgery"},{"code":"95956","display":"Monitoring and localization of seizure activity over 24-hour period using electroencephalograph (EEG)"},{"code":"95957","display":"Digital analysis of electrical brain wave activity (EEG)"},{"code":"95958","display":"Measurement and recording of electrical brain wave activity (EEG) in a specific area of the brain"},{"code":"95961","display":"Mapping of electrical brain wave activity (EEG) using electrodes on brain surface to provoke seizure activity or assess brain function, first hour"},{"code":"95962","display":"Mapping of electrical brain wave activity (EEG) to provoke seizure activity or assess brain function"},{"code":"96004","display":"Physician review interpretation and report of motion analysis during walking or functional activity"},{"code":"96040","display":"Medical genetic patient or family counseling services each 30 minutes"},{"code":"96101","display":"Psychological testing with interpretation and report by psychologist or physician per hour"},{"code":"96102","display":"Psychological testing with interpretation and report by technician per hour"},{"code":"96103","display":"Psychological testing with interpretation and report by computer"},{"code":"96116","display":"Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes"},{"code":"96118","display":"Neuropsychological testing, interpretation, and report by psychologist or physician per hour"},{"code":"96119","display":"Neuropsychological testing by technician with interpretation and report by a qualified healthcare professional per hour"},{"code":"96120","display":"Neuropsychological testing by a computer with interpretation and report by a qualified healthcare professional"},{"code":"96121","display":"Neurobehavioral status examination by qualified health care professional with interpretation and report, additional 60 minutes"},{"code":"96125","display":"Standardized thought processing testing, interpretation, and report per hour\""},{"code":"96127","display":"Brief emotional or behavioral assessment"},{"code":"96130","display":"Psychological testing evaluation by qualified health care professional, first 60 minutes"},{"code":"96131","display":"Psychological testing evaluation by qualified health care professional, additional 60 minutes"},{"code":"96132","display":"Neuropsychological testing evaluation by qualified health care professional, first 60 minutes"},{"code":"96133","display":"Neuropsychological testing evaluation by qualified health care professional, additional 60 minutes"},{"code":"96136","display":"Psychological or neuropsychological test administration and scoring by qualified health care professional, first 30 minutes"},{"code":"96137","display":"Psychological or neuropsychological test administration and scoring by qualified health care professional, additional 30 minutes"},{"code":"96138","display":"Psychological or neuropsychological test administration and scoring by technician, first 30 minutes"},{"code":"96139","display":"Psychological or neuropsychological test administration and scoring by technician, additional 30 minutes"},{"code":"96146","display":"Psychological or neuropsychological test administration and scoring by single standardized instrument via electronic platform with automated result"},{"code":"96150","display":"Health and behavior assessment each 15 minutes"},{"code":"96151","display":"Health and behavior re-assessment each 15 minutes"},{"code":"96152","display":"Health and behavior intervention, individual each 15 minutes"},{"code":"96153","display":"Health and behavior intervention, group each 15 minutes"},{"code":"96154","display":"Health and behavior intervention, family and patient each 15 minutes"},{"code":"96155","display":"Health and behavior intervention, family each 15 minutes"},{"code":"96156","display":"Health behavior assessment, or re-assessment"},{"code":"96158","display":"Health behavior intervention, individual, face-to-face; initial 30 minutes"},{"code":"96159","display":"Health behavior intervention, individual, face-to-face; each additional 15 minutes"},{"code":"96160","display":"Administration and interpretation of patient-focused health risk assessment"},{"code":"96161","display":"Administration and interpretation of caregiver-focused health risk assessment"},{"code":"96902","display":"Microscopic examination of hairs to detect hair shaft abnormality"},{"code":"97001","display":"Physical therapy evaluation"},{"code":"97002","display":"Physical therapy re-evaluation"},{"code":"97003","display":"Occupational therapy evaluation"},{"code":"97004","display":"Occupational therapy re-evaluation"},{"code":"97005","display":"Athletic training evaluation"},{"code":"97006","display":"Athletic training re-evaluation"},{"code":"97010","display":"Application of hot or cold packs to 1 or more areas"},{"code":"97014","display":"Application of electrical stimulation to 1 or more areas, unattended by physical therapist"},{"code":"97016","display":"Application of blood vessel compression or decompression device to 1 or more areas"},{"code":"97018","display":"Application of hot wax bath to 1 or more areas"},{"code":"97022","display":"Application of whirlpool therapy to 1 or more areas"},{"code":"97024","display":"Application of heat wave therapy to 1 or more areas"},{"code":"97026","display":"Application of low energy heat (infrared) to 1 or more areas"},{"code":"97028","display":"Application of ultraviolet light to 1 or more areas"},{"code":"97032","display":"Application of electrical stimulation to 1 or more areas, each 15 minutes"},{"code":"97033","display":"Application of medication through skin using electrical current, each 15 minutes"},{"code":"97034","display":"Therapeutic hot and cold baths to 1 or more areas, each 15 minutes"},{"code":"97035","display":"Application of ultrasound to 1 or more areas, each 15 minutes"},{"code":"97039","display":"Physical medicine service or procedure"},{"code":"97110","display":"Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes"},{"code":"97112","display":"Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes"},{"code":"97113","display":"Water pool therapy with therapeutic exercises to 1 or more areas, each 15 minutes"},{"code":"97116","display":"Walking training to 1 or more areas, each 15 minutes"},{"code":"97124","display":"Therapeutic massage to 1 or more areas, each 15 minutes"},{"code":"97127","display":"One-on-one therapeutic interventions focused on thought processing and strategies to manage activities"},{"code":"97139","display":"Therapeutic procedure"},{"code":"97140","display":"Manual (physical) therapy techniques to 1 or more regions, each 15 minutes"},{"code":"97150","display":"Therapeutic procedures in a group setting"},{"code":"97151","display":"Behavior identification assessment by qualified health care professional, each 15 minutes"},{"code":"97152","display":"Behavior identification assessment by technician under direction of qualified health care professional, each 15 minutes"},{"code":"97153","display":"Adaptive behavior treatment by protocol, administered by technician under direction of qualified health care professional to one patient, each 15 minutes"},{"code":"97154","display":"Adaptive behavior treatment by protocol, administered by technician under direction of qualified health care professional to multiple patients, each 15 minutes"},{"code":"97155","display":"Adaptive behavior treatment with protocol modification administered by qualified health care professional to one patient, each 15 minutes"},{"code":"97156","display":"Family adaptive behavior treatment guidance by qualified health care professional (with or without patient present), each 15 minutes"},{"code":"97157","display":"Family adaptive behavior treatment guidance by qualified health care professional without patient present, each 15 minutes"},{"code":"97158","display":"Group adaptive behavior treatment with protocol modification administered by qualified health care professional to multiple patients, each 15 minutes"},{"code":"97161","display":"Evaluation of physical therapy, typically 20 minutes"},{"code":"97162","display":"Evaluation of physical therapy, typically 30 minutes"},{"code":"97163","display":"Evaluation of physical therapy, typically 45 minutes"},{"code":"97164","display":"Re-evaluation of physical therapy, typically 20 minutes"},{"code":"97165","display":"Evaluation of occupational therapy, typically 30 minutes"},{"code":"97166","display":"Evaluation of occupational therapy, typically 45 minutes"},{"code":"97167","display":"Evaluation of occupational therapy established plan of care, typically 60 minutes"},{"code":"97168","display":"Re-evaluation of occupational therapy established plan of care, typically 30 minutes"},{"code":"97169","display":"Evaluation of athletic training, typically 15 minutes"},{"code":"97170","display":"Evaluation of athletic training, typically 30 minutes"},{"code":"97171","display":"Evaluation of athletic training, typically 45 minutes"},{"code":"97172","display":"Re-evaluation of athletic training, typically 20 minutes"},{"code":"97530","display":"Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes"},{"code":"97532","display":"Development of cognitive skills to improve attention, memory, or problem solving, each 15 minutes"},{"code":"97533","display":"Sensory technique to enhance processing and adaptation to environmental demands, each 15 minutes"},{"code":"97535","display":"Self-care or home management training, each 15 minutes"},{"code":"97537","display":"Community or work reintegration training, each 15 minutes"},{"code":"97542","display":"Wheelchair management, each 15 minutes"},{"code":"97545","display":"Work hardening or conditioning, first 2 hours"},{"code":"97546","display":"Work hardening or conditioning"},{"code":"97750","display":"Physical performance test or measurement with report, each 15 minutes"},{"code":"97755","display":"Assistive technology assessment to enhance functional performance, each 15 minutes"},{"code":"97760","display":"Training in use of orthotics (supports, braces, or splints) for arms, legs and/or trunk, per 15 minutes"},{"code":"97761","display":"Training in use of prosthesis for arms and/or legs, per 15 minutes"},{"code":"97762","display":"Evaluation of orthotic or prosthetic use, each 15 minutes"},{"code":"97763","display":"Management and/or training in use of orthotics (supports, braces, or splints) for arms, legs, and/or trunk, per 15 minutes"},{"code":"97799","display":"Physical medicine or rehabilitation service or procedure"},{"code":"97810","display":"Acupuncture 1 or more needles, first 15 minutes"},{"code":"97811","display":"Acupuncture 1 or more needles"},{"code":"97813","display":"Acupuncture 1 or more needles with electrical stimulation, first 15 minutes"},{"code":"97814","display":"Acupuncture 1 or more needles with electrical stimulation and re-insertion of needles"},{"code":"98925","display":"Osteopathic manipulative treatment to 1-2 body regions"},{"code":"98926","display":"Osteopathic manipulative treatment to 3-4 body regions"},{"code":"98927","display":"Osteopathic manipulative treatment to 5-6 body regions"},{"code":"98928","display":"Osteopathic manipulative treatment to 7-8 body regions"},{"code":"98929","display":"Osteopathic manipulative treatment to 9-10 body regions"},{"code":"99026","display":"Hospital mandated on-call service in the hospital, each hour"},{"code":"99027","display":"Hospital mandated on-call service outside the hospital, each hour"},{"code":"99050","display":"Services provided in the office when the office is normally closed"},{"code":"99056","display":"Services provided out of the office at patient request"},{"code":"99058","display":"Services provided on an emergency basis in the office"},{"code":"99090","display":"Analysis of clinical data stored in computers"},{"code":"99091","display":"Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days"},{"code":"99170","display":"Examination of genital and anal region of child using an endoscope, suspected trauma"},{"code":"99201","display":"New patient office or other outpatient visit, typically 10 minutes"},{"code":"99202","display":"New patient office or other outpatient visit, typically 20 minutes"},{"code":"99203","display":"New patient office or other outpatient visit, typically 30 minutes"},{"code":"99204","display":"New patient office or other outpatient visit, typically 45 minutes"},{"code":"99205","display":"New patient office or other outpatient visit, typically 60 minutes"},{"code":"99211","display":"Established patient office or other outpatient visit, typically 5 minutes"},{"code":"99212","display":"Established patient office or other outpatient visit, typically 10 minutes"},{"code":"99213","display":"Established patient office or other outpatient visit, typically 15 minutes"},{"code":"99214","display":"Established patient office or other outpatient, visit typically 25 minutes"},{"code":"99215","display":"Established patient office or other outpatient, visit typically 40 minutes"},{"code":"99217","display":"Hospital observation care on day of discharge"},{"code":"99218","display":"Hospital observation care, typically 30 minutes"},{"code":"99219","display":"Hospital observation care, typically 50 minutes"},{"code":"99220","display":"Hospital observation care, typically 70 minutes"},{"code":"99221","display":"Initial hospital inpatient care, typically 30 minutes per day"},{"code":"99222","display":"Initial hospital inpatient care, typically 50 minutes per day"},{"code":"99223","display":"Initial hospital inpatient care, typically 70 minutes per day"},{"code":"99224","display":"Subsequent observation care, typically 15 minutes per day"},{"code":"99225","display":"Subsequent observation care, typically 25 minutes per day"},{"code":"99226","display":"Subsequent observation care, typically 35 minutes per day"},{"code":"99231","display":"Subsequent hospital inpatient care, typically 15 minutes per day"},{"code":"99232","display":"Subsequent hospital inpatient care, typically 25 minutes per day"},{"code":"99233","display":"Subsequent hospital inpatient care, typically 35 minutes per day"},{"code":"99234","display":"Hospital observation or inpatient care low severity, 40 minutes per day"},{"code":"99235","display":"Hospital observation or inpatient care moderate severity, 50 minutes per day"},{"code":"99236","display":"Hospital observation or inpatient care high severity, 55 minutes per day"},{"code":"99238","display":"Hospital discharge day management, 30 minutes or less"},{"code":"99239","display":"Hospital discharge day management, more than 30 minutes"},{"code":"99241","display":"Patient office consultation, typically 15 minutes"},{"code":"99242","display":"Patient office consultation, typically 30 minutes"},{"code":"99243","display":"Patient office consultation, typically 40 minutes"},{"code":"99244","display":"Patient office consultation, typically 60 minutes"},{"code":"99245","display":"Patient office consultation, typically 80 minutes"},{"code":"99251","display":"Inpatient hospital consultation, typically 20 minutes"},{"code":"99252","display":"Inpatient hospital consultation, typically 40 minutes"},{"code":"99253","display":"Inpatient hospital consultation, typically 55 minutes"},{"code":"99254","display":"Inpatient hospital consultation, typically 80 minutes"},{"code":"99255","display":"Inpatient hospital consultation, typically 110 minutes"},{"code":"99281","display":"Emergency department visit, self limited or minor problem"},{"code":"99282","display":"Emergency department visit, low to moderately severe problem"},{"code":"99283","display":"Emergency department visit, moderately severe problem"},{"code":"99284","display":"Emergency department visit, problem of high severity"},{"code":"99291","display":"Critical care delivery critically ill or injured patient, first 30-74 minutes"},{"code":"99363","display":"Anti-clotting management for patient taking blood thinner, first 90 day therapy"},{"code":"99364","display":"Anti-clotting management for patient taking blood thinner"},{"code":"99366","display":"Medical team conference with patient and/or family, and nonphysician health care professionals, 30 minutes or more"},{"code":"99367","display":"Medical team conference with physician, 30 minutes or more"},{"code":"99368","display":"Medical team conference with nonphysician health care professionals, 30 minutes or more"},{"code":"99374","display":"Physician supervision of patient home health agency services, 15-29 minutes per month"},{"code":"99375","display":"Physician supervision of patient home health agency services, 30 minutes or more per month"},{"code":"99377","display":"Physician supervision of patient hospice services, 15-29 minutes per month"},{"code":"99378","display":"Physician supervision of patient hospice services, 30 minutes or more per month"},{"code":"99379","display":"Supervision of nursing facility patient services, 15-29 minutes per month"},{"code":"99380","display":"Supervision of nursing facility patient services, 30 minutes or more per month"},{"code":"99381","display":"Initial new patient preventive medicine evaluation infant younger than 1 year"},{"code":"99382","display":"Initial new patient preventive medicine evaluation, age 1 through 4 years"},{"code":"99383","display":"Initial new patient preventive medicine evaluation, age 5 through 11 years"},{"code":"99384","display":"Initial new patient preventive medicine evaluation, age 12 through 17 years"},{"code":"99385","display":"Initial new patient preventive medicine evaluation age 18-39 years"},{"code":"99386","display":"Initial new patient preventive medicine evaluation age 40-64 years"},{"code":"99387","display":"Initial new patient preventive medicine evaluation, age 65 years and older"},{"code":"99391","display":"Established patient periodic preventive medicine examination infant younger than 1 year"},{"code":"99392","display":"Established patient periodic preventive medicine examination, age 1 through 4 years"},{"code":"99393","display":"Established patient periodic preventive medicine examination, age 5 through 11 years"},{"code":"99394","display":"Established patient periodic preventive medicine examination, age 12 through 17 years"},{"code":"99395","display":"Established patient periodic preventive medicine examination age 18-39 years"},{"code":"99396","display":"Established patient periodic preventive medicine examination age 40-64 years"},{"code":"99397","display":"Established patient periodic preventive medicine examination, age 65 years and older"},{"code":"99401","display":"Preventive medicine counseling, approximately 15 minutes"},{"code":"99402","display":"Preventive medicine counseling, approximately 30 minutes"},{"code":"99403","display":"Preventive medicine counseling, approximately 45 minutes"},{"code":"99404","display":"Preventive medicine counseling, approximately 60 minutes"},{"code":"99406","display":"Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes"},{"code":"99407","display":"Smoking and tobacco use intensive counseling, greater than 10 minutes"},{"code":"99408","display":"Alcohol and/or substance abuse screening and intervention, 15-30 minutes"},{"code":"99409","display":"Alcohol and/or substance abuse screening and intervention, greater than 30 minutes"},{"code":"99411","display":"Group preventive medicine counseling, approximately 30 minutes"},{"code":"99412","display":"Group preventive medicine counseling, approximately 60 minutes"},{"code":"99420","display":"Administration and interpretation of health risk assessment instrument"},{"code":"99421","display":"Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes"},{"code":"99422","display":"Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes"},{"code":"99423","display":"Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes"},{"code":"99429","display":"Preventive medicine service"},{"code":"99441","display":"Physician telephone patient service, 5-10 minutes of medical discussion"},{"code":"99442","display":"Physician telephone patient service, 11-20 minutes of medical discussion"},{"code":"99443","display":"Physician telephone patient service, 21-30 minutes of medical discussion"},{"code":"99444","display":"Physician or health care professional evaluation and management of patient care by internet (email) related to visit within previous 7 days"},{"code":"99446","display":"Telephone or internet assessment and management service provided byconsultative physician with verbal and written report, 5-10 minutes of medical consultative discussion and review"},{"code":"99447","display":"Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 11-20 minutes of medical consultative discussion and review"},{"code":"99448","display":"Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review"},{"code":"99449","display":"Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review"},{"code":"99450","display":"Basic life and/or disability examination"},{"code":"99451","display":"Telephone or internet assessment and management service provided by consultative physician with written report, 5 minutes or more of medical consultative discussion and review"},{"code":"99452","display":"Telephone or internet referral service, 30 minutes"},{"code":"99453","display":"Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment"},{"code":"99454","display":"Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days"},{"code":"99455","display":"Work-related or medical disability examination"},{"code":"99456","display":"Work-related or medical disability examination"},{"code":"99457","display":"Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes"},{"code":"99458","display":"Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute"},{"code":"99460","display":"Initial hospital or birthing center newborn infant evaluation and management per day"},{"code":"99461","display":"Initial newborn infant evaluation and management per day"},{"code":"99462","display":"Subsequent inpatient hospital care of newborn per day"},{"code":"99463","display":"Initial inpatient hospital or birthing center same date care and discharge of newborn"},{"code":"99468","display":"Initial inpatient hospital critical care of newborn, 28 days of age or younger, per day"},{"code":"99469","display":"Subsequent inpatient hospital critical care of newborn, 28 days of age or younger, per day"},{"code":"99471","display":"Initial inpatient hospital critical care of infant or young child, 29 days through 24 months of age, per day"},{"code":"99472","display":"Subsequent inpatient hospital critical care of infant or young child, 29 days through 24 months of age, per day"},{"code":"99473","display":"Self-measured blood pressure; patient education/training and device calibration"},{"code":"99474","display":"Self-measured blood pressure measurements"},{"code":"99475","display":"Initial inpatient hospital critical care of infant or young child, 2 through 5 years of age, per day"},{"code":"99476","display":"Subsequent inpatient hospital critical care of infant or young child, 2 through 5 years of age, per day"},{"code":"99477","display":"Initial intensive care of newborn, 28 days of age or younger, per day"},{"code":"99478","display":"Subsequent intensive care of recovering low birth weight infant, per day"},{"code":"99479","display":"Subsequent intensive care of recovering low birth weight infant, per day"},{"code":"99480","display":"Subsequent intensive care of recovering low birth weight infant, per day"},{"code":"99483","display":"Assessment of and care planning for patient with impaired thought processing, typically 50 minutes"},{"code":"99484","display":"Care management services for behavioral health conditions, at least 20 minutes clinical staff time"},{"code":"99487","display":"Complex chronic care management services 60 minutes clinical staff time"},{"code":"99488","display":"Complex chronic care coordination services, first hour with 1 face-to-face visit, per calendar month"},{"code":"99489","display":"Complex chronic care management services each additional 30 minutes clinical staff time"},{"code":"99490","display":"Chronic care management services at least 20 minutes per calendar month"},{"code":"99491","display":"Chronic care management services by qualified health care professional, 30 minutes or more per calendar month"},{"code":"99492","display":"Initial psychiatric collaborative care management, first 70 minutes in the first calendar month"},{"code":"99493","display":"Subsequent psychiatric collaborative care management, first 60 minutes in subsequent month of behavioral health care manager activities"},{"code":"99494","display":"Initial or subsequent psychiatric collaborative care management, additional 30 minutes in the first calendar month"},{"code":"99495","display":"Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge"},{"code":"99496","display":"Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge"},{"code":"99497","display":"Advance care planning by the physician or other qualified health care professional"},{"code":"99498","display":"Advance care planning by the physician or other qualified health care professional"},{"code":"99499","display":"Evaluation and management service"},{"code":"99605","display":"Medication therapy management services to a new patient provided by a pharmacist 15 minutes"},{"code":"99606","display":"Medication therapy management services to an established patient provided by a pharmacist 15 minutes"},{"code":"99607","display":"Medication therapy management services provided by a pharmacist"},{"code":"C1749","display":"Endoscope, retrograde imaging/illumination colonoscope device (implantable)"},{"code":"C2638","display":"Brachytherapy source, stranded, iodine-125, per source"},{"code":"C2639","display":"Brachytherapy source, non-stranded, iodine-125, per source"},{"code":"C2640","display":"Brachytherapy source, stranded, palladium-103, per source"},{"code":"C2641","display":"Brachytherapy source, non-stranded, palladium-103, per source"},{"code":"C2642","display":"Brachytherapy source, stranded, cesium-131, per source"},{"code":"C2643","display":"Brachytherapy source, non-stranded, cesium-131, per source"},{"code":"C2644","display":"Brachytherapy source, cesium-131 chloride solution, per millicurie"},{"code":"C2645","display":"Brachytherapy planar source, palladium-103, per square millimeter"},{"code":"C2698","display":"Brachytherapy source, stranded, not otherwise specified, per source"},{"code":"C2699","display":"Brachytherapy source, non-stranded, not otherwise specified, per source"},{"code":"C8937","display":"Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)"},{"code":"C9724","display":"Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy"},{"code":"C9725","display":"Placement of endorectal intracavitary applicator for high intensity brachytherapy"},{"code":"C9726","display":"Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure"},{"code":"C9727","display":"Insertion of implants into the soft palate; minimum of three implants"},{"code":"C9728","display":"Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple"},{"code":"C9733","display":"Non-ophthalmic fluorescent vascular angiography"},{"code":"C9734","display":"Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance"},{"code":"C9735","display":"Anoscopy; with directed submucosal injection(s), any substance"},{"code":"C9738","display":"Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)"},{"code":"G0008","display":"Administration of influenza virus vaccine"},{"code":"G0009","display":"Administration of pneumococcal vaccine"},{"code":"G0010","display":"Administration of hepatitis b vaccine"},{"code":"G0071","display":"Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only"},{"code":"G0104","display":"Colorectal cancer screening; flexible sigmoidoscopy"},{"code":"G0105","display":"Colorectal cancer screening; colonoscopy on individual at high risk"},{"code":"G0121","display":"Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk"},{"code":"G0124","display":"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician"},{"code":"G0129","display":"Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization treatment program, per session (45 minutes or more)"},{"code":"G0130","display":"Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)"},{"code":"G0141","display":"Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician"},{"code":"G0143","display":"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision"},{"code":"G0144","display":"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision"},{"code":"G0145","display":"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision"},{"code":"G0147","display":"Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision"},{"code":"G0148","display":"Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening"},{"code":"G0163","display":"Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient\u0027s condition, each 15 minutes (the change in the patient\u0027s condition requires skilled nursing personnel to identify and evaluate the patient\u0027s need for possible modification of treatment in the home health or hospice setting)"},{"code":"G0164","display":"Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes"},{"code":"G0202","display":"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed"},{"code":"G0204","display":"Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral"},{"code":"G0206","display":"Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral"},{"code":"G0219","display":"Pet imaging whole body; melanoma for non-covered indications"},{"code":"G0235","display":"Pet imaging, any site, not otherwise specified"},{"code":"G0246","display":"Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education"},{"code":"G0250","display":"Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests"},{"code":"G0251","display":"Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment"},{"code":"G0252","display":"Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)"},{"code":"G0289","display":"Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee"},{"code":"G0296","display":"Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)"},{"code":"G0339","display":"Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment"},{"code":"G0340","display":"Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment"},{"code":"G0341","display":"Percutaneous islet cell transplant, includes portal vein catheterization and infusion"},{"code":"G0342","display":"Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion"},{"code":"G0343","display":"Laparotomy for islet cell transplant, includes portal vein catheterization and infusion"},{"code":"G0364","display":"Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service"},{"code":"G0380","display":"Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"},{"code":"G0381","display":"Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"},{"code":"G0382","display":"Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"},{"code":"G0383","display":"Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"},{"code":"G0384","display":"Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"},{"code":"G0390","display":"Trauma response team associated with hospital critical care service"},{"code":"G0396","display":"Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes"},{"code":"G0397","display":"Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes"},{"code":"G0398","display":"Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation"},{"code":"G0399","display":"Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation"},{"code":"G0400","display":"Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels"},{"code":"G0402","display":"Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment"},{"code":"G0403","display":"Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report"},{"code":"G0404","display":"Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination"},{"code":"G0405","display":"Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination"},{"code":"G0406","display":"Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth"},{"code":"G0407","display":"Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth"},{"code":"G0408","display":"Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth"},{"code":"G0409","display":"Social work and psychological services, directly relating to and/or furthering the patient\u0027s rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)"},{"code":"G0410","display":"Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes"},{"code":"G0411","display":"Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes"},{"code":"G0422","display":"Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session"},{"code":"G0423","display":"Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session"},{"code":"G0425","display":"Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth"},{"code":"G0426","display":"Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth"},{"code":"G0427","display":"Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth"},{"code":"G0428","display":"Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)"},{"code":"G0431","display":"Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter"},{"code":"G0434","display":"Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter"},{"code":"G0436","display":"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes"},{"code":"G0437","display":"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes"},{"code":"G0438","display":"Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit"},{"code":"G0439","display":"Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit"},{"code":"G0442","display":"Annual alcohol misuse screening, 15 minutes"},{"code":"G0443","display":"Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes"},{"code":"G0444","display":"Annual depression screening, 15 minutes"},{"code":"G0445","display":"High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes"},{"code":"G0446","display":"Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes"},{"code":"G0447","display":"Face-to-face behavioral counseling for obesity, 15 minutes"},{"code":"G0448","display":"Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing"},{"code":"G0451","display":"Development testing, with interpretation and report, per standardized instrument form"},{"code":"G0452","display":"Molecular pathology procedure; physician interpretation and report"},{"code":"G0454","display":"Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist"},{"code":"G0458","display":"Low dose rate (ldr) prostate brachytherapy services, composite rate"},{"code":"G0459","display":"Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy"},{"code":"G0461","display":"Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain"},{"code":"G0462","display":"Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)"},{"code":"G0463","display":"Hospital outpatient clinic visit for assessment and management of a patient"},{"code":"G0466","display":"Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit"},{"code":"G0467","display":"Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit"},{"code":"G0468","display":"Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv"},{"code":"G0469","display":"Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit"},{"code":"G0470","display":"Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit"},{"code":"G0473","display":"Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes"},{"code":"G0475","display":"Hiv antigen/antibody, combination assay, screening"},{"code":"G0476","display":"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"},{"code":"G0501","display":"Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)"},{"code":"G0502","display":"Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies"},{"code":"G0503","display":"Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient\u0027s mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment"},{"code":"G0504","display":"Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure); (use g0504 in conjunction with g0502, g0503)"},{"code":"G0505","display":"Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home"},{"code":"G0506","display":"Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)"},{"code":"G0507","display":"Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team"},{"code":"G0508","display":"Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth"},{"code":"G0509","display":"Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth"},{"code":"G0511","display":"Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month"},{"code":"G0512","display":"Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month"},{"code":"G0513","display":"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)"},{"code":"G0514","display":"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)"},{"code":"G0515","display":"Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes"},{"code":"G2010","display":"Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment"},{"code":"G2011","display":"Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes"},{"code":"G2012","display":"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion"},{"code":"G6001","display":"Ultrasonic guidance for placement of radiation therapy fields"},{"code":"G6002","display":"Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy"},{"code":"G6003","display":"Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev"},{"code":"G6004","display":"Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev"},{"code":"G6005","display":"Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev"},{"code":"G6006","display":"Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater"},{"code":"G6007","display":"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev"},{"code":"G6008","display":"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev"},{"code":"G6009","display":"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev"},{"code":"G6010","display":"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater"},{"code":"G6011","display":"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev"},{"code":"G6012","display":"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev"},{"code":"G6013","display":"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev"},{"code":"G6014","display":"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater"},{"code":"G6015","display":"Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session"},{"code":"G6016","display":"Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session"},{"code":"G6017","display":"Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment"},{"code":"G6018","display":"Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)"},{"code":"G6019","display":"Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique"},{"code":"G6020","display":"Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)"},{"code":"G6022","display":"Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique"},{"code":"G6023","display":"Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)"},{"code":"G6024","display":"Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique"},{"code":"G6025","display":"Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)"},{"code":"G6027","display":"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed"},{"code":"G6028","display":"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)"},{"code":"G9156","display":"Evaluation for wheelchair requiring face to face visit with physician"},{"code":"G9157","display":"Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes"},{"code":"H0001","display":"Alcohol and/or drug assessment"},{"code":"H0002","display":"Behavioral health screening to determine eligibility for admission to treatment program"},{"code":"H0003","display":"Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs"},{"code":"H0004","display":"Behavioral health counseling and therapy, per 15 minutes"},{"code":"H0005","display":"Alcohol and/or drug services; group counseling by a clinician"},{"code":"H0006","display":"Alcohol and/or drug services; case management"},{"code":"H0007","display":"Alcohol and/or drug services; crisis intervention (outpatient)"},{"code":"H0008","display":"Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)"},{"code":"H0009","display":"Alcohol and/or drug services; acute detoxification (hospital inpatient)"},{"code":"H0010","display":"Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)"},{"code":"H0011","display":"Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)"},{"code":"H0012","display":"Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)"},{"code":"H0013","display":"Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)"},{"code":"H0014","display":"Alcohol and/or drug services; ambulatory detoxification"},{"code":"H0015","display":"Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education"},{"code":"H0016","display":"Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)"},{"code":"H0017","display":"Behavioral health; residential (hospital residential treatment program), without room and board, per diem"},{"code":"H0018","display":"Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem"},{"code":"H0019","display":"Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem"},{"code":"H0020","display":"Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"},{"code":"H0021","display":"Alcohol and/or drug training service (for staff and personnel not employed by providers)"},{"code":"H0022","display":"Alcohol and/or drug intervention service (planned facilitation)"},{"code":"H0023","display":"Behavioral health outreach service (planned approach to reach a targeted population)"},{"code":"H0024","display":"Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)"},{"code":"H0025","display":"Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)"},{"code":"H0026","display":"Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)"},{"code":"H0027","display":"Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)"},{"code":"H0028","display":"Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment"},{"code":"H0029","display":"Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)"},{"code":"H0030","display":"Behavioral health hotline service"},{"code":"H0031","display":"Mental health assessment, by non-physician"},{"code":"H0032","display":"Mental health service plan development by non-physician"},{"code":"H0033","display":"Oral medication administration, direct observation"},{"code":"H0034","display":"Medication training and support, per 15 minutes"},{"code":"H0035","display":"Mental health partial hospitalization, treatment, less than 24 hours"},{"code":"H0036","display":"Community psychiatric supportive treatment, face-to-face, per 15 minutes"},{"code":"H0037","display":"Community psychiatric supportive treatment program, per diem"},{"code":"H0038","display":"Self-help/peer services, per 15 minutes"},{"code":"H0039","display":"Assertive community treatment, face-to-face, per 15 minutes"},{"code":"H0040","display":"Assertive community treatment program, per diem"},{"code":"H0045","display":"Respite care services, not in the home, per diem"},{"code":"H0046","display":"Mental health services, not otherwise specified"},{"code":"H0047","display":"Alcohol and/or other drug abuse services, not otherwise specified"},{"code":"H0048","display":"Alcohol and/or other drug testing: collection and handling only, specimens other than blood"},{"code":"H0049","display":"Alcohol and/or drug screening"},{"code":"H0050","display":"Alcohol and/or drug services, brief intervention, per 15 minutes"},{"code":"H1000","display":"Prenatal care, at-risk assessment"},{"code":"H1001","display":"Prenatal care, at-risk enhanced service; antepartum management"},{"code":"H1002","display":"Prenatal care, at risk enhanced service; care coordination"},{"code":"H1003","display":"Prenatal care, at-risk enhanced service; education"},{"code":"H1004","display":"Prenatal care, at-risk enhanced service; follow-up home visit"},{"code":"H1005","display":"Prenatal care, at-risk enhanced service package (includes h1001-h1004)"},{"code":"H1010","display":"Non-medical family planning education, per session"},{"code":"H1011","display":"Family assessment by licensed behavioral health professional for state defined purposes"},{"code":"H2000","display":"Comprehensive multidisciplinary evaluation"},{"code":"H2001","display":"Rehabilitation program, per 1/2 day"},{"code":"H2010","display":"Comprehensive medication services, per 15 minutes"},{"code":"H2011","display":"Crisis intervention service, per 15 minutes"},{"code":"H2012","display":"Behavioral health day treatment, per hour"},{"code":"H2013","display":"Psychiatric health facility service, per diem"},{"code":"H2014","display":"Skills training and development, per 15 minutes"},{"code":"H2015","display":"Comprehensive community support services, per 15 minutes"},{"code":"H2016","display":"Comprehensive community support services, per diem"},{"code":"H2017","display":"Psychosocial rehabilitation services, per 15 minutes"},{"code":"H2018","display":"Psychosocial rehabilitation services, per diem"},{"code":"H2019","display":"Therapeutic behavioral services, per 15 minutes"},{"code":"H2020","display":"Therapeutic behavioral services, per diem"},{"code":"H2025","display":"Ongoing support to maintain employment, per 15 minutes"},{"code":"H2026","display":"Ongoing support to maintain employment, per diem"},{"code":"H2027","display":"Psychoeducational service, per 15 minutes"},{"code":"H2028","display":"Sexual offender treatment service, per 15 minutes"},{"code":"H2029","display":"Sexual offender treatment service, per diem"},{"code":"H2030","display":"Mental health clubhouse services, per 15 minutes"},{"code":"H2031","display":"Mental health clubhouse services, per diem"},{"code":"H2032","display":"Activity therapy, per 15 minutes"},{"code":"H2033","display":"Multisystemic therapy for juveniles, per 15 minutes"},{"code":"H2034","display":"Alcohol and/or drug abuse halfway house services, per diem"},{"code":"H2035","display":"Alcohol and/or other drug treatment program, per hour"},{"code":"H2036","display":"Alcohol and/or other drug treatment program, per diem"},{"code":"H2037","display":"Developmental delay prevention activities, dependent child of client, per 15 minutes"},{"code":"M0064","display":"Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders"},{"code":"P3000","display":"Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision"},{"code":"P3001","display":"Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician"},{"code":"P7001","display":"Culture, bacterial, urine; quantitative, sensitivity study"},{"code":"Q0035","display":"Cardiokymography"},{"code":"Q0091","display":"Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory"},{"code":"Q0092","display":"Set-up portable x-ray equipment"},{"code":"Q0111","display":"Wet mounts, including preparations of vaginal, cervical or skin specimens"},{"code":"Q0112","display":"All potassium hydroxide (koh) preparations"},{"code":"Q0113","display":"Pinworm examinations"},{"code":"Q0115","display":"Post-coital direct, qualitative examinations of vaginal or cervical mucous"},{"code":"Q2034","display":"Influenza virus vaccine, split virus, for intramuscular use (agriflu)"},{"code":"Q2035","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"},{"code":"Q2036","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"},{"code":"Q2037","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"},{"code":"Q2038","display":"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"},{"code":"Q2039","display":"Influenza virus vaccine, not otherwise specified"},{"code":"Q5010","display":"Hospice home care provided in a hospice facility"},{"code":"S0195","display":"Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine"},{"code":"S0199","display":"Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs"},{"code":"S0260","display":"History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)"},{"code":"S0302","display":"Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)"},{"code":"S0311","display":"Comprehensive management and care coordination for advanced illness, per calendar month"},{"code":"S0353","display":"Treatment planning and care coordination management for cancer, initial treatment"},{"code":"S0354","display":"Treatment planning and care coordination management for cancer, established patient with a change of regimen"},{"code":"S0601","display":"Screening proctoscopy"},{"code":"S0610","display":"Annual gynecological examination, new patient"},{"code":"S0612","display":"Annual gynecological examination, established patient"},{"code":"S0613","display":"Annual gynecological examination; clinical breast examination without pelvic evaluation"},{"code":"S0622","display":"Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)"},{"code":"S2053","display":"Transplantation of small intestine and liver allografts"},{"code":"S2054","display":"Transplantation of multivisceral organs"},{"code":"S2055","display":"Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor"},{"code":"S2060","display":"Lobar lung transplantation"},{"code":"S2065","display":"Simultaneous pancreas kidney transplantation"},{"code":"S2102","display":"Islet cell tissue transplant from pancreas; allogeneic"},{"code":"S2103","display":"Adrenal tissue transplant to brain"},{"code":"S2117","display":"Arthroereisis, subtalar"},{"code":"S2140","display":"Cord blood harvesting for transplantation, allogeneic"},{"code":"S2152","display":"Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition"},{"code":"S2260","display":"Induced abortion, 17 to 24 weeks"},{"code":"S2265","display":"Induced abortion, 25 to 28 weeks"},{"code":"S2266","display":"Induced abortion, 29 to 31 weeks"},{"code":"S2267","display":"Induced abortion, 32 weeks or greater"},{"code":"S2300","display":"Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy"},{"code":"S3904","display":"Masters two step"},{"code":"S4011","display":"In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development"},{"code":"S4013","display":"Complete cycle, gamete intrafallopian transfer (gift), case rate"},{"code":"S4014","display":"Complete cycle, zygote intrafallopian transfer (zift), case rate"},{"code":"S4015","display":"Complete in vitro fertilization cycle, not otherwise specified, case rate"},{"code":"S4016","display":"Frozen in vitro fertilization cycle, case rate"},{"code":"S4017","display":"Incomplete cycle, treatment cancelled prior to stimulation, case rate"},{"code":"S4018","display":"Frozen embryo transfer procedure cancelled before transfer, case rate"},{"code":"S4020","display":"In vitro fertilization procedure cancelled before aspiration, case rate"},{"code":"S4021","display":"In vitro fertilization procedure cancelled after aspiration, case rate"},{"code":"S4022","display":"Assisted oocyte fertilization, case rate"},{"code":"S4023","display":"Donor egg cycle, incomplete, case rate"},{"code":"S4025","display":"Donor services for in vitro fertilization (sperm or embryo), case rate"},{"code":"S4026","display":"Procurement of donor sperm from sperm bank"},{"code":"S4028","display":"Microsurgical epididymal sperm aspiration (mesa)"},{"code":"S4035","display":"Stimulated intrauterine insemination (iui), case rate"},{"code":"S4037","display":"Cryopreserved embryo transfer, case rate"},{"code":"S4040","display":"Monitoring and storage of cryopreserved embryos, per 30 days"},{"code":"S4042","display":"Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle"},{"code":"S5190","display":"Wellness assessment, performed by non-physician"},{"code":"S8030","display":"Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy"},{"code":"S8055","display":"Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)"},{"code":"S8080","display":"Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical"},{"code":"S8085","display":"Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)"},{"code":"S8930","display":"Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient"},{"code":"S8940","display":"Equestrian/hippotherapy, per session"},{"code":"S8950","display":"Complex lymphedema therapy, each 15 minutes"},{"code":"S8990","display":"Physical or manipulative therapy performed for maintenance rather than restoration"},{"code":"S9015","display":"Automated eeg monitoring"},{"code":"S9025","display":"Omnicardiogram/cardiointegram"},{"code":"S9110","display":"Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month"},{"code":"S9117","display":"Back school, per visit"},{"code":"S9152","display":"Speech therapy, re-evaluation"},{"code":"S9472","display":"Cardiac rehabilitation program, non-physician provider, per diem"},{"code":"S9473","display":"Pulmonary rehabilitation program, non-physician provider, per diem"},{"code":"S9475","display":"Ambulatory setting substance abuse treatment or detoxification services, per diem"},{"code":"S9476","display":"Vestibular rehabilitation program, non-physician provider, per diem"},{"code":"S9480","display":"Intensive outpatient psychiatric services, per diem"},{"code":"S9484","display":"Crisis intervention mental health services, per hour"},{"code":"S9485","display":"Crisis intervention mental health services, per diem"},{"code":"T1006","display":"Alcohol and/or substance abuse services, family/couple counseling"},{"code":"T1007","display":"Alcohol and/or substance abuse services, treatment plan development and/or modification"},{"code":"T1009","display":"Child sitting services for children of the individual receiving alcohol and/or substance abuse services"},{"code":"T1010","display":"Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)"},{"code":"T1012","display":"Alcohol and/or substance abuse services, skills development"},{"code":"T1015","display":"Clinic visit/encounter, all-inclusive"},{"code":"T1040","display":"Medicaid certified community behavioral health clinic services, per diem"},{"code":"T1041","display":"Medicaid certified community behavioral health clinic services, per month"},{"code":"T2048","display":"Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem"},{"code":"V5362","display":"Speech screening"},{"code":"V5363","display":"Language screening"},{"code":"V5364","display":"Dysphagia screening"}]}]}}